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ABSTRACT 
 
CONSTITUTIONALIZING HEALTH: 
RIGHTS, DEMOCRACY AND THE POLITICAL ECONOMY OF HEALTH POLICY 
 
Matthew M. Kavanagh 
 
  Devesh Kapur     
Jennifer Prah Ruger 
 
In recent decades there has been an increasing trend toward “constitutionalizing” health—
identifying health as a right in national constitutions. Today more than half of written constitutions 
in the world contain such a right. Whether that is good, bad, or immaterial for the production of 
population health, however, is much debated. Does constitutionalization improve wellbeing or 
might it simply distract from or distort good health policy? This dissertation uses a nested analysis 
that pairs a large-N statistical analysis of 40 years of global health data with in-depth interviews 
with over 165 policymakers, activists, elected officials, lawyers, and judges in South Africa, India, 
Malawi, and Thailand. Empirical evidence shows that constitutionalizing health is a significant 
development in the institutions of health governance and can contribute to improved wellbeing. 
Over forty years of global health data, we can observe a small but significant health dividend for 
countries that have adopted the right to health, when controlling for the major alternative 
explanations of cross-national variation in mortality. Tracing health policy issues in South Africa 
and India reveals a right that operates as a “policy anchor”—tying health to the fundamental 
national political bargain and providing an innovation in the institutions of governance that helps 
policy entrepreneurs gain a foothold from which to drive policy to expand health capabilities. 
Shadow cases in Thailand and Malawi show that this shift can matter even without judicial 
intervention but depends on sufficient support structure to enable the full institutionalization of 
health as a right. These findings contribute to literature on law and rights, sharpen models of the 
public policy process, and respond to the need to better understanding the broader set of 
institutions in the political economy of development that drive improvements in population health. 
In a broader context, this study suggests that constitution-writing is health policymaking. Greater 
attention to constitutions and the process of institutionalizing rights is warranted for those engaged 
in global health, with implications for the U.S. and other countries of the global North as well. 
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CHAPTER 1: INTRODUCTION 
 
 
 
 
 In 2005, democratic South Africa’s African National Congress—the party of liberation and 
avowed social democracy—was presiding over strong economic growth and dismantling racial 
hierarchies. Together these factors should have yielded a time of improving health and health policy. 
But in fact ANC leaders were refusing to roll out AIDS treatment despite aid and scientific 
consensus, costing the country an estimated 3.8 million “person years” over five years.1 It was only 
when lawyers, social movement actors, and the courts mobilized the country’s constitutional right 
to health that policy was rewritten and a robust AIDS response began in earnest. Today, South 
Africa’s infant mortality is dropping and life expectancy is increasing, in considerable part because 
of that move.  
																																																						
1 Chigwedere et al. 2008. 
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 A decade later, the Indian government of Narendra Modi declared its intention to pass 
legislation to deepen the institutionalization of health as a right in India’s legal foundations—
following South Africa’s path toward constitutionalizing health. In the final Health Policy, however, 
this idea was abandoned. 
Did the Modi government miss an opportunity to improve public health or was it wise to 
avoid the move toward constitutionalization? Is there any reason to believe that casting health as a 
right actually matters for the wellbeing of populations and, if so, in what ways? Or is that too high 
a hope in a world in which the law is more often a tool of the powerful and where judges, after all, 
cannot order improvements to the health of individuals or groups in society.  
This dissertation makes the case that the right to health can make a difference for health 
outcomes. “Constitutionalizing” health—casting it as an enforceable right in the central legal 
bargain governing the state—can contribute toward improvements in population health. A 
constitutionally enshrined right to health (RtH), in the data analyzed here, is linked to both better 
health outcomes and improved health service delivery.  This relationship relies on the ways in which 
constitutions can shift the political economy of health policy—the structures of decision-making, 
power relationships, and ideas that shape the distributive politics of health. It is not that judges have 
hit on brilliant jurisprudential logic to address intractable health problems where health experts fail. 
It is also not uniformly beneficial, with some examples where rights do not live up to their promise. 
On balance, though, this dissertation shows constitutionalization as a political process that expands 
the venues of policymaking, opens previously closed policy processes, and shifts the terms of debate 
in ways that can be particularly positive for a set of issues involving complex negotiations over 
resources, regulation, and access. The core contention here is that constitutionalization shifts the 
institutions governing health in a country. My argument advances the burgeoning comparative 
literature on institutions and development and provides particular insights on institutional change 
and its consequences. 
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In the contemporary world, rights bring both an ideational framework and a distinct set of 
actors to a given policy arena. There is no guarantee, however, that this will improve matters. 
Indeed, there is reason to be wary of overly-individualist frameworks and inexpert judges in an 
arena of complex, policy-centric decisions about contentious resource allocation issues. Saving a 
life with an expensive new medicine, for example, could doom many more to early mortality if it 
undermines the ability of the health system to procure vaccines. Setting minimum benefits for 
private health insurance schemes could improve access to basic medical care, but might trigger 
price increases that deny others coverage altogether. With such complex ethical and policy 
questions, it is reasonable to be skeptical that what is written in the constitution will have any 
significant effect on aggregate levels of wellbeing or worry that inexpert judges will actually distort 
public health policy and undermine overall health. Empirical evidence, however, suggests greater 
optimism. As I show in the evidence here, following South Africa’s lead toward 
constitutionalization can prove distinct benefit to long lives and pro-health cycles of policymaking.  
 
Constitution Writing as Public Health Policy 
Part of the motivation for this inquiry is that constitutionalization of health is increasingly 
common, as figure 1.1 illustrates. Before the 1940s, health did not figure in the set of rights 
embodied in national constitutions. That began to change in the post-war period and, in recent 
decades, not only has the number of written constitutions in the world expanded rapidly, so too 
has the portion that include a facially-enforceable right to health. In 1970 just 17% of written 
constitutions had an explicit right to health, but by 2010 that number grew to 51%. The norms 
change is clearer still by looking at the choices made by the drafters of new constitutions: In the 
decade of the 1970s only 35% of the over three hundred new constitutions written included a right 
to health, but it was included in 64% of new constitutions in both the 1990s and 2000s. 
U.S. constitutional longevity can encourage thinking of constitution-making as a rare and 
rarified activity. In reality, however, the average life expectancy of a national constitution is just 19 
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years.2 In any given year several new or significantly revised constitutions are being drafted and 
writers must decide what to include. The right to health has joined the “menu” of oft-adopted 
constitutional provisions, though there is still significant variation in the decision whether to adopt. 
While the South African constitution drafters included a right to health in 1996, the Nigerian 
drafters did not in 1999. When the newly created country of Kosovo wrote its constitution in 2008 
drafters opted not to include a specific right to health, but drafters in Timor-Leste did in 2002. 
Grappling with conflict, the Democratic Republic of Congo’s leaders chose a different 
constitutional path when they included a right to health in their 2011 revised constitution than did 
South Sudan the same year. Finland, with world’s lowest under-5 mortality rate, left the right to 
health out of both the constitution it approved in 1999 and the major amendments of 2011, even as 
Hungary’s 2011 constitution included such a right.  
																																																						
2 Elkins, Ginsburg, and Melton 2009. 
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In this context, the question of whether constitutionalizing health has any affect at all on 
population wellbeing is a significant one. If the right to health can be beneficial, as I suggest, then 
constitution making is health policymaking and should be of significant interest to public health 
experts, officials, and scholars. So too if putting health in rights terms actually distorts good health 
policy and undermines wellbeing—in which case a great many countries are being led down the 
proverbial garden path and public health officials should sound the alarm. There is, however, 
remarkably little empirical evidence to guide drafters.    
 
 
The Debate: does constitutionalization help, hurt, or just distract? 
Prominent ethicists and theorists of law, human rights, and public health have argued on 
normative grounds that a right to health should improve both health and health policy.3 A wide 
variety of analysis has explored its philosophical grounding,4 legal basis,5 imperatives for medical 
and public health practice,6 and the obligations of states under international standards, given that 
nearly every country is now party to at least one treaty touching on the right to health.7  Recognizing 
health as a right is theorized to improve equity, quality, and quantity of health-related policy while 
also affecting the political norms and coalitions that govern health. 8  Human-rights based 
approaches to health, scholars have argued, increase accountability and access to quality healthcare 
as well as other public goods essential to wellbeing.9  
However, many of the broad findings in social science, law, and public health cast doubt 
on whether a constitutional RtH will ever have a meaningful, let alone beneficial, effect.10 These 
																																																						
3 Sen 2008; Sen 2004; Ruger 2010aa; Farmer 2005; Mann et al. 1994. 
4 Ruger 2007; Wolff 2012; Daniels 2001; Meier, Brugh, and Halima 2012. 
5 Chapman 1997; Harrington and Stuttaford 2010; Grodin et al. 2013; Young 2008. 
6 Mann et al. 1994; Gruskin, Mills, and Tarantola 2007; Beyrer et al. 2007; Beracochea, Weinstein, and Evans 2010; Yamin 2015. 
7 UN Committee on Economic, Social and Cultural Rights 2000; Tobin 2012; Hunt 2003; Grover 2013; Gostin and Sridhar 2014; 
Gostin et al. 2016. 
8 Backman et al. 2008; Ruger 2007; Forman, Ooms, and Brolan 2015. 
9 Yamin 2015; Bustreo and Hunt 2013. 
10 Reviewed in Hirschl and Rosevear 2011.  
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might be described in two broad categories: skeptical intimations that constitutional health rights 
will not matter for wellbeing, and pessimistic findings that suggest they will actually harm public 
health.  
The idea that a right to health will not actually matter, in practice, finds support in many 
of the theories and findings in social science. Skeptics point, for example, to the example of Nordic 
countries that have largely not moved toward constitutionalizing health, yet have achieved world-
leading health outcomes.11 Across a variety of high performing countries from the OECD—from 
Norway and Iceland to South Korea—skeptics suggest moderate population size, electoral 
democracy, strong market economies, a large middle class, and well-developed labor and civil 
society are what matters driving strong welfare states, relatively equitable distribution of resources, 
and high overall standard of living for better health. “And what is the net impact of the variance on 
the constitutionalism axis?” asks Hirschl. “Quite negligible, frankly.”12  Studies in development 
support this contention, suggesting health is dictated almost exclusively by demographic and 
economic factors—poorer, more unequal, and more ethnically stratified countries are less healthy 
because of a paucity of resources, coordination problems, state capacity, and other mechanisms.13 
Studies of the social determinants of health show how economic and social status inequalities 
structure a clear gradient of health.14 Explanations range from the psychosocial impact of life in 
unequal societies to unhealthy living conditions due to urbanization, material deprivations from 
class and gender inequality, and deeper political economy pathologies.15  
There is a small but growing literature exploring political institutions’ effect on health, but 
among comparative studies that include the global South, this has largely been confined to studies 
of electoral democracy and related freedoms. There is a robust debate in the political economy of 
development literature whether democracy improves health, with proponent suggesting it does by 
																																																						
11 Hirschl 2011. 
12 Hirschl 2014, 181. 
13 Preston 1975; Summers and Pritchett 1996; Filmer and Pritchett 1999; Biggs et al. 2010; Lieberman 2009.  
14 Marmot et al. 2008; Marmot and Wilkinson 2005; Braveman, Egerter, and Williams 2011.  
15 Solar and Irwin 2010; Wilkinson and Pickett 2009; Shen and Williamson 1999; Krieger 2001. 
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expanding incentives for public goods provision, information, and accountability.16 As a “meta 
institution,” democratic participation has been described as a critical element for health and 
development,17  alongside some limited attention to the role of political parties and power of 
left/labor forces.18 Constitutional health rights have little to contribute independently that is not 
accounted for by these factors and so, while not explicitly stated, many seem to dismiss health rights 
as essentially epiphenomenal.19  
Foundational judicial politics studies, while not focused on health rights, imply important 
policymaking will simply reflect the preferences of the dominant or hegemonic political coalition; 
while executives may well delegate tasks to other branches such as courts, the health policy decisions 
that result will not significantly differ from the will and interests of this coalition, regardless of any 
constitutional rights.20 Upendra Baxi, for example, suggests that social rights litigation in India 
offers little to the masses because it is more about aggrandizement of elites (lawyers and judges) 
than about transformative change.21 Actors such as judges will be unlikely to act meaningfully in 
important but politically sensitive policy areas like health, many  have argued, due to incapacity, 
fear of reprisal or loss of legitimacy.22 Similarly, studies of health and welfare states suggest political 
parties and ideological alignments largely influence health-related policies. Social democratic 
government is what matters.23  
More pessimistic findings suggest that the right to health will matter, but will have a 
negative impact. First, based on a view of rights as “trumps” in the words of Dworkin, many worry 
they are an inappropriate framework for use in health policy, which requires balancing multiple 
																																																						
16 Gerring, Thacker, and Alfaro 2012; Besley and Kudamatsu 2006; Acemoglu et al. 2014; Lena and London 1993; Dreze and Sen 
1989; McGuire 2010; Przeworski et al. 2000; Ross 2006; Ruger 2005. 
17 Rodrik 2008a, 166. 
18 Beckfield and Krieger 2009; Navarro et al. 2006; Navarro and Shi 2001. 
19 See, for example, the Commission on Social Determinants of Health, which, while mentioning human rights in several places, 
includes laws and rights only to land tenure and gender equity among the 59 recommendations aimed at impacting health outcomes—
no mention of a constitutional right to health as possibly beneficial. CSDH 2008; Solar and Irwin 2010. 
20 Dahl 1957 suggests this broad formulation; theories of hegemonic preservation put forward by Hirschl 2004 and Smith 2009; and 
the concerns about an "establishment revolution" that does little for the poor in Baxi 1985. This is also the logic that underlies the 
claim that some nations have “sham constitutions,” especially when it comes to socioeconomic rights in Law and Versteeg 2013.  
21 Baxi 1985. 
22 Cross 2000; Michelman 2008; Rosenberg 2008. 
23 Huber and Stephens 2012; Muntaner et al. 2011; Navarro and Shi 2001. 
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interests.24 Rights are too individualist, too adversarial, and don’t address the core problems of 
cooperation, state capacity, and institution-building needed to improve wellbeing.25 The middle-
class may use rights claims to gain access to expensive medicine, for example, but the poor are 
unlikely to access rights-based venues or effectively make rights-based claims on health issues. The 
result, in limited resource environments, will be to shift resources away from public goods and 
toward club goods.26  
Insofar as rights lead to courts, the literature on judicial politics challenges the legitimacy 
and utility of courts as actors in policy issues such as health. From a normative perspective, many 
see the real power of the right to health as an ethical framework for public policy and decision-
making, rather than for legal enforcement. 27  Unelected courts face a “countermajoritarian 
difficulty” when they overrule policies enacted by elected officials that are assumed to reflect the 
will of the majority.28 Socio-economic rights raise the specter of undercutting democracy—“in the 
end, we would have the courts running everything—raising taxes and deciding how the money 
should be spent.”29 Even if we wanted them to, though, pessimists also suggest courts are simply 
not set up to tackle polycentric health policy issues, in which each change to regulation, financing, 
and governance affects the rest of the system.30 Working on a case-by-case basis, courts lack the 
tools to readily develop appropriate policies in a system characterized by “irreducible uncertainty, 
contestability, and contingency.”31 Courts can only offer a “pretentious, inexpert, probably vain but 
nevertheless resented attempt to reshuffle the most basic resource-management priorities of the 
public household against the prevailing political will.”32 The judiciary lacks real “influence over 
																																																						
24 Dworkin 1978. Note Dworkin himself argued against inclusion of socioeconomic rights in the South African Constitution as 
described in Sachs 2009, 168. 
25 Siegler 1980; Kapur 2013. 
26 Horowitz 1977; Daniels 2001; Ross 2006; Landau 2012; Ferraz 2010; Glendon 2008. 
27 Ruger 2010a; Daniels 2008. 
28 Bickel 1962. But see Graber 1993 arguing judicial review can actually increase accountability and Scheppele 2005 arguing that 
under some conditions courts can be more democratic than elected officials—a theme I return to below.  
29 Tushnet 2000, 169. 
30 Kaye 1989; Fuller 1960. And see Epstein and Stannard 2012, 265; Epstein 1997 for a broader economic attack on the idea of a right 
to healthcare, arguing it distorts markets and results in poorer health overall. 
31 Michelman 2008, 21; and see Rosenberg 2008, 16, 21. 
32 Michelman 2008, 21. 
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either the sword or the purse,”33 and as Sunstein reminds us, courts do not control the bureaucracy 
needed to create systems and programs to improve health—and so their orders will make little or 
no difference, except to instill cynicism about rights.34  Octavio Ferraz argues this leads to an 
intractable dilemma for courts stuck between usurpation and abdication that cannot be reconciled 
under democracy, such that it is likely better to avoid constitutionalizing health.35    
Finally, a challenge from the left argues rights talk and courts are too often captured by 
neoliberal discourse and are structured to serve the interests of the middle- and upper-classes. As a 
result, in areas like health, rights mobilization and a turn to legal challenge is unlikely to effectively 
address major issues driving ill health and health inequities. Instead it has the potential to harm 
reformist social movements by distracting activists, resources, and political energy from more 
effective political and lobbying strategies. 36  “Ultimately, the Constitution facilitates inequality 
because it serves as a myth-making, deradicalising meme, its grounding in property rights typically 
trumps activist claims to human (socio-economic) rights.”37 
Are both the ethicists and constitution-writers mistaken? Is it simply a façade with little 
real impact? Worse yet, could well-intentioned rights implementation undermine wellbeing by 
distorting health policy and shifting power away from the poor?  
Despite scholarly attention, there remains insufficient empirical evidence on the effects of 
constitutionalization on health to answer these questions.38  
An extensive empirical literature on human rights treaties helps drive the skepticism—
many scholars have found that states that ratify human rights treaties often do not actually change 
their behavior or may even engage in worse behavior.39  Studies of health-focused treaties and 
impact on health outcomes have not been shown to perform any better.40 Rights instruments are 
																																																						
33 Hamilton 1788. 
34 Sunstein 1993, 37. 
35 Ferraz 2014. 
36 Hirschl 2004, 198. 
37 Bond 2014. 
38 Gauri and Gloppen 2012; Gauri and Brinks 2015. 
39 Hafner-Burton 2013; Hathaway 2002; Hill and Jones 2014; Hafner-Burton and Tsutsui 2005; Neumayer 2005. But see Fariss 2016. 
40 Hoffman and Røttingen 2015. 
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thus criticized as empty promises at best or, worse, as fig-leaves used as cover for rights violation. 
While some important studies have shown a positive effect, this is often conditional on other factors 
such as regime type and domestic politics.41 Ratification of the Convention on the Rights of the 
Child, for example, has been shown very weakly linked to immunization rates—but with effects 
only on some immunizations and among countries in some income levels.42 With international 
instruments often the inspiration and guide for constitution-writing it is fair to question whether 
constitutional provisions will prove any more robust.43 
Rigorous comparative empirical work on the impact and performance of constitutional 
rights is relatively limited, but recent studies have advanced the discussion, in part building off the 
insights from the international treaties literature.44 Several studies have found that while judicial 
institutions matter, constitutional rights themselves are not associated with improvements in the 
realization of those rights.45 More recent works by Melton, Camp Keith, and Chilton & Versteeg 
do find a benefit from some constitutional rights provisions, but with strong variation across 
categories of rights.46 Few of these studies, however, have addressed the constitutionalization of 
health and other socio-economic issues. Law and Versteeg find countries that promise a wide 
variety of rights to be less successful at honoring their constitutional obligations than those that 
promise few—with the authors labeling many constitutions “shams” for promising rights they do 
not deliver.47 The right to health is one example of such a sham, they argue, because life expectancy 
rates are worse in countries with an explicit constitutional right to health than in countries that lack 
such rights. This model, however, fails to effectively account for the widely recognized economic 
and social determinants of cross-national variation in mortality—from wealth to inequality to 
racial/ethnic stratification—which are not simply erased by constitutionalization. As Elkins, 
																																																						
41 Simmons 2009; Risse et al. 2013; Fariss 2016. 
42 Simmons 2009, 332; Gauri 2011. 
43 Elkins, Ginsburg, and Simmons 2013. 
44 Davenport 1996; Camp Keith 2002; Chilton and Versteeg 2016a; Ginsburg and Huq 2016. 
45 Cross 1999; Camp Keith, Tate, and Poe 2009. 
46 Chilton and Versteeg 2016a; Melton 2014; Camp Keith 2012. 
47 Law and Versteeg 2013. 
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Ginsburg and Melton note this also fails to account for the effect of time and the mechanisms at 
work in constitutionalization. 48  Chilton and Versteeg apply a more robust model and find 
countries with the right to health do not spend more on health, which they suggest is evidence 
constitutional provisions have little impact.49 It is not clear, however, that public health spending 
is a good way to evaluate the impact of constitutions since there is significant debate about whether 
health expenditure data is comparable across countries and whether it is a good predictor of either 
health system strength or population health outcomes.50 Furthermore, one major critique of health 
as a right is that it will lead to distort budgets and increase spending on expensive health goods for 
individuals.  A better set of measures is needed that considers the broader political economy 
contexts in evaluating the effect of constitutionalization on health outcomes and policy. 
Another robust and growing empirical literature that bridges political science, law, and 
public health has focused on litigation of health rights through case studies on the role of courts in 
enforcing a positive right to health.51  This work has found decidedly mixed results. It provides 
mounting evidence that courts, legislative bodies, and civil society in a significant number of 
countries are engaging with the RtH in complex ways. One set of national examples is aggregated 
and coded in Table 1.1 showing whether the authors found significant court action—which I define 
as multiple cases in which courts use a fundamental right to health to order changes against the  
																																																						
48 Elkins, Ginsburg, and Melton 2016. 
49 Chilton and Versteeg 2016b. 
50 Filmer and Pritchett 1999; Nixon and Ulmann 2006; McGuire 2006; Aísa, Clemente, and Pueyo 2014. 
51 Biehl et al. 2009; Brinks and Gauri 2014; Yamin 2014; Ferraz 2016. 
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preferences of some other part of the state. 
In thirteen out of the sixteen country cases, 
there was clear court action on the right to 
health.  The impact of this litigation varies 
between case examples, with some that fit 
the skeptical, pessimistic, and optimistic 
viewpoints on framing health as a right. 
Brinks and Gauri look across five countries 
to analyze the opportunity structures that 
enable health rights litigation and then track 
the impact based on an analysis of the 
number of cases, degree of implementation 
of decisions, and expected benefits based on 
type of case. 61  Using qualitative and 
quantitative evidence, they argue there is a 
modest net benefit of health rights 
litigation, but with wide differences 
between countries and varieties of 
litigation, with some types that “seem more 
prone to regressive effects.”62 Yamin and Gloppen build off this study to construct a framework 
that incorporates greater attention to the political sphere and adds the dimensions of efficacy, cost, 
																																																						
52 Biehl et al. 2012. 
53 Landau 2012. 
54 Godoy 2013. 
55 Maleche and Day 2014. 
56 Forman 2008. 
57 Gauri and Brinks 2008. 
58 Yamin and Gloppen 2011. 
59 Langford 2008. 
60 Flood and Gross 2014. 
61 Gauri and Brinks 2008. 
62 Ibid., 340. 
Table	1.1:	Legal	case	studies	of	the	right	to	health	
Country	 Major	authors	 Significant	
court	
action?	
Type	of	
enforcement	
Argentina	 Bergallo	b	 Yes	 individual	
Brazil	 Biehl	et	al.,52	
Hoffman	&	Bentes,	
a	Ferraz	b	
Yes	 individual	
Canada	 Jackman	&	Porter,c	
Floodd	
Yes	 collective	
Colombia	 Landau,53	
Yamin/Parra-
vera/Gianellab		
Yes	 individual	&	
collective	
Costa	Rica	 Wilson	b	 Yes	 individual	&	
collective	
Guatemala	 Godoy54	 Yes	 individual	
Hungary	 Foldesd	 Yes	 collective	
India	 Shankar	&	Metha,a	
Parmar	&	Wahi	b,	
Yes	 individual	&	
collective	
Indonesia	 Susantia	 Yes	 collective	
Ireland	 Nolanc	 Unclear	 collective	
Kenya	 Maleche	&	Day55	 Yes	 collective	
New	
Zealand	
Manningd	 Yes	 individual	
Nigeria	 Odinkalua	 No	 n/a	
South	
Africa	
Forman,56	Berger,	
a	Cooper,b	
Yes	 collective	
United	
States	
Hoffmand	 No	 n/a	
Venezuela	 Gonzalez,c		
Cabrera	&	Gomesd	
Yes	 individual	&	
collective	
Authors	gathered	in	edited	volumes	(others	in	citations):		
a	Brinks	&	Gauri57				b	Yamin	&	Gloppen58					c	Langford59	dFlood	&	Gross60	
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and recipient characteristics to the analysis of the impact of litigation.63 Overall the picture they 
paint is even more complex, with some indications of “improved governmental responsiveness and 
systemic changes that benefit disadvantaged groups” but other examples where the benefits of the 
particular case were marginal and the costs high.64 Flood and Gross look more broadly at health 
rights in a large selection of upper- and middle-income countries. They find that the impact varies 
substantially based on the financing structure of the health system, making it very difficult in the 
majority of settings to assess how court victories expanding access in the public sector are balanced 
against cleavages in access and resources between public and private health systems.65 Some of the 
most robust debate has centered in Latin America, especially Brazil where Ferraz has argued 
strongly that judicialization undermines health policy by serving middle class interests while Biehl 
and collaborators have presented evidence from a multi-year study of thousands of cases that 
counters that claim—showing litigants are primarily poor, seeking access to medicines they were 
supposed to receive under government programs, and can serve as an instrument for the poor to 
hold the state accountable.66  
These mixed findings are perhaps unsurprising in the context of law and social science 
literature, which finds that law and rights operate on multiple levels—and that courts are but one 
venue in which they play out. It is in the “shadow of the law” rather than in the courtroom that 
much of the most important impact of legal thinking, institutions, and actors is seen.67 Starting 
with litigation, then, is likely to give only one view of the broader institutional shifts under 
constitutionalization.  
In this dissertation, while I build off this literature, I also depart from it by decentering 
litigation and court orders.  I focus more broadly on constitutionalization as a process that changes 
																																																						
63 Yamin and Gloppen 2011, 9–12, 304–29. 
64 Ibid., 299–301, 327–8. 
65 Flood and Gross 2014, 471. 
66 Ferraz 2010; Biehl, Socal, and Amon 2016. 
67 Mnookin and Kornhauser 1979; Scheingold 2004, 3, and see Galanter 1983; McCann 2006. Legal mobilization scholarship has been 
broadly moving away from a focus on courts to the broader political, social, and ideational shifts wrought by rights frameworks. 
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the rules of the game for policymaking and suggest the jurisprudential questions likely matter less 
than the ways rights shift power over resource distribution. 
 
 
A Political Economy of Health Policy: beyond litigation to institutions 
Political economy work on institutions does find a broad and important role for 
“constitutionalized” rights for national development. Institutions in this framework are “rules of 
the game”—both formal and informal— “embedded in the organizational structure of the polity or 
political economy” that structure human interaction.68 Arising out of political bargains, political 
institutions set “appropriate behavior” for actors and situations and, in so doing, create winners 
and losers. Over time, institutions become “locked in” as they provide increasing returns for 
compliance and inspire strong defense from those who benefit. Organizations rise and evolve to 
take advantage of the institutional environment. Institutions come to shape and condition the 
interests of both individuals and groups as they play an actively “constitutive role” in shaping social 
values.69 Smith and others argue that there is an “influence of enduring structures of legal ideas” 
that cannot be simply explained as the instrumental rhetoric of political actors, an understanding 
that runs counter to those who dismiss the articulation of health as mere words. 70 Tushnet and 
Khosla argue that, in comparative perspective, law “is not merely epiphenomenal or 
inconsequential with respect to some larger force at work. Implicit is an understanding that legal 
norms and institutions also have the potential to shape sociopolitical realities in their own distinct 
fashion; for that reason, legal design matters.”71 Legal frameworks assert an ongoing structural 
influence that constrains some actors, empowers others, and privileges a certain range of policy 
																																																						
68 Hall and Taylor 1996, 938; North 1990; March and Olsen 1983; March and Olsen 2008. 
69 Chang and Evans 2005; Hall and Taylor 1996. 
70 Smith 1988; Burgess 1993. 
71 Tushnet and Khosla 2015, 6. 
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options in ways that cannot always be easily predicted at the time of drafting, yet significantly shape 
the distribution of resources and political power.  
The most prominent examples of this work in development focus on the relative 
institutionalization of a variety of rights, including private property, contracts, and market access, 
as drivers of economic growth.72  Newer work increasingly suggests that a far wider range of 
institutions affect the prosperity of nations and that institutions drive not just economic but also 
broader welfare measures.73 In political science, electoral democracy and related participation and 
expression rights are the most widely studied institutions; a significant debate continues about the 
effect of democracy on economic outcomes and development indicators such as education and 
health. 74  Meanwhile other politico-economic institutions have also been linked to health.  
Lieberman, for example, has shown that ethnic boundary institutions have a direct effect on 
responses to HIV.75 Peter Evans, in a recent volume on health and institutions, pushes further and 
argues for identifying what he terms “successful societies institutionalism,” to help explain why 
democratic governance seems to be important but insufficient to generate large improvements in 
population health.76 
Constitutionalization of health as a right can best be understood in this light—as part of 
the institutional framework governing health and health policymaking. Thinking about 
constitutionalization in political economy terms—as rules of the game—suggests a move away from 
using the outcomes of court cases as the starting point for understanding the impact of health rights. 
To understand its effects and judge their impact we need to look instead at the whole health and 
health-policy system.  We should be able to trace empirically the impact of constitutionalization on 
both wellbeing and health policy. I make use of a nested analysis in this study to do so—to test for 
a link between constitutionalization and improved wellbeing and, at the intermediate level, to 
																																																						
72 De Soto 2000; North 1990; Acemoglu, Johnson, and Robinson 2005; Kaufmann, Kraay, and Mastruzzi 2004; Brunetti, Kisunko, 
and Weder 1997. 
73 Hall and Lamont 2013; Rodrik 2000; Rodrik 2008b; Chang 2011. 
74 Gerring, Thacker, and Alfaro 2012; Przeworski 2008; Doucouliagos and Ulubaşoğlu 2008; Stasavage 2005. 
75 Lieberman 2009. 
76 Evans 2009. 
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differences in the cycles of health policymaking.  From what might be called a “policy process” 
approach, courts and litigation are an important part of the policy system but neither the only, nor 
necessarily the most important, part of that system.77 In that sense I build off, but depart from, most 
previous studies of health rights that center litigation, and instead focus broadly on questions of 
how constitutionalization impacts wellbeing and health policy processes. Bringing insights and 
tools from political economy to the study of the law and law-like rules can help expand the field of 
comparative constitutionalism78—in this case bridging the gap between existing normative and 
doctrinal studies of socioeconomic rights and the large field of empirical research on health and 
social policy. 
 
An Institutional Theory of the Right to Health: hypotheses and concepts 
My hypothesis, for which I show empirical support in the chapters that follow, can be 
simply described in two parts. I describe these more fully in chapters 2 and 3, but a summary and 
explication of concepts is worth noting here.  
First, constitutionalizing health—casting health as an enforceable right and embedding it 
in the basic law of a country—can benefit overall wellbeing of populations. This claim is not 
universal—as with any institutional formulation, health rights have a multitude of effects and, taken 
from different perspectives, geographies, issues, and populations, have attributes that are good, bad, 
and/or immaterial. On balance, however, I suggest constitutionalization is likely to improve 
wellbeing. Mortality and morbidity indicators are disproportionately driven by the poor and 
marginalized, who are saddled with much of the premature death and sickness in societies 
throughout the world. My hypothesis is that constitutionalization of health improves health in the 
aggregate, including by significantly improving the wellbeing of these poorer and marginalized 
																																																						
77 See Sabatier and Jenkins-Smith 1993 arguing for looking at policy change as a process over more than a decade. 
78 Hirschl 2014. 
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segments of society even as it may do less for those with higher incomes, bringing equity benefits 
along with overall improvements.    
 Second, a constitutional right to health operates as an institution in the national political 
economy of health. It shifts the appropriate actors, venues, and actions in health policy with 
significant effect on the policy agenda and the eventual distribution of resources. Much of the 
concern about the right to health, I believe, stems from a base conceptualization of rights as “trumps” 
that will override the kind of complex public health policymaking necessary to weigh competing 
needs amidst limited resources and capacities. An institutional view, on the other hand, points us 
away from this conceptualization. Through this study I have come instead to conceptualize rights 
as “policy anchors”—borrowing a metaphor from fiscal policy to indicate an enduring and specific 
political commitment that is part of, rather than apart from, policy frameworks and is capable of 
plasticity to accommodate shifting conditions and countervailing, buffeting forces.79 The RtH can 
set new “rules of the game,” providing opportunities for which individuals and organizations evolve 
to take advantage.  
The idea that judges and courts are applying legal reasoning to issue orders that end 
contentious health policy processes, for good or for harm, is simply not empirically accurate. 
Instead, bargaining over policy continues regardless of the rights environment. Under a right to 
health the institutional framework in which health policy operates is different in what are largely 
pro-health ways. The game is equally rigorous and challenging, but the field on which it is played 
changes. Constitutionalization unblocks policy change, which is critical in health policy that so 
often depends on adapting to fit new science and evolving conditions. The health system built 
before a major expansion of private insurance or for a less urbanized population, for example, must 
shift with economic and demographic changes. The system may have been effective in delivering 
penicillin and vaccinations but it has to change to fight AIDS. Health policy that implicitly assumes 
de jure or de facto racial, ethnic, or caste segregation has to evolve if it is to effectively tackle inequity.  
																																																						
79 Mishkin 2007. 
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Constitutionalization provides particular opportunities to open up the process of policy-making—
allowing a shift in the venue for health policy to include courts and other rights bodies. Rights 
mobilization in this context holds the prospect of “expanding the conflict” to bring in powerful new 
actors including judges and lawyers. This changes the terms of debate in ways that destabilize the 
kind of closed bureaucratic policymaking systems that often characterize health policy and inhibit 
innovation, change, and improvement.80 In this context, rights change the policy landscape as 
much or more outside the courtroom, which explains why studies of litigation may miss the ways 
in which simply the possibility of going to court, and the framework of health as a right, changes 
the politics of health policy in issue areas that never even come before the judiciary. Fundamentally 
this opportunity changes the bargaining power of key actors including patients, civil society and 
non-governmental groups, and health actors inside the state vis-à-vis the rest of government.  
Constitutionalization also puts critical new tools in the hands of health actors that can 
expand the information available to publics and governments and shift the structures of 
accountability that govern health. The idea of “voice” in health policymaking is much talked-about, 
largely in the context of democracy and transparency for improving wellbeing.81  The opportunities 
that come with legal mobilization—from discovery and subpoenas to the media coverage—can be 
critical to realizing voice in ways that are underappreciated. Finally, rights provide an important 
ideational shift in health policy—providing what Sen and Beitz both call “reasons for action” that 
are anchored in the national political bargain and undermine the ideas that often foster closed, 
static policy environments while enhancing the legitimacy of policy options focused on action and 
equity over inaction.82 
Constitutionalization can be especially important when dealing with health issues that 
primarily affect poor or marginalized people who often lack the power to move the levers of 
																																																						
80 Schattschneider 1975 on the expansion of conflict in policymaking, and see Baumgartner and Jones 1993 for a discussion of policy 
monopolies as barriers to policy change, explored further in chapter 4.  
81 Paul 1994, vol. 1388; CSDH 2008. 
82 Sen 2004; Beitz 2009. 
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democracy to change health policy in their favor. As Emily Zackin shows in a U.S. context, it is 
often not possible for unpopular political actors (stigmatized people living with HIV, for example) 
to make effective constitutional arguments and political change without courts, but engaging courts 
can actually promote public deliberation on issues that matter for them.83 
Similar processes are at work in a variety of countries and health policy issue areas. Perhaps 
the most well-known example of health rights in action is the South African Constitutional Court 
case on access to treatment for pregnant women to prevent HIV transmission to their children.84 
The Court’s decision was critical to shifting South African AIDS policy toward implementing 
antiretroviral treatment despite the President’s objections.  As I describe in chapter 4, however, the 
court case itself was only one part of the opportunity structure created by the rights environment. 
Constitutionalization not only gave patients standing to sue, but also broke open policymaking 
around antiretroviral drugs well beyond the limited questions raised in the case by exposing 
information that was not available to the public despite a free press, shifting power dynamics within 
the ANC-led government toward pro-health leaders, and providing legitimacy to social movement 
groups and clinicians who had been opposing President Mbeki at the height of his power and 
popularity. The political question shifted toward how the government could justify not acting on 
the claims of rights-holders. In the end, a significant improvement in population health is 
attributable not to a court case alone, but to the shifts enabled by institutionalization of health rights. 
A decade later, an entirely different set of circumstances saw the right to health mobilized 
in South Africa’s Eastern Cape on behalf of poor, black rural residents’ need for ambulances and 
EMS services to address leading causes of rampant maternal and child mortality. In an example as 
psychically far from the halls of the Constitutional Court as possible, the intervention of the South 
African Human Rights Commission forced local government officials to hear from communities, 
justify their policy choices, and reveal critical information to the public. It opened the door to badly 
																																																						
83 Zackin 2008. 
84 Minister of Health and Others v Treatment Action Campaign and Others 2002. 
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needed policy change and redistribution of resources that high profile media coverage, electoral 
competition, and social mobilization over a decade had failed to trigger.   
In India, Supreme Court intervention on HIV resulted not in a landmark case but in a 
series of forced negotiations that similarly opened the door to pro-health policy shifts. In Thailand, 
rights instantiation inside the National Health Security Office has provided opportunities for 
individuals to bring claims on key health services that have re-shaped Thailand’s vaunted universal 
health programs.  
These examples reflect a shift in the political economy of health and, where health is 
constitutionalized, it improves population wellbeing. As I show in chapters 3-6, these shifts increase 
the quality of health-related policy; increase health-supporting resource allocation—either growing 
expenditures, health workforce, and infrastructure, and/or allocating them to more health-
impactful areas; and improve implementation of promised policies through greater information 
and accountability. 
 
Concepts & Conceptual Boundaries 
 
At the outset, it is critical to specify three concepts: the right to health, health-related policy, and 
institutionalization.  
 
The right to health (RtH):  While the idea of “positive” rights was out of favor among the drafters of 
many early constitutions in the global North—the U.S. Constitution, for example, famously omits 
them—framing social welfare and access as rights has a long history. The Carta De Foresta of 1217, 
sister document to the Magna Carta, set out economic and social entitlements directly affecting 
people’s daily lives, including a right of access to herbs and “vert” used in medieval medicines.85 
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Later in the French revolutionary period,86 and in the emergence of European welfare rights,87 
health rights surfaced as well. The post-war international conception is concretized in the UDHR 
and appears in the constitution of the World Health Organization as the “enjoyment of the highest 
attainable standard of health.”88 It was not until recent decades, however, that we have seen a RtH 
incorporated in large numbers of national constitutions.  
This project necessitates identifying when a right exists empirically—a deeply contested 
question.89 Joseph Raz’s oft-cited definition suggests rights exist if, all other things being equal, a 
person’s wellbeing (interests) is sufficient reason for holding others (including the state) under a 
duty. 90  In this case the specific interest is in health—and drawing on the health capabilities 
approach, it is possible to both differentiate it from a right to be healthy, which no state can 
guarantee, but also to denote a broader conception than simply a statutory right to access medical 
care.91 I believe it is appropriate, in this context, to consider that a right to health exists in a country 
when people can make a rights claim on the state and/or private actors, either individually or in 
groups, for feasible improvements in their health capability.  
Following Sen, I do not argue a right does not exist if it is not perfectly enforced.92 As 
Goertz notes, however, a concept to which there is no negative pole is not empirically useful.93 
Following my hypothesis, then, I will focus on the degree to which a country has institutionalized a 
right to health. My assumption is that in some countries the state has no specific duty against which 
citizens can make claims and thus there is no institution of health as a right.  
I am looking specifically to national constitutions as the starting point—whether they 
contain explicit language or have been clearly interpreted as supporting an enforceable right to 
																																																						
86 Porter 1998, 56; Risse 1999, 302-05. 
87 Ruggie 1982. 
88 World Health Organization (WHO) 1946. 
89 See, e.g. Dworkin 1978; Rawls 1999; Beitz 2009. 
90 Raz 1984, 195. 
91Ruger 2010b; Sen 1999. Note this accords, albeit imperfectly, with the international conceptualization of a right to the “highest 
attainable standard of health.”  
92 Sen 2004. 
93 Goertz 2006. 
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health (i.e., not simply a value or policy principle). The growing number of constitutions that meet 
this standard is illustrated in figure 1.1. My focus here is on the constitutional RtH not because 
words on a page are decisive, but because the inclusion of an RtH in a national constitution is a 
clear, empirically visible move toward institutionalizing an RtH.  I recognize that some societies 
without a constitutionalized form likely have strong health rights in practice. However, I believe a 
focus on constitutions is theoretically justified. While some worry about “sham constitutions”94 
constitution-making is a uniquely decisive moment in the life of contemporary nation-states. Over 
time, the value and significance of written constitutions in the political life and policy-making of 
countries has only grown in most of the world.95  
As discussed below, in my quantitative analysis I will use specific forms of constitutional 
text to operationalize this broader concept for large-N analysis. In constructing a comparative study 
on the RtH, the constitutionalization of the right is not only an empirically legible starting point for 
study across time and space but it also represents a decisive move to law, which is important in the 
political process of institutionalization. It is, of course, an imperfect and noisy measure. However, 
for time-series large-N analysis I would suggest it provides at least comparable validity to other 
measures of rights instantiation used in scholarship on constitutions, international law, and 
political economy of development.96  
My qualitative work will use the existence of this constitutional text as a starting point for 
deeper analysis seeking to analyze the degree to which the RtH has been institutionalized. Since the 
ability to make claims are central to my concept of the RtH, meaningful and utilized opportunities 
to make claims for feasible improvements in their health capability will be key to the analysis.  
 
 
																																																						
94 Law and Versteeg 2013. 
95 Ginsburg, Elkins, and Blount 2009. 
96 Ginsburg et al. 2012; Simmons 2000; Law and Versteeg 2013, but see Choudhry 2012; Hirschl and Rosevear 2011 identifying such 
operationalization as best matched with qualitative study; and see measures of “institutions” in political economy in (Acemoglu, 
Johnson, and Robinson 2005) or democracy (Freedom House 2014). 
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Constitutionalization, Institutionalization, and Mobilization 
A set of related concepts are relied upon throughout this dissertation that deserve 
clarification here. The concept of “constitutionalization” comes from studies in law and political 
science and reflects a political, not just a legal or jurisprudential, phenomenon in which key areas 
of policy are cast in rights terms and as a part of the fundamental national legal-political bargain, 
with an explicit enforcement mechanism—usually the courts.97 The related “judicialization” of 
issues, in which courts take up increasing power over policy outcomes and engage in complex back-
and-forth with legislative bodies, is a piece of constitutionalization.98 It is judicialization that has 
most been the subject of increasing attention in health.99  However, as I argued above, looking 
primarily to courts and judges provides an insufficiently broad picture of constitutionalization. The 
bigger concept includes more fully the ways that a rights framework affects the politics of health as 
constitutionalization is both internalized and used as a tool by legal and non-legal actors—from 
bureaucrats to legislators to social movement groups. On the one hand, either action by courts or 
the threat of action by courts motivates other actors—legislators and bureaucrats—to act differently 
when the threat of court intervention exists. On the other hand, the framework of health as a right 
can both change the preferences of actors and shift the balance of power within the state, including 
over critical resource allocation decisions since “balancing competing priorities” and “fulfilling 
constitutional obligations” carry quite different implications.100 For the purposes of sections of this 
analysis, particularly the quantitative section in Chapter 2, I use constitutional provisions to serve 
as a practical marker of the constitutionalization of the right to health. 
Constitutionalization, I argue, reflects a shift in the institutions governing the political 
economy of health, including critical distributional questions. Identifying the right to health as an 
“institution” helps further clarify the difference between text in a document and a real, empirically 
																																																						
97 Hirschl 2004, 31–49; Elkins 2010. 
98 Shapiro and Sweet 2002; Tate and Vallinder 1995. 
99 Gauri and Brinks 2008; Rodríguez Garavito 2013; Biehl et al. 2009. 
100 See, e.g. Béland 2005 on how the ability to successfully frame policy alternatives can be decisive in the policy process. 
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observable “enduring collection” of rules and practices that shape the options and incentives of the 
various actors in a given polity and remain relatively invariant to particular circumstances or the 
preferences of individuals.101 Stemming from political bargains, institutions dictate “appropriate” 
behavior and “structure conflict so as to privilege some interests while demobilizing others.”102 
Institutions have been shown, for example, to set out the range of options for policy change in 
dealing with economic growth and crisis103 and restructuring social welfare systems.104   
Creating an institutional environment that privileges the interests of individuals in 
achieving core health capabilities should improve health outcomes. In an environment of broadly 
weak institutions—as characterizes many low- and middle-income countries—elite capture of 
resources undermines provision of public goods that can improve health, especially for the poor 
and marginalized. As constitutions are rewritten or revised, these constitutional moments often 
reflect a “critical juncture”105 in which the seeds of a new institution may be planted.  
I use institutionalization in this project as a matter of degree. I have in mind the degree to 
which a potential set of new rules and practices have actually become “locked-in.” North describes 
how institutions come to provide increasing returns for compliance. 106  Opportunities are 
increasingly created to participate in and to defend the institution. Organizations evolve to take 
advantage of new opportunities—from social movement groups choosing tactics to courts 
formulating decisions.  In this case, we can judge the relative institutionalization of an RtH by the 
degree to which such opportunities exist—can patients go to court to affect health policy? Can civil 
society organizations make constitutional claims on health in venues that matter? Can health actors 
rely on a RtH as a reason for action? Without a constitutional right, the answer to these questions 
is no—but there is also a range of matters from legal standing rules to the density of rights-
supporting organizations that affect relative institutionalization. These are similar to the way 
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property rights and other rights-based institutions are analyzed in the political economy of 
development literature.107 A right to health, then, should be similarly considered to range from 
non-existent to strongly institutionalized. As described in the case study chapters below, South 
Africa has a highly institutionalized right to health as indicated by active judicial action on the right 
to health, multiple pieces of legislation and policy at national and provincial levels referring to the 
constitutional framework, wide penetration in public discourse, organizations rising to make use 
of the constitutional framework, etc. Malawi, on the other hand, has seen only limited 
institutionalization of the right to health and commensurately limited impact of 
constitutionalization. If my hypothesis is correct, then institutionalization of this type should 
increase the positive impact of the right to heath; however, the alternative hypotheses above suggest 
that greater institutionalization might simply further distort health policy and undermine health. 
This is the empirical question at the heart of my case studies. I also hypothesize that the particular 
form of institutionalization likely matters. For example, it may matter whether a right to health was 
negotiated into the constitutional text explicitly (e.g. South Africa, Thailand) or has been judicially 
interpreted (e.g. India).  These differences guide my case  selections described below.  
 
Health Policy 
I am explicitly taking an approach that relates to the concept of “health capability,” which 
implies a broad conception of the aspects of policy and national decision-making that might impact 
people’s ability to functionally achieve health and to do so with agency.108 Jennifer Prah Ruger’s 
conceptualization more fully captures what matters for people’s lives than do explorations either 
framed around “opportunity” as the core concept or focused solely on “access” to medical services, 
capturing the complex processes that drive cross-national differences in health outcomes. I take a 
broad concept, on this basis, of what constitutes health-related policy. The health capabilities 
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paradigm bridges debates over health care and the social determinants of health—recognizing the 
reality that both contribute to wellbeing without falling into nebulous debates in which every policy 
can be linked to health implications. It adds an important layer of complexity to epidemiologic and 
social determinants dialogues, recognizing that group-level factors may have individually 
heterogeneous effects.109 Focusing on identifying how well individuals can act within social and 
economic systems as agents of their own health to achieve health “functioning,” this framework 
draws important attention to how broader freedoms and power dynamics intersect with access and 
social structures to produce prospects  for health agency. 110   This is especially important for 
understanding the effect of constitutionalization, which changes how health policy is made, who 
the actors are, and how power is distributed in these processes.  
In this context, I understand health policy to include health care services, public health 
including societal regulations intended to impact health, environmental health, medicines, health-
related research, health education and prevention efforts, and other community and welfare-state 
programs aimed at improving health. Many other policy issues impact health (from education 
policy to income redistributive taxation), but I do not expect that the constitutional environment 
will have a significant effect on these issues that are largely governed by other constitutional 
elements.    
As described below, the qualitative level of analysis in this project focuses on tracing policy 
issues where the right to health has been mobilized. There is a long history of rights mobilization 
on HIV/AIDS and it is not surprising that this figures prominently in my case studies.111 This 
matters for wellbeing since, led by countries in sub-Saharan Africa, HIV contributes significantly 
to the cross-national variation in health—for women aged 15-49 years, for example, HIV/AIDS is 
the leading cause of death worldwide.112  The area of essential medicines—policy and practice of 
which medicines will be available, to whom, at what prices, and under what intellectual property 
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rules—has also been a major area of litigation, civil society mobilization, and international 
attention.113 This likely matters a great deal for health on two fronts: first, the degree to which 
medicines are available and affordable does have a significant effect on health outcomes—especially 
in the area of the major infectious disease killers like malaria, TB and HIV and to a lesser degree on 
non-communicable diseases. Of the 40 million annual deaths in developing countries (many 
among children), about 10 million are due to acute respiratory infections, diarrheal diseases, 
tuberculosis, and malaria—all conditions for which drugs can be life-saving if they are available and 
affordable.114 Apart from the direct benefit, there is also a major opportunity cost question—while 
spending on drugs is a small part of overall health expenditure in high-income countries it can be 
25-66% of health spending in developing countries. 115  In most low-income countries, 
pharmaceuticals are the largest public expenditure on health after personnel costs, and are the 
largest household health expenditure. Choosing to, for example, implement a strategic generic drug 
program instead of maximalist IPR rules can free up major resources for other urgent needs from 
paying midwives to drilling bore holes for water.116   
If constitutionalization only matters in these two areas, however, it would be difficult to see 
how it would substantially affect aggregate wellbeing. Therefore, part of this study aims to explore 
the impact not just of these two areas, but beyond, to test how far the effect of a right to health 
travels. If correlation with positive health measures is truly causal, we should be able to link a right 
to health with decision-making in other areas—budgeting, primary healthcare delivery, maternal 
& child health, and perhaps farther afield. Identifying whether these connections exist—whether 
the legal complex and rights-based claims-making matter here—is a key part of the process tracing 
level of analysis in chapters 4-6.  
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Mobilization 
Finally, I follow legal mobilization scholars, who show that it is possible, in the course of 
broader policy struggles, to track when and how rights are mobilized. This is the process in which 
individuals and groups make claims about legal rights (theirs or others’) and engage the legal 
complex in formal lawsuits or less formal rights talk opportunities in order to defend or to 
develop those rights.117 When rights are mobilized, the institutionalization of the right to health 
becomes most visible.  As such, in the case studies below I use interview data to identify sets of 
policy issues in each country on which the right to health was mobilized, and then engage in 
process tracing before and after mobilization to identify how constitutionalization affects policy 
and health outcomes. 
 
Adjudicating Between Competing Theories 
This study is designed to adjudicate between a set of alternative theories, each of which has 
support in academic literatures. The skeptical view suggests constitutionalization will have no real 
effect on population health. The pessimistic view instead worries that constitutionalizing health is 
actually a bad idea—introducing a framework that is too individualistic, governed by inexpert 
judges that will distort health policy and drive resources away from public health goods. Instead, as 
I described above, I see the constitutionalization of health as a move to institutionalize an “ethical” 
framework for health that is likely to change health-related policy and policymaking in ways that, 
on balance, benefit wellbeing. While the impact is likely to be different between countries and 
between population groups, I see the most significant mechanism in opening policymaking and 
shifting power balances in ways likely to have a positive effect in the aggregate. 
These are hypotheses with implications that should be visible and empirically testable. If 
my hypotheses are correct then, contrary to the alternative theories in the literature, we should to 
be able to observe: better health outcomes in countries with an RtH, controlling for the dominant 
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social science explanations for cross-national variation in health outcomes such as wealth, 
inequality, homogeneity, social determinants, and preferences of the dominant political coalition. 
Policymaking linked to those outcomes should be able to be credibly described as different from 
how it would otherwise have been without an RtH—in process, actors, and outcome. Second, we 
should also see positive outcomes from the involvement of the legal complex (and likely the 
interaction of the legal complex and social movements) that, over a substantial period of time, do 
not distort or divert resources from good public health or away from the poor. 
 
Research Design: Nested Analysis 
This study’s research design is 
structured to both adjudicate 
between competing hypotheses 
and, if my hypotheses prove 
correct, to generate sufficiently 
fine-grained data to uncover 
causal links. To do so requires 
analysis on at least two levels, 
illustrated in Figure 1.2, First, a high-level empirical relationship between an RtH and health 
outcomes. Then, at a second level, causal evidence about the mechanisms underlying this 
relationship.  
I tackle this question using a “nested analysis” that combines a large-N regression with 
small-N fieldwork-based case studies.118 Chapters 2 and 3 go into greater detail below about the 
particular methodological choices made for each of these two levels. Combining quantitative and 
qualitative research, this strategy allows me to investigate the question at these two different levels 
of analysis and triangulate between the different types of causal leverage generated by each level of 
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analysis.119 While mixed methods are not appropriate for some types of studies, and nested analysis 
brings with it specific pitfalls,120 it is particularly well-suited for the question asked in this study for 
two major reasons. First, wellbeing in a nation is over-determined—with a broad literature that 
actually leaves relatively small unexplained variation in health outcomes, even as some “explanatory” 
variables merge multiple causal factors which are themselves explained by distal factors.  In this 
context, a finding of significant impact for which we can be confident in generalizability is likely to 
only be observable across a large set of data. As discussed below, however, these same confounding 
factors make causal identification particularly difficult. So, following others who look at similar 
questions of policy, institutions, and welfare, I combine the forms of leverage at each level.121  
The large-N analysis helps me establish whether there is, in the world, a relationship 
between having an RtH and health outcomes—providing a high number of observations to 
overcome the well-known problem of many variables with too few cases. 122  Comparative 
constitutional studies often suffer from a problem of external validity and selection bias due to over-
reliance on a small set of much-studied cases—which can be overcome through large-N study.123 
However, large-N statistical analysis alone is poorly suited for complex causal theories or 
uncovering causal mechanisms124—which are required for this study to confidently adjudicate 
between theories that variously suggest an RtH will be immaterial, harmful, or helpful for 
population health. My hypothesis is not that words on paper do the work, but instead that 
constitutions matter insofar as they institutionalize rights in the political economy of a nation and 
therefore affect policy, which in turn affects health. The critical question, then, is how? We can only 
be confident that any large-N relationship in this context is causal if it is paired with evidence of 
the mechanism that is doing the work. Large-N analysis alone is also problematic in the study of 
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phenomena subject to equifinality. 125  In this case, there is ample evidence that similar health 
outcomes can result from different combinations of economic, social, and service-delivery factors. 
McGuire, for example, shows how an increase in GDP, a reduction in inequality, or a significant 
expansion of health services separately contribute to similar-sized reductions in child mortality in 
various contexts.126 My hypothesis is that an RtH acts similarly—it contributes to a specific causal 
pattern that results in improved health outcomes, but it does not act alone. As such, the task here 
is to discover the different causal patterns at work and whether the RtH emerges as truly important 
rather than just a spurious correlation. There is also a particular task in this research of establishing 
directionality. Research on the social determinants of health, for example, finds social structures 
drive health equity and, one might expect, would also contribute to the writing of constitutions that 
themselves do little work except reflecting an underlying predisposition.127 In this context, revealing 
between-country effects and uncovering mechanisms are both critical—and best accomplished 
through a nested analysis.  
At the first level, I assemble a panel dataset, focusing on the period 1970 to 2010 for which 
there is wide availability of data on each of the critical variables, and construct a robust model to 
reflect the major explanations for variation in mortality within the economics and social 
determinants of health literature. As described in the next chapter, this incorporates data including 
GDP, inequality, women’s education, ethnic fractionalization, urbanization, and other variables 
that have consistent support within the literature.128 I also test measures of democracy, to reflect the 
major well-studied political institution in the literature.  
At the second level of analysis, I conducted fieldwork in four countries to uncover the 
plausible mechanisms through which an RtH impacts population health. By gathering “causal 
process observations” to augment the “dataset observations” in my large-N analysis, I am able to 
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gain greater purchase on whether the relationship observed statistically is causal.129 My primary 
causal leverage at this level comes from within-case analysis, using data from over 165 in-depth 
interviews supplemented by archival research to engage in process tracing of recent health and 
health-related policymaking.130 I began by identifying health policy issues where the right to health 
was mobilized and traced the processes starting well before and continuing well after mobilization 
in order to understand whether and how the process and outcomes of policymaking shifted. Doing 
so, I show with empirical evidence the link between cause and effect and how the RtH acts through 
specific mechanisms to affect health-related policy, which in turn affects health outcomes. My 
theory operates in a world marked by multiple, complex interaction effects—with 
constitutionalization interacting with other political, demographic, and economic factors. Process 
tracing as a method is especially well suited in such a context, and helps me uncover what are path-
dependent processes that lead to better health.131    
 
Country Case Selection 
The hypotheses and the implications for a right to health are global and so the dataset for 
the large-N analysis features the universe of cases is as well. The vast majority of premature 
morbidity and mortality, however, occurs in low- and middle-income countries, so the search for 
effective pro-health institutions is of particular practical importance there. Given the need to limit 
the population of interest for the small-N study, I focus on the global South—limiting the scope 
conditions for the study on that basis. The implicit presumption in most development literature is 
that Northern institutions are superior and should be emulated in the South—efficacious 
constitutionalization, innovation coming largely from the South, would provide the opposite.     
In the nested analysis, the large-N statistical study is designed to illuminate between-case 
relationships between health and constitutionalization while the qualitative portion of the study 
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builds on this relationship with a focus on collecting “within-case” data. This is gathered from 
countries that do have an RtH in order to show the mechanisms at work in health-related policy—
whether a right to health can truly be identified as causal.  
I focus on a paired comparison to allow “dual-process tracing”132 between similar cases, 
both of which have an RtH, yet have very different histories of institutionalization and 
judicialization—South Africa and India. With limited time for research and well-developed theory, 
random case selection is both inefficient and likely to produce an unrepresentative sample.133 
Following Rohlfing, who suggests model-building cases as a first step in nested analysis, several 
processes in South Africa—specifically around the HIV response, explored in preliminary 
fieldwork and identified in literature—serve together as a “pathway case” and informed my initial 
hypothesis.134 In South Africa, the RtH has reached high-profile status and been mobilized by the 
legal complex, social movements, and political leaders.135 There is still significant debate, however, 
about whether the RtH in South Africa actually matters for health—whether, outside a few high 
profile Constitutional Court cases, health policy is different or better because of it.136 The South 
Africa case study, here seeks to delve deeper—to trace policy processes over a longer period and 
include less studied examples to add further data in this area. Following Lieberman, I draw on India 
as an “on the line” example for comparison.137 With a low residual in my quantitative analysis, India 
is seemingly well-explained by a theory that the right to health matters controlling for other factors 
and is most likely to reveal causal processes in small-N analysis.138  India also provides a well-
matched pair to South Africa as a middle-income, highly diverse, highly unequal constitutional 
democracy governed by common law and featuring a strong judiciary. Yet in India the causes of ill-
health are different (less HIV) and the history of the institutionalization of the right to health is also 
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quite different—judicially derived from constitutional interpretation rather than from 
constitutional drafting.139  
In addition, to test the theory I conducted field work for two additional cases—Malawi and 
Thailand, which are included here as brief shadow cases in the appendix. Malawi provides a low-
income case with many similarities for comparison to South Africa including region, colonial 
history, a strong judiciary, and recent emergence from autocratic rule.140 Thailand, for its part, 
provides a test outside a common law system and in a country in which the judiciary, while strong, 
is not “progressive” in the sense of actively courting socio-economic rights or supporting 
governments that do and thus constitutionalization is not judicialization.141 The basic concept in 
choosing these cases is to evaluate whether there are mechanisms that operate according to my 
theory in such diverse settings—that tie institutionalization of a right to health to better health-
related policies and thus eventual improved health. 
 
Outline and Summary Findings 
I divide the empirical chapters into two sections: Quantitative and Qualitative. 
Section 1 focuses on the connection between a constitutional right to health and indicators 
of wellbeing. Constructing a dataset of 144 countries over 40 years, statistical analysis shows that 
countries with the right to health have better health outcomes on average, even after controlling for 
the dominant explanations for cross-national variation in wellbeing from public health, economics, 
and political science literature. Using a measure for the gender ratio in under-5 mortality, I also 
show evidence that countries with a right to health have more equitable health outcomes. These 
findings are supported by further analysis that shows constitutionalizing countries provide more of 
what matters for the poor. They do not spend more on health overall, but a greater portion of health 
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spending is public, with lower out-of-pocket expenses, and they achieve greater coverage of key 
health services such as immunization and skilled birth attendance. 
Section 2 provides a next level of analysis about how constitutionalization works based on 
over 165 in-depth interviews with policymakers, judges, lawyers, activists, and elected officials in 
South Africa, India, Malawi and Thailand. This section has two goals: First, I seek to test whether 
the quantitative relationships uncovered in section 1 can be causally connected to 
constitutionalization through policymaking processes that would explain the significant health 
dividend the large-N data suggest. Second, understanding the causal mechanisms through which 
constitutionalization improves population health might enable us to identify ways to deepen those 
mechanisms and expand them to new issues and geographies.   Chapter 3 provides an overarching 
explanation of the qualitative findings that outlines the mechanisms at work in 
constitutionalization drawn from the case studies that follow, which trace twenty different policy 
issues.  
Chapter 4 focuses on South Africa—our best example of a strongly institutionalized right 
to health—showing that the constitutionalization has had a wide impact on health policy issues well 
beyond the handful of high profile court cases that have captured international attention. South 
Africa is hardly a success story on health, which is part of what makes it a particularly interesting 
example for study—overcoming huge barriers from the legacies of apartheid to the demographic 
youth bulge is a major social task. From HIV/AIDS to maternal mortality, prison conditions, user 
fees in healthcare, and the regulation of private insurance, the decision to include health as a right 
in the 1994 Constitution has had a significant impact on the wellbeing of South Africans. Chapter 
5 turns to India, where the type of institutionalization of the right to health is quite different. A key 
set of decisions by India’s Supreme Court and lower courts have identified a right to health as 
judicially enforceable, which has triggered a large number of court cases throughout the country—
tackling a host of different issues. India’s judicially-driven constitutionalization has given rise to a 
different politics of health rights than in South Africa, one which on some fronts has had lesser 
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impact. There are, however, important similarities in the mechanisms of just how 
constitutionalization affects health policy, which provides important evidence that these 
mechanisms are generalizable, while the differences in the details suggest ways that different 
settings might yield lessons for each other about maximizing health benefits.  
I also make reference in this section to Annex D, which includes short case studies on 
Thailand and Malawi, which provide out-of-sample tests aimed at exploring how my findings from 
the core comparison of South Africa and India travel to very different contexts. Thailand, the non-
common law example, which has a well-functioning universal health system, shows an example in 
a unique context of how constitutionalization plays out in a context where courts play a surprisingly 
small role yet cascading impact of rights instantiation is still seen in a set of bureaucratic and 
legislative initiatives. Malawi, meanwhile, reveal the limits of constitutionalization in spaces where 
insufficient “support structure” undermines institutionalization of health rights. Importantly, 
however, Malawi shows relatively high institutionalization of negative rights like freedom of 
expression and political association and my inquiry suggests investment in institution building 
could yield results in health rights as well.  
In chapter 6 I conclude by highlighting the ways that my findings speak to debates in both 
scholarship and practice. Finding that the right to health matters—that by shifting the institutional 
environment in which health policy is made, constitutionalization can improve wellbeing—has 
implications for scholarship in political science, law, and economics. Challenging pessimistic 
accounts of “positive” rights, my findings contribute to scholarship that looks beyond the much 
debated, narrow set of institutions in development literature to address an innovation in 
institution-building that comes from the global South. Electoral democracy has received far more 
attention than it perhaps deserves when it comes to improving health and a turn to additional 
institutions, including constitutionalization, is warranted. Indeed, as I argue in the conclusion, 
there are important lessons for wealthy countries like the U.S.—most often positioned as the 
exporters of “good” institutions—about how rights frameworks that are showing impact in 
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complex, difficult health environments might be adapted to address some of the inequities and poor 
health outcomes experienced by many in the U.S. and countries like it. On a practical matter, I 
conclude by noting that foundations, international aid agencies, and United Nations bodies spend 
a great deal of money and time addressing rights and governance on the one hand and public health 
on the other. Truly connecting the two is today only in its infancy. These findings suggest, though, 
that constitution-writing is health policy work and that global health funders might get as much 
benefit by supporting lawyers, NGOs, and rights work as they do from building clinics and drug 
supply chains.  
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SECTION I: CONSTITUTIONALIZATION IMPROVES HEALTH 
  
Chapter	Two:	Estimating	the	Effects	
	
39	
 
 
 
 
 
 
 
 
 
 
Chapter 2 Estimating the Effects of a Right to Health: Quantitative Evidence 
 
 
 
 
 
Leave South Africa’s capital of Pretoria via the N4 highway north and in just over four 
hours you will arrive in Botswana’s capital of Gaborone. These two countries share a border and a 
complicated history in the Southern African region. Botswana has many of the ingredients for 
better health than its neighbor: higher GDP, stronger economic growth, lower economic and 
gender inequality, fewer ethnic divisions and electoral democracy that is both longer-standing and 
by several measures, as strong, if not stronger.1 Yet South Africa’s under-5 mortality rate is 10% 
lower. The reasons behind this difference are multiple and complex, but one interesting difference 
between the two countries is South Africa’s constitutional protection of health as a right while 
Botswana provides no such constitutionalization. Does this matter? 
This chapter outlines empirical evidence to address this question and suggest whether the 
right to health is beneficial, harmful, or simply a distraction. To do so, I model the effect of 
protecting health as a constitutional right using forty years of global health data. 
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Chapter	Two:	Estimating	the	Effects	
	
40	
The analysis below shows that countries with a constitutional right to health have better 
population health, controlling for the dominant explanations of cross-national variation in 
mortality from public health, political science, and economics literature. The effect is statistically 
significant and robust, showing an effect that is roughly equivalent, for example, to the difference 
between the United States and an “average” high-income country, or between Zimbabwe and its 
better-off neighbor Zambia. This positive impact is particularly important for questions of health 
equity as countries with a right to health show particular benefits in girls’ mortality rates compared 
to boy’s. Countries pursuing constitutionalization are similar to countries that are not in the total 
amount spent on health, which undermines both the suggestion that health rights are 
epiphenomenal to social commitment to health and that health rights will result in out-of-control 
spending. Instead, I present evidence that constitutionalizing countries invest more effectively in 
public health, resulting in significantly better coverage of several key measures of health service 
provision, in line with an overall finding of a small but significant mortality dividend from 
constitutionalization. While none of this data is perfect and causal identification necessarily relies 
on the nested qualitative evidence detailed in chapters 4 and 4, this chapter nonetheless presents 
strong pieces of evidence that institutionalizing a RtH has a beneficial effect on population health 
and, likely working through governance and health policy, is a net positive for the health system.  
 
The Right to Health in National Constitutions: Distinct Institution 
As described in chapter 1, the right to health takes a variety of forms—from international 
treaties conferring state obligation to ideational tools of social movements to culturally constructed 
expectations of private actors. This study uses one subset: an explicitly articulated right to health in 
a written constitution. This clearly under-identifies the right to health, but much as private property 
laws under-represent the institution of private property, I suggest constitutional provisions can 
serve as a valid, if incomplete, indicator for empirical evidence of a broader institution. 
For the constitutional right to health variable, this study makes use of a dataset compiled 
by the Comparative Constitutions Project—a systematic catalogue of formal characteristics of 
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written constitutions, both current and historical, for most independent states since 1789.2 The 
dataset provides panel data for country years with over 13,000 country year observations. This 
project uses a subset of this data that codes a categorical variable based on whether the constitution 
includes an explicit reference to a seemingly enforceable right to health. This includes, for example, 
South Africa where Section 27 sites an explicit right to health but not Nigeria where a constitution 
from the same era included a policy directive toward health but not a right,3 as seen here: 
 
Nigeria (1999)    Article 17.  South Africa (1996)    Section27.  
(1) The State social order is founded on ideals 
of Freedom, Equality and Justice 
(…)  
(3) The State shall direct its policy towards 
ensuring that-  
(c) the health, safety and welfare of all 
persons in employment are 
safeguarded and not endangered or 
abused;  
(d) there are adequate medical and 
health facilities for all persons. 
 
1. Everyone has the right to have access to   
a. health care services, including 
reproductive health care;  
b. sufficient food and water; and  
c. social security, including, if they are 
unable to support themselves and their 
dependants, appropriate social assistance.  
2. The state must take reasonable legislative 
and other measures, within its available 
resources, to achieve the progressive 
realisation of each of these rights.  
 
  Based on data reliability on other variables, observations are included from 1970-2010. 
Given the expanding number of independent states with written constitutions, this provides annual 
observations for an increasing number of countries—118 in 
1970 and 188 in 2010 (see figure 1.1). 
  Health rights in the constitutions of the world show great 
variation across time and space. In 1970 only 17% of written 
constitutions had an explicit right to health, while by 2010 that 
number surpassed 50%. Norms around constitutional 
construction clearly changed over the recent decades—in the 
																																																								
2 Melton et al. 2013. 
3 The one exception here is India where, in 1995, the Supreme Court identified health as a constitutional right. To my knowledge India 
is unique in having such a clear judicially derived right. In robustness checks dropping India does not change results below.  
Table	2.1	Countries	
With	a	Right	to	Health	
		
Latin	America	 61%	
W.	
Europe/U.S./Canada	
20%	
E.	Europe	 92%	
Sub	Saharan	Africa	 43%	
Middle	East/N.Africa	 56%	
South	Asia	 43%	
East	Asia	 59%	
Oceania	 15%	
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1970s only 35% of the over three hundred new constitutions written included a right to health but 
in both the 90s and in the 2000s 64% included a right to health. Clearly, though, there is still 
substantial variation—even in the most recent decade many constitution writers chose not to 
include a right to health. Given this clear trend all analyses below include controls for year effects 
and, in a robustness check, the impact of including the age and year of the constitutional system 
are tested, with models proving robust.  
There is also relative diversity in adoption of a right to health geographically and 
economically. In 2010 just over half of all countries had a right to health, which included countries 
from every region of the world. As shown in Table 1, between 40 and 60 percent of countries in 
most regions had a right to health, though Oceana and Western Europe showed lower coverage 
while nearly all constitutions in Eastern Europe had a right to health. This supports the idea of 
diffusion effect between countries, though it is clearly incomplete.4 Countries at all income levels 
had adopted a constitutional right to health in 2010—60% of low-income, 58% of lower-middle and 
62% of upper-middle-income countries, and 29% of high-income countries. It is reasonable to 
assume here that a country with higher health indicators has less need for a policy anchor in health.  
Legal tradition is associated with the likelihood of adopting a right to health—68% of civil 
law countries compared to 26% of mixed and 15% of common law countries had a right to health.5 
This is, however, not found to be an important confounding variable in regression analyses. 
The data shows countries across the 
democracy spectrum have largely split in adopting a 
right to health. Democratic countries, strongly 
democratic countries (customarily defined as those 
with a Polity-IV score at least 6), and autocratic 
countries each split nearly evenly between those which 
																																																								
4 O’Connell 2010. 
5 Legal system classification coded Muslim, civil law, common law, or civil/common law mixed based on University of Ottawa 
JuriGlobe University of Ottawa n.d.. 
Table	2.2	 	 	
Polychoric	correlations,	2010	 	
		
Right	to	
Health	 		
Income	category	 -0.16	 *	
Democracy	 -0.05	 *	
Legal	system	 0.33	 *	
*	.05	signif.	in	basic	correlation.	 	
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do and do not have a constitutional right to health. Interestingly, strongly autocratic countries have 
slightly more often adopted a right to heath—65% had done so in 2010. 
In sum, while some categories of countries are somewhat more likely to have a right to 
health, there is substantial variation across all types of countries. Table 2 shows the correlation 
matrix between the right to health and these variables, illustrating low correlations. The right to 
health is not unduly tied to major political economy classes.  
This suggests that the right to health is, as theorized, a distinct institution and that a cross-
national statistical analysis is appropriate to evaluate the degree to which this institution matters.  
 
Estimating Dominant Theories of Health: Wealth, Social Determinants & Democracy 
To begin, this chapter first builds a model of the dominant theories of what matters for 
health and then tests whether, within that context, a right to health provides any analytic leverage.  
The models here use under-5 mortality rates, the probability of death between birth and 5 
years per 1,000 live births, as the major outcome measure of interest to represent health outcomes 
following Caldwell.6 Under-5 mortality is widely recognized as the most appropriate indicator of 
the cumulative exposure to the risk of death during early years of life.7 Using under-5 mortality 
also provides us with two important theoretical advantages. First, it is a measure of health likely to 
be affected by health systems more directly than some others given its limited timeframe. Unlike 
infant mortality measures, however, under-5 mortality captures the effect of multiple years of 
potential intervention in the health of a person. If institutions matter for health then they should 
act by ensuring provision of medicines when people are sick, doctors to care for them, healthier 
living conditions, etc., which are likely well-captured in the first five years of life. Mindful of Ross’s 
findings that missing national health data are not random and have a considerable biasing effect on 
																																																								
6 Caldwell 1990. 
7 Ahmad, Lopez, and Inoue 2000. 
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cross-national research,8 imputed child mortality estimates developed by IHME9 are used to 
provide wide geographic and time cover for the 1970-2010 period.  
A series of models are assembled here with log under-5 mortality as the dependent variable 
to estimate the impact of having a constitutional right to health. There are strong time/progress 
patterns in the global dataset, which is addressed in two ways: by including the year as a control 
variable in the dataset (as a variable rather than a fixed effect, though both are tested) and by 
checking the robustness of the results with an auto-distributive lag model to account for these 
effects.  As described in the robustness checks below, cognizant of the potential connection between 
RtH provisions and the age and year of constitution and the legal system, each is tested as a variable 
and neither holds significant predictive power. The right to health, on the other hand, is shown as 
a significant factor in all of the estimations. 
 
Models 1 & 2: Wealthier is Healthier & Rights 
Perhaps the most consistent finding in cross-national studies of mortality is the curvilinear 
relationship between higher national income and lower mortality—illustrated by the classic Preston 
curve.10 This influential theory cum stylized fact that “wealthier is healthier” suggests that national 
income is the most important explanatory variable in understanding mortality.11 It explains not 
only outcomes, but also state capacity, expenditure and inputs.12 As such, I make use of an IHME 
data set with among the widest available GDP estimates in dollars running from 1970-2010.13 
Model 1 estimates the basic theory that GDP (logged) explains health outcomes.  
Figure 2.1 shows the clear trend in both 1970 and 2010 that, indeed, wealthier is healthier. 
The labeled countries are those with a right to health. We can see, beyond the clear expansion of 
																																																								
8 Ross 2006. 
9 Rajaratnam et al. 2010. 
10 Preston 1975. 
11 Summers and Pritchett 1996; Pritchett and Viarengo 2010. 
12 Gerdtham and Jönsson 2000; Hitiris and Posnett 1992. 
13 James et al. 2012. 
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countries with the right to health, that while healthier is wealthier many countries fall well above or 
below the line and thus under- or over-perform the expectations of the reduced form model.  
 While the graphs do not tell a clear story of significance, it does seem that there are more 
over-performers among those with the right to health than there are under-performers—providing 
some initial support to the theory. This also shows up in model 2 reported below, which adds health 
rights to the equation showing the impact of health rights in the context of the restricted “wealthier 
is healthier” hypothesis.  
Figure 2: Test of Wealthier is Healthier 
		
Model 3: Economic & Social Determinants of Health 	
If growth in GDP were the only reason for improved health, countries would move along 
a fixed curve without substantial change to that curve over time. But we see that over time people 
live substantially longer at a given level of income—China’s income rise has not been nearly as large 
as what would have been needed several hundred years ago to reach the life expectancy it has 
today.14 Preston himself noted that income growth explained only a comparatively small part of 
the life expectancy differences through space and time.15 
A large literature has attempted to establish the set of other national assets that affect 
mortality cross-nationally that can better reflect the demographic and social determinants of health. 
																																																								
14 Cutler, Deaton, and Lleras-Muney 2006. 
15 Preston 1975. 
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Several core variables including women’s education and ethnic fractionalization have consistently 
been shown to be associated with mortality, while others such as inequality have been debated. 
While the boundaries between theories are not always clear, much of the literature conforms to the 
expanded theory that these social and demographic factors differ between countries and cause a 
between-country gradient of health.16 Indeed, Filmer and Pritchett argue that they can explain 
nearly all variation in child mortality with just six economic and social factors.17  
While no consensus exists about the “right” set of variables that explain health, a set of 
often-discussed factors can be used to represent the social and demographic determinants of health. 
Theoretical explanations for including each variable are below along with basic measurement 
specifications. See Annex C for full sourcing and scaling.  
 
Female education is among the variables most widely found to be associated with lower 
child mortality.18 As a variable it has been found to be encompassing—capturing a variety 
of individual and social determinants of health including fertility level, women’s 
empowerment, economic resources available to households, and general knowledge and 
beliefs about disease and prevention.19 It is also likely a good representation of important 
aspects of state capacity.20 Here, estimates of the age-standardized mean years of education 
for men and women developed in Gakidou et al. are used, which provide wide cross-
national coverage between 1970 and 2010 for the mean years of education of women of 
reproductive age 15-44.21 
 
Ethnic fractionalization has been linked directly and indirectly to poorer mortality. The 
literature broadly suggests that ethnic fractionalization leads to an inability to coordinate 
																																																								
16 CSDH 2008. 
17 Filmer and Pritchett 1999. 
18 Caldwell 1986; Cleland and Van Ginneken 1988; Gakidou et al. 2010. 
19 Caldwell 1990; Sen 1999; Cleland and Van Ginneken 1988; Hatt and Waters 2008. 
20 Shen and Williamson 1997. 
21 Gakidou et al. 2010. 
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policy toward pro-health outcomes and reduces incentives for public goods creation.22 La 
Porta suggests that ethnic diversity leads to corruption and low government performance.23 
Lieberman shows that, in societies with strong ethnic boundaries, political resistance 
develops to addressing intra-group stigmatized health conditions like HIV/AIDS and 
reduces effective response to epidemics.24 This paper makes use of the widely used measure 
of ethnolinguistic fractionalization, based on the 1985 measure as calculated in Montalvo 
and Reynal-Querol,25 which represents the probability that two randomly selected 
individuals in a country belong to different ethnolinguistic groups. 
 
Inequality and its impact on mortality are hotly debated in the literature. Seminal studies 
have found a strong relationship between inequality and poor health outcomes on a variety 
of measures.26 Wilkinson & Pickett reviewed evidence showing that inequality was 
associated with low social capital and social mobility and more racism, along with higher 
rates of obesity, teenage birth, mental illness, and homicide.27 Others, however, have failed 
to find a direct relationship between inequality and health in a variety of measures and have 
suggested that other correlated factors are actually doing the work.28 Biggs et al. found a 
complex and contingent effect of poverty and inequality on health depending on the 
prevailing economic situation and that inequality and poverty exert independent, 
substantial effects on the relationship between national income level and health.29 The 
debate will not be settled here, thus inequality is included in the regression analysis. A 
robustness check of the regression without the measure shows it does not impact the 
analysis. One of the standard measures of gini coefficient is used here—the degree of 
inequality in national distribution of income among individuals or households, as 
																																																								
22 Alesina, Baqir, and Easterly 1999; Easterly 2001. 
23 La Porta et al. 1999. 
24 Lieberman 2009. 
25 Montalvo and Reynal-Querol 2005. 
26 Rodgers 1979; Wilkinson 1992. 
27 Wilkinson and Pickett 2007. 
28 Judge, Mulligan, and Benzeval 1998; Deaton 2003. 
29 Biggs et al. 2010. 
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calculated by World Income Inequality Database, which provides wide but imperfect 
coverage.30 
 
Urbanization and population density both reflect geographic and societal factors that are 
linked to health and mortality in a variety of relatively intuitive ways, such as disease 
transmission and density of health services, which are unlikely to be reflected in any of the 
other control variables.31 Since, while similar, they are not likely to impact mortality 
identically (e.g. denser but less urbanized populations might have better reach of health 
services while avoiding negative disease-transmission effects of mega-cities) are likely 
important. As such, following standard practice, measures of both are included as control 
variables.32  
 
Conflict/Political Violence is clearly a direct cause of excess mortality and a significant 
public health threat.33 A magnitude score of episodes of civil and ethnic violence and 
warfare developed by the Polity dataset34 was included in the original model. However, it 
fails to reach significance in any of the specifications and changes neither the model fit nor 
effect size of variables of interest substantially. As such, it is dropped from the base model. 
This comes as little surprise since other factors above including ethnic fractionalization and 
women’s education likely soak up the direct effect given the complex nature of political 
violence.35  
 
Region and year are both also included in all the regressions, as is customary. Controls for 
time encompass a variety of factors including technological progress and scientific 
																																																								
30 UNU-WIDER 2010. 
31 Cutler, Deaton, and Lleras-Muney 2006; Galea 2002. 
32 Filmer and Pritchett 1999; McGuire 2010. 
33 De Jong 2010. 
34 Marshall 2014. 
35 Pedersen 2002. 
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knowledge.36 Regional dummies help control for the effects of colonial history and region-
specific differences in political stability.37  
 
Model 4: Institutions Matter—Democracy  
Amartya Sen puts it clearly: “Individuals live and operate in a world of institutions. Our 
opportunities and prospects depend crucially on what institutions exist and how they function.”38 
He suggests that examining both political and socioeconomic freedoms are critical. Yet while the 
connection between democracy and health has been much analyzed, the conception of a right to 
health as a critical institution shaping socioeconomic freedoms has been insufficiently examined. 
Both of these intuitions likely operate indirectly, likely through the provision of services and 
orientation of the state to health efforts.  
A significant set of authors in several disciplines have argued democracy—conceptualized 
and operationalized to include the elements of both free, competitive elections and core political 
freedoms—reduces child mortality and improves life expectancy.39 As an institution Sen proposes 
that democracy has both an instrumental and a constructive role in health and development—
proving a “hearing” for a population’s needs and allowing them to be understood in societal 
context.40 Building on this, some suggest that democracies’ responsiveness to public opinion and 
openness to social movements concerned with health lead to improved outcomes.41 Acemoglu and 
Robinson argue that the biggest change in democracy is who controls political power—the masses 
or the rich elite—with democracy favoring mass interests in public goods like health rather than 
private wellbeing.42 Bueno de Mesquita et al.’s work suggests that democracies encourage public 
health provision because, as opposed to small-selectorate autocracies, leaders in democracy are held 
																																																								
36 Deaton 2013. 
37 Englebert 2000; Alesina et al. 1996. 
38 Sen 1999. 
39 Gerring et al. 2016; Gerring, Thacker, and Alfaro 2012; Besley and Kudamatsu 2006; Przeworski et al. 2000; Lena and London 
1993; Moon and Dixon 1985. 
40 Sen 1999. 
41 Shandra, Shandra, and London 2010. 
42 Acemoglu and Robinson 2005, 107. 
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accountable by a large electorate, from which they must form a winning coalition that likely benefits 
from public health improvements.43 
But other research has shown that whether democracy has a direct effect on health is much 
less clear.44 Ross finds, for example, there is no direct effect of democracy on infant or child 
mortality after filling in often-dropped but important countries and suggests this is due to a failure 
of benefits and spending to pass to the poorest sectors of society.45 
Given the theory, Polity-IV is used here as a measure of democracy, which provides an 11-
point scale from -10 (autocracy) to +10 (democracy) measuring executive recruitment, constraints 
on executive authority, and political competition. Of the available measures, it is most likely to 
capture the kind of democratic environment theorized in the literature to improve mortality.  
 
Model 5: Constitutional Right to Health 
Democratic governance, however, represents only half of the rights paradigm—so called 
“first generation” civil and political rights. The core research question is whether socio-economic 
rights, in this case the right to health, have an additional role in shaping the institutional milieu that 
affects health. Do constitutional health rights matter for people’s health, even controlling for 
wealth, social and demographic determinants, and democracy? Therefore, the final model includes 
the constitutional right to health variable alongside the variables for the three other explanations. 
	
Estimation Strategy  
The following model is estimated as the core “Right to Health” model: 
yit =β0t +β1 right to health i, t-1 + β2 democracy i, t-1 + β3 GDP per cap i, t-1 + gΖ it-1 + αi +εit 
 
Y represents health outcomes, in this case log Under-5 mortality, while Z represents a 
matrix of additional controls for the expanded “wealthier is healthier” model. Here αi represents 
																																																								
43 De Mesquita et al. 2002. 
44 McGuire 2013; McGuire 2010; Nelson 2007; Weede 1993. 
45 Ross 2006. 
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time stable “unobserved heterogeneity” between countries not otherwise accounted for and ε is the 
error term.  
 
Specifically: 
Ζit = β4 female education it + β5 ethnic fractionalization it + β6 inequality it + β7 urbanization it + 
β8 population Density it + year + ε 
 
A wide variety of estimation strategies are available for time series, cross-sectional panel 
data—none of which are perfect, which suggests the use of several alternative estimators. Variations 
on ordinary least squares is among the most widely used because of its ease of interpretation and 
strong efficiency performance. This model employs OLS for the core model conducted using Stata 
with standard errors reported (Table 2.3), with lagged independent variables. Conscious of the 
complex error structures that characterize panel data, however, a series of additional regressions 
using different estimators was also conducted for robustness checks that the findings hold. As Reed 
and Ye find, “estimators that perform well on efficiency grounds may perform poorly when 
estimating confidence intervals, and vice versa.”46 The core model is therefore fit with three 
additional estimators: FGLS, PCSE, and an ADL model. Parks’ Feasible Generalized Least Squares 
(FGLS) estimator is a common alternative to OLS, but is known to underestimate error terms in 
comparatively small and finite samples like those used in cross-national research.47 Beck and Katz 
suggest a version of OLS with panel corrected standard errors (PCSE) though this too has been 
criticized as inefficient in “practical research situations.”48 Variations on autoregressive distributed 
lag (ADL) models can also help account for a variety of weaknesses in standard OLS.49 ADL models, 
however, shift the analysis away from long-term process effects on levels to one of short term 
change and, in models like ours, is likely to substantially underestimate the effects of all IVs while 
																																																								
46 Reed and Ye 2011, 986. 
47 Parks 1967. 
48 Beck and Katz 1995; Reed and Webb 2010. 
49 De Boef and Keele 2008. 
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increasing the risk of falsely significant and insignificant coefficients due to measurement error.50 
Focus on levels over annual change better fits this paper’s theory and also has the advantage of 
making the quantitative analysis comparable to previous studies that estimate the dominant 
theories used as a basis for this analysis.51 The core model uses a random effects model at the 
country level with time (year) as a continuous IV and fixed effects at the region level. Beck and Katz 
(1995) and others have argued for the use of country fixed effects specifications in order to deal 
with omitted variable bias, but since the theoretical function of a right to health is as much about 
between-country effects as within-country effects this is not ideal. A right to health is still significant 
in a fixed effects specification but, for these reasons, it is not used here for the core estimation. 
Perhaps even more importantly, the inclusion of unit dummies severely biases the estimates of the 
true effect of time invariant or slowly changing dependent variables such as ours. “In these cases, 
allowing for a mild bias resulting from omitted variables is less harmful than running a fixed effects 
specification.”52 To better check the effects of regional effects, a fully multilevel model is also fit in 
which countries are nested within regions. The results for each of these estimation strategies are 
included in Table A of the Annex—each supporting the core finding that the right to health has 
significant independent effect on health outcomes.  
 
Results	
Table 2.3 shows the main regression results. Each model includes both the coefficients of 
the regression results and a column in which all of the independent variables are transformed into 
standard deviation equivalents for easier comparability.	
As expected, in the sample higher log GDP per capita was strongly associated with lower 
mortality rates. A first check in model 2 confirms that having a right to health in the constitution 
has a significant beneficial effect on mortality, even when considering wealth.  
																																																								
50 Achen 2000; Huber and Stephens 2001, 58. 
51 Filmer and Pritchett 1999; Przeworski et al. 2000. 
52 Plümper, Troeger, and Manow 2005, 334. 
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The variables in model 3, reflecting the fuller social and demographic determinants of 
health, show strong predictive value—together they provide a good model for under-5 mortality, 
with each of the values showing significance with the anticipated sign. As expected, income and 
women’s education have an effect that is both significant and large, with a clear but more moderate 
effect of ethnic fractionalization. In line with some of the debates in the literature, however, 
inequality is significant but has a much weaker effect, when controlling for the other variables in 
the model.  
Columns 7 and 8 show that, in the sample, even after controlling for the broad 
determinants of health, democracy has a statistically significant beneficial impact on under-5 
mortality. As we might expect from the literature, however, that impact is somewhat muted. A one 
standard deviation change in democracy score provides less than 5% of the impact that a standard 
deviation change in per capita GDP has in the model. Given the indirect nature of the theorized 
effect, and the inclusion of other factors that soak up much of the variation, this should not surprise 
us. 
Columns 9 and 10 of the table show us that having a constitutional right to health is 
associated with a decrease in under-5 mortality, significant at the 1% level, even after controlling 
for the most common explanatory variables. Not surprisingly, the effect is small compared to, for 
example, income or women’s education that together account for much of the state and societal 
capacity to address health. But it is notable that the effect is the equivalent of a major change in 
polity score—as large as going, in 2010, from a country like Iran, Belarus or Libya (under Gaddafi) 
to one like Switzerland or Costa Rica. It has a similar effect as going from the ethnic diversity of 
Malawi or Colombia to that of the Netherlands. This suggests an important institutional effect, 
bolstering the theory that having a right to health is beneficial for health outcomes. 
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Additional Robustness  
With the use of a variety of additional estimators described above (and in Annex A) these 
findings appear quite robust. In the full models (model 5) the data covers 144 countries through 
the use of imputed and estimated data on most variables. While not every country is covered and 
not for every year, the added coverage addresses Ross’s chief concerns of biased results by providing 
estimates for non-reporting countries across the democratic and economic spectrum. This 40-year 
dataset includes results for three times as many observations (3,584) as Ross reports in his 30-year 
panel and more than twice as many as Przeworski et al. in their 40-year dataset.53 Inequality data 
is the most incomplete data, a challenge this analysis shares with many studies and which is 
problematic to address through imputation beyond what is included here, so as a robustness check, 
regressions were re-run without the gini measure and also without the measure of democracy.54 
This raised the number of countries observed to 161 and the observations to 6,013 but did not 
substantively change any of the findings.  
To check the robustness of the findings the regressions were also repeated under a series of 
different conditions that might theoretically change the findings. None did. Because the majority 
of Eastern European countries have a right to health and comparatively few countries in the 
U.S./Canada/W. Europe group do, I re-ran the core mortality regression without each region and 
see no change in the effects. Clearly there is also a trend toward including a right to health in 
constitutions. To test whether there is some omitted effect of having recently written a constitution 
or simply of the era of the constitution in force, both the age of the constitution and the year in 
which it was written were tested in the regression. Neither was significant and RtH remained 
significant. To test whether the right to health is simply standing in for the legal system both a 
dichotomous civil/common law variable and a 5-level variable for legal system as outlined above 
was included as an IV. Neither is significant or affects the results. 
 
																																																								
53 Ross 2006; Przeworski et al. 2000. 
54 Jenkins 2014. 
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Assessing Health Equity: The Sex Ratio Model  
If the right to health works as theorized, then it should produce not just lower mortality 
rates, but greater equity in access to the services and conditions that enable wellbeing. Large-n data 
for cross-national comparisons in wellbeing across social cleavages is difficult to come by. One such 
measure, however, can be found in sex-differentiated mortality data. Under conditions in which 
girls and boys have the same access to resources such as food, healthcare, and living conditions, 
boys have higher mortality rates than girls owing to early-life biological advantages.55 Yet as 
Amartya Sen famously observed in many parts of the world this female advantage is eroded when 
girls are deprived of medical care and nutrition, resulting in millions of “missing women.”56 The 
“sex ratio” of child mortality rate is thus an important measure to help understand the degree of 
equity in national health and social systems.57 While some countries, notably India and China, 
experience overall sex imbalances due to selective abortion, ratios of under-5 mortality rates instead 
detect differential early access to health-enhancing resources.58  
On this basis, an additional model was constructed to estimate the effect of the right to 
health on the ratios of under-5 mortality of boys compared with girls. We used data developed by 
the United Nations Inter-agency Group for Child Mortality Estimation (UN IGME), which 
estimated annual rates of under-5 mortality for 153 countries.59 Each country had a maximum of 
three observations, one per decade, so our total N for this panel is significantly smaller. Nonetheless 
it provides an important, validated cross-national measure to assess health equity. An additional 
OLS regression was conducted using this data in two models: one (7b) that includes only health 
right by itself and another that includes the full base model used above. Each of the regressions 
																																																								
55 Waldron 1987. 
56 Sen 1992. 
57 Sawyer 2012; United Nations 2011. 
58 Hill and Upchurch 1995; Million Death Study 2010. 
59 Sawyer 2012. 
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Table	2.4:	Right	to	Health	&	Sex	Ratios
Model	7(a) Model	7(b)
Sex	Ratio Sex	Ratio
	 (Under	5	Mortality) (Under	5	Mortality)
Health	Right 1.836** 1.788*
(0.677) (0.890)
Under	5	Mortality	 -4.088** -0.426
(0.471) (1.327)
Log	GDP	(pc) -0.349
(0.803)
Democracy				 -0.018
(0.061)
Women's	Education	
(years) 	 1.214**
	 (0.289)
Ethnolinguistic	
Fractionalization 2.877
(2.521)
Inequality -0.030
(0.048)
Urbanization 0.066
(0.041)
Population	Density 0.000
(0.001)
Year	Control yes yes
Regional	Fixed	Effects no no
Observations 408 275
Number	of	Countries 143 121
R2 0.386 0.397
**	p<0.01,	*	p<0.05,	+	p<0.1
All	independent	variables	are	lagged	one	year.	Standard	errors	are	listed	in	
parentheses.	Constants	not	reported.
includes the overall under-5 mortality rate, taking note of epidemiologic impact of different overall 
levels of mortality on the sex ratio.60  
The results are shown here in Table 2.3. In both models, the right to health is associated 
with a small but significant increase in the sex ratio of under-5 mortality. This holds even including 
a measure of women’s education levels that likely includes important aspects of discrimination and 
equity at work in differential mortality rates. This suggests greater equity in access to healthcare 
and health-enhancing resources in countries with a constitutional right to health. This adds support 
to the overall theory of a positive institutional effect of the right to health and confidence that the 
theorized mechanisms of action remain plausible.  
 
 
 
 
 
 
  
																																																								
60 United Nations 2011, 66. 
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Democracy & Health Services: evidence on the functioning of a right to health 
 
The central claim of this chapter is that a right to health is a broadly beneficial institution 
for population health. If this claim is true we should be able to see its effects in the politics and 
policy of countries. Given the theory of the right to health relies on courts, social movements, and 
bureaucracies we might also expect to see that the right operates differently in more democratic 
environments. Evidence of both is presented below—quantitatively in this section and further 
developed qualitatively in section 4. 
 
Democracy   
Much existing literature has investigated whether democracy improves health, with mixed 
results as described above. In this context one might assume that constitutional rights and the 
attending institutional environment are not likely to matter nearly as much as the simple ability of 
populations to demand health and mobilize through the electoral process to demand government 
changes. The evidence in Table 2.3, however, undermines this presumption. The broader 
institutional environment—including the protection of health as a right—may actually help explain 
why democracy by itself seems insufficient to promote large changes in health.  
Constitutional rights can operate in contexts weak in electoral democracy—especially in 
contexts where courts and/or bureaucracies are powerful and at least quasi-independent.61 
Nonetheless, the operating of the right to health, as hypothesized above, is likely most effective 
where democracy is stronger. If it does represent a political institution that give rise to organizations 
and claims, those organizations and claims surely operate more effectively where political protest 
and electoral pressures can be used to articulate and enforce them. This would be what we might 
expect from Sen’s point that entitlements and political process are distinct but interdependent 
phenomena. Conversely, however, it might be that the right to health is simply a byproduct of 
democracy—simply reflecting the will of a pro-health governing coalition. To test this question, the 
																																																								
61 Ginsburg and Moustafa 2008; Peerenboom and Ginsburg 2013; Solomon 2007. 
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(1)
Model	6
	 Interaction	Model
Health	Right -0.075**
(0.011)
Health	Right	X	
Democracy -0.006**
(0.001)
Democracy				 0.002
(0.001)
Log	GDP	(pc) -0.299**
(0.012)
Women's	Education	
(years) -0.082**
(0.006)
Ethnolinguistic	
Fractionalization 0.344**
(0.121)
Inequality -0.002**
(0.001)
Urbanization 0.006**
(0.001)
Population	Density -0.000**
(0.000)
Year	Control yes
Regional	Fixed	Effects yes
Observations 3,584
Number	of	cowcode 144
regional	dummies yes
r2 0.894
Table	2.5:	Right	to	Health	&	Democracy	Interaction
DV:	Log	Under	5	Mortality	(per	1,000	live	births)		1970-
All	independent	variables		lagged	one	year.	Standard	errors	are	listed	in	
parentheses.	Constants	not	reported.
**	p<0.01,	*	p<0.05
main estimation is replicated with an interaction effect between democracy and a right to health 
included. The results in table 2.5 show that with this interaction the RtH remains significant, as 
does the interaction term, but democracy loses significance. This provides strong support to the 
contention that a right to health has an independent power, which is made significantly stronger in 
a context of democratic governance. This power does not seem to be simply a byproduct of 
democracy—and indeed we cannot reject the null hypothesis that democracy has no effect that is 
not accounted for by other parts of the political institutional environment. This is explored further 
in the brief case studies below.  
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 Health Spending & Service Delivery 
In thinking about a right to health, no one would suggest that it operates directly—courts 
cannot order that people become healthy any more than legislators can craft laws that do so. 
Specifying in detail the exact mechanisms through which a right to health operates is the subject of 
later chapters. However, there is significant qualitative and quantitative evidence that supports the 
mechanisms theorized above. This section presents data showing that countries with a 
constitutional right to health deliver more and better health services to their populations—just one 
part of improving health, but an important one.  
The wealthier is healthier paradigm suggests a neoliberal policy agenda with very little 
priority for the project of public health and provision of health services—one that assumes health 
will inexorably follow improvements in economic situation. Many have challenged this paradigm, 
arguing that, regardless of income level, health spending, provision of health services, and 
prioritization decisions are essential for health outcomes.62 McGuire shows this empirically—
demonstrating, for example, that to achieve a decline of 5 points in infant mortality a country might 
have to decide between a goal of increasing GDP per capita by $391, reducing inequality by 9.4 gini 
points, or increasing the share of births attended by a skilled attendant by 13%.63  
If the right to health operates as hypothesized, health service provision should be a critical 
part of the story and we would expect a clear direct effect of having a right to health on service 
delivery. To explore this, the right to health is tested on a series of spending and health service 
delivery measures. Several of the key variables from the previous regressions that are suggested in 
political science and economics literature to affect policymaking are also included as control 
variables. Specifically, spending, policy coordination, and expanded health service delivery have 
been linked to national wealth, ethnic boundaries, inequality, and democratic governance.64 State 
capacity is also clearly related to service delivery, which GDP significantly accounts for. The other 
measure that also partially accounts for state capacity in the dataset, women’s education, is 
																																																								
62 Sachs and McArthur 2005; Kim, Farmer, and Porter 2013; Deaton 2013. 
63 McGuire 2010. 
64 Alesina, Baqir, and Easterly 1999; Besley and Kudamatsu 2006; Gerdtham and Jönsson 2000; Lieberman 2007. 
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problematic to use here since it is itself a service delivery measure—and, in fact, inclusion does not 
dramatically change the results and actually lowers the fit in several models and so it is not included 
here. 
Table 2.5 shows the outcomes of the spending and service delivery regressions. There is a 
significant effect of having a right to health on two commonly-used measures of health services—
the percent of births attended by a skilled health worker and the rate of DTP3 immunization of 1-
year-olds. Both show a clear and significant positive relationship: 7.6% more children’s 
immunization and 3.8% more skilled birth attendance is associated with countries having a right to 
health, even controlling for wealth and democracy. Having a constitutional right to health is 
associated with higher public spending on health as a percent of GDP, but the finding does not 
reach statistical significance. However there is a significant relationship with higher public 
spending as a portion of total health spending. We cannot be sure that governments spend more 
overall, but they do clearly pick up a larger portion of the overall health tab in countries with a right 
to health—leaving people themselves less to spend. This is seen again in the lower percentage of 
health expenditures coming “out of pocket” for patients. Health spending is not an uncontroversial 
measure since the direct effect of spending on health outcomes is debated.65 Nonetheless, the 
finding that, controlling for other variables, people have to spend less on health in countries with a 
right to health could help explain the observed mortality differences. Especially among the poor, 
lower spending by patients is likely to increase use of preventive and curative health services.  
The final measure is the median availability of common generic medicines (%) in the public 
sector, using data from the World Health Organization. This variable is included because of the 
strong case-study data explored below that the right to health may be seen most visibly in provision 
of medicine to people through court cases and government policy-making. The measure is only 
limitedly available, however, and should be taken with a note of caution (the regression includes 
2004 data, which has the widest country coverage at 16 countries). The relationship, however, is 
																																																								
65 Sachs 2001; Filmer and Pritchett 1999. 
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notable: 30% more medicines are available in the countries with a right to health and the finding is 
significant.  
These data suggest that the right to health is strongly related to pro-health spending 
patterns and service delivery, with the medicine data suggesting that the pathway seen in case-study 
evidence may be widespread and significant. 
Annex B includes results from the main regression using the under-5 mortality DV while 
controlling for measures of spending and service outcomes as IVs. As expected, the right to health 
still appears to decrease mortality, but the findings are not significant in four of five formulations 
and the magnitude of the coefficient is substantially reduced. This result supports the idea that the 
right to health is having its impact by working through the health system (rather than capturing 
some unrelated aspect of society), which follows findings by Rajkumar & Swaroop that governance 
institutions (health rights) are often the bridge between public health spending and health 
outcomes.66  
  
																																																								
66 Rajkumar and Swaroop 2008. 
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Table	2.6:	Health	Rights	Effect	on	Spending	&
	Service	Delivery
1970-2010	(except	m
edicines	availability	2004)
(1)
(2)
(3)
(4)
(5)
(6)
DVs:
Public	Health	
Expenditures	(%
	
GDP)
Public	Health	
Expenditures	(%
	
Total	Health	Exp)
Out	of	Pocket	Exp	
(%
	Total	Health	
Exp)
Skilled	Birth	(%
	
Attended)
Im
m
unization	(%
	1-
year	DTP3)
Availability	of	
M
edicines	in	the	
Public	Sector	
(2004)
Health	Right
0.087
2.573**
-1.713+
3.780**
7.657**
29.775*
(0.103)
(0.963)
(0.921)
(1.212)
(0.992)
(11.559)
Dem
ocracy				
0.449**
3.783**
-3.578**
7.444**
2.740**
-13.736*
(0.073)
(0.733)
(0.809)
(0.928)
(0.665)
(5.073)
Log	GDP	(pc)
0.017*
0.162*
-0.109
0.173*
0.099
2.703**
(0.008)
(0.072)
(0.071)
(0.082)
(0.061)
(0.773)
Ethnolinguistic	
Fractionalization
-1.130*
-6.741
2.796
-20.361**
-16.426**
-91.192**
(0.471)
(4.856)
(5.708)
(6.663)
(4.433)
(20.477)
Inequality
-0.016**
-0.256**
0.068
0.042
-0.228**
2.004
(0.006)
(0.052)
(0.049)
(0.060)
(0.055)
(1.293)
Year	Control
yes
yes
yes
yes
yes
yes
Observations
1,309
1,756
1,323
607
2,857
15
Num
ber	of	
Countries
111
143
113
124
144
15
R
2
0.577
0.393
0.352
0.526
0.377
0.821.
**	p<0.01,	*	p<0.05,	+	p<0.1
All	independent	variables	are	lagged	one	year.	Standard	errors	are	listed	in	parentheses.	Constants	not	reported.
Chapter	Two:	Estimating	the	Effects	
	
64	
DV:	
Amenable	
Mortality	
(per	100,000)
Health	Access	
&	Quality	
(0-100)
Health	Right 	-46.47** -22.56** 3.56** 0.85*
	11.49 (8.58) (.81) (0.40)
Log	GDP	(pc) -84.36** 5.84**
(6.10) (0.31)
Women's	Education	(years) -5.32+ 1.46**
(2.89) (0.16)
Year	Control n yes n yes
Observations 835 771 835 771
Number	of	Countries 180 167 180 167
R2 0.03 0.65 0.76 0.79
Table	2.7:	Testing	Healthcare	&	Amenable	Mortality
**	p<0.01,	*	p<0.05,	+	p<0.10
All	independent	variables	are	lagged	one	year.	Standard	errors	are	listed	in	parentheses.	Constants	not	reported.
Confirmatory Evidence: Healthcare Access and Quality 
Finally, as an overall check on the findings in this chapter, two additional dependent 
variables were tested that measure amenable mortality and healthcare access and quality. Barber et 
al. used data from the 2015 Global Burden of Disease study to create estimates of mortality from a 
subset of causes like AIDS, diabetes, or appendicitis that is broadly amenable to effective and timely 
health care, removing much of the effects of local environmental and behavioral risks.67 They also 
construct a summary measure–the Healthcare Quality and Access (HAQ) Index. These measures 
provide significant benefit over other measures in that they get directly at the question of healthcare 
which, as discussed in the chapters that follow, is where much (but not all) of the activity of 
constitutionalization plays out. Unfortunately, estimates are only available for a limited number of 
years—meaning that when we use these measures as our DV there is insufficient power to test our 
full model against all the covariates. The right to health is, however, appears beneficial when the 
full model is run. In a paired down model where we test the right to health alone and include the 
most critical controls—GDP and Women’s Education—the right to health is significant and 
beneficial. Countries with a right to health have lower amenable mortality and score better on the 
index of healthcare access and quality.  
 
  
																																																								
67 Barber et al. 2017. 
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Conclusion 
Health data across four decades supports the contention that the right to health is good for 
people’s health. Estimating the most widely promulgated theories of the economic and social 
determinants of health and the connection between health and democracy provide a basis from 
which to empirically evaluate the effect of the right to health. While it is broadly true that wealthier, 
more equal, homogenous, and democratic countries are healthier, this chapter shows that even 
taking that into consideration, a constitutional right to health is a significant and beneficial 
institutional factor. More children survive until their 5th birthday in countries with a right to health, 
at least in part because the institutional environment shaped by a right to health encourages more 
and better delivery of health services.  
It is clear, however, in the case-study evidence presented in subsequent chapters that rights 
can be an important institution for promoting health and that constitutional provisions provide a 
basis for action. Suggestions that a right to health might actually undermine health outcomes are 
not supported by the data from a recent forty-year period. Instead, the evidence suggests that health 
actors would be well advised to attend to constitutional drafting processes as they seek to improve 
the health of nations.  
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CHAPTER 3:  CONSTITUTIONS & HEALTH POLICY CHANGE—  
  QUALITATIVE EVIDENCE 
 
 
 
 
 In 1970, just a handful of countries had enshrined a right to health in their national 
constitutions. Fewer than fifty years later, just over half have done so. How does this matter for 
health policy?  
 Quantitative data presented in chapter 2 showed that countries with a constitutional right 
to health have better health outcomes, even after controlling for the dominant social, economic, 
and political explanations for cross-national variation in wellbeing.1 The impact after these controls 
is small but statistically significant—consistent with a relatively new institution in the political 
economies of health in countries. Those with a right to health do not spend more on health overall, 
but a larger portion of what they do spend is public—with lower out-of-pocket costs, wider 
availability of medicines, and better coverage of key health services. More evidence is needed, 
however, to establish the causal mechanism at work here—especially in the face of skepticism from 
																																																								
1 Kavanagh 2016. 
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scholarship in international development, judicial politics, and public health that variously ignores, 
dismisses, or expresses alarm at moves to constitutionalize health.  
 In this chapter I show how constitutionalization impacts wellbeing—describing evidence 
of important political institution-building. That this innovation is being led from countries in the 
global South is all the more reason to attend to its impact, including potential lessons for both 
similar countries and countries like the U.S., where health inequity remains a challenge and policy 
change is often blocked. Several important collections on the right to health have advanced our 
understanding of litigation and judicial action—with evidence of mixed and conditional impact.2 
Using a broader policy process approach that de-centers court orders to focus on policies that 
influence wellbeing and access to healthcare, I show it is in the “shadow of the law”—the process, 
language, and threat of litigation—where health rights matter most.3 In that context, it is notable 
that health-enhancing impact can be seen in countries with large and complex health challenges. 
 Based on fieldwork tracing policy processes in South Africa, India, Malawi, and Thailand, 
I find that constitutionalizing health creates an institutional context that is more health- and health 
equity-conducive. It is not only, or even primarily, a story about courts and legal orders—which 
some see as an anti-democratic way to tackle complex distributive issues. Instead, I show that, 
where a right to health is institutionalized, the process of health policymaking is different. The right 
to health acts as a policy anchor: for modern governments buffeted by a multitude of issues and 
countervailing pressures, constitutional rights can focus political power and attention to improve 
health policy. It acts through three mechanisms: 1) Unblocking policy change by dismantling closed, 
monopolistic policy processes: Even in strong democracies, complex issues in health policy are 
delegated to sub-systems of bureaucrats, experts, and interest groups that often exclude outsiders 
and defend the status quo. Anchoring health in the constitution gives the opportunity to “expand 
the conflict” by shifting some questions to courts and other rights venues, which destabilizes these 
closed systems and opens room for policy change; 2) Improving the bargaining endowments of key 
																																																								
2 Gauri and Brinks 2008; Yamin and Gloppen 2011; Flood and Gross 2014. 
3 Policy process: Sabatier and Jenkins-Smith 1993; Baumgartner, Jones, and Wilkerson 2011. Mnookin and Kornhauser 1979 on 
‘shadow’ idea. 
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actors: Rights mobilization does not end bargaining over policy issues but puts a particular set of 
tools at the disposal of state and non-state actors seeking to spur health-enhancing policy change. 
Discovery can bring out information; subpoenas can call individual policymakers to account; 
reputational risk posed by litigation can raise the incentives for action by policymakers; and 
public/media narratives can legitimate change—all of which affects bargaining outside the 
courtroom, regardless of any court order; 3) Providing reasons for action: Anchored in the core 
national political bargain, constitutional health rights provide a discourse with the power to 
undermine ideas that legitimate closed policy monopolies while enhancing the legitimacy of policy 
options focused on action over inaction. 
 These mechanisms connect constitutionalization to policy and, through policy, to 
improved health outcomes—contesting the skepticism about the impact of constitutional health 
rights that can be seen in several contexts. For example, neither the World Health Organization’s 
Commission on Macroeconomics and Health nor its Commission on Social Determinants of 
Health recommended writing or amending constitutions to include health rights, even though the 
WHO Constitution was among the founding documents conceptualizing health as a right.4 U.S. 
and OECD-based health policy research can include a broader perspective on how law might 
impact policy by attending to innovations in health governance coming out of the global South.5 
This also challenges international development scholarship to look beyond democracy and 
property/market institutions as the keys for development.6 These elements have proved powerful 
in oft-cited Nordic examples—where enviable health achievement without constitutionalization 
has been evidence for skeptics.7 A broader perspective, however, shows these standard institutions 
have proved insufficient to foster significant advances in population health and the health security 
of communities in many countries.8 The complex, diverse contexts where much of the world’s 
																																																								
4 Sachs 2001; CSDH 2008; Marmot et al. 2012.  
5 Law and health in much of the U.S. (e.g. Hacker and Skocpol 1997; Kersh and Morone 2002; Oberlander 2010; Peterson 2011) and 
comparative work (e.g. Immergut 1992a; Marmor and Wendt 2012; Fox 2014) is limited to OECD experience. 
6 Przeworski et al. 2000; Besley and Kudamatsu 2006; Haggard, MacIntyre, and Tiede 2008; Acemoglu 2012; Gerring et al. 2016. 
7 Hirschl 2011, 458. 
8 Ross 2006; McGuire 2010; Powell-Jackson et al. 2011; Wullert and Williamson 2016; and see Ogata and Sen 2003 on human 
security.  
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preventable mortality occurs (e.g. low- and middle-income countries; regions of the U.S.) are 
replete with examples in which democratic pressures alone fail to deliver policy change needed to 
secure wellbeing. Scholars are thus increasingly exploring a broader set of health-supporting 
institutions that can “enable communities to press governments into action on a sustained basis.”9 
I show constitutionalization does just this. Finally, understanding a constitutional health right as a 
“policy anchor” also questions one of the most dominant metaphors in legal studies, which 
describes rights as “trumps.”10 This conceptualization helps explain the concern that rights will 
distort good public health policy if inexpert, unelected judges usurp power from policymakers, 
negate necessary trade-offs, and apply individualist frameworks. I show, however, that rights in 
these cases do not short-circuit the policy process—acting instead as institutions to increase the 
opportunities for, and likelihood of, health-enhancing policy change.  
 This chapter proceeds as follows: I begin with an overview of the methods used to trace the 
impact of the right to health on policy outcomes. I then describe in detail the findings of this study 
on the mechanisms through which constitutionalization impacts health policy. Later chapters in 
this section explore these mechanisms across a variety of health policy issues and contexts through 
case studies—beginning with a multi-part chapter on South Africa that details in depth examples 
on emergency medical services, HIV treatment, and tuberculosis in prisons and then explores an 
additional set of issues where the right to health was mobilized and then a chapter that explores 
issues similarly mobilized in India. The annex includes brief case studies on Malawi and Thailand 
that extend this work. Together, these cases reveal how the right to health operates in these 
countries as an important, beneficial part of the political economy of health in countries where it is 
institutionalized.  
 
 
 
																																																								
9 Hall and Lamont 2009, 15. 
10 On “trumps” see Dworkin 1978, who worried about socioeconomic rights in S. Africa according to Albie Sachs (2009). And see 
Sunstein 1993; Landau 2012. 
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Methods & Concepts: A Policy Process/Political Economy Approach  
 This chapter is based on over 165 semi-structured interviews conducted between 2013 and 
2017 during fieldwork in South Africa, India, Malawi, and Thailand. As discussed in chapter 1, 
these countries were chosen to enable a paired within-case analysis of India and South Africa and 
then to test findings in different systems in Malawi and Thailand. The goal of the interviews was to 
reveal evidence on the causal impact of constitutionalizing health as a right through “process 
tracing.”11 Key informants in the interviews included elected officials, civil servants, judges, lawyers, 
activists, and academics with first-hand knowledge of policy processes under exploration. These 
interviews were supplemented with archival research from a variety of sources. A full 
methodological discussion appears in chapter 1; the interview protocol and list of interviews are in 
the appendix. 
 To understand the institutional effects of constitutional rights and assess their impact, we 
need to look at the whole policy system, of which courts and the legal complex are just one part. In 
this sense I build off, but depart from, important previous studies of health rights that center 
litigation, and instead focus on tracing the policy process over a decade or more.12 I place these 
processes in an applied political economy framework that identifies both the key structural features 
and relevant individuals and organizations, as well as how their motivations (financial, political, 
ideational) and relative power lead to eventual policy outcomes.13 Research began by identifying 
from initial interviews, a set of health-related policy issues during the past two to three decades in 
which multiple informants suggested the right to health had been “mobilized.” Since the goal of 
this portion of the research is to gain inferential leverage on what happens when the machineries 
of constitutionalization are engaged, we focus on tracing policies where rights are mobilized to 
understand whether this matters for the policy process and, if so, how. I use the term “mobilized” 
here following the work of legal mobilization scholars to indicate actors making use of rights as a 
strategic tool to change policy and/or practice—which might include litigation, threat of litigation, 
																																																								
11 Tarrow 2010; Bennett and Checkel 2014. 
12 Sabatier and Jenkins-Smith 1993, arguing that “a decade or more” is needed to evaluate a policy process. 
13 Hall 1997; Besley 2006; Bump and Reich 2013; Fox and Reich 2015. 
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filing complaints to a rights body, and using other legal tools to assert a rights-based claim.14 At any 
given moment, in each country under study, there were many active health policy issues—from 
insurance regulation to medicine safety to staffing clinics, etc. Many saw no rights mobilization. 
The health policy issues where rights were mobilized became the units of this study—and for each, 
I have worked to trace the policy process from a time at least several years before rights mobilization 
to several years after. Some might argue this reflects selecting on the dependent variable. The core 
question for this section, however, is how constitutionalization works. Does it, as critics argue, 
distort health policy and undermine democratic pressures? Or is it beneficial to health policy and 
outcomes? This effort builds off the large-N correlation-based evidence in chapter 2 which shows 
a mortality dividend from constitutionalization and tests whether there is a causal pathway that 
would support this result. This section therefore uses a different logic of “within case analysis” to 
generate greater and deeper causal leverage over the effect of institutionalized health rights—to 
directly link rights with policy change (or not) and rule out rival explanations. While it is tempting 
to instead try to pair policy issues with or without rights mobilization in a difference-in-difference 
design, this is unlikely to add to casual identification with a small universe of issues characterized 
by multiple interaction effects.15 Instead, using “causal process observations” provides the chance 
to augment the between-case data with mechanism-based evidence connecting rights with policy 
outcomes and health impact.16 I therefore sought to identify as many of the issue areas where rights 
were mobilized as possible—using multiple initial interviews to craft the issue list and reaching 
exhaustion in both South Africa and India. While my cases explore the universe of examples I 
identified, there may well be others. I am confident I have identified most of the major issues, but 
for my purposes the list need not be exhaustive. My goal in this section is not to quantify impact, 
but to gain analytical leverage over the causal processes at work and whether constitutionalization 
is positive, negative, or inconsequential for eventual health policy. 
																																																								
14 McCann 1994; Scheingold 2004; Simmons 2009. 
15 George and Bennett 2005, 170–8. 
16 Collier, Brady, and Seawright 2010. 
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 Table 3.1 lists the policy issues identified in South Africa and India where rights 
mobilization occurred, arranged roughly by the impact of constitutional rights on eventual health 
outcomes—policy issues traced in chapters that follow. This is a broad-strokes continuum of 
impact, more illustrative than quantitative, meant to show that while each issue saw rights 
mobilization, the degree to which rights mattered was not uniform—a reality returned to below. 
Table	3.1:	Health	Policy	Issues	Subject	to	Rights	Mobilization	by	Nominal	Level	of	Impact	
Impact	 South	Africa	 India	
High		 HIV	Treatment	 HIV	Treatment	
		 Eliminate	User	Fees	 Intellectual	Property	&	Access	to	Medicine	
	 Drug	pricing	 LGBTI/Sodomy	Laws	
	 Eastern	Cape	Emergency	Services	 Clinical	Trials	
	 		 Rural	Health	
	 National	Health	Insurance	 Emergency	Medical	Care	
	 Private	Sector	Health	Inquiry	 Maternal	Health	
	  Irrational	Medicines	
	 Silicosis	&	TB	in	Mines	 Charitable	hospitals	
		 Migrants	access	to	health	 Private	Healthcare	Regulation	
Low	 TB	in	Prisons	 Drug	Pricing	
Source:	Author	estimations.	Impact	level	is	roughly	nominal	based	on	author	estimation	but	is	not	systematically	measured.	
 
 In the South Africa and India cases below, I present results of a content analysis of nearly 
1,500 newspaper articles from fifteen years dealing with the right to health, demonstrating that the 
constitutional right to health is addressed in the public and political discourse of the country. I call 
this availability, meaning the idea of a constitutional right to health is recognized beyond the 
discourse of lawyers, which is a precondition for mobilization.  
 My hypothesis in this section is that the right to health functions as an institution as 
theorized in political economy literature. That institution might be more or less well-established, 
and, if my hypothesis is correct, the right will have more effect where it is more institutionalized. 
For this purpose, I operationalize institutionalization loosely as a continuum based on the presence 
of the following: 1) a clear, enforceable right to health in the written constitution; 2) decisions by 
the national apex court enforcing the right; and 3) national legislation referencing the right. Each 
chapter below identifies countries’ degree of institutionalized right and distinguishes the degree of 
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institutionalization from the degree of impact on health policy. Table 3.2 shows it ranges from 
South Africa to Malawi (most to least). I note, and explore in greater depth in Chapter 4, that India 
is seemingly unique in the world in the degree of litigation on health rights based on a judicially 
derived right to health through a constitutional right to life.  
 
 
 
 
 
 
 
Theoretical Framework: Policy Change, Democracy, and Rights 
 
  This section describes in greater detail the mechanisms across the various policy issues 
studied in South Africa, India, Malawi, and Thailand and the context for our conclusions. In brief, 
we can see that health policy change is often needed to improve health, but blocked. Democracy is 
the most widely studied political institution theorized to improve health policy, but examples from 
this research illustrate that democratic pressures are often insufficient to spur change. In practice, 
a variety of institutions and practices block policy change under democracy—most prominently, 
widespread policy monopolies that prevent policy entrepreneurs from disrupting the status quo. 
Such monopolies are regular features of policy environments since policymaking attention is 
inherently limited and delegation to sub-systems is necessary as policy agreements are reached and 
attention moves on. Securing policy-change to improve health, however, requires overcoming the 
stability of equilibriums which will be easier in some institutional environments than in others.  
 In this context, scholars have drawn attention to the broader need to understand 
institutions of “successful societies” beyond electoral democracy that promote population health 
Table	3.2:	Institutionalization	of	the	constitutional	right	to	health	
	 1.	clear	right	in	the	
written	constitution	
2.	enforcement	
decisions	by	apex	court	
3.	legislation	
referencing	right	
South	Africa	 ü	 ü	 ü	
Thailand	 ü	 	 ü	
India	 	 ü	 ü	
Malawi	 ü	 	 	
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and ensure health security for their people.17 The constitutionalized right to health should be seen 
in this context—it functions as a distinct institution, and its impact on health outcomes can be 
linked directly to its role in policy change. As outlined below, constitutionalizing health makes 
health-enhancing policy more likely by destabilizing policy monopolies and increasing bargaining 
power of policy entrepreneurs, while providing “reasons for action” as ideational resources that 
support these mechanisms. 
 
Policy Change & Improving Health  
 
 Through tracing policy areas in which the right to health is mobilized, I find that a key 
piece of the power of constitutionalizing health comes in how it unlocks opportunities for policy 
change. In health, policy change is necessary to improve outcomes and equity over time. 
Knowledge, technology, and capacity drive progress in health, yet all require political action to 
move from idea into impact. As Angus Deaton traces, significant differences in health outcomes up 
to the present day can be directly attributed to the translation of basic medical and scientific 
knowledge into practice—translation mediated by politics, policy, and state capacity.18 The specific 
element of “change” is important. Without opportunity to depart from the status quo, health and 
sanitation services are not expanded to reach those excluded; emerging health issues are not tackled 
in new and technologically optimal ways; financing systems are not reformed to meet changing 
demographics; social determinants are not tackled with new responses; and local institutions are 
not required to adapt to changing national priorities. 
 Where policy change is blocked, the prospects for improving health are limited. In 
particular, addressing health inequities, which requires addressing historical legacies in healthcare 
and social determinants, is especially dependent upon policy change.19  
																																																								
17 Evans 2009. 
18 Deaton 2013, 93–100. 
19 Smith, Hill, and Bambra 2015; Navarro 1995; Beckfield and Krieger 2009. 
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 While on some health issues the best policy is contentious and unclear, answers for many 
of the biggest health issues driving cross-national differences in wellbeing are not particularly 
complex or controversial. AIDS treatment saves lives; ambulances and midwives are critically 
important for rural areas; rampant TB epidemics inside prisons have to be controlled. I find that 
where rights are being mobilized, the policy change needed is most often to: a) decide to act in the 
first place; b) spread the decided action to all places and parts of the population; c) ensure 
implementation on the frontlines; and d) ensure tools and resources for implementation are made 
available. I use the term “better” or “improved” health policy below largely in this vein, albeit not 
uncritically, and try when possible to link policy to outcomes. 
 Policy change is, of course, not inherently positive. Indeed, there are some examples below 
in which pro-health actors sought to limit change. On the whole, however, with the advance of 
knowledge, I show it is often blocked policy change in South Africa, India, Malawi, and Thailand 
that inhibits health. My point is that there is every reason to expect that “policy stability” is a barrier 
to improving health and equity.20  
 
Is Democracy, Not Rights, Spurring Change? Empirical & Normative Arguments 
  
 In this project, one of the biggest challenges is distinguishing between the effects of life 
under a constitutional democracy—with electoral competition, open media, social movements, and 
some degree of separation of powers—from the effects of constitutionalizing health as a right. They 
are of course inter-related and, as shown in chapter 2, there is significant interaction between the 
two concepts. My goal in this section, however, is to seek to separate the effects—to trace the effects 
of constitutionalizing health as distinct from the effect of these other freedoms. Theoretically, the 
right to health is a “positive” right and content-specific—framing health-related obligations of the 
state in terms of individuals and duty-bearers. As I explain further below, constitutionalization of 
health has the effect of “anchoring” health policy and expanding the set of actors engaged in the 
																																																								
20 I use the term policy stability from (Tsebelis 2002) to particularly connote systematically blocked policy change. 
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policy process—providing new tools in the service of realizing health capabilities. One challenge to 
this narrative is the suggestion that what is actually being observed is the effective deployment of 
the mechanisms of electoral democracy—that the improvements in wellbeing observed in chapter 
2 can in fact be better explained by electoral competition, party ideologies allowed to compete for 
influence, social movements free to demand accountability and gain attention in open media, and 
the other freedoms of life under more open government.21  
 It is therefore worth briefly reviewing the literature on health and democracy as context 
before proceeding to explain the mechanisms through which the qualitative case studies suggest 
the right to health acts on population wellbeing—which, I find, include some of the same elements 
that are theorized to matter under democracy but, in practice, often fail to unblock needed policy 
change.  
 There is a significant body of thought—most prominently described by Amartya Sen—
suggesting the electoral pressures and political freedoms of democratic regimes contribute to 
improved health and longer lives.22 These claims have empirical support in political science,23 
economics,24 and public health.25 The connection is distal—working largely, though not exclusively, 
through policy change. Many find the link between democracy and health to be missing, small, or 
highly contingent, as I will return to later. Nonetheless, there is a well-developed set of four broadly 
constructed mechanisms from literature that analysts suggest link democratic governance and 
greater likelihood of pro-health policy change—which might be shorthanded as incentives, 
information, accountability, and association. Political economy work finds governments facing 
popular elections have greater incentive to provide public goods, including public health. Elected 
leaders are forced to respond to the “median voter” who benefits from redistributive public health 
efforts, while autocrats who depend on a small, identifiable “selectorate” have the option of 
																																																								
21 I ground this discussion in a “democracy” that most closely resembles what Dahl labels “polyarchy”—focused on electoral 
competition, constraints on executive power, and protection of civil and political freedoms. Dahl 1971.  
22 Sen 1983; Sen 1999. 
23 Moon and Dixon 1985; Przeworski et al. 2000; Navia and Zweifel 2003; McGuire 2010; Wigley and Akkoyunlu-Wigley 2011; 
Gerring, Thacker, and Alfaro 2012. 
24 Besley and Kudamatsu 2006; Kudamatsu 2012. 
25 Lena and London 1993; Franco, Álvarez-Dardet, and Ruiz 2004; Ruger 2005; Welander, Lyttkens, and Nilsson 2015; Lin et al. 
2012; Mackenbach and McKee 2013; Patterson and Veenstra 2016. 
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targeting club goods instead.26 Others find electoral democracy shifts incentives by allowing 
emergence of Left parties committed to health and welfare expansion.27 Information has been 
shown to be critical—a flourishing press and opposition politics under democracy can ensure both 
health information for the public and information to government about how to calibrate policy. 
Democracy encourages provision of data and explanations for policies, as “democratic elections 
(with choice of parties) forces the party in power to justify its policies or reform them in accordance 
with people’s needs.”28 Electoral competition also provides the accountability mechanism through 
which voters can punish leaders who fail. Democracy raises the expectations of equity, demand for 
health services, and the expectation that health will improve, to which politicians must respond if 
they do not want to face the wrath of “retrospective” voters. Freedom of association under 
democracy also encourages health policy change. Civil society and social movements demand 
greater public action on health and spread health information directly.29 The development of 
knowledge networks of experts, officials, and interest groups can drive pro-health policy change. 
These key mechanisms of electoral democracy suggest that democracies should encourage policy 
change toward improving public health.  
 Democracy is also seen as a normative good for health—electoral democracy provides not 
just empirical short-term health benefits but a just model for health policymaking that gives voice 
to the population, including those worst off, and promotes polycentric policymaking able to 
balance different needs and interests.30 Elections change the preferences of rulers which changes 
policy—and by extension policy change that cannot be explained by elections and related freedoms 
lacks democratic legitimacy. Rights enforcement is thus suspect in such distributive politics: if they 
act as a “trump” and bring an inappropriately “strong” and individualistic framework to health 
																																																								
26 Meltzer and Richard 1981; De Mesquita et al. 2002; Boix 2011; Acemoglu and Robinson 2005. 
27 Huber and Stephens 2012, 105, 148; and see Moon and Dixon 1985; but see Haggard and Kaufman 2008 who find a more 
contingent role for Left parties.  
28 Ruger 2005, 301, and on voters demands see Powell Jr and Whitten 1993; Berry and Howell 2007; Hobolt, Tilley, and Banducci 
2013. 
29 Haggard and Kaufman 2008, 16; Cordner, Brown, and Morello-Frosch 2014. 
30 Ruger 2005. 
Chapter	Three:	Qualitative	Evidence	
	
	
79	
policy that needs cooperation and balancing it could undermine the “public” in public health.31 
Hirschl suggests resort to law primarily serves to preserve hegemonic dominance against more 
democratic redistribution of resources.32 The “countermajoritarian difficulty” of courts may be 
especially problematic in such a context with limited resources in which the health needs of the few 
could very directly undermine the health of the many if inexpert courts distort health policy.33 
 There is, however, increasing challenge to the empirical link between health and 
democracy—with many studies either challenging the link or finding it has very significant scope 
conditions.34 While democracy may often work as theorized (see e.g. McGuire’s work showing 
democratic pressures in South Korea and Indonesia triggering policy change35) evidence suggests 
democracy is insufficient to ensure large-scale public health advances. While idealized democracy 
should result in improved health, politics often prevents the translation of knowledge and evidence 
into policy and practice.36 The United States provides a key example in which, despite a much-
touted democracy, health policy change has remained blocked for decades at a time. Scholars have 
linked this failure to political culture, class structure, powerful interest groups, and political 
institutions that diffuse power and create myriad ways for interest groups to block health-
enhancing change.37 The particular role of the wealthy in blocking policy change favored by, and 
beneficial to, majorities is notable.38 The core question for wellbeing, then, may well be less about 
deliberation and more about whether political institutions can effectively support diffusion of a 
normative commitment to wellbeing taken forward in policy change.39 
 In tracing the impact of the right to health, there are two particular questions that need 
answering: First, is constitutionalization as I have framed it doing the work or is policy change 
																																																								
31 Dworkin 1978; Siegler 1980; Kapur 2013. And see Epstein and Stannard 2012, 265; Epstein 1997 for a broader economic attack on 
the idea of a right to healthcare, arguing it distorts markets and results in poorer health overall. 
32 Hirschl 2004. 
33 Bickel 1962. But see Graber 1993 arguing judicial review can actually increase accountability and Scheppele 2005 arguing that 
under some conditions courts can be more democratic than elected officials—a theme I return to below.  
34 Gauri and Khaleghian 2002; Shandra et al. 2004; Ross 2006; McGuire 2010; Powell-Jackson et al. 2011; Chuang et al. 2013; Batniji 
et al. 2014; Mackenbach and McKee 2013; Wullert and Williamson 2016. 
35 McGuire 2010, 223-7-73. 
36 Smith 2013a. 
37 Morone 1990; Hacker and Skocpol 1997; Oberlander 2007; Steinmo and Watts 2008; Marmor and Barer 2012. 
38 Bartels 2009; Hacker and Pierson 2010; Page, Bartels, and Seawright 2013. 
39 Ruger 2007. 
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actually attributable to other democratic pressures? And second, is constitutionalization giving 
courts too much power and distorting health policy by “trumping” a balanced public health 
approach—ending important policy debates with court orders focused on the needs of the few? 
 
Beyond Democracy: Institutions and Policy Change 
 
 There is a robust literature in political science and economics that finds that political 
institutions, democratic and undemocratic alike, often support the status quo. Literature on veto 
players, for example, shows that policy change is often blocked if there are many veto players with 
significant ideological distance between them who are internally cohesive, resulting in “policy 
stability.”40 Historical institutionalists have also shown that in any given policy battle, prior 
decisions limit options for the very kind of policy change that may be needed to enhance health.41 
Policies become “locked in” as path-dependent processes create new constituencies, administrative 
capacities, and expectations among policymakers and the public, which work to sustain policy 
equilibriums in self-reinforcing political cycles.42 Institutions act as filters for knowledge 
translation—selectively favoring only certain interpretations of policy goals and the possible means 
to achieve them.43 Meanwhile, officials facing electoral uncertainty and expecting their political 
rivals to reverse their policy decisions have plenty of room in democratic systems to take proactive 
steps to protect those decisions by insulating agencies and programs from the future exercise of 
public authority.44 In this sense, there is every reason to expect that even in democratic politics, 
there will be major barriers to health-enhancing policy change.  
 Scholars have increasingly shown how institutions can shift—both dramatically at “critical 
junctures” and through endogenous, incremental changes over time.45 Competing institutions that 
																																																								
40 Immergut 1992b; Tsebelis 2002; König, Tsebelis, and Debus 2010, vol. 16. 
41 Steinmo, Thelen, and Longstreth 1992; Pierson 1996; Hacker 2002; Katznelson 2009; Fioretos, Falleti, and Sheingate 2016. 
42 Pierson 2000. 
43 Weir 1992; Smith 2013b. 
44 Moe 1990; Moe 2005. 
45 Mahoney and Thelen 2009. 
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provide new venues for policymaking can be a critical part of overcoming institutional limits to 
policy change—which is a key element of constitutionalizing a right to health.  
 Kingdon’s influential framework notes that policy change is driven by “policy 
entrepreneurs”—individuals and groups pushing new ideas.46 While some literature assumes 
democratic pressures will trigger preference shifts in rulers—by convincing those in office or by 
replacing them—this often does not hold. 
 In practice, a great deal of health policymaking occurs not in the macro-political sphere of 
elected officials but instead in what Cobb & Elder call “systems of limited participation.”47 These 
systems have been well described in political science literature—variously called policy monopolies, 
policy sub-systems, iron triangles, and sub-governments.48 Punctuated Equilibrium Theory (PET), 
pioneered by Baumgartner and Jones, identifies these systems as the reason why even clearly 
disadvantageous policy equilibriums and stability are maintained for long stretches with only small 
changes.49 The critical idea is that modern governments throughout the world must address a wide 
variety of policy issues simultaneously and, in the regular course of policymaking, delegate many 
to sub-systems in which a smaller group of officials, bureaucrats, experts, and interest groups do 
much of the work of policymaking.50  
 These sub-systems often become “policy monopolies” that seek to exercise exclusive 
control over both the decision-making and political understanding of a policy issue and can block 
(or enact) change. They may do so for a variety of reasons: Bureaucratic agents are often risk averse; 
caught in a complex web of competing interests in which any change is likely to rouse the ire of 
some powerful constituency, bureaucrats are often the enemies of change.51 Prospect theory 
explains why a variety of actors in these sub-systems, worried about the unknown implications of 
upsetting the current policy equilibrium, may similarly act to maintain the status quo.52 Others, 
																																																								
46 Kingdon 2003. 
47 Cobb and Elder 1971. 
48 Adams 1981; Berry 1989; Sabatier and Jenkins-Smith 1993; Weible, Sabatier, and McQueen 2009. 
49 Baumgartner and Jones 1993; Jones and Baumgartner 2012. 
50 Walt et al. 2008; Shiffman 2007; Timmermans and Scholten 2006; Green-Pedersen and Walgrave 2014; Ohemeng and Anebo 2012; 
Liu and Jayakar 2012; Tosun 2013; Lam and Chan 2015; Chan and Zhao 2016; Baumgartner et al. 2015. 
51 Wilson 1989, 69, Brehm and Gates 1999; Wood 2010; Workman 2015. 
52 Kahneman and Tversky 2000; Mercer 2005. 
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meanwhile, are motivated more directly by financial or personal gain. As a result, in practice, policy 
monopolies are recognizable and common: 
 
“Policy monopolies have two important characteristics. First, a definable 
institutional structure is responsible for policymaking, and that structure limits 
access to the policy process. Second, a powerful supporting idea is associated with 
the institution. These buttressing policy ideas are generally connected to core 
political values…”53 which legitimate the exercise of exclusive authority over 
policymaking. 
 
A key point here is that monopolies deflect the attention of the macro political sphere—high-level 
politicians and officials—who lack both interest in attending to the policy issue (since they see 
delegation to the monopoly as legitimate) and the capacity to attend to the issue (given constraints 
on time and competition for space on the political agenda). By marshaling a politically resonant 
central idea, they justify both the content of the policy and the continuation of their existence. 
Actors conduct “maintenance” of the monopoly—taking small actions that defect criticism while 
bolstering the idea at the core of the monopoly and, through “communicative discourse” aimed at 
macro political actors, give the impression the monopoly is acting appropriately and taking 
criticism into account.54 Monopolies thus create a mechanism for “negative feedback” in which 
challenges to the status quo do not grow into significant policy change but instead are dealt with 
inside a closed system where cosmetic changes maintain overall stability. Policy entrepreneurs, 
especially those lacking substantial political power, are not able to mobilize the macro political 
stream to attend to their reframing of problems and solutions.55 Monopolies often explain the lack 
of policy change where democratic pressures were applied and failed. 
 A good example can be seen on the issue of Emergency Medical Services in the Eastern 
Cape of South Africa, which I take up in depth in Chapter 4.1. For decades, EMS services were 
basically nonexistent in much of the rural province due to policy legacies from the Apartheid era, 
and policy change was blocked by a small monopoly of self-interested actors—some directly 
																																																								
53 Baumgartner and Jones 1993, 7. 
54 Schmidt 2008 on discourse and Mondou, Skogstad, and Houle 2014; Wyszomirski 1998 on monopoly maintenance. 
55 Shiffman and Smith 2007. 
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benefiting, some just risk averse—protected by a few powerful regional politicians. Media exposés, 
patient complaints, and even pressure from national government were all defected into 
bureaucratic change management plans that went nowhere, shielded by the idea that 
“transformation” would take time but people should have faith in the ANC, party of liberation and 
Nelson Mandela.56 
 These insights about policy change give structure to my findings. Centrally, what I show in 
the qualitative studies of policy issues in the following chapters is this: constitutionalization creates 
important opportunities to disrupt policy monopolies and open space for policy change. 
 
Constitutionalizing Health: Rights as a Policy Anchor  
 
 Constitutionalizing health as a right, in this study, shows an appreciable effect on policy in 
ways that enhance health and health equity. It does so because a constitutional right to health acts 
as a “policy anchor.” For contemporary governments buffeted by a wide variety of countervailing 
political currents and winds, it focuses political attention and power in health-enhancing ways. In 
monetary policy, an “anchor” refers to a long-term policy commitment (e.g. money supply or 
exchange rate targets) used to achieve price stability. Policy outcomes independently and flexibly 
take shape around the nominal anchor, as a wide array of market and public sector actors change 
their expectations to address economic conditions in ways that result in inflation control.57 A policy 
anchor thus sets background assumptions that remove certain important questions from the day-
to-day political and economic vicissitudes. It encourages progress toward a goal while setting the 
power of the state against actions that would undermine it. The cases explored below in South 
Africa, India, Malawi, and Thailand suggest the right to health operates in this way—providing a 
stable anchor point in a sea of competing forces that legitimizes a particular direction for state 
action and provides a point of leverage for policy entrepreneurs. In this way, the constitutional right 
																																																								
56 Patel 2013; Prince, Horner, and Makhubu 2007; Sapa 2007; Mkokeli 2002. 
57 Mishkin 2007, 4–20. 
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becomes an institution governing the political economy of health—part of the “rules of the game” 
that create a logic of “appropriateness” for specific actors to engage in specific actions in specific 
venues.58 While it is tempting to see the right to health as simply instrumental rhetoric for political 
actors, an institutional view understands that law and constitutions constrain some actors, 
empower others, and privilege a certain range of policy options.59 As I document below, 
constitutionalization anchors health in a particular politics that encourages weakening of policy 
monopolies that block change and unlocks specific tools which increase the bargaining power of 
pro-health actors, while providing reasons for action that prove powerful in health policy debates. 
 Given the relative ubiquity of institutional barriers to health-enhancing policy change, the 
search for alternative institutions that support pro-health policymaking is important. Ruger argues 
that a normative right to health is best understood through a health capacity paradigm as an “ethical 
demand for health equity.”60 It should not simply be a legal principle for courts to enforce access to 
healthcare, but instead is a claim for social organization toward redistribution of resources to 
provide people the capacity to be healthy, requiring diffusion of a norm throughout society and 
concomitant political action in legislation and regulation. Recognizing that this norm is far from 
sufficiently diffused in most societies, however, I argue constitutionalization is doing the work of 
advancing this norm across multiple venues inside and outside courts.61  
 Norm diffusion happens because the right works as an anchor, not as Dworkin’s metaphor 
of a “trump.” Looking at the whole policy cycle on issues where the right to health is mobilized, 
rather than starting with litigation, shows how a right to health works differently. I show that in 
nearly all cases described below, policy processes that feature right-to-health mobilization do not 
end in court decisions. Bargaining that does take account of balancing needs and weighting 
priorities continues, but with power relationships and normative frameworks that are different 
from how they would be without the rights mobilization. Court cases while important, play a largely 
																																																								
58 March and Olsen 1983; Chang 2011. 
59 Smith 1988; Burgess 1993; North and Weingast 1989. 
60 Ruger 2010, 118. 
61 See, e.g. work on norm diffusion in Finnemore and Sikkink 1998; Risse-Kappen, Ropp, and Sikkink 1999, though whether the 
source of the norm in this case is international is less important here than the effects of constitutionalization. 
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indirect role. Few policy changes are attributable only to court orders; many are traceable to the 
threat of orders and the experience of being challenged in courts. Rights become resources in the 
hands of a variety of actors, which they make use of outside the courtroom—and in so doing 
advance a norm. Rather than standing in tension with Ruger’s focus on norm diffusion over legal 
enforcement, I find evidence that the right to health in practice provides new actors and venues an 
opportunity to get involved, a reason to do so, and a normative framework for that engagement. 
 
Deconstructing Health-Related Policy Monopolies 
 
 By anchoring health in the core national political-legal agreement, a constitutionalized 
right to health helps open policy cycles—drawing the attention of the macro political sphere to 
critical health issues and destabilizing problematic policy equilibrium. The institutional 
environment under constitutionalization makes a specific “venue shift”—going to court—a clear 
recourse for actors excluded from policymaking. In this way, it opens new opportunities to, in the 
words of Schattschneider, “expand the conflict” to include others who may be more favorable to 
their policy change and shift the power dynamics that allow some perspectives to be ignored.62 
These “losers” in health policy are often those whose shorter lives and higher rates of illness drive 
poor health statistics and who are depending on some form of policy change to better address their 
ill health.63 Alongside them are the policy entrepreneurs inside and outside government who are 
promoting policy ideas that are not taken up and policy change that does not happen because of 
exclusive cycles and spaces. These policy entrepreneurs are, under a rights framework, also “norm 
entrepreneurs” seeking to promote a new ethnical framework for health policy decisions. In health, 
																																																								
62 Schattschneider 1975; Mortensen 2007, 347. 
63 Of course, there are certainly examples of other losers in some health policy decisions—tobacco corporations in high-income 
countries, for example. In public health policy, however, not only are corporations less often the obvious losers but importantly they 
largely were previous winners. The move to regulate an industry on public health grounds was often itself policy change that began 
with destruction of a previous policy monopoly. (Cairney 2007; Worsham 2006; Givel 2006). This idea of winners becoming losers 
who then continue as actors in the policy cycle admittedly requires further explanation in the literature, but as “losers,” regulated 
companies face a distinctly different challenge from attracting attention to destroy a policy monopoly. 
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these may include government public health officials and bureaucrats with ideas that challenge the 
status quo, civil society groups and activists, academics, and opposition politicians.  
 Both the idea of rights and the possibility of going to court bring a powerful actor into 
health policy: the legal complex. This includes, most prominently, lawyers—and particularly “cause 
lawyers”—who hold a position of power and privilege in society. Cause lawyers, however, are just 
one part of this broader legal complex that includes government lawyers, judges, court 
administrators, bureaucratic actors as drafters and appliers of regulation, and technical specialists 
in law, such as accountants.64 In many countries, in addition to official judiciary, there are quasi-
judicial entities such as human rights commissions, ombudsman offices, and others, which exercise 
some of the key power and capacity of other judicial bodies.  
 In the example mentioned above in the Eastern Cape, entrepreneurs inside government 
(including the short-lived head of the health department) and outside (e.g. NGOs and AIDS 
activists) offered policy solutions to a widely recognized public health problem but came up against 
strong interests in maintaining the status quo. As detailed in the chapter below, the Human Rights 
Commission (HRC) became an alternative venue to address blocked health policy on emergency 
medical services. Leveraging the legitimacy of the HRC brought powerful new allies from the 
Commission into the policy issue, who dealt with the question of EMS on rights terms and actively 
brought the voices of rural Black South Africans into the policy sphere alongside those who had 
traditionally exercised exclusive authority. 
 In health policy, excluded health policy entrepreneurs—especially those facing policy 
monopolies that are particularly resistant to democratic pressures—who can harness the power and 
legitimacy of the legal complex to challenge the monopoly are more likely to open space for policy 
change. It is worth noting that most of the work of the legal complex is not rights work, per se—it 
is instead the adjudication of disputes of various sorts, including disputes between different 
branches of the state. Courts get their “courtness” from this work, which provides a reserve of 
legitimacy that can then be used in the service of rights work that may challenge the state more 
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directly.65 Thus, a shift in venues out of health-related policy spaces inside the state bureaucratic 
and political policy arms and into judicial or quasi-judicial bodies can bring powerful allies in the 
goal of opening policy to review and participation by others. Even strong policy monopolies may 
be required to open themselves to review and questioning in courts, given the broad power they 
exercise to legitimately do just that.  
 There has been a significant push by the executive and sometimes the legislatures in each 
of the case studies to try to weaken the courts—but little of that seems to be tied specifically to 
judicial engagement in health rights cases, but it does explain why the court in several cases seem 
wary of going further than they do. What we can see here, though, is that court intervention is 
important but bargaining and venue shifting is more important than court orders as the major 
driver of change, thus constitutionalization does not rest alone on any court’s enforcement of a 
particular minimum core obligation alone.  
 
Increasing Bargaining Endowments of Health Policy Entrepreneurs 
 
 Socio-legal scholars have long shown that most disputes that could be brought to court 
never are, and most of those disputes that are brought to court result in bargaining rather than clear, 
authoritative decisions. Much of the import of the legal system on more standard civil matters is 
not what happens in court decisions and enforcement, but “in the shadow of the law.”66 Such is the 
case in the health rights policy issues observed in South Africa, India, and Thailand. In different 
but parallel ways, law and rights protection in each context shows the prospect of changing the 
relative power of actors, because the threat of third-party intervention shapes social interactions. 
Courts provide “bargaining endowments” to actors outside the courtroom—giving information to 
all parties about both the substantive entitlements and the rules/process that would likely be applied 
if a party were to resort to a courtroom challenge. 
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 On the other hand, mobilizing the right to health can bring a far wider set of “action 
repertoires” than just enforceable court orders to open health-related policy issues to attention.67 
While I use terms that come from law and the judiciary, they play out in various spheres under 
constitutionalization by changing the relative power of players in broader policy negotiations. 
These include: 
• Discovery of information, as judicial and quasi-judicial bodies have the power to compel 
the sharing of evidence. This enforced sharing can have significant impact on destabilizing 
policy monopolies that thrive on selective sharing of information. Democratic theorists 
value information flows as a key mechanism—informing leaders about problems to be 
solved, voters of the performance of their government, publics about health threats—and 
they are key to policy change. Exclusive control over information is thus an important force 
for policy stasis. As doctors and AIDS activists in South Africa shifted their fight to the 
courts it was publicly shown that each of the Mbeki government’s reasons for not rolling 
out antiretrovirals was based on false or misleading information.  
• Subpoena of officials is a key part of the accountability function of legal institutions and a 
key way rights can drive improved health policy—increasing transparency and 
encouraging coordination across divisions.68 That high-level officials from Eastern Cape 
government were forced to show up, listen to testimony of affected communities, and 
present their response in front of the public changed the power dynamics between the state 
and communities. In interviews, officials themselves identified that experience—more than 
the HRC report and recommendations themselves—as the reason for changes in policy 
since “…I was forced to explain certain things that had been standard practice and, in fact, 
some of them I could not explain.” (Interview SA-29; and SA-27) 
																																																								
67 By action repertoires I mean here a broader conception that just political campaigning or social movement literature but the full 
range of tactics deployed by a wide variety of political actors, most similar to how the term is used in Kriesi, Tresch, and Jochum 
2007. 
68 Gloppen, Gargarella, and Skaar 2004. 
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• Reputational risks associated with being the subject of judicial or quasi-judicial inquiries 
change the incentives of policymakers—officials prefer not to be ordered into court and 
take action to avoid it. In India, interviews with government officials showed how on HIV, 
maternal health, and other issues action and attention came when senior officials realized 
they would have to directly connect themselves to the existing policy status quo through 
appearances or affidavits. “Somebody comes running to me saying that, ‘Sir, we have to do 
something. Otherwise on the 13th of next month you have to appear before this judge.’ 
Then all the stops will be pulled out and something would be done. (Interview IN-42) 
• Media narratives that come from rights-based venues improve the bargaining power of 
entrepreneurs. The law requires a certain kind of language and argumentation that, while 
often inaccessible in its details, can also provide clearer narrative about the need for policy 
change. Whether they are exonerated or condemned in the end, the spotlight turned on 
health policies challenged as producing rights violations is bright and can be especially 
important where arcane, technical-seeming issues are couched as such to preserve a policy 
monopoly. In the Novartis case the narrative shifted, under the spotlight of the case in the 
public view. The multinational pharmaceuticals industry sought to keep the conversation 
focused on technical details about the WTO and increased efficacy as an appropriate 
standard in Section 3(d) of the Indian Patent Act, but it quickly became about whether the 
State could achieve its obligations to provide essential medicines without placing limits on 
excessive patenting by multinational pharmaceuticals.  
 
 Policy researchers have shown that actor power is a critical factor in policy change in health 
and development issues.69 Together, the set of resources described above shifts the bargaining 
endowments in health policy in favor of change over inaction and entrepreneurs over those 
invested in the status quo. Increased information flows, personal accountability of officials, and 
increased incentives to act are all products of rights mobilization that, even without a court order, 
																																																								
69 Shiffman and Smith 2007. 
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shift negotiations—with the potential to change the goals and framing of policy, the process of 
policymaking, and its implementation.  
 
Ideational Tools & “Reasons for Action”  
 
 Rights are also, of course, ideas. Work in the area of discursive institutionalism has 
provided increasing clarity on how ideas function on multiple levels to affect policy and both shape 
and are shaped by institutions.70 Much of the anxiety about constitutionalizing health lies in the 
power of rights as an idea. Dworkin reportedly worried that a rights framework would be too strong 
and absolutist for use in South Africa in policy areas such as health.71 Looking at rights in the 
context of a broader policy process approach in South Africa, India, Thailand, and Malawi, 
however, shows the idea of health rights has mostly been used instead as “reasons for action.”72  
 Within institutions that change slowly, ideas are central tools for promoting policy change. 
Rights provide a new language that legitimizes claims making by individuals and groups. “This is 
our right” as an idea is quite different from “we want” or “we need”—and its discursive power lies 
in being able to disruptively inject the capabilities of individuals and groups into policy discussions 
framed only in aggregates and budgets.73 Specifically, health rights as “reasons for action” are a 
mechanism to improve health in several ways: 
 Most obviously, the idea of rights provides the legitimacy for a venue shift and the 
deconstruction of policy monopolies. Rights, as ideas, are far more easily mobilized by policy 
entrepreneurs than by policy monopolies. In South Africa, the constitutional provision in Section 
27 that explicitly mentions not just a right to health, but specifically emergency services, provided 
the reason for the HRC to act when requested. Meanwhile, as Baumgartner and Jones note, ideas 
used to legitimate monopolistic policy cycles are impenetrable in certain venues but less so in 
																																																								
70 Schmidt 2002; Schmidt 2008. 
71 Dworkin 1978; Sachs 2009, 168; Tushnet 2009. 
72 Sen 2004; Beitz 2009 share this framework of reasons for action.  
73 Ruger 2006. 
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others.74 In health, concepts like “cost-effectiveness analysis” or “sustainability” or “financial risk 
protection” have walled off key decisions as technical, bureaucratic areas of authority when they 
are, in reality, issues of distributive politics. Thinking in rights terms, the legal complex brings a 
new set of standards for judging acceptable conduct. As an issue moves venues and the dominant 
idea that might otherwise have deterred intervention is undermined in the framework of rights, the 
policy monopoly begins to crack.  
 Secondly, rights provide an ideational framework that encourages change and contributes 
to the bargaining power of policy entrepreneurs. Institutions impose constraints on what ideas 
agents may take into consideration—and rights can shift this ideational scope. South African courts, 
for example, have disrupted the powerful idea that limited resources in health-related policy is an 
endpoint of health policy debates. They have instead used a discourse in which “progressive 
realization” and “reasonableness” require attention to time—how and when health services will be 
provided, not whether.75 In this way, ideas can operate on policy at multiple levels—from the most 
simple type of policy solutions to broader macro philosophies. The effect of conceptualizing health 
as a right can be seen in the case studies here not just in courts, but in the actions of government 
officials, bureaucrats, civil society actors, and others. The right to health in these cases operates as 
a mid-range idea—a framework or “program” that underpins policy and policy cycles.76 The result 
is not jettisoning complex balancing of public health, but instead an infusion of urgency and 
specificity into that balancing, which lends particular weight to policy options that emphasize 
action and delegitimizes those that focus on stasis.  
 Finally, ideas also shape coalitions as “magnets” that attract some while repelling others.77 
In this Eastern Cape this included the creation of a wide-reaching coalition ranging from legal 
service groups to former anti-Apartheid activists committed to the constitution.  
 
 
																																																								
74 Baumgartner and Jones 1993. 
75 Constitutional Court of South Africa 2002. 
76 Schmidt 2008. 
77 Béland and Cox 2016. 
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Support/Opportunity Structures & International Factors 
 
 Building on work in judicial politics, I find that “opportunity structures” often dictate how 
and whether constitutionalization will have a meaningful effect on a given issue. The ease of filing 
cases and the degree to which the judiciary takes note of, rules on, and enforces health rights drives 
both demand and supply of litigation and affects the impact.78 Charles Epp, in a comparative study, 
showed that activist judges and rights-promoting constitutions are insufficient alone to trigger 
“rights revolutions” and that “support structures” are necessary—organizations committed to 
establishing rights, able lawyers who will mount cases, and sources of financing for litigation.79 I 
find evidence supporting these as necessary for policy impact of health rights as well.  
 This is not quite the same as saying that strong, organized civil society matters for policy 
change or that ‘high levels of social mobilization’ advances population health.80 Instead the claim 
here is more specific—it is in the interaction between the legal complex and health policy 
entrepreneurs that constitutionalization most clearly takes shape. Those policy entrepreneurs often 
include social movements and NGOs from organized civil society, but also include government 
officials (as we see in cases in both South Africa and India) and public health physicians, academics, 
and activists that are not particularly connected to organized civil society. In fact, quite a few of the 
issues identified are narrow and have little or no social mobilization behind them. But it is the 
availability and accessibility of lawyers, legal aid groups, and legalistic actors that span the inside 
and outside of government like the Human Rights Commission that act as a bridge to connect 
policy entrepreneurs to decision-makers through rights venues and rights claims.  
 As illustrated in broad strokes in Table 3.1 above, there is a spectrum of the degree of 
impact that the constitutional rights framework has on eventual health outcomes, in part 
attributable to those support structures. In Malawi, this becomes especially clear: interviews with 
judges in Malawi’s highest courts show great willingness to consider cases and acceptance among 
																																																								
78 Gauri and Brinks 2008; Yamin and Gloppen 2011. 
79 Epp 1998. 
80 Evans 2009. 
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some that health might be judiciable under the constitution.81 Yet while there is significant rights 
mobilization on political freedoms, that mobilization is missing on health—in part because cases 
are not easy to bring, but largely because there is a very limited supply of able human rights lawyers, 
and the financing for rights cases comes almost exclusively from political actors like political parties 
interested in speech and elections but not health and socioeconomic rights. This stands in contrast 
to South Africa and India, where strong support structures drive cases.  
 A policy process approach, though, provides a further insight: the degree of impact on 
policy change is also conditioned by the nature of that issue’s policy space. The cohesion of the 
policy monopoly, the power of the idea maintaining the status quo, and the political strength of 
both the policy entrepreneurs and the monopolists all affect impact. This is perhaps best illustrated 
by the issue at the bottom of Table 3.1 for South Africa—TB in prisons. A landmark ruling handed 
down by the Constitutional Court was an apex moment of a long effort by doctors and activists that 
finally drew macro political attention to cycles of TB infection that had long been ignored with 
severe consequences for prisoners and the communities to which they returned. Yet when Justice 
Edwin Cameron returned to the prison a few years later, he found very little changed.82 As explored 
in depth below, this stemmed not from lack of judicial openness or sufficient resources and support 
structure lawyers, but directly from the strength of the policy monopoly exercised by Department 
of Corrections officials and its capacity to absorb and deflect challenge.  
 International factors are also important to mention—both as a source of text and concept 
in contemporary constitutions and as an important set of pressures and ideas in health policy.83 
Beth Simmons has shown that treaty ratification can affect domestic politics in ways not dissimilar 
to what I find in the right to health.84 It is notable, however, how infrequently interview and archival 
data shows international institutions (e.g. UN, WHO, World Bank, etc.) as major players in these 
policy processes or international instruments (e.g. WHO Constitution, ICESCR in this case) as the 
																																																								
81 Interviews MW-10-18. 
82 Cameron 2015. 
83 Elkins, Ginsburg, and Simmons 2013; Mehta 2010; Birn, Pillay, and Holtz 2009; Marmor, Freeman, and Okma 2005. 
84 Simmons 2009. Posner critiques insufficient attention to treaty/constitution relationship (2012), which is also needed here in future 
work. 
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source of rights claims. Part of this is attributable to research focus; tracing international-level 
processes was not a major part of the design of this study. It is also true, however, that while 
diffusion of policy ideas and international pressures impact health politics, this has not changed the 
reality that national-level actors and institutions shape policy change. It is national actors that must 
adapt and implement transnational ideas and that mediate international forces.85 We do see 
international factors mattering for the support and opportunity structures, however. Funding for 
rights “support structure” organizations came from abroad. Transnational networks provided 
additional power, ideas, and inspiration for policy entrepreneurs in civil society and government 
as well as judicial actors, in ways predicted by existing literature.86 International aid group MSF, for 
example, provided information used by NGOs pushing for reform in the Eastern Cape—and the 
third HRC panel member was a South African doctor formerly employed by MSF. This shows how 
the policy anchor provided by constitutionalization can provide legitimacy for domestic actors to 
leverage international ones.  
 
Conclusion 
 
 In the chapters that follow I trace a series of policy issues—starting in South Africa and 
building out to a comparison with India, Thailand, and Malawi. In each, the power of the right to 
health comes in providing this institutional and ideological anchor that significantly changes the 
policy cycle outside the courtroom. In this institutional landscape, policy monopolies are harder to 
maintain, and ideas that sustain policy stasis in the face of poor health outcomes are delegitimized—
which opens new space for health-promoting policy change. The opportunity to shift the venue of 
policymaking out of the closed space of a small group of risk-averse bureaucrats and self-interested 
actors can make way for a new ideational framework and new actors. By anchoring health in the 
constitution, the right to health can deconstruct the policy monopoly blocking change, increasing 
																																																								
85 Campbell 2004; Béland 2010; Ban 2016. 
86 Keck and Sikkink 1998; Risse-Kappen, Ropp, and Sikkink 1999; Slaughter 2009. 
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the bargaining power of key actors inside and outside government, and providing reasons for action 
that drive significant reforms. In each of the cases below, constitutionalization often triggers 
mechanisms related to information, incentives for public goods, and accountability theorized to 
improve health under democracy—but which electoral pressures and political freedoms prove 
insufficient to activate.  
 These findings are, of course, based on the empirical evidence from the African and Asian 
cases below; further work is needed to see how these dynamics play out in places like Latin 
America or Europe, where particular institutional factors such as a civil law system may change 
the effects.87 Tracing the secondary effect of international rights norms and ideas on the proximal 
domestic policy processes in health remains an area ripe for further exploration. 
 The evidence gathered for the case studies here directly connects the right to health to 
changes in health policy—which is, in turn, directly related to the drivers of poor health and 
mortality. This provides significant evidence of a causal pathway for the effect we observe in the 
large-N analysis that showed countries with right to health are healthier than similar countries 
without. For countries with a basic right to health, the evidence in this chapter suggests that the 
effect of this right might be deepened by more opportunities for rights mobilization. Expanding the 
support and opportunity structure for actors inside and outside government to do so through 
increasing legal services, for example, or expanding the venues like human rights commissions and 
increasing their capacity to take on health cases could have impact.  
 Meanwhile, countries like the United States facing significant health problems and health 
inequities might also learn from these mechanisms. Most recent judicial action on health in the 
United States has been about challenges (largely unsuccessful) to the expansion of the state’s role 
in health; these are not the only way to think about health and constitutional law. Even where 
amending the written constitution seems unlikely, further research might help us understand how 
moves to create judicial and quasi-judicial venues to deal with health and broaden the legalized 
																																																								
87 See, for example, Ferraz 2009 and Landau 2012 expressing worry about Brazil and Colombia’s high-volume court systems. But see 
Biehl et al. 2012; Biehl 2015 whose detailed empirical work suggests some of these concerns are misplaced. Their work hints that 
some of the same mechanisms I find may be at work in Brazil.  
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framework might affect health policy and whether the mechanisms described here might have 
potential to improve health policymaking in this country.  
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CHAPTER 4: HEALTH & RIGHTS IN SOUTH AFRICA 
 
 
 
 
South Africa is not, by most measures, a success story on health. Mortality rates are far 
higher and (public) health services far poorer than one would expect for an upper-middle-income 
country. South Africa’s child mortality rates are closer to those of Eritrea and Bangladesh—each 
with a fraction of South Africa’s GDP per capita—than those of similarly wealthy countries. Given 
the discussion in Chapter 2, however, South Africa’s poor health outcomes are not such a mystery. 
From a broader perspective, South Africa’s economic and demographic endowments would predict 
poor health outcomes. Legacies of colonialism and Apartheid leave South Africa among the 
countries with the most unequal wealth distributions and highest ethnic/racial fragmentation on 
the planet.1 From these two factors alone, we might expect serious challenges in coordinating 
effective policy as well as direct negative effect on health. In addition, South Africa has seen rapid 
urbanization since the fall of Apartheid and is facing significant challenges in education, violence, 
                                                
1 World Bank 2017; Lieberman 2009. 
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gender equity and state capacity. We should expect South Africa to face serious health challenges 
and difficulty driving policy change to improve wellbeing and equity.  
In addition to demographic factors, South Africa faces a series of challenges with 
governance. Many of the intentions and promises of the post-Apartheid government have not 
materialized. The reasons behind this are many and include: low public spending on health, limited 
capacity and poor quality in public sector health services, strongly embedded interests in the private 
health sector, multiple competing levels of government authority over health, provincial political 
fiefdoms that encourage poor management and corruption, limited political power of rural people 
and those living in poverty, and dynamics within the governing coalition that undercut health.  
What, then, has been the role of changing political institutions in addressing this 
challenging demographic, economic, and governance context? South Africa is widely lauded for its 
successful transition to multiparty electoral democracy and protection of political freedoms—
ranked among the most robust democracies in the world by most measures. Yet as I show below, 
on critical issues in South Africa, the mechanisms through which democracy is theorized to 
improve health have not had that effect.  
South Africa also is one of the highest-profile examples of constitutionalization of health 
in the world—with the right to health embedded in the country’s famed 1996 constitution and a 
series of health rights cases at the Constitutional Court that have drawn global attention. Skeptics, 
however, are quick to point out that these court cases have been relatively few and the outcomes, 
from a jurisprudential perspective, have been decidedly mixed. Touching on only a handful of key 
health issues, it is hard to see how the decisions of apex courts have made significant improvements 
in the wellbeing of South Africans on the whole.  
 In this chapter I show how the framework I laid out in chapter 3 provides a fuller picture 
of constitutionalization in South Africa. Starting from a wide-ranging set of health policy issues 
where the right to health has been mobilized in the country, I show that the effect of 
constitutionalizing health in South Africa has been to directly address several of these widely 
recognized barriers to better health. Exploring the right to health as a “policy anchor” in the political 
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economy of health in South Africa points, for example, to how the engagement of rights actors in 
the Eastern Cape has opened political space to address a decades long failure of management in the 
EMS sector and the legacies of Apartheid in one of the countries most challenged provinces. We 
can see, too, how incentives and actors shift in a variety of contexts far from the Constitutional 
Court. At the competition commission, for example, constitutionalization has helped slash the 
price of medicines and secured access to information critical for addressing the realities of South 
Africa’s two-tiered public/private health system. In the most well-known court cases, too, including 
Minister of Health v. Treatment Action Campaign, which opened access to AIDS drugs, rights and 
the judicial decision act not as a “trump” but instead as a piece in a broader policy process that is 
distinctly different because of the constitutionalization of health. There are other issues where 
constitutionalization has a far smaller effect—including the issue of tuberculosis in prisons, a 
massive unaddressed health problem for the country, where the evidence suggests significant rights 
mobilization has not moved the needle on policy change. Exploring the limits of impact, though, 
teaches a lot about the mechanisms of action and suggests where and how rights-based-work takes 
hold. On the whole, I find evidence of a wide-ranging impact of constitutionalization of health 
policy that shifts incentives, moves resources, and ultimately improves wellbeing through 
addressing critical questions in the governance of health in South Africa. 
 
Health of South Africans 
 South Africans today live significantly shorter lives than similar countries as illustrated 
below—well over a decade shorter than citizens of other BRICS countries, for example. Much of 
this is directly related to HIV rates and the country’s initially poor response to the AIDS crisis. Over 
20 years since Nelson Mandela became president, South Africa still has far higher rates of infant, 
child, and maternal mortality than would be expected for its income and relative level of 
development.  
Indicators over time show a mix of good news and bad. As shown in Figure 4.1, South 
Africa saw a significant decline in life expectancy beginning in the late 90s that has only reversed 
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itself in recent years—putting South Africans today only about as well off in longevity as they were 
thirty-five years ago. This reality reflects South Africa’s “quadruple burden” of disease, experienced 
only in the Southern African region: hyper-endemic HIV and TB epidemics, high maternal and 
child mortality, high levels of violence and injuries, and a growing burden of non-communicable 
diseases. 
 
 
 
 
 
 
  
 
 
 
 
 
 
  
Table	4.01	South	Africa	Health	Indicators	Compared	to	Similar	Countries	
		 GDP	per	capita		
(PPP,	current	intl	$)	
Life	expectancy	at	
birth		
(years)	
Under-5	
Mortality		
(per	1,000	births)	
Maternal	
mortality		
(per	100,000	births)	
HIV	prevalence		
(%	ages	15-49)	
People	living	
with	HIV*	
Kenya	 3,089	 62.1	 49.4	 510	 6	 1,500,000	
India	 6,105	 68.3	 47.7	 174	 0.3	 2,100,000	
Namibia	 10,411	 64.9	 45.4	 265	 13.6	 210,000	
South	Africa	 13,195	 57.4	 40.5	 138	 19	 7,000,000	
China	 14,451	 76.0	 10.7	 27	 0.1	 501,000	
Brazil	 15,474	 74.7	 16.4	 44	 0.6	 830,000	
Global	Avg	 15,691	 71.7	 42.5	 216	 0.8	 36,700,000	
Source:	2015	data	from	World	Development	Indicators,	World	Bank	*UNAIDS		NACO		National	Health	and	Family	Planning	Commission	of	the	
People’s	Republic	of	China	
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Fig	4.1	South	Africa	Health	Indicators
Child	mortality	rate,	under-5	(per	1,000	live	births)
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In recent years, however, life expectancy has been on the rise and both child and maternal 
mortality have turned sharply downward. Just since 2010, child death from pneumonia has been 
nearly halved.2 This reflects a decade of significant progress but much more work to do.  
With over 7 million people currently living 
with HIV, South Africa has the largest epidemic in 
the world. Both the drop in life expectancy and 
significant rise in infant and child mortality during 
the late 90s and early 2000s were caused by an out-
of-control epidemic of untreated HIV.3 Until recent 
years, patients admitted with HIV-related illnesses 
occupied more than half of the beds in many South 
African hospitals.4 Tuberculosis, long a problem of 
its own in South Africa, exploded as the HIV 
epidemic left millions with weakened immune 
systems. Today, TB kills more people than any 
other cause, though HIV/AIDS is the underlying 
reason as reflected in Table 4.02.5 HIV has been both an immediate and proximal cause of South 
African’s poor health as the disease devastated the health workforce, undermining efforts to expand 
and strengthen the post-Apartheid health system. Today, even as both deaths and transmission 
rates of HIV are dropping, population growth and “youth bulge” in the country mean the absolute 
numbers of both remain significant.6  
High child mortality rates reflect striking levels of preventable deaths. HIV plays a role 
through both pediatric AIDS deaths and by leaving children without healthy parents to care for 
them. Meanwhile, main causes of death among children—respiratory tract infection, diarrheal 
                                                
2 Massyn et al. 2016. 
3 UNAIDS 2016; Chopra, Lawn, et al. 2009; Ndirangu et al. 2010. 
4 Long et al. 2016. 
5 Stats SA, 2017; Institute for Health Metrics and Evaluation 2017. 
6 Seekings 2014; Whiteside 2014. 
Table	4.02	Leading	Causes	of	Premature	
Death,	South	Africa	
1	 HIV/AIDS	
2	 Interpersonal	violence	
3	 Lower	respiratory	infection	
4	 Road	injuries	
5	 Tuberculosis	
6	 Ischemic	heart	disease	
7	 Diabetes	
8	 Cerebrovascular	disease	
9	 Diarrheal	diseases		
10	 Preterm	birth	complications	
11	 Self-harm	
12	 Hemorrhagic	stroke	
13	 Neonatal	encephalopathy	due	to	
birth	asphyxia	and	trauma	
14	 Chronic	obstructive	pulmonary	
disease	
15	 Ischemic	stroke	
Dark	blue:	infectious	or	childhood	disorders;	Light	
blue:	violence/injury;	Gray:	non-communicable	
disease	
Source:	Global	Burden	of	Disease,	IHME,	2016.	
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disease, sepsis and tuberculosis—are preventable and curable. Indeed, the bulk of childhood death 
is the result of avoidable factors, as much as 61% of which are direct health system failures.7 
Maternal mortality has been similarly damaging with rates as illustrated in Figure 4.1 that remain 
far higher than in the early 1990s when data became available—much of it avoidable. In addition 
to devastating levels of violence, South Africa faces a large and growing problem of non-
communicable diseases. If HIV and TB were to be controlled, then the major deaths from disease 
in the country would be from stroke, diabetes, and heart disease.8 Rates on NCDs are going in the 
wrong direction even as progress is being made against HIV and TB.  
A key point here is that much of South Africa’s mortality and ill health is amenable to 
change through basic preventative and curative health services. Expansion of those services in the 
last decade has contributed significantly to the positive turn in health indicators, even as progress 
remains fragile.  
 
Political and Racial Economies: Historical Legacies 
The poor health of South Africans is a direct product of its particular history—with the 
twin legacies of mining and Apartheid structuring the country’s contemporary challenges. Since 
the discovery of diamonds in Kimberly in 1867 and gold in the Witwatersrand in 1886, the mining 
sector has become a cornerstone of South Africa’s economy. At its height in the 1980s, minerals 
extraction constituted 21% of the economy and employed 763,000 people—and while it has fallen 
to the 6th largest industry in the country, it remains among the most politically dominant.9 With 
mining came a political economy that determined disease patterns that persist—creating a set of 
companies able to exercise incredible power to move both people and policy. Massive migration, 
along with coercive laws, taxes, and restrictions on land use, moved cheap, migrant, male labor out 
of agriculture and into mining towns. Migration came from both within South Africa and from 
other countries in the region—at its height in the 1970s, nearly half a million men from Botswana, 
                                                
7 Stephen et al. 2011; Nannan et al. 2012. 
8 Whiteside 2014, 181. 
9 Stats SA 2017. 
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Lesotho, Swaziland, Malawi, and Mozambique migrated to South Africa’s mines.10 These migration 
patterns have had a major effect on the health of South Africa through nearly all facets of life; 
patterns of violence, the construction of slums, the structures of Black South African families, sexual 
practices, the provision of public and private healthcare, etc. provided fertile ground for the spread 
of infectious diseases and construction of a fractured, ineffective health system for the majority 
population.11 Hundreds of thousands of black people working in South Africa’s cities were pushed 
into single-sex hostels that were overcrowded and poorly ventilated, with male hostels often served 
by sex workers. This oscillatory migratory pattern—living temporarily in cities or mining towns, 
with regular visits to rural homelands in and outside South Africa—was key to the spread of 
tuberculosis and STDs in the first half of the 20th century.12 HIV came to South Africa likely 
through migrant workers from Malawi and it is due in no small part to migrant mining labor that 
the Southern African region is today home to the highest rates of disease in the world.13  
The Apartheid system built off the political economy of mining, the periods of Dutch and 
English colonialism, and of the segregation that preceded it. The system of rigid racial hierarchy 
classified South Africans into categories—White, Asian/Indian, Coloured, or Black/Bantu—that 
determined where a person could live and work, whom they could marry, whether they could vote, 
and which system they could access for school, healthcare, and social protection. The 1945 Urban 
Areas Consolidation Act crafted the rules of legal segregation while the 1952 Abolition of Passes 
and Coordination of Documents “Natives” Act required all black South African adults to carry a 
“pass book” in white neighborhoods. These laws were reinforced by draconian repression from a 
state that denied Black people citizenship, removing millions to rural Bantustans.14 Apartheid South 
Africa was governed for the benefit of the white population, with massive inequality, racial division, 
and widespread poverty among the majority. The country was divided into multiple layers of 
administrative units that were never particularly viable—white-ruled provinces, “independent” 
                                                
10 Whiteside 1986. 
11 Marks and Andersson 1987; Coovadia et al. 2009. 
12 Karim et al. 2009. 
13 Whiteside 2014. 
14 Clark and Worger 2016. 
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Bantustans or ethnic homelands, “self-governing” areas like KwaZulu-Natal; and separate 
administrations for Coloureds, Indians, and Whites.15  
The African National Congress (ANC), which formed in 1912 and opposed the formation 
of the South African republic, was banned and went into exile after police killed protesters against 
the pass laws in Sharpeville in 1960, sparking unrest and a national state of emergency. Anti-
Apartheid organizing inside and outside the country became militant and multiple civil society 
networks mobilized on a massive scale through the 1980s, which saw widespread protests and state-
sponsored violence in response. Eventually, pressure from social movement organizing along with 
reform efforts within the white ruling class, facing a major economic downturn, resulted in the first 
national democratic elections that brought the ANC to power in 1994.16 
The two-tier health system under Apartheid included a publicly financed public sector 
serving the majority of the population and a private sector funded primarily through medical aid 
schemes for a small white minority. The public system was highly inequitable, with few facilities in 
rural areas, and was broadly designed to provide very limited health services to women, children, 
and farm workers. It was racially fragmented into fourteen different operating authorities—10 
Bantustan health departments, three racial “own affairs” health departments, and the national 
Department of Health.17 The private sector, meanwhile, consumed the majority of resources to 
serve less than a quarter of the population with private insurance and focused services on expensive 
tertiary hospitals and in the major urban areas around Johannesburg, Cape Town, and Durban, 
creating vast geographic and population inequalities.18 Privatization and deregulation led to 
massive resource misalignment—with an 87% increase in private for-profit hospital bed 
availability, for example, between 1988 and 1993.19 As a result, whiter, wealthier communities were 
often over-serviced in terms of healthcare by most estimations—leading to high spending with little 
health impact, a trend that has proved hard to reverse. Meanwhile, apart from the health system, 
                                                
15 Price 1986. 
16 Wood 2000. 
17 Schneider, Barron, and Fonn 2007. 
18 Coovadia et al. 2009. 
19 McIntyre et al. 1995. 
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the social, economic, and environmental conditions under Apartheid were deeply damaging to the 
wellbeing of Black South Africans—overcrowded squatter settlements, migrant labor, poor access 
to water and electricity, malnutrition from both income poverty and being forced onto infertile 
land, and un- or underemployment.20 By the end of Apartheid in 1994, the inequity was deep: infant 
mortality was ten times higher in the black population than among whites and massive numbers of 
maternal deaths among Black women were going largely uncounted by the government, which 
refused to collect statistics.21  
 
Contemporary Socioeconomic Context 
The legacies of both the chaotic governance structures and the racial hierarchies remain—
ethnic boundaries and inequality drive poor health both directly through deprivation and indirectly 
through challenges in setting effective health policy.22 A decade after the fall of Apartheid, the 
legacies of this system were still quite clear with life expectancy in 2004 ranging from 64 years for 
white people to 49 years for black people—reflecting both deep inequality and poorer health even 
among whites than should be expected for a country of South Africa’s wealth.  
 
                                                
20 Seekings and Nattrass 2016; Jinabhai, Coovadia, and Abdool-Karim 1986. 
21 Chopra, Daviaud, et al. 2009. 
22 Lieberman 2009; David and Collins 2014; Wilkinson and Pickett 2009. 
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Since the fall of Apartheid and until very recently, South Africa has enjoyed strong 
economic growth except at the height of the global recession in 2009—largely matching or beating 
the global average. As seen in Figure 4.2, the significant deterioration in health in the 1990s and 
2000s caused by HIV occurred at a time when economic growth should have been fostering 
improvements. Poverty rates in South Africa increased slightly in the late 1990s, likely undermining 
health, but have seen a steady decline since then—even through the 2008-09 recession. Rates of 
hunger followed roughly the same trajectory. Nonetheless, poverty rates remain markedly high—
with somewhere between 20% and 46% of the population living in income poverty depending on 
the cut off—its rates are far higher than similar countries.23 
South Africa has, by several measures, the most unequal distribution of income and wealth 
in the world.24 It also has one of the highest unemployment rates, with a quarter of the population 
out of work and far higher rates among young people.25 The historical legacy of state repression has 
left the country with a vast police and prison complex and the highest rate of incarceration in Africa 
by far, twice that of Zimbabwe for example.26 Gender inequity and violence against women and 
against LGBT people remains a far more significant factor in health outcomes than in most 
countries. This mix of unemployment, poverty, gender inequity, and incarceration has been a 
driver of the country’s HIV and TB epidemics with which the health system has been unable to 
cope.  
South Africa also faces distinctive demographic realities that undergird the health 
challenges. Continued population growth and urbanization are both linked to the inequality and 
poverty figures. The combination of rapidly declining fertility rates and mortality due to HIV have 
resulted in a population “bulge,” with the largest cohort of South Africans currently in their 20s and 
early 30s. This population bulge combines with significant urbanization—with urban provinces of 
                                                
23 Seekings and Nattrass 2016. 
24 See, e.g. World Development Indicators gini score  
25 Seekings and Nattrass 2016. 
26 Institute for Criminal Policy Research 2016. 
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Gauteng and the Western Cape growing 57 and 47 percent respectively between 1996 and 2011 
while the rest of the country grew just 17 percent.27  
Together, the social and economic determinants of health explain much of the poor health 
outcomes experienced in South Africa. The health system, while struggling to keep up, is distorted 
in ways that have proved very hard to address and, as such, has struggled to rectify these realities.  
 
Democracy  
Since 1994, South Africa has been hailed as a successful democracy and so, as we consider 
the effect of constitutionalizing health we must also consider both the possibility that electoral 
democracy is actually doing the work on health, or that constitutionalization is actually 
undermining democratic governance on health. In the measures widely used by political scientists 
to measure electoral democracy and political freedoms, South Africa scores a 9 (out of 10) in 
Polity and a strong designation of “Free” by Freedom House.28 For most of the last decade The 
Economist Intelligence Unit has ranked the country among the three strongest democracies in the 
global South, with scores roughly equal to France.29  
The African National Congress (ANC) has, since the fall of Apartheid, been the leading 
party in South African electoral politics—winning large margins at the national level and 
exercising continuous control over the Presidency since transition. These electoral victories have 
led some to label South Africa a “dominant party system” in which the lack of alternation in apex 
politics may reflect a far weaker democracy than the international comparisons capture.30 As 
Southall and others argue, however, this mischaracterizes the nature of ANC power, which is 
constrained by constitutional, political, and economic realities.31 While the ANC peaked at 69.7% 
of the national vote in the 2004 election, South Africa has been characterized by fierce electoral 
competition including local and provincial electoral losses for the ANC and multiple parties—
                                                
27 Seekings 2014. 
28 Marshall and Jaggers n.d.; Freedom House 2014. Note Freedom House score is 2 (1 is best, 7 worst). 
29 Economist Intelligence Unit 2017, though it has seen a significant dip in the last year under the cloud of the Zuma presidency. 
30 Giliomee and Simkins 1999; Southern 2011. 
31 Southall 2017. 
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from the Zulu Inkatha Freedom Party early on to the DA today—that capture significant vote-
share and major public attention. Meanwhile, the ANC itself has been a place of significant 
internal debate and contestation—famously including the open competition between leaders 
representing different national constituencies that culminated in the ouster of President Mbeki at 
the Polokwani ANC conference.32 Since the democratic opening, the ANC has also ruled as part 
of a tripartite alliance between the ANC, South African Communist Party, and the largest union 
confederation, COSATU. The Alliance, while criticized as overly dominated by the ANC and 
perhaps contrary to the interests of South Africa’s working class, has also provided an additional 
layer of complexity to South Africa’s democracy.33  
Components of democracy identified by Sen and Ruger as keys toward realizing the 
freedoms that improve health are largely present both de jure and de facto in South Africa:34 
vibrant multiparty democracy exists with highly contested elections even as ANC exercises “weak 
dominance”;35 free media including 47 daily and weekly newspapers in multiple languages and 
widely watched public and private TV news as well as widespread internet use;36 open public 
discussion leading to flows of information about health, including an entire media outfit 
dedicated to health policy and information;37 guaranteed freedoms of assembly, association and 
expression actively protected by legal and political branches, albeit controversially; and the 
practical ability to voice complaints and opposition perhaps best illustrated by the several 
hundred service delivery protests (including health services) of varying sizes that occur each 
year.38 
 
Post-Apartheid Governance of the Health & Welfare State  
The election of Mandela brought great hope and expectations; since as far back as the 1955 
                                                
32 Piper and Matisonn 2009; Booysen 2017. 
33 Habib and Taylor 2001; Piper and Matisonn 2009. 
34 Sen 1999; Ruger 2005. 
35 Southall 2017. 
36 Mokgata 2013. 
37 https://www.health-e.org.za/about/ 
38 Alexander, Runciman, and Ngwane 2016. 
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Freedom Charter, the ANC had been focused on a program to build a health and social security 
system that worked for all. A self-proclaimed social democratic party working to build a 
“developmental” state, the ANC’s ideological commitments suggests the kind of left-leaning, 
ambitious party that many have linked to successful welfare states and improvements in health.39 
Meanwhile, the ruling tripartite alliance of the ANC, SA Communist Party, and the major labor 
confederation COSATU have modeled their political alliance on a socialist-grounded corporatist 
alliance between state, labor, and capital. Rhetorically, health and welfare policy have reflected this 
outlook. In practice, however, the South African health system has not achieved universalism, 
equity, or quality. As I describe below and in detail through the case studies in this chapter, low 
spending, limited capacity, poor accountability and management, powerful vested private and 
political interests, complex multi-level authority over health, limited power of rural and poor 
people, and particular dynamics within the ANC have undercut transformation of health and 
welfare systems. These challenges are important to understand as one explores the impact of rights 
on health because it is in this real context, with particular barriers to success, that the shift toward 
a constitutionalized politics of health is occurring. 
The ANC, through successive administrations, has repeatedly declared a commitment to 
creating a “comprehensive system of social security” built around a concept of solidarity.40 In some 
ways the post-Apartheid welfare state moves toward this ideal. South Africa today spends a larger 
portion of its GDP on social welfare programs than any major developing economy with coverage 
that is without peer in the world—moving from 2.4 million people receiving social grants at the 
time of the 1994 elections to 16 million by the 2014 round, with major redistributive and anti-
poverty effects.41 As Seekings and Nattrass show, however, moves toward a more universal social 
security and health system have largely been blocked. The dramatic expansion has been 
parametric—an expansion of eligibility, including across racial and geographic lines—rather than 
                                                
39 The party has a complicated relationship with the idea of a “welfare state” but broadly subscribes to a social democratic rather than 
liberal welfare state as described in Seekings and Nattrass 2016. It also, though, is focused on building a developmental state, limits 
the decommodification that the party is willing to support. There is, however, little question of the party’s left/socialist history and 
leanings, which have been linked by thinkers like Navarro et al. 2006; Huber and Stephens 2001 and others to improved wellbeing.  
40 South Africa 1997a. 
41 Seekings and Nattrass 2016, 143. 
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a departure from the Apartheid-era “liberal” welfare state characterized by means tested 
programs.42 There is not, for example, a universal pension or unemployment program and the idea 
of national health insurance is still only in the planning stages two decades after the government 
declared its intention to build such a program. “South Africa's social safety net has a very loose 
weave,” writes Michael Samson.43 While government has repeatedly committed, as the 2012 
Treasury Budget Review pledged, to a “major restructuring of South Africa’s social protection 
arrangements” to “eliminate gaps” and ensure “all South Africans will benefit from new 
arrangements and risk will be shared,” reforms have largely been blocked.44 Policy hangover from 
the Apartheid government and path-dependent effects including strong constituencies for the 
status quo along with some limited fiscal space have gotten in the way of major reform efforts.  
Table	4.03:	South	Africa	Post-Apartheid	Health	System 
		 1995	 2000	 2005	 2010	 2014	
Health	Indicators	 	     
Life	expectancy	at	birth		
			(years)	
61.37	 55.84	 51.56	 54.39	 57.18	
Maternal	mortality	ratio		
			(per	100,000	live	births)	
62	 85	 112	 154	 140	
Under-5	mortality	(per		
			1,000	live	births)	
62.1	 75.3	 75.2	 53.8	 41.4	
AIDS-related	Deaths		
		
	 	190,000		 345,607	 	320,000		 	180,000		
Incidence	of	tuberculosis		
		(per	100,000	people)	
	 585	 932	 948	 834	
	
Health	System	&	Financing	
	     
Health	expenditure,	total		
			(%	of	GDP)	
8.3	 8.1	 7.8	 8.5	 8.8	
Public	Health	expenditure			
			(%	of	total	health	exp)	
41.4	 40.8	 42.7	 46.9	 48.2	
Public	Health	expenditure			
			(%	of	government	exp)	
13.0	 13.6	 13.0	 14.1	 14.2	
Public	Health	expenditure	
		(%	of	GDP)	
3.4	 3.3	 3.3	 4.0	 4.2	
Private	Health	expenditure			
			(%	of	GDP)	
4.9	 4.8	 4.5	 4.5	 4.6	
Physicians		
			(per	1,000	people)		
0.59	 0.69*	 0.77*	 		 0.78*	
Source:	World	Development	Indicators,	Statistics	South	Africa,	UNAIDS			
*Data	from	year	prior	based	on	availability	
   
                                                
42 Ibid., 142–52. 
43 Samson 2002, 73. 
44 South Africa 2012. 
Chapter	4:	South	Africa		
	
 
111 
 The health sector in particular has seen these dynamics clearly at work. The system 
inherited by the new government in 1994 was actually comparatively well-resourced, with among 
the highest total spending on health among middle-income countries, at 8.5% of GDP.45 It was in 
South Africa that the first human-to-human heart transplant was performed by Christiaan Barnard 
in December 1967, signifying a health system that served a white minority quite well.46 The key 
challenge was not funding, but the massive inequalities in the distribution of resources. More than 
half of doctors, 93% of dentists and 89% of pharmacists were in the private sector serving the 
minority with access. 47 There was also a major imbalance in the system toward hospitals and only 
very meager resources  for primary care services, especially in Black areas.  
 The ANC’s 1994 manifesto health plan and 1997 “White Paper For the Transformation of 
the Health System” fit into the broader ANC macroeconomic proposals under the Reconstruction 
and Development Programme (RDP) with a broad focus on ensuring “the health of all South 
Africans must reflect the wealth of the country” through addressing both health service delivery 
and the social drivers of ill health from poverty and clean water to women’s education.48 These 
founding documents placed responsibility for healthcare firmly at the door of the state and pledged 
to dismantle the inequity of the two-tiered health system through an integrated, democratic, 
decentralized, and equitable national health service.  
Inequity, however, has persisted. Today, the lowest socio-economic groups bear the largest 
burdens of ill health—including both infectious and non-communicable diseases.49 Yet these same 
groups have the lowest level of health service utilization and derive the least benefits from these 
services when they are used.50 This has been significantly exacerbated by the HIV and TB epidemics, 
which hit the health workforce particularly hard and exacerbated human resources shortages that, 
in turn, left the public system incapable of offering either HIV or primary healthcare effectively. 
The disparities in expenditure between the public and private sectors relative to the population they 
                                                
45 McIntyre et al. 1995. 
46 Hunt 2006. 
47 McIntyre et al. 1995. 
48 African National Congress 1994; South Africa 1997b. 
49 Ataguba, Akazili, and McIntyre 2011. 
50 Marten et al. 2014; Ataguba and McIntyre 2013. 
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serve have widened over time.51  
As shown in Table 4.03, public health spending did not change much as percent of GDP in 
the first decade after Apartheid and has risen significantly since then—both in real terms and as a 
portion of government spending. There has been significant movement toward redistributing 
resources between geographic areas and levels of care. The gap in spending per person dependent 
on public sector health services, between the best- and worst-resourced provinces, declined from a 
five-fold difference in 1992/93 to a two-fold difference in 2005/06 and spending on primary health 
care increased to over 22% of total public-sector health-care expenditure.52  
However, substantial inequities and efficiencies remain. Public spending overall remains 
only 4.1%, which is lower than the average of 6% among other middle-income countries. The 
national public health sector, staffed by just 30% of the doctors in the country, remains the sole 
provider of health care for more than 40 million people.53 Many public-sector hospitals and clinics 
are in a state of crisis due to underfunding and mismanagement—with run-down infrastructure, 
stock outs of essential medicines, and staffing shortfalls that undermine quality patient care. Up to 
25% of those who lack health insurance pay out of pocket for private sector care in order to escape 
the poor quality available in the public sector.54  
 Rural communities have seen significant expansion in health services with a great many 
new clinics built since 1994 to serve the roughly 40% of the population living in rural areas. 
Expenditure continues to be lower per-capita in rural provinces and in rural districts. In Eastern 
Cape, for example, per capita spending in the major urban Nelson Mandela Bay district was double 
the expenditure in rural districts. This has a direct relationship to health service quality and 
outcomes. Rural Eastern Cape province, for example, has double the case fatality for children with 
Pneumonia as Gauteng province.55 
On the other hand, private spending remains 50% of total health expenditure, which is 
                                                
51 Ataguba and Alaba 2012. 
52 Coovadia et al. 2009. 
53 Mayosi and Benatar 2014, 1345. 
54 Ibid., 1346. 
55 Massyn et al. 2016, 125. 
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among the highest in the world.56 There are 83 private insurance plans funding the health needs of 
only 16.2% of the population.57 Spending through these plans in South Africa is the highest in the 
world and is six times higher than in any OECD country and represents more than six times the 
2013 OECD average of 6.3%.58  
At its 2007 policy conference the African National Congress (ANC) renewed its resolve to 
introduce a National Health Insurance (NHI), which would aim to achieve universal access to 
health care. The plan, however, has been slow to appear. There is a multitude of powerful actors 
invested in the status quo—ranging from health insurance companies to the 8.8 million people who 
have private health coverage, including nearly all of the leaders in government, business, and even 
the NGO sector. It also reflects a major challenge challenges in financing. Modeling of the resources 
needed suggests that although total expenditure on health care would not have to increase very 
much, spending from public funds would need to increase dramatically—from around 4% of GDP 
to more than 6%.59 
 Governance in the health sector has been a major challenge—with multiple competing 
levels of authority and significant issues in poor performance and corruption. The immediate focus 
in the Mandela government was consolidating the health system and by 1995 the government had 
re-structured the fourteen different departments of health in to nine provincial health departments 
and one National Department of Health. While South Africa is not technically a federal state, the 
relatively powerful provincial governments have significant control over the health sector under 
the National Health Act, which defined both the district health system and primary healthcare as 
provincial responsibilities. The National Department of Health has overall responsibility for setting 
health policy and crafting guidelines and regulations, but provincial authorities develop their own 
policies in relation to these national policies. In the late 1990s, national funding for health shifted 
from allocations made by the Minister of Health to block grants based on the Treasury’s complex 
                                                
56 South Africa 2017. 
57 Council for Medical Schemes 2015. 
58 South Africa 2017. 
59 McIntyre and Ataguba 2012. 
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“Equitable Shares” formula based in part on the size of the population not covered by private health 
insurance.60 These unconditional grants are disbursed directly to the provinces to cover all social 
spending and provincial authorities allocate health spending from within them, along with some 
additional “conditional” transfers for key disease programs. Overall the National Department of 
Health directly controls just 2.5% of government health expenditure.61 This governance structure 
has created several challenges including centralization of power among provincial authorities, 
which vary significantly in their capacity and their outlooks, resulting in notable differences in 
service delivery and outcomes.62 Many of the provincial administrations have significant 
vulnerabilities inherited from their evolution from Apartheid-era Bantustans and other structures, 
which were characterized by divisive politics, poor governance and corruption. Rispel et al. show 
how today, the complexity in the health system, together with a high degree of centralization of 
decision-making and authority, have led to high levels of corruption and poor performance in some 
provinces.63 Stuckler, Basu, and McKee, meanwhile, have shown that provinces with greater 
capacity and infrastructure to provide health services have captured a greater portion of national 
health resources creating political “infrastructure-inequality traps” for higher need provinces.64 
Divided authority has limited what National Department of Health can do to address the problems. 
 
Constitutionalization of Health in South Africa 
South Africa’s post-Apartheid constitution-making process reflected not only the final 
process toward democracy and the elimination of legalized racial hierarchies, it also reflected a 
revolution in South African law—shifting from parliamentary sovereignty to constitutionalism. 
The core decision to create a judicially enforceable constitution was among the most important 
agreements in the negotiated interim constitution and the basis for the constitutionalization in 
South Africa on a wide variety of fronts.65 Well before the ANC was unbanned and the constitution-
                                                
60 South Africa 2001. 
61 Health Policy Project 2016. 
62 Massyn et al. 2014. 
63 Rispel, de Jager, and Fonn 2015. 
64 Stuckler, Basu, and McKee 2011. 
65 Klug 2000. 
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writing process began, there was significant debate on the question of whether the inclusion of 
socioeconomic rights was appropriate as part of the new constitutionalism of the republic.66 The 
ANC argued forcefully for their inclusion, suggesting in one submission to the process that they 
explicitly envisioned the kind of “policy anchor” I argue has been created in practice: 
“The ANC believes that the wide-scale injustices and inequalities of the past 
require the inclusion of particular socio-economic rights in a South African Bill of 
Rights. The inclusion of such rights within a Constitution records a country's 
vision and aspirations for the future. The new Bill of Rights cannot therefore shy 
away from including within the scope of its protection, fundamental rights, which 
while posing difficulties in enforcement reflect important principles in the 
promotion of a society based on justice and equality, a society which seeks to 
redress the imbalances of the past.”67 
 
The right to health was a prominent part of the rights argued for by the ANC, drawing 
explicit inspiration from international instruments including the African Charter on Human and 
Peoples' Rights and the International Covenant on Economic, Social and Cultural Rights.68 Albie 
Sachs, later a Constitutional Court Judge, was among the early advocates of including health rights 
in the constitution—inspired in part by international conversations that bridged the Atlantic.  
 
“We believed there was a need not just for procedural justice but for substantive 
equality and we had to break new ground. It was through engaging not just with 
each other but with thinkers in the U.S., Brazil, parts of Asia, with the two 
Marthas—Minnow and Nussbaum—and with Jonathan Mann, Roberto Unger 
that we crafted a clearer idea of the transformative power for health that could be 
found in the law.”69  
 
The ANC had a number of reasons to support the inclusion of socio-economic rights but 
among these was a concern to prevent an overly-expansive reading of the right to property that 
might challenge future policy goals like restructuring a health system dominated by private health 
                                                
66 The two sides summarized nicely in Sachs 1992 and Davis 1992. 
67 African National Congress 1995. 
68 Ibid. 
69 Interview SA-02, Albie Sachs, October 22, 2015. 
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schemes. In this way, including the right to health was both a statement of values and insurance 
against future moves by private interests to limit the policy space for transformation.70 
The 1992 draft Bill of Rights put forward by the ANC included a section entitled “right to 
health” that declared, “a comprehensive national health service shall be established linking health 
workers, community , state institutions, private medical schemes and individual medical 
practitioners so as to provide hygiene education, preventative medicine and health care delivery to 
all.”71 During the negotiations on the interim constitution, however, socioeconomic rights were 
shelved due to resistance from the National Party until the process under the elected assembly 
where the ANC had a freer hand.  
Section 27 of the final text of the constitution states, in part: 
1. Everyone has the right to have access to — 
health care services, including reproductive health care… 
2. The state must take reasonable legislative and other measures, within its 
available resources, to achieve the progressive realisation of each of these rights. 
3. No one may be refused emergency medical treatment. 
 
The Constitution also includes sections rights to health services for children (§28(1)(c)) and 
prisoners (§35(2)(e). While these sections focus on healthcare alone, the public health responsibility 
of government is arguably also influenced by its duties under the Constitution’s broader range of 
socioeconomic rights including to water (§27(1)(b) and housing (§26).  
 As I use it in this section of the project, however, constitutionalization reflects something 
more than just the existence of a right in constitutional text. For it to matter in the way I am arguing, 
it must truly be “available” in the society—institutionally prominent enough to be picked up and 
used by actors. Two indicators help identify the degree to which that is the case: first, whether the 
right to health exists in public discourse; and second, whether courts are using the right to health 
on a variety of different cases. In South Africa both are true.  
                                                
70 Dixon and Ginsburg 2011 call the inclusion of socioeconomic rights in the SA constitution an "insurance swap"--health and such 
socioeconomic rights in exchange for property rights protection, inclusion of which was a dealbreaker for the National Party. 
71 African National Congress 1992. 
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Table	4.04:	Media	Coverage	of	Constitutional	Health	Rights	2001-2016
 As shown in table 4.04, the right is an active idea in public debate. I coded a sample of 
articles from South Africa’s 10 largest newspapers, which included over 80 articles explicitly dealing 
with the constitutional right to health. While internationally the discussion tends to focus on HIV 
treatment, the articles in the sample dealt nearly as much with maternal and child health as with 
AIDS and also focused on reproductive health, basic health services, and the price of medicine. 
Importantly, the “major actors” in these articles were most commonly activists and were as often 
doctors as they were lawyers, lending support to my contention that constitutionalization has as 
much to do with what happens outside court as inside. 
 
 
 
 
 
 
 
 
 
 
 
 
The constitutional provision has also been the basis for a range of key legislation including 
the National Health Act of 2003, which provides the legal backbone for the South African health 
system and is the legislative source of current public health powers, cites Section 27 extensively in 
its preamble as the source of authority for key policies.72 In addition both the Choice on Termination 
of Pregnancy Act 92 of 1996 and the recent White Paper on National Health Insurance for South 
Africa draw their legal source and mandate from health rights in the constitution.  
                                                
72 See discussion in Pieterse 2014. 
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 Meanwhile there is ample evidence that South African courts are taking up the right to 
health in cases. The first reported decision came not under Section 27, but under a claim on the 
Section 35 right of detained persons to “the provision, at state expense, of adequate… medical 
treatment.” The first Section 27 case reached the Constitutional Court in 1998 in Soobramoney v. 
Minister of Health (Kwa-Zulu Natal).73 In that case the Constitutional Court upheld a decision to 
deny Mr. Soobramoney access to renal dialysis based on state hospital rules, finding that the state’s 
good faith decision not to extend dialysis to all, reached rationally after considering cost and 
demand, did not violate the state’s constitutional obligation. Probably most important case came a 
few years later in 2002 with Minister of Health and Others v. Treatment Action Campaign, which 
sidestepped the logic in Soobramoney to clearly show courts would enforce the constitutional right 
to health.74 Explored in greater detail in the case study below, this case took place amidst the 
dramatic battle over the Mbeki government’s refusal to roll out HIV/AIDS treatment in the public 
health sector. Here the Court found the government’s position denying access to Neverapine to 
prevent the transmission of HIV from mother to child (MTCT) was unreasonable and held that the 
state had an obligation not to ignore urgent health needs, especially those of excluded segments of 
society that could not afford medical services. The Court ordered the government to devise and 
implement a comprehensive MTCT plan and remove restrictions on the drug Nevarapine.  
 From there over a dozen cases have reached the apex court dealing with the right to health. 
The cases have been varied and complex, showing the right to health inspires robust activity in the 
courts. Several of these cases are taken up in the case studies of policy issues below. Alone, they do 
not necessarily suggest an ultimately widespread impact on population health. I outline below, 
however, how they fit into a broader set of policy issues where rights mobilization never reaches a 
major court decision yet still has a significant impact on the eventual health outcome. 
 
 
                                                
73 1998 (1) SA 765 (CC). 
74 2002 (5) SA 721 (CC). 
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Constitutionalization in a Complex Health Context  
 A constitutional right to health is not a magic bullet—it cannot simply make people 
healthier. This is nowhere more obvious than in South Africa where the challenges facing the health 
sector are immense. Despite relative wealth and high democracy, the demographic challenges alone 
present health authorities with a steep climb to addressing historical inequities and improving 
health overall. Low public health spending, along with highly-entrenched and politically powerful 
private systems, undercuts health for the majority. Meanwhile, complex and competing levels of 
authority mean that some provinces still lack basic service delivery despite the availability of 
financing and commitment at the national level. All this is visible before we even delve into the 
specifics of key policy areas like HIV, where disastrous decisions have had long-lasting effects.  
 What a right to health does do is to change the “rules of the game” in the politics of health. 
Seen in the context described here, constitutionalization matters because it acts on several of these 
key barriers to better health. As I describe in Chapters 4.2 through 4.5, the right to health has been 
mobilized on a wide set of health issues and there is evidence it has helped address some of the 
stickiest challenges in the health in the country. In teasing out the impact of this mobilization it is 
clear that the effect has been far from universal in this complex environment, but on the whole, 
there are clear, observable benefits to the wellbeing of South Africans.  
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4.2: Emergency Health Services Policy in the Eastern Cape 
 
“We understood that there are these things called an ambulance that government 
has sent out, but we had not seen them here. When we are very sick or when 
women are in labor, then we hope: that we can walk some kilometers to the public 
road and that there are cars coming; or that that our family has enough to hire a 
car. If not, then that is when people die waiting.” —Community leader, Xhora 
Mouth, Eastern Cape (Interview SA-23) 
 
“In short, our health emergencies are financially devastating. They drive us deeper 
into poverty and make it even harder for us to climb out.” —Xhora Mouth 
community statement to the South African Human Rights Commission 
 
In this section I explore the particular case of emergency medical services in the Eastern 
Cape province as a first example of constitutionalizing health policy. Access to emergency services 
is both a question of equitable expansion and of basic health security as it affects vulnerability to 
catastrophic health crisis. This is in many ways a least-likely case for rights-based policy change to 
actually have an impact, given expectations in much of the literature. The Eastern Cape is a large 
rural area, and the beneficiaries of policy change in this case are poor, Black people living in an 
impoverished rural area. Given expectations in the literature that rights and courts will serve the 
interests of the elite, or at least the middle class, many would not expect impact. In this case the 
policy issues at stake are also complex and involve multiple, competing trade-offs—exactly the sort 
of policy area some believe cannot be handled effectively in rights terms. As such, it is a good test 
of the hypothesis that rights can be beneficial to population health. The region I focus on here is 
also extremely distant, both geographically and psychologically, from the Constitutional Court’s 
home on Constitution Hill in Johannesburg. As a case that features no apex court decision, it also 
provides a most interesting test of the theory I laid out in the preceding chapter.  
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Of Ambulances & the Social Determinants of Health in the Eastern Cape 
“You’ve got the poorest people in South Africa paying R7-800 rand [about US$65] 
that nobody had for a private car to get them to hospital. It was killing people, just 
all the time.” —NGO leader, Xhora Mouth (Interview SA-22) 
 
South Africa’s Eastern Cape (EC) Province is the second largest in South Africa—home to 
over 6.5 million people.75 Under Apartheid, much of the province was part of two vast Xhosa-
speaking “Bantustans” (Transkei & Ciskei) that were profoundly and intentionally underdeveloped. 
While most such Apartheid-era homelands were smaller and divided into many parts, aiding their 
eventual incorporation into the new South Africa, the Transkei was larger than Switzerland and 
presided over by a series of authoritarian leaders who left little governance infrastructure. After the 
fall of Apartheid, the Eastern Cape combined these homelands with the areas around the white-
controlled urban centers of Port Elizabeth and East London. Two decades later, the province 
remains deeply challenged; it is home to more unpaved roads considered “poor or very poor,” for 
example, than most of the rest of the country combined.76 At the time of democratization, 
healthcare expenditure was at R250 ($20) per person in the previously white part of the Eastern 
Cape, but R70 ($6) in the former Ciskei and just R40 ($3) in the Transkei.77  
For much of the past decade, public health experts, elected officials, community leaders, 
activists, and the media have bemoaned the poor state of the EC health system—from major staffing 
shortages to crumbling infrastructure, unpaid bills, mismanaged hospitals, and drug shortages. 
Petty corruption and graft have been a significant problem—reflecting management failures on a 
large scale. 
Emergency Medical Services (EMS) has been a particularly consistent failure in the 
province—with stories sparking regular outrage.78 In one eight-month period, for example, 
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newspapers reported that a woman gave birth to a stillborn child after waiting more than 40 hours 
for EMS to arrive; a teenage girl fell from an apartment building and suffered for six hours on the 
ground with her family, waiting for an ambulance to arrive; and an older woman died in a 
magistrate’s court after waiting 90 minutes for an ambulance.79  
While transportation may not seem like the most essential health system aspect, in South 
Africa and the Eastern Cape in particular, it plays a critical role in wellbeing and mortality, 
especially maternal and child wellbeing. Given the rural nature of the EC, the poor road 
infrastructure, deep poverty, and the high costs of private transportation, this is a major barrier to 
healthcare. In South Africa as a whole, the neonatal mortality rate is strikingly high, at 15 per 1,000 
births; neonatal deaths (those in the first 28 days) constitute 40% of all the under-5 deaths, with 
most deaths occurring in the early days of this period.80 Maternal mortality is similarly common—
with estimates as high as 400 of every 100,000 births ending in the mother’s death.81 The EC, in 
particular, is home to the highest rates of both maternal and child deaths in the country—where a 
shocking number of women die in childbirth, babies are stillborn, and children die from basic 
causes such as diarrhea and pneumonia.82 Researchers have shown that more than half of these 
deaths are preventable with basic interventions in the health system.83  
A critical challenge in the Eastern Cape, then, is getting people into the system. The 
province has the lowest rates of attendance at antenatal clinics for prenatal care—often because 
parents cannot arrange transportation. As shown below in Table 4.05, year after year the EC has 
had the lowest portion of children who are born in facilities, often leaving mothers to give birth 
without any trained birth attendant. While in the United States, fewer than 1% of babies are born 
while women are trying to get to medical facilities, in the EC that number is upwards of 7-10%, 
while many others never actually try.84 Problems with emergency health services are a key factor. 
“Mothers here in the rural areas are lucky if they can get a kombi [shared taxi van] out at the main 
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road,” noted one interview respondent. “But if you can’t walk the long distance to the main road, 
or it’s nighttime, or there’s just no one coming, then you have to hire a private car—which means 
asking all your neighbors to borrow. Most people just don’t go.”85 
Table	4.05:	Births	in	facilities	(%)	
Province	 2002	 2006	 2010	 2014	
Eastern	Cape	 58.4	 68.4	 66.2	 78.6	
North	West	 59.4	 70.5	 69.1	 74.4	
Mpumalanga	 60.5	 84.9	 73.9	 80.4	
KwaZulu-Natal	 62.2	 74.0	 73.5	 81.7	
Western	Cape	 65.0	 88.2	 84.1	 88.1	
Free	State	 65.6	 73.4	 89.6	 86.3	
Northern	Cape	 67.4	 81.3	 86.2	 88.2	
Gauteng	 70.1	 98.0	 94.4	 95.6	
Limpopo	 71.2	 89.5	 85.6	 91.6	
Source:	District	Health	Information	System	(DHIS).	Department	of	Health.86	
 
Strikingly, studies have linked lack of transportation to health facilities and between 
facilities (when a higher level of care is needed) to up to one-quarter of deaths and severe 
complications related to birth for both mother and baby.87 This results not only in death and injury, 
but also in HIV transmission—which is almost entirely preventable during birth, but only with HIV 
testing and timely administration of antiviral drugs by a clinician. With HIV and related TB, still 
the leading killer in South Africa, millions of women giving birth are HIV positive.88  
While those in childbirth are among the most obvious, many others need transport. 
Emergency transport is critical for the elderly and for the young—with many stories of infants and 
young children dying waiting for an ambulance because their parents had no way to get them to a 
hospital. Meanwhile, “planned patient transport” (PPT) is critical for the elderly, those with chronic 
diseases, and the disabled, for whom the high cost of transport and the long distances to medical 
care result in missing needed medical care, dropping off treatment, and poorer health outcomes. 
“In this wheelchair, there is no way for me to get to the main road,” shared one respondent whose 
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hilltop home was only accessible by vehicles with four-wheel drive. “When I got TB, I know I was 
supposed to go regularly to the clinic. They said if I didn’t, I could develop resistance, but how do I 
do that?”89 Healthcare for many is inaccessible for practical purposes.  
Equally important is the economic toll of the lack of EMS. An analysis done by Jane Goudge 
of the University of Witwatersrand found that the cost of transportation regularly pushed medical 
costs for families in the Eastern Cape well past the level internationally recognized as a “catastrophic 
burden.”90 Over half of Eastern Cape households receive a social grant, and about 37% are reliant 
on that grant as their main source of income—grants that usually run about 1,200 rand per month 
(about $100).91 Incomes for many workers are not much more. In this context, an emergency 
requiring a taxi that often costs 700-800 rand (about US$66) means spending as much as 50% of 
household income, at the expense of other needs like food and shelter that also impact health.92 
Disability, chronic illness, or repeated emergency needs means medical transport costs push people 
into debt, building on the cycle of social determinants that connect income, inequality, and poor 
health. 
 
Limits to the Pressures of Democracy for Policy Change  
“We have been talking with those seeking to be elected or who have been elected. 
They always agree with us and say, ‘we need a clinic’ or ‘we need ambulances,’ but 
it never happens.” —Community leader Folokwe, Eastern Cape (Interview SA-24) 
 
Over the past decade, there have been waves of pressure for change—marked at various 
points by the kind of “focusing” events described in the literature as opening the possibility for 
policy change.93 From headline-grabbing deaths and the resignation in protest of Dr. Trudy 
Thomas, the first post-Apartheid Member of the Executive Council (MEC) for health (equivalent 
to the provincial minister), to strikes by EMS workers over deplorable conditions, none of these 
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potential “focusing events” have opened windows for the kinds of policy change needed.94 Instead, 
a strong, quickly-adapting policy monopoly has maintained several conditions: insufficient 
sustained investment for EMS in the province along with concentration of the investment that does 
occur in the major urban, formerly-white areas. A specific policy that ambulances must be based at 
public facilities with a certain level of infrastructure has been particularly pernicious—meaning 
communities with no clinic (and thus greatest need for transport) also have no ambulance, while 
formerly white communities that benefitted from an over-building of clinics under Apartheid have 
more than their share.  
	
Table	4.06:	Advantaged	vs.	disadvantaged	
districts	in	the	Eastern	Cape	
Sarah	
Baartman	
District		
O.R.	Tambo	
District	
People	per	ambulance	 8,502	 34,124	
People	per	district	hospital	 45,058	 151,660	
%	Population	white	&	colored	 45.9%	 0.7%	
%	Population	Black	 53.3%	 99%	
%	of	households	with	piped	water	 79%	 39%	
Source:			ECDoH	Annual	Performance	Plan	2013/14-2015/16	p	178	(2011/12	data);	SAHRC	
Eastern	Cape	Hearing	Report,	2015;	Stats	SA	Community	Survey	2016.
95
	
 
A set of overlapping groups has helped prop up the policy status quo: risk-averse 
bureaucrats, whiter/wealthier communities, politicians supported by patronage, and self-interested 
public and private sector actor-supported stability of policy that has thoroughly failed rural, Black 
South Africans. The relative power of residents of Port Elizabeth, East London, and similar areas 
keeps some level of ambulance services there (albeit of questionable quality at times) at the expense 
of expansion to the former Transkei and Ciskei.96 “Advantaged communities are actually very afraid 
of losing services, so powerful politicians in this province would call up DOH at the first sign of 
rationalizing services,” one official reported.97 A comparison of two districts in the province 
illustrates the disparities: as table 4.06 shows, there were four and a half times as many people per 
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ambulance in the O.R. Tambo district, formerly part of the Transkei, than in the richer and 
significantly more white and colored district municipality of Sarah Baartman, which surrounds 
Port Elizabeth. It is notable that these are based on the total number of ambulances, but the South 
African Human Rights Commission (HRC) found that serious mismanagement resulted in 30-40% 
being out of service for various reasons. Nonetheless, the EC Department of Health (ECDoH) has, 
at least in theory, posted sufficient ambulances to the wealthier, whiter district to meet the national 
standard of 1 per 10,000, while they are far from that level in O.R. Tambo.  
African National Congress (ANC) powerbrokers have used the EMS as patronage jobs to 
secure voting blocs—meaning, here, electoral pressures actually fomented club goods. Others seem 
to have simply believed reform was nearly impossible and focused on simply concealing the effects 
to avoid the ANC being blamed.98 Owners of private ambulance services had close ties to ANC 
political leaders and benefited from fallback business from both individuals and public-sector 
hospitals when EMS was unavailable. There is also some evidence of officials receiving kickbacks 
from contractors who did not adequately perform.99 Meanwhile, even capable and honest civil 
servants were nonetheless highly risk averse—finding that inaction was less likely to upset the 
balance of power and that justifying the status quo was good for their professional lives. “It was, of 
course, always easier to just continue what had always been done—pay the doctors in the high-level 
hospitals and don’t worry when there’s no money left to expand EMS or other services,” a relatively 
new official reported of his predecessors.100 All of this was exacerbated by exit to private care among 
the wealthy and upper-middle classes, meaning many of the decision-makers are not reliant on 
public sector ambulances.  
Responsible actors have justified the current state of affairs as the unavoidable effects of 
Apartheid—claiming the moral high ground for the ANC as the party of liberation, working at 
“transformation” as quickly as possible under difficult circumstances. “They just say: we are the 
party of Mandela and ‘a better life for all.’ These are troublemakers spreading lies,” reported one 
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activist.101 Officials also pointed to limited resources—both financial and human—as a powerful 
reason for inaction, with petty corruption and poorly trained staff difficult to change quickly. “They 
told us they couldn’t put ambulances in Xhora Mouth because there were bad roads, which was a 
problem for [Department of] Roads and Transport. There was no secure place to park it because 
the community was poor and there was no infrastructure. Meanwhile, they could not hire 
competent workers from the communities to drive or to answer emergency calls because education 
is bad in the area,” reported one health activist from the EC.102 This idea, or “policy image” in 
Baumgartner and Jones’ terminology, was powerful—it allowed ECDoH to portray its funding 
decisions and their outcomes as reasonable, passing blame to other departments, to national 
government, and to the former regime. Like any powerful idea, this has elements of truth to it: 
funding was insufficient, and fixing the EMS problem was multidimensional. Yet outside experts, 
former leading national health officials, and others all expressed the same consensus in interviews: 
getting ambulances to Xhora Mouth and the rest of the province was possible and urgent.103 
Looking over two decades, it becomes clear that failure to coordinate on policy for change, both 
intentional and negligent, prevented doing so. 
Electoral pressures that should incentivize change have largely failed to achieve serious 
policy change in the Eastern Cape for a variety of reasons. A set of ANC leaders has been part of 
supporting outsourcing of EMS services, defending insufficient budgeting for EMS, and covering 
up mismanagement and under-spending of existing resources. The ANC has regularly won 
majorities in the province at the both the provincial and national level. However, competition in 
South Africa has been fierce, and the opposition has fought hard for election. Opposition parties 
have controlled some municipal governments since 2000 and, beginning in the 2004 election, the 
ANC began to drop below 50% in substantial areas of the province but maintained pluralities in 
multi-party elections, losing several districts in subsequent elections in 2009, 2014, and 2016. 
Opposition parties including the Democratic Alliance, United Democratic Movement, Economic 
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Freedom Fighters, and Congress of the People hold a significant minority bloc of seats in the 
provincial legislature, and the opposition regularly highlighted the failures of EMS and the broader 
health system in their drive get votes.104 Some might misinterpret ANC electoral success as evidence 
of limited electoral competition, but South Africa’s proportional representation electoral system 
has ensured vote-seeking is aggressive, as the ANC competes strongly for votes to offset other 
regions of electoral weakness.105 Meanwhile, information has been widely available—both 
information for voters and information to government about the performance of the system. A 
series of high-profile newspaper stories in the province has revealed health system failures and, in 
particular, the collapse and inaccessibility of EMS—with headline-grabbing stories of babies, 
mothers, and elders dying while waiting for an ambulance.106 A documentary film about the 
shocking state of public ambulances aired on local television.107 A Human Rights Watch report 
brought international attention, documenting failures of ambulances and inter-facility transport 
leading to deaths among mothers and children.108 And a respected journal published reports on 
how a many-hours wait was both common and directly linked to avoidable perinatal death.109 Some 
legislators responded with grandstanding and the sharing of informational reports of their own—
but seemed unwilling or unable to change things.110 At one point, the chairperson of the Health 
Standing Committee demanded publicly that the National Department of Health and Office of the 
Premier intervene to fill critical staffing shortages the EMS that ECDoH seemed incapable of filling, 
but changes failed to materialize.111  
In one particularly notable episode, an award-winning 2007 investigation by the Daily 
Dispatch showed how public emergency services and maternal health linked to Frere Hospital were 
all but collapsing—revealing negligence, staff shortages, incompetence, and lack of equipment; even 
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a case of a cleaning worker delivering a baby.112 The national Deputy Minister of Health Nozizwe 
Madlala-Routledge responded by visiting and declaring the situation a “national emergency,” 
calling for change.113 She went in part because of stories of pregnant women dying while waiting 
for ambulances to get to the clinic—and also because she heard that the MEC for health was actually 
part owner in an ambulance service and she worried about the political ramifications (a story later 
substantiated this).114 But instead of change, the provincial MEC for health accused her of lying, 
and national Minister of Health Manto Tshabalala-Msimang used that as a convenient excuse to 
get rid of her deputy, with whom she had clashed on HIV. 
Throughout this period and beyond, there were multiple attempts to use the levers of 
democracy to address the issues. Advocacy group Public Service Accountability Monitor (PSAM) 
issued a damning report in 2004 on the Eastern Cape DoH’s accounting and spending practices.115 
Describing what they called the “Emergency Medical Services Fiasco,” they revealed that the 
emergency medical rescue services budget for ambulance and planned patient transport was 
regularly under-spent—by 12% in 2002/3 and 15% in 2003/4. The privatized ambulance fleet was 
failing to provide services, and up to 60% of the entire ambulance fleet of the province was out of 
commission because of mechanical problems. In the short-term, there were some changes in 
personnel in response to the report, but change was short-lived, and PSAM and other civil society 
groups largely found themselves frozen out of decision-making.116 EMS workers went on strike at 
least twice in the post-Apartheid period because of working conditions, without significant effect. 
There was even a march to the provincial parliament in Bhisho. Yet for years, there were no 
meetings between organized civil society and ECDoH officials.117 Most importantly, service delivery 
did not improve.  
Even when the national government was clearly aware of the problems, change was largely 
blocked by the power of local elites in the broader ANC structures. A confidential internal report 
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commissioned by national Minister of Health Barbara Hogan in 2009 found that “On the basis of 
the norm of one ambulance per 10,000 population, the province should have a fleet of 700 vehicles. 
In fact, there are only 180 available.”118 The report found that contracts for ambulances were 
inappropriately negotiated and both far too expensive and failing to deliver services. In 2010, the 
new national Minister of Health Aaron Motsoaledi responded to advocacy by groups by appointing 
Dr. Siva Pillay as Superintendent-General of the ECDoH with a reform mandate that included EMS. 
He fired the entire regional leadership of the ambulance service, along with 1,284 other staff, and 
began to reorient the department. But powerbrokers in the Eastern Cape clashed overtly with him—
including leaders in the provincial ANC who were critical national players in the party and its 
electoral strategy.119 He was quickly pushed out, despite the Minister of Health’s strong backing.  
The evidence suggests that very little had changed before 2012. While PSAM had 
documented under-spending and politicians promised to address it, in 2011/12 and 2012/13 under-
spending on EMS was 4.8% and 14.4%, respectively—with as much as 44% of the planned patient 
transport budget going unspent.120 More importantly, though, it is clear that the planned 
expenditures were far too insufficient to reach even the basic levels of EMS services of 1 ambulance 
per 10,000 people. The department essentially planned to fail—leasing some ambulances, claiming 
other ambulances were on the way, procuring ambulances without four-wheel-drive capacity that 
were in any case unable to reach most of the population, and setting targets that would fall far short 
of the declared minimum for any foreseeable future. And reports of long waits for ambulances 
resulting in injury and death continued.121 
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Mobilizing the Right to Health  
“The testimony was very moving. I mean, I sat there listening to the testimonies 
and the pain that people were going through; it was actually very—was very kind 
of intense… I felt that I was there responding to the communities as an accountable 
officer.” —Senior Official, Eastern Cape Department of Health (Interview SA-29) 
  
“The Human Rights Commission was helpful because it called Department of 
Health but it also called Treasury, it called Department of Transport, it called 
others to come and account. When we went for the budget bid this year, we then 
had to be saying how we will actually implement… this we have known was 
important for quite some time but maybe we couldn’t make happen with all the 
political players.” —Senior Official, Eastern Cape Department of Health (Interview 
SA-27) 
 
Beginning in 2012, a set of actors began mobilizing the health rights framework in a much 
more substantive way. Rights bodies had previously taken note of the failures of the EC health 
systems and had written reports.122 But in 2012, things changed, as legal aid organization 
SECTION27 and the AIDS social movement group Treatment Action Campaign got involved in 
the case of “Village Clinic.” This had been the site of the very first AIDS treatment clinic in the 
country set up by MSF (Doctors Without Borders)—profiled in a widely read book by Johnny 
Steinberg.123 The ECDoH decided to stop paying its relatively low rent for the building that housed 
the clinic, for reasons that are still not clear, and instead moved it into a large tent in an open field. 
Because of connections with MSF, the Treatment Action Campaign, and SECTION27, there was a 
strong response to this move—including the filing of a lawsuit against the national and provincial 
health authorities on right-to-health grounds and a settlement with the Minister of Health agreeing 
to build a new clinic. This itself is a notable case of rights mobilization dealt with in Chapter 4, but 
I raise it here because by 2012 there was a significant “support structure” that had already 
successfully mobilized the legal complex for health policy change on a small level. Shifting focus to 
the EMS problem, the rights-based groups joined together with health workers’ unions and some 
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older anti-Apartheid era groups to create a new coalition—the Eastern Cape Health Crisis Action 
Coalition (ECHCAC). The rights frame helped structure this coalition, bringing in Black Sash, for 
example—a women’s anti-Apartheid and human rights group that was not largely involved in 
health policy. The coalition began by writing a series of letters to provincial health leaders—which 
at first went unanswered. After litigation began, responses were quick in coming.  
 On March 12, 2013, the Eastern Cape Provincial Office of the Human Rights Commission 
received a complaint from the Nqileni Village community in Xhora Mouth. Xhora Mouth is a rural 
community with high rates of TB from its dependence on migrant mining labor—and where the 
nearest clinic is a two-and-a-half-hour walk, involving at least one river-crossing via boat. With the 
help of a local economic development NGO called Bulungula Incubator, Xhora Mouth residents 
filed a complaint on the grounds that the constitution guaranteed health—and emergency 
healthcare in particular—as a basic right, which was denied their community, where there were no 
ambulances or planned patient transport. The local HRC conducted an investigation and 
substantiated the claim—finding available ambulances, response times, essential equipment, 
staffing, and ability to navigate rugged rural terrain were all lacking. A few months later, the 
ECHCAC groups found out about this inquiry just as they were launching a new, highly critical 
report labeled Death and Dying in the Eastern Cape: An Investigation into the Collapse of a Health 
System.124  
Highlighting this issue in their report, legal aid group SECTION27 had begun to compile 
a founding affidavit on the EMS issue specifically—seeing a clear case for litigation on the issue, but 
also recognizing the limitations of litigation. Given the opportunity, they used the material to push 
the Human Rights Commission national office to take the complaint up as a critical set of questions 
for the HRC’s mission. The commission, with prodding from the ECHCAC groups, agreed to 
conduct a series of consultations with communities to gather more and more evidence on the failure 
of the EMS. 
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After an initial request for information went unanswered by the ECDoH, the HRC 
subpoenaed a series of documents from the department relating to the size of the ambulance fleet, 
plans to increase the size, the state of ambulances, response times, and under-spending of the 
emergency medical services budget.125 The response of the ECDoH provided highly unsatisfactory 
and contradictory information, while claiming that this issue was not appropriate for rights-based 
inquiry.  
In response, the HRC launched hearings. In addition to two commissioners from the 
HRC—Deputy Chairperson Pregs Govender and Commissioner Bokankatla Malatji—Dr. Prinitha 
Pillay, a former MSF doctor working for the Rural Health Advocacy Project, was appointed to 
provide expertise on the subject, since neither commissioner was fully conversant in rural health 
systems.126 The HRC asked the ECHCAC to identify four communities where they could gather 
testimony. Lusikisiki, Xhora Mouth, Chintsa East, and Hamburg were chosen, each of which then 
elected a representative to attend the formal hearing.  
Even before the hearing formally occurred, very significant bargaining had begun, as the 
ECHCAC groups made it clear they would work with SECTION27 to consider a lawsuit on EMS 
and support the HRC process. As a result, ECHCAC groups were finally granted meetings around 
this time with local officials—meeting once with the MEC and twice with the superintendent-
general in 2013/14. They demanded increased spending on EMS and coverage in rural areas.127 
Under pressure and attention, the EC government revised its EMS budget for 2013/14 upward to 
R812m. In November 2014, as preparations were getting under way for the hearing, supplemental 
funding was again made available for the EMS service—R83.4 million; R62 million of which was 
allocated for leasing ambulances in order to increase the size of the current fleet, and R21.3 million 
to fund the employment of additional staff.128 Health expenditure on EMS had been hovering 
around 4% of total provincial health spending for many years. Figure 4.3 below shows that trend 
                                                
125 South African Human Rights Commission 2015, 20. 
126 Interviews SA-22, SA-23. 
127 Interview SA-20. 
128 South African Human Rights Commission 2015, 43. 
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was broken beginning in 2013/14—with EMS taking a notable increase in its share of EC health 
expenditures, inside a total budget that itself increased.129  
At the hearing, 200 people were in attendance. The ECHCAC bused in 20 people from each 
of the communities, while the Treatment Action Campaign brought out their members from the 
urban communities. The subpoena is a critical power held by the HRC—an institutional tool 
enabling them to compel government to appear. When Treasury did not show up on the first day 
of the hearing to join representatives of Health, Planning and Roads & Transport, the threat of a 
subpoena quickly encouraged them to send a representative. By convening all the parties, the 
Commission changed the accountability dynamic that had previously existed, in which each 
department blamed the others for the problem. This finally enabled an apples-to-apples 
comparison on funding, targets, and goals—and the Commission spent a lot of time sorting fact 
from fiction. Fulfilling a critical informational role, it uncovered critical details—that ECDoH had 
regularly failed to spend its limited EMS budget and that, contrary to the official narrative, current 
plans did not put the ECDoH on track to meet even its own targeted number of ambulances. During 
the two-day-long hearing, government officials who had been reluctant to meet with civil society 
groups were compelled not only to present reports and data, but also had to listen to the community 
representatives present on the impact of failing EMS service on their lives, health, and finances. The 
hearings were open and public and received quite a bit of media coverage.  
“It wasn’t just a foreign court thing,” one respondent shared. “It was really happening in 
people’s lives. It also makes it, I think, even more uncomfortable for department officials. You sit 
in front of a court, and you’ve got your lawyer talking for you. Here you sit in front of 200 people, 
and you have to stand up and say, ‘This is why the ambulance didn’t come when you called it for 
your sister.’ It’s a much more direct-accountability mechanism…. The Minister is currently talking 
a lot about how there is ‘malicious compliance’ in some of the provinces thwarting the orders from 
national government and courts, so this was critical.”130  
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This also empowered change-agents inside the ECDoH. As illustrated in the quote that 
opened this section, some ECDoH officials—including a few brought in specifically to fix the 
problems raised by the HRC complaint—found they now had winning arguments.131 Where 
previous efforts to increase and shift the budget, add EMS staff, and buy ambulances that could 
actually reach rural areas were blocked in either DoH or Treasury, they now gained new traction.  
 
Policy change outcomes 
The outcomes of this case will continue to roll out over the coming years, but several 
outcomes can be observed. The first is increased resources for the EMS—which took a distinct jump 
following rights mobilization, hitting its highest level since apartheid in both total rand and portion 
of health expenditures in 2015/16. It will reportedly rise again this year. In addition, recent years 
have seen significant under-spending—especially on planned patient transport. For the first time 
in recent years, EMS is on track to have zero or close to zero under-spending.  
In addition, the ECDoH reports additional shifts: procuring 141 new four-wheel-drive 
capable ambulances and creating a new policy on response time that explicitly sets the target as 
fifteen minutes in urban areas and forty-five minutes in rural areas.132  
                                                
131 Interview SA-27, 29. 
132 Interviews SA-27, SA-29. 
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 At a national level, the national Department of Health has moved to regulate ambulances—
long neglected, despite clear direction in the Health Act of 2003. While the first draft focused largely 
on the private sector, after extensive comments and lobbying from ECHCAC groups, the 
promulgated regulations deal with public sector delivery and speak directly to the EC example.  
 
 
  
 Finally, it is notable that a new MEC for health took office in 15 and hired a new EMS 
director. For the first time ever, the ECDoH superintendent-general and the director of EMS visited 
Xhora Mouth in 2015 and met with residents to hear more about their concerns.  
Most importantly, perhaps, Xhora Mouth now has an ambulance stationed much closer. 
At least three times since the hearing, an ambulance has been called and has shown up to ferry 
patients to hospital. It has taken far longer than the promised 45 minutes, and most people are still 
quite wary of trusting the ambulance will show up for life-or-death moments, but there is clear 
progress. In October, officials report, there will be a new four-wheel-drive ambulance based in the 
parking lot of the organization that helped residents file a human rights complaint.133 
 
 
 
 
                                                
133 Interviews SA-28, SA-29. 
Table	4.07:	Under-spending	on	EMS	(Rand	‘000s)	
		 2011/12	 2012/13	 2013/14	
		
Appropriatio
n	
Expen
d	
%	
under-
spend	 Appropriation	
Expen
d	
%	
under-
spend	 Appropriation	 Expend	
%	
under
-
spend	
Emergenc
y	
transport	 657,569	
633,7
97	 -3.6%	 698,408	
603,7
08	 -13.6%	 795,687	
784,89
8	 -1.4%	
Planned	
transport		 20,193	
10,79
1	 -46.6%	 25,756	
15,81
7	 -38.6%	 30,202	 28,04	 -7.1%	
Total	 677,762	
644,5
88	 -4.9%	 724,164	
619,5
25	 -14.4%	 825,889	
812,94
6	 -1.6%	
Source:	Human	Rights	Commission,	2015.	
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Figure 4.4: Leaders from Xhora Mouth and surrounding villages meet with the head of the EMS in Bisho, 
2015.  Figure 4.5: The new ambulance parked near Xhora mouth, 2016. 
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4.3: HIV/AIDS AND THE POLITICS OF LITIGATION 
 
“We do have a constitution. It has its own limits. But that constitution is the most 
important thing. We have a constitution that guarantees the right to health. 
Without that I think we would be in a different state” –Treatment Action 
Campaign Leader living with HIV (Interview SA-43) 
 
“I think the Right to Health is the indispensable start, it gets things moving that 
otherwise might not. I’m not sure how it matters after that but it does open things 
up to where we can take a look and see…” –Justice, Constitutional Court of South 
Africa (Interview SA-03) 
 
“I think people began to take note of what the constitution means in the context of 
health policy implementation… at the beginning it was all about [Mbeki] asserting 
his authority and closing the question on AIDS, but in the end South Africa is a 
country with a right to health clause and that was what caused it to tip toward what 
people needed even against his authority, if I may put it that way.” –Former Senior 
Health Official (Interview SA-07) 
 
 
We turn now to a case that contrasts in many ways with that of the EMS in the Eastern 
Cape. Perhaps the most internationally known case of the constitutionalization of health lies in the 
high-profile fight over AIDS treatment in South Africa—an example that pitted activists and the 
Constitutional Court against the country’s President and Minister of Health. Where the Eastern 
Cape example illustrates the possibility of rights mobilization through quasi-judicial bodies to affect 
the health of the rural poor, in a case that has garnered little notice outside South Africa, the AIDS 
treatment struggle played out on a global stage. Drawing the attention of heads of state and media 
throughout the world, legal scholars have both celebrated and critiqued the case. Kapczynski and 
Berger call it “one of the most celebrated human rights cases in the world,”134 and Bilschitz notes it 
“demonstrates that socio-economic rights can offer important protections to the vulnerable against 
unreasonable government policies,” even as he worried at the time, that it “may well amount to very 
little” because the court lacked an enforcement mechanism.135 The EMS and AIDS treatment cases, 
different as they are in scale, follow a similar path in which policy change was blocked by 
monopolies that were ultimately only disrupted by health rights mobilization that changed the 
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actors, interests, and ideas at play. Together these contrasting cases illustrate well how 
constitutionalization effects policymaking.  
In 1996 scientists at the International AIDS Conference in Vancouver announced definitive 
evidence that combination therapy with antiretrovirals (ARVs) was effective against HIV. Brazil 
announced it would begin public distribution of ARVs to those living with HIV immediately that 
year. Yet in South Africa—despite a similar economic, social, health and political context136—it 
would take years before ARV roll out began. A conservative estimate found that failure to 
implement an even minimally effective program resulted in 3.8 million “person-years” lost over 5 
years.137 That policy decision, however, was reversed, and today South Africa has the world’s 
largest ARV treatment program and one of the most progressive policy frameworks for the use of 
antiretroviral medicines to prevent HIV transmission.138 This turn around happened not because of 
a change of heart among officials, a breakthrough in scientific evidence, a change of government 
or officials in charge of health, or successful international pressure; the turning point came because 
of the institutional opportunity structure created by the constitutionalization of health, which 
enabled organized activists and human rights lawyers to destabilize the closed policymaking system 
on AIDS treatment and secure sufficient political power to override the persistent will of the 
President and Minister of Health.   
 
The Early Political Challenges of AIDS in South Africa 
In 1982, AIDS claimed its first two South African lives while the country was deep in the 
control of the Apartheid regime. While the government in the 1980s took some basic steps to 
address HIV, including securing the blood supply, the Apartheid government lacked both the will 
and the credibility to effectively address HIV. The real force of the epidemic, however, became clear 
at the same time the transition to democracy began. In 1990, the first national surveys of women 
attending antenatal clinics found an HIV prevalence of 0.8%. A year later the rate had doubled to 
                                                
136 See Lieberman 2009, Chapter 4 for a ramarkable comparison of the two countries including similar economic power, complicated 
federal politics, comparatively strong public health systems facing strong pressures to expand/change, and an epidemic that was 
actually larger in Brazil in 1990. 
137 Chigwedere et al. 2008. 
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1.5% and it became abundantly clear that South Africa was in the early stages of a rapidly growing 
HIV epidemic.139  
 For a time, it seemed AIDS might be a health issue that could be effectively tackled by a 
new, pro-active democratic government. Returning from exile in countries that were already well 
in the throes of HIV epidemics, ANC leaders were well aware of the potential crisis. The Health 
Secretariat began discussions on a plan before the ANC was unbanned and, in 1990, met in Maputo 
at a conference with representatives of the internal struggle which produced a statement on the 
urgent priority of addressing the disease.140 Two years later, in a rare show of unity, the ANC and 
the Apartheid government together hosted a conference inside the country and began crafting a 
strategy to address AIDS before a date had even been agreed for elections. They launched NACOSA 
(the National AIDS Committee of South Africa), an umbrella body meant to coordinate the AIDS 
response, which created the AIDS Plan—a two-year strategy that was lauded both in the country 
and internationally for its progressive and comprehensive approach.141 It is worth noting that two 
of the eight members of the drafting team would go on to become health ministers in the new South 
African government: Dr. Nkhosazana Dlamini-Zuma and Dr. Manto Tshabalala-Msimang.142 
 The government that came to power in 1994 brought not only a strong plan but a clear 
picture of what inaction would look like. Their health manifesto showed this clarity:  
“HIV/AIDS is emerging as a major public health problem, with over 2,000 reported 
cases at the end of 1993, and 500,000 people infected with HIV. Forecasts to the 
year 2000 predict that there will be between 4 and 7 million HIV-positive cases, 
with about 60% of total deaths due to AIDS, if HIV prevention and control 
measures remain unaddressed. Similarly, credible predictions indicate that by the 
year 2005, between 18% and 24% of the adult population will be infected with HIV, 
that the cumulative death toll will be 2.3 million, and that there will be about 1.5 
million AIDS orphans.”143 
 
 This worst-case projection is a chillingly accurate picture of what came to pass over the 
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following decade, at the end of which roughly 2.4 million people had died of AIDS.144 How did this 
happen? 
 Despite an initially promising start, the Mandela government stumbled quite dramatically 
in implementation. The AIDS Plan, adopted as one of the first steps of the government of national 
unity, designated AIDS as a “presidential lead project” giving it access to preferential funds. 
Unfortunately, in practice implementation was left almost entirely to the newly formed Department 
of Health under the leadership of Nkhosazana Dlamini-Zuma, which was also at the time laboring 
to create a single bureaucracy from the fractured and under-resourced structures left by the 
previous government. This sapped both energy and resources from the AIDS plan that had been 
designed as a multi-sectoral effort. Unfortunately, the government also engaged in a series of 
“disastrous high profile ‘quick fix’ solutions.”145 First the Department of Health commissioned a 
stage sequel to the popular anti-Apartheid film called Sarafina II meant to spread anti-AIDS 
messaging. The 14 million rand effort was a complete failure—the tender process was violated 
resulting in accusations of mismanagement of funds, the script was widely panned, and the project 
was scrapped.146 This was followed shortly thereafter by statement from a cabinet meeting 
announcing the development of Virodene P058—a new South African-created treatment for HIV 
that was immediately decried by other experts.147 The Medicines Control Council (MCC) found 
out only after the announcement and promptly banned further testing of the substance, which over 
the course of a year-long scandal was revealed to be an industrial solvent, dimethylformanide, 
which had no impact on HIV.148  
These early missteps not only undermined progress against HIV and cast the government 
response in a very poor light, but it set up a dynamic that would continue—pitting activists and 
NGOs who publicly spoke out about the poorly-managed response against an increasingly 
defensive government.  
                                                
144 Cumulative death toll was approximately 2.4 million people by 2005 (based on calculations from UNAIDS 1998; Chigwedere et al. 
2008). 5.5 million people were living with HIV and the prevalence rate estimated between 16.8-20.7% (UNAIDS 2006). 
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 Political leadership also did not appear as it had been hoped and expected. Nelson Mandela, 
consumed by the vast demands on his time, did not place AIDS high on the political agenda of his 
government—delegating to his deputies F.W. De Klerk and Thabo Mbeki who brought neither his 
power nor charisma.149 Mandela first spoke about AIDS in 1997 at the World Economic Forum in 
a powerful speech that was unfortunately not repeated inside South Africa. Indeed, one particularly 
harsh assessment suggests that “measured minute by minute, during his presidency, Mandela 
probably spent more time with the Spice Girls and Michael Jackson than he did raising the AIDS 
issue with the South African public.”150  
 While leadership has been a central factor in the AIDS response, structural factors 
undergirded the broader challenges and magnified the importance of leaders’ (in)actions. There 
was a broad “institutional logjam” in reorienting the South African public service from the goals of 
control, constraint, and regulation towards new social goals.151 The AIDS Plan envisioned a strong 
central policymaking and coordination role, but under the quasi-federal system of South Africa’s 
new constitutional structure, it was the provinces that were meant to actually execute the program 
and the complexity of competing authorities and conflicting roles was very significant. Provinces 
allocated the centrally-distributed funding as they saw fit, resulting in major differences in the 
prioritization of HIV—ranging from just R2.5 million in one province to as much as R55 million 
in another in the 1998/99 fiscal year.152 Meanwhile, a system of “sunset clauses” kept civil servants 
in their jobs and bureaucracies largely in place, including both Apartheid officials and divisive 
Bantustan authorities, meaning that there was little innovation, accountability, or bottom-up 
pressure to address the AIDS pandemic. 
The growing crisis in South African AIDS policy might well have righted itself with either 
strong political leadership or a public health system bureaucracy with unified commitment and 
capacity. Lacking the latter, however, the problems in Pretoria were amplified with few political 
openings to address them. 
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Failure in the Era of ARV Treatment—Rise of a Policy Monopoly 
A few months after the ANC was elected, results from a study were published in the New 
England Journal of Medicine showing that the use of the drug AZT could drastically cut the 
transmission of HIV from mother to child and, within a few years, new medicines and dosages 
made prevention of mother-to-child transmission (PMTCT) possible on a wide scale, including in 
the global South.153 In 1997 scientists announced a breakthrough at the International AIDS 
Conference in Vancouver—that a combination of highly active antiretroviral drugs could reverse 
the course of AIDS—bringing people back from edge of death. It was also quickly evident that 
ARVs not only halted death but also the transmission of HIV in adults.154 In the U.S. AIDS deaths 
plummeted. The treatment era had begun.  
By this time, AIDS policy in South Africa was becoming the province of an increasingly 
small, insulated, and technocratic group. After the collapse of the Government of National Unity, 
government health policy became increasingly centralized. Following the Virodene scandal, 
independent bodies like the MCC and Medical Research Council were restructured under the 
control of the Department of Health. Minister Dlamini-Zuma had a tense relationship with both 
civil society groups and with the clinicians who were realizing the epidemic was growing out of 
control after the early AIDS program missteps.  
When the Minister announced in October 1998 that the government would not be making 
AZT available for PMTCT and that all previously-planned pilot projects would be stopped, many 
were caught off guard. Her argument that government could not afford the cost of a PTMTC 
program were especially puzzling in the face of work by prominent South African researchers 
showing the costs were more than offset by reduced pediatric HIV cases.155 What many hoped 
would be a short delay quickly hardened into a government position that using ARVs for PMTCT 
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was too expensive and, in Dlamini-Zuma’s words, “will have a limited effect on the epidemic.”156  
Thabo Mbeki became President in 1999 and, when Dlamini-Zuma was redeployed to the 
foreign ministry, there was some optimism for renewed leadership under Mbeki, who had shown 
engagement in the AIDS fight. He appointed Manto Tshabalala-Msimang minister, who made an 
early trip to Uganda to see their PMTCT program and announced she was looking into securing a 
sustainable supply of AZT.157 
“Dr. Tshabalala-Msimang, as a feminist, had been among those fighting for 
people’s rights to health. And Thabo Mbeki when he was Deputy President seemed 
focused on the importance of addressing [HIV].” –Former Senior ANC Leader 
(Interview SA-5) 
 
This optimism was quickly dashed, however, when the President made a speech before the 
National Council of Provinces in which he suggested AZT was unsafe. Despite the drug being on 
the World Health Organization’s essential drug list and having passed both the US FDA and South 
African MCC approval process, Mbeki instead called on leaders to consult the “huge volume of 
literature on this matter available on the Internet.”158 The President had been introduced to the 
work of widely-discredited AIDS dissidents by several people in his orbit and had apparently read 
widely from a network of websites that argued that HIV is a harmless passenger virus and that 
poverty and ARVs themselves were the real source of AIDS mortality.159 This fit, many have 
suggested, with Mbeki’s worldview that understood the role of Western science in colonialism and 
yearned for African solutions over dependence on the global North. In May 2000, while his peers 
in countries like Thailand and Botswana were preparing new HIV treatment programs, Mbeki 
instead launched a Presidential Panel to investigate the causes of AIDS, on which he included a 
group of widely discredited American dissident-scientists who denied the impact of HIV and the 
efficacy of ARVs. The Minister of Health quickly shifted her stance to opposing the rollout of 
treatment and over the coming years would espouse a variety of alternatives to using ARVs 
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including vitamins, olive oil, garlic and African potatoes.160 While ARVs are powerful drugs with 
clear side effects— especially early on—their benefit had been clearly established by this time and 
in both the Global North and South they were used to spectacular effect to halt the wave of 
unchecked AIDS deaths.  
The South African government not only missed its opportunity to be an early leader in HIV 
treatment but failed to introduce ARVs in the public sector for years after scientific and global 
political consensus had endorsed their use. Explaining this development includes a variety of 
factors. Some analysts focus on leadership and the personal role of Mbeki and Tshabalala-Msimang, 
who expended significant political capital to sustain their opposition to AIDS treatment. Nattrass 
labels Mbeki’s stance “denialism” and finds policy was driven by his stance that “resonated with 
him intellectually; and then for reasons relating to his personality, he refused to concede ground.”161 
Parkhurst & Lush suggest that that leadership made a critical difference in South African policy, 
comparing it to the process in Uganda.162 Lieberman argues against seeing Mbeki as autonomous 
from his political environment and argues that denialism in the South African administration was 
the product of the ANC’s need to elevate the social standing of Black South Africans amidst a 
racially charged epidemic.163 Others argue the failure was also driven structurally—that South 
Africa’s public and political institutions were predisposed to support the anti-treatment stance for 
instrumental reasons.164 The ideas driving this paradigm were important, but the mechanism was 
not irrationality of the President; instead, it was the ways that the limited capacity for change and 
inadequate human resources faced by the post-apartheid government inclined a variety of actors to 
disperse responsibility for the epidemic across many levels and avoid accountability through 
obfuscation. While accountability was diffused, power over policy was increasingly centralized 
within the Presidency under Mbeki, who restructured the executive from a cabinet jointly 
responsible to parliament to a presidency as the “ultimate adjudicator” with deputy ministers and 
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directors general responsible to the President and prominent officials in the Presidency playing the 
key role in coordinating policy across government.165   
AIDS treatment policy thus became the monopoly domain of a small group within the 
South African government and was largely resistant to change despite fierce challenge using each 
of the key levers of democracy. The centralization of power in the Presidency (even within the 
cabinet) and the power struggle between different levels of government exacerbated the influence 
of this group. Unlike most policy monopolies, this one existed at the apex of South African politics, 
rather than in the bureaucracy. It was nonetheless rooted in a technocratic politics that mobilized 
powerful ideas to deflect criticism and contain opposition. It left even those inside government who 
opposed the policy sidelined and powerless, as suggested by two former senior civil servants:  
“Many of us were trapped. There were a number of the reasons that were being 
advanced that were legitimate concerns in government. … What was very difficult 
was trying to persuade people that those questions should never be justification 
not to, in a very managed, well-monitored way, to start doing something. But that 
was subject to real power and in the end people just used those arguments to argue 
nothing was to be done… there was no unanimity but we could not break 
through.” (Interview SA-06) 
 
“I remember our DG coming back from one of the cabinet meetings very frustrated 
but angry that the statistics were being questioned. It was not informed by any real 
technical insight, or foresight… it was a political combination of things that could 
not be questioned.” (Interview SA-07) 
 
 
There were two powerful main threads to the ideas driving the anti-treatment policy 
monopoly in South Africa—one political and one far more technocratic, both deployed quite 
successfully. The first might be labeled the “nationalist” or “anti-colonialist” political thread that 
weaves together narratives of racism, pharmaceutical-company greed, and a defense of African 
knowledge to challenge the use of antiretrovirals and instead focus attention on poverty and poor 
nutrition as the drivers of AIDS.166 The history of colonial medicine in Africa and the support for 
Apartheid from the white medical establishment, including a move to self-segregation and the 
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broad lack of responsibility taken for those actions, both undercut the credibility of scientists and 
encouraged an oppositional relationship with the ANC. The strong anti-colonial mission of the 
ANC was then relied on by anti-treatment camp to justify itself—casting proponents of ARVs as 
aligned with a racist conception set on pathologizing and medicalizing Africans. In a speech at Fort 
Hare in October 2000, Mbeki proclaimed:  
“And thus does it happen that others who consider themselves to be our leaders 
take to the streets carrying their placards, to demand that because we [black people] 
are germ carriers and human beings of lower order that cannot subject its passions 
to reason, we must perforce adopt strange options, to save a depraved and disease 
people from perishing from self-inflicted disease… Convinced that we are but 
natural-born, promiscuous carriers of germs, unique in the world, they proclaim 
that our continent is doomed to an inevitable mortal end because of our 
unconquerable devotion to the sin of lust.”167 
 
A text circulated anonymously within the ANC in 2002, but was later credited to Mbeki 
and allies, called Castro Hlongwane, Caravans, Cats, Geese, Foot & Mouth and Statistics: HIV/Aids 
and the Struggle for the Humanisation of the African that articulated this view at length. The long, 
twisting text interspersed quotes from Fanon’s critique of Western medicine with a challenge to the 
data on antiretroviral medicines, claiming they had killed presidential spokesman Parks 
Mankahlana who “died, vanquished by the anti-retroviral drugs he was wrongly persuaded to 
consume.”168  
Antiretrovirals were being pushed, it was claimed, for the benefit of multinational 
pharmaceutical companies and supporters had been duped into carrying the water for these outside 
influences. An ANC National Executive Committee Statement supporting the Presidential Panel 
claimed demand for ARVs “derives from cheap politicking or from benefits lavished by the lobby 
of powerful local and international interests.” The brash statement by Mbeki’s spokesman Parks 
Mankahlana put the motivation more clearly:  
“The tragedy is that HIV/AIDS is not going to succumb to the machinations of the 
profiteering pharmaceutical companies and their propagandists. Like the 
marauders of the military industrial complex who propagated fear to increase their 
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profits, the profit takers who are benefiting from the scourge of HIV/AIDS will 
disappear to the affluent beaches of the world to enjoy wealth accumulated from a 
humankind ravaged by a dreaded disease.”169  
 
This anti-colonial, anti-pharmaceutical thread spoke powerfully to the ANC leadership at 
various levels, socialized in a revolutionary political struggle for freedom and cognizant of very real 
history of white efforts to control black reproduction and sexual health, including Apartheid 
government research into contraceptive methods to induce sterility in the African population and 
alleged attempts to spread HIV through a network of infected sex workers.170 The anti-treatment 
grouping around Mbeki mobilized race in a powerful way to draw a line between the origins of the 
epidemic and the scientists, activists, and politicians arrayed in opposition to the government’s 
stance.  
Lieberman argues that the strong racial boundary institutions in South African society 
made this line of argument particularly resonant in the ANC and throughout society.171 This 
explains, in part, why this policy monopoly was so uniquely strong and able to mobilize a surprising 
degree of negative feedback that contained pro-treatment dissent by marking it as counter to the 
struggle for African freedom. 
The second piece of the narrative was technocratic—what Nicoli Nattrass calls the 
“discourse of unaffordability” and “rhetoric of expertise.”172 From the earliest period when activists 
and medical clinicians began demanding national roll out of AZT to prevent mother to child 
transmission, government claimed it was unaffordable. “I have to look at the whole picture,” argued 
Minister Dlamini-Zuma in 1998. “If you have limited resources, you may decide to put your 
resources into preventing mothers getting infected in the first place. These are difficult issues we 
have to face.”173 This came despite evidence that the investment in PMTCT would save money 
overall. The rhetoric also continued even after the maker of AZT, Glaxo-Wellcome, agreed to 
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reduce the price by 75%.174 This discourse of unaffordability was powerful and continued to justify 
the government’s failure to roll out AIDS treatment for all people living with HIV. AIDS drugs 
were, of course, quite expensive—topping $10,000 per patient per year in wealthy countries, a price 
completely out of reach for the South African public sector. Other governments, however, 
responded quite differently. In Brazil, for example, an Institute of Medicine report notes that “In 
1996, the Brazilian public health system began widespread and free provision of ARVs for all 
citizens… by 2001, public and private laboratories were manufacturing 63 percent of the ARVs 
available to Brazilians… seven of the 13 ARVs being used to treat Brazilians are domestically 
produced; others have been procured by the government on the international market through 
aggressive negotiation of prices.”175 The South African government did not pursue any of these 
strategies aggressively but continued to use affordability as a reason for inaction. Instead, it argued 
for an alternative path that focused on addressing poverty and encouraging nutrition in place of 
ARVs. Tshabalala-Msimang justified her advocacy for garlic, olive oil and African potatoes saying, 
“These things are affordable for South Africans, not like things like ARVs, which are not.”176  
As it became clear that public pressures were undercutting this argument, government 
shifted instead to focus on the challenges of making any intervention sustainable and on the 
complexity of crafting an effective HIV treatment program given the limits in technical expertise, 
human resources, and system capacity. “Managing AIDS is very complex. For instance, of South 
Africa's 20,000 doctors, only 2,000 are actually able to manage HIV and AIDS properly in this 
country,” Tshabalala-Msimang said in defense of her department’s resistance to starting a 
treatment program.177  
Both the cost and the system preparedness were highly technical arguments—which were 
difficult, on their face, to dispute—enabling the deflection of debate and discouraging non-expert 
ANC leaders from engaging. Technical staff at the ministry was set to work to justify the policy 
using complex arguments and intentionally obfuscating presentation of data. 
                                                
174 Mbeki sparks row over Aids drug 1999. 
175 Institute of Medicine 2004, 73. 
176 Notable quotes from the year that was... 2003. 
177 Manto punts ‘eccentric’ Aids plan once more 2004. 
Chapter	4:	South	Africa		
	
 
150 
“You are trying to think of stuff to say that would convince someone that we as 
technocrats have got a very thought-through argument based on data from Home 
Affairs and on that basis, we can justify [the anti-treatment policy] (Interview SA-7) 
 
 Insofar as it was a technical debate between economists or health policy experts inside and 
outside government, the anti-treatment paradigm was highly effective at containing dissent. It was 
not until 2004, after a series of stinging court losses and eight years after the U.S., Brazil, and 
Thailand launched treatment programs, that ARVs began rolling out in the public sector. Even 
then, it was over the active objection of the Minister of Health. In the interim nearly 1,000 people 
were dying each day from AIDS.  
 
Resisting Democratic Pressures  
 
 A basic premise behind the effect 
of democracy on health is that 
openness, freedoms, and electoral 
incentives will change policy either 
by changing the preferences of 
leaders or changing the leaders to 
those with different preferences. 
On AIDS policy at the end of the 
1990s and early 2000s, neither 
happened despite significant, vocal, and powerful opposition to the anti-treatment stance.  
Post-Apartheid democratic freedoms did provide a clear avenue for the free flow of 
information and evidence. News from the 1996 International AIDS Conference in Vancouver came 
quickly to South Africa through both media and leading South African Clinicians, who returned 
from the scientific conference with enthusiasm about what was possible. Registration of the new 
Figure	4.6:	Cartoon	Depicting	South	Africa’s	First	&	Second	Ministers	of	
Health	
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“dramatically effective” AIDS drugs in the country generated headlines that year.178 As the 
government stance against treatment in the public sector became clear, expert voices were quickly 
and quite publicly heard offering a corrective—demonstrating both the science backing ARVs and 
the evidence of cost-effectiveness (and often cost savings) of implementing a program. “The 
government's refusal to give AZT to pregnant women for the prevention of maternal-fetal HIV 
transmission flies in the face of evidence,” wrote William Malegapuru Makgoba, the first Black 
president of the Medical Research Council of South Africa. “To conflate causation with cofactors 
through a mixture of pseudoscientific statements is scientifically and politically dangerous,” he 
wrote, calling it “merely another entry in a lengthening list of politically driven decisions regarding 
the South African AIDS crisis.”179 
The 2000 International AIDS Conference was held in Durban, South Africa at the height 
of the controversy. In the lead up the co-chair of that conference, Professor Jerry Coovadia, very 
publicly laid out the case for ARVs and made a plea for President Mbeki to “leave the science to the 
scientists.”180 In a powerful symbolic move for post-Apartheid South Africa, Archbishop 
Ndungane, the head of the Anglican church, Bishop Dandala, the head of the Methodist church, 
High Court Judge Edwin Cameron, and Coovadia wrote together to Mbeki asking him to 
reconsider his stance. Mbeki was defiant. “I am taken aback by the determination of many people 
in our country to sacrifice all intellectual integrity to act as salespersons of the product of one 
pharmaceutical company,” he responded.181 The ministers of health, arts & culture, and minister in 
the president’s office responded together, calling Coovadia and colleagues “journeymen rather than 
geniuses,” who were simply seeking acceptance by global elites. Since they would not be satisfied 
with “anything short of provision of antiretrovirals in the public health system,” the ministers 
claimed they had to “draw a clear line between informed and responsible recommendations on 
therapeutic interventions by scientists and standing out as the frontline troops of the 
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pharmaceutical industry.”182 The AIDS conference drew 12,000 scientists, clinicians, media and 
people from NGOs from around the world to South Africa.183 Mbeki spoke at the conference but, 
despite hopes, he failed to support HIV treatment or renounce denialist views—focusing his 
remarks instead on the impact of poverty. 
Doctors Without Borders (MSF in South Africa) made a powerful public statement by 
opening a set of clinics in Khayelitsha, the sprawling 500,000 person formerly-black township 
outside Cape Town in 2000. In May 2001, with the support of the local Western Cape provincial 
government then under opposition control, MSF began offering treatment to a handful of people 
with advanced HIV, publicly demonstrating the efficacy of ARVs—work that the ANC government 
dismissed. The Western Cape government had already undertaken a small-scale PMTCT program 
at this point—which the national government called politically motivated “playing games with the 
lives and hopes of vulnerable people."184 
Dissention within the governing coalition was also significant. No less respected voices 
than Nelson Mandela appealed for a change of policy. Yet when Mandela addressed the National 
Executive Committee he was met with a “scathing attack” that suggested in the meeting and later 
in papers that Mandela was selling out to the pharmaceutical companies for money.185 Archbishop 
Desmond Tutu, the coordinating bodies of COSATU and the SACP, the premier of Gauteng (a key 
ANC leader), and the Anglican Church all made statements calling for speedy rollout of an ARV 
program without changing the government stance. In 2000, a (likely intentionally) leaked draft of 
an ANC health policy committee report called for an end to the anti-treatment and denialist stances 
of government, but dissent was quickly squashed.186 International pressures were also significant. 
Leaders from Bill Clinton and Bill Gates to Ban Ki Moon sought a change in approach. Over 5,000 
people, including Nobel prizewinners and directors of leading research institutions around the 
world signed the “Durban Declaration” published in Nature.187 Even when the embodiment of 
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Mbeki’s driving economic vision of African renaissance—the New Partnership for Africa's 
Development (NEPAD)—was overshadowed by his AIDS policies, government policy persisted.188 
While Mbeki did personally “withdraw” from the public conversation on AIDS and AIDS 
treatment after receiving such significant blowback, what Cameron calls the “dead hand of denial” 
continued to drive government policy until it was eventually confronted by rights mobilization.189 
The media throughout this period played a strong role in exposing government hypocrisy 
and the impact of AIDS in South Africa. It also provided a vigorous space for debate and challenge 
to the anti-treatment stance. Tshabalala-Msimang was even directly challenged on live national 
radio after she refused to say whether she believed HIV caused AIDS.190 
 At the end of 1998, the Treatment Action Campaign was launched by a group of ANC 
activists and people living with HIV. As described in greater depth below, the campaign engaged in 
a long-running activist campaign that included picketing the opening of Parliament in 1999 and 
2000, high profile marches with tens of thousands and a series of civil disobedience efforts. The 
results were mixed, and I argue below these are best understood as part of a broader rights 
mobilization. But as one interviewee put it, “protests alone drew attention and made our demands 
clear, but government proved it could was willing to put up with them—it was not enough.”191 
 Electoral incentives were insufficient to break the impasse. There was a significant 
opposition in South Africa throughout this period, but in the earliest years of AIDS the most 
important parties opposite the ANC—the Democratic Party and Inkatha Freedom Party—did little 
to make it a campaign issue. DeWaal and others have argued the 2004 election pushed Mbeki to 
shift his position.192 Toward the end of the election the Democratic Alliance and the broader 
“Coalition for Change” with IFP mounted significant attack on the ANC’s AIDS record—and could 
stand on their own records, having undertaken limited pro-treatment policies in the Western Cape 
and Kwa-Zulu Natal where the DA and IFP respectively had ruled for periods since the democratic 
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transition. The DA’s Tony Leon gave a speech declaring “Across the nation, the ANC has broken 
its promises on AIDS,” and Patricia de Lille of the Independent Democrats took a public HIV test 
and demanded Mbeki do the same, claiming “we are 10 years behind from the rest of the world in 
terms of fighting the AIDS pandemic and are still in denial.”193 These challenges came quite late in 
the process, however. As described below, after consistent resistance the ANC had already given in 
to demands and court orders and launched its operational plan to roll out ARVs. At best, electoral 
concerns may have encouraged the ANC to speed up the implementation; however, the ANC did 
not take the kinds of actions that would suggest electoral pressures were driving policy. Throughout 
the campaign, and for several years thereafter, Tshabalala-Msimang remained Minister of Health 
and continued to speak publicly against ARVs and in favor of nutrition as an alternative despite 
withering critique and mockery. Rather than rebranding its policy for an election year, government 
continued to fight ARV rollout up until the last moment to avoid further legal action well into 2004. 
While mentioned in vague terms, the ANC election manifesto showed little priority for HIV and 
Mbeki’s closely-watched State of the Nation address shortly before the 2004 election barely 
mentioned HIV.194  
This likely reflected important calculations: first, there was a broad view that “the ANC was 
entrenched, [AIDS treatment policy] was not a real threat to their continued ruling.”195 Even many 
leading members of AIDS activist groups like the Treatment Action Campaign were ANC members 
and the leading opposition, DA, was seen at the time as a largely white party unlikely to capture a 
significant vote share of the Black population awaiting ARVs. In 2004 the ANC won in a landslide—
increasing its parliamentary majority to two-thirds.  
 While AIDS rose in political importance over the period, it was far from topping the 
priority list. Table 4.08 shows Afrobarometer polling data conducted just after the International 
AIDS Conference had raised the profile on the AIDS treatment fight significantly. It shows that, 
while AIDS makes the list of important issues for the public, it is down in fifth place and pales in 
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comparison to other priorities like jobs and crime on the list of what ordinary people think 
government should address. Surprisingly, both the proportion of people who knew someone who 
had died of AIDS and the number of cumulative deaths in a country are poor predictors of the 
proportions of people who cite AIDS as a national political priority. 
 While South Africans placed AIDS 
far lower in their political priorities than 
those in Botswana, it was about the same as 
in Namibia—illustrating the reality pointed 
out by Whiteside et. al. that this is a 
regional phenomenon that, even in the 
highest-burden region in the world, AIDS 
does not top the political priority list. 
“Faced with grinding poverty and 
widespread unemployment, people may be 
more concerned with getting a chance to earn an income, feed their families, protect themselves 
from crime and insecurity, and obtain basic health care, than with being saved from a largely 
invisible killer.”196 Even though polling also showed just 39 percent said that government was 
handling AIDS “well” or “very well,” the relatively low priority placed on this undercut the 
incentives for politicians to act.  
Finally, South Africa’s electoral system itself undermined the internal democracy of the 
ANC that might otherwise have helped shake loose policy change. Under the list-based 
proportional representation system in South Africa, those toward the top of the party list are 
essentially guaranteed their seats while those at the bottom have their positions in jeopardy. The 
ordering of the list came from the very same place at the apex of the ANC where the monopoly on 
HIV policy sat—which increasingly came to mute dissent inside the ANC and substantially dis-
incentivize going outside the party with complaints, which could clearly get you moved to the 
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Table	4.08	AIDS	as	a	Public	Priority,	Afrobarometer	2000	
Spontaneous	answer:	“What	are	the	most	important	problems	facing	
this	country	that	government	should	address?”	
South	Africa	 Botswana	 Namibia	
Job	Creation	76%		 Job	Creation	58%		 Job	Creation	54%		
Crime/Security	60%	 AIDS	24%		 Education	46%		
Housing	25%		 Education	20%		 General	Svcs	21%		
Education	13%		 Poverty	17%		 Health	18%		
AIDS	13%		 Health	15%		 AIDS	14%		
Health	12%	 Farming	/	Agric	14%		 	
Poverty	11%		 Crime	/	Security	12%		 		
Source:	Whiteside	et.	al.,	2002.	Includes	only	those	responses	that	garnered	at	
least	10%	of	responses.	
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bottom of the list in Mbeki’s ANC. 
 
The Treatment Action Campaign—New Organization Created to Take Advantage of 
Constitutionalization 
 
On Human Rights Day, December 10th, 1998, the Treatment Action Campaign (TAC) was 
founded as an offshoot of the National Association of People Living with HIV. It was, from the 
start, an organization that rose to take advantage of the particular institutional environment created 
by the 1996 Constitution.  
 
“The constitution was integral to TAC right from the beginning… you could sort 
of draw a line between South African civil society organizations that believe that 
the constitution is the key to campaigning for rights and organizations that believe 
a constitution is a sell-out document... TAC falls very, very much on the side of the 
constitution.” (Interview SA-41) 
 
Founded by a group that included the former and current directors of the AIDS Law 
Project, Zackie Achmat and Mark Heywood, TAC’s governing documents set out the group’s 
commitment to “support the constitutional vision” of South Africa and: 
 
“Challenge by means of litigation, lobbying, advocacy and all forms of legitimate 
social mobilisation, any barrier or obstacle, including unfair discrimination, that 
limits access to treatment for HIV/AIDS in the private and public sector”197 
 
While there had been movements based on human rights and health in South Africa 
through the 1980s, these were focused mostly on the right to health as a part of the equality rights 
violations of Apartheid more than a conception of a positive right to health, per se.198 By the late 
1990s, though, those groups had withered or dissolved under the processes of transformation as 
leaders focused on building a non-racial health system. The rise of TAC reflected not a continuation 
of a previous history of health and human rights, but instead is best seen as a part of a set of post-
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Apartheid “new” social movements that emerged in the late 1990s and 2000s. Following the relative 
lull directly after transition, when much of the movement structure was absorbed into the state, a 
set of groups emerged that simultaneously drew on the long repertoire of dissent and activism in 
the county while linking to emerging networks and waves of internationalized protest.199 TAC falls 
in a unique place within this larger phenomenon insofar as it blends wide grassroots mobilization 
and organizing with “rights-based opposition [which] attempts to hold the government to 
constitutionally enshrined rights within the current liberal order.”200 
While high profile demonstrations attracted the most attention for TAC, a key part of their 
strategy was to popularize the very idea of health as a constitutional right. Much of the daily work 
after the initial launch was building a base of people—mostly Black, living with HIV, many very 
poor—who were literate in the unique blend of science and constitutional rights that became central 
to TAC’s work. One TAC leader recalled: 
“I remember when I joined…we had to learn and live on Section 27 of the 
Constitution, to a point where we practically memorized everything and each word 
and what it means. I think for us it became a living document that way, because we 
discussed it and we debated: what does it mean to have limited resources? What 
shows us the state has an obligation to deliver PMTCT? It was a document that we 
used to refer to that like your living bible. We even said jokingly that it must look 
dirty and torn to show you’re actually using it.” (Interview SA-43)  
 
 By 2003, the group had nearly 10,000 members spread across the country—a relatively 
small portion of the then-roughly 5 million people living with HIV in the country but, given the 
depth of engagement, a remarkable grassroots presence for a group that was just 6 years old.201 
There were 110 TAC branches at the time throughout much of the country, though centered in the 
major urban provinces of Gauteng, Western Cape, and KwaZulu Natal where the group was 
regularly able to pull out 10,000-15,000 people for demonstrations.202 This grassroots power 
combined with treatment and constitutional literacy proved critical in exploiting the opportunities 
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created by the process of litigation where, as described below, a symbiotic relationship between 
TAC pressure and pro-treatment civil servants was critical to creating policy change from legal 
developments. 
 The group’s initial policy campaign in 1998 was crafted around what the founders believed 
would be a powerful and achievable demand: immediate introduction of a national program to 
prevent the transmission of HIV from mother to child. TAC called for pregnant women to have a 
right of access to AZT that could reduce the risk of transmission. Government’s stance at the time 
was that AZT was too expensive (at the time, Mbeki’s stance was not yet formed or public). So, 
when TAC started, they began with a savvy multi-target goal in which they made primary demands 
on the South African government in rights terms, but made AZT’s maker, Glaxo-Wellcome, a 
secondary target.203 The group identified profiteering by the patent holder on an essential medicine 
as the root cause of a violation of the right to healthcare. By explicitly tying their demand to the 
Constitution they made it an issue that demanded a legal remedy—flowing from the state’s duty to 
progressively realize the right to health, they demanded government negotiate aggressively and, if 
that failed, consider bypassing the patent on AZT.  
Much of their initial campaigning was aligned with the governments (initially fair) frame 
that AIDS drugs were expensive. A meeting on April 30th, 1999 between TAC and Minister Zuma 
led to a joint statement challenging the price of ARVs and declaring, “government would name an 
affordable price for the implementation of AZT to pregnant mothers and report within six weeks 
on the price and other issues pertaining.”204 TAC mobilized a South African and global audience to 
shame Glaxo-Wellcome, demanding a price reduction. "We are not the government's friend on this 
issue, but Glaxo-Wellcome could be doing more to make AZT available at cost price," said one TAC 
leader during a protest of the Glaxo offices.205 In this aspect TAC’s initial work aligned it in some 
key ways with the government against big pharma, even as it pushed against reluctance by Minister 
Zuma.  
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 Price reductions came quickly. Glaxo quickly announced a drop in price to the lowest in 
the world—which was costly, but manageable. A new drug for PMTCT, Nevirapine, soon replaced 
AZT which was not only cheaper but was offered via donation to the government. University of 
Cape Town economist Nicoli Nattrass showed that even paying state tender prices the government 
would save about R341,000 (about $43,000) every six months by implementing a PMTCT 
program.206 Prices fell not just for monotherapy drugs for PMTCT but for first-line combination 
AIDS therapies generally. Selling for more than $10,000/year from branded companies, by June of 
2000 Brazil was producing a full cocktail of ARVs for $2,767 and, by early 2001, the Indian company 
Cipla was offering a generic version on the international market for just $350/year. Government, 
however, continued to argue the drugs were too expensive and not effective.  
 Following the international AIDS conference, which ended with an appeal from Nelson 
Mandela for a nation-wide PMTCT program, the MinMEC committee (comprised of national 
Minister of Health and the nine provincial health ministers (MECs)) affirmed the current policy of 
not using AZT. Unable to resist the pressure, the MinMEC agreed to consider Nevirapine but only 
after a two-year period in which pilots would be conducted, limited to two sites per province, 
commencing only once it was approved by the MCC—a strikingly intransigent move in a context 
where other countries were increasingly implementing not just AZT based mother to child 
prevention programs, but full-blow ARV treatment programs for HIV-positive adults and children.  
 As the Mbeki government’s intransigence on PMTCT and ARV treatment more broadly 
became clearer, TAC increasingly shifted toward confrontation with the state. Between 1999 and 
2001, there were meetings with both Minister Dlamini-Zuma and Tshabalala-Msimang, 
demonstrations throughout the country, multiple memoranda presented to leaders at different 
levels, and a 50,000-person petition presented to President Mbeki.207 TAC, COSATU and a set of 
pediatricians who had formed the “Save Our Babies” campaign increasingly built the case for 
action. Along with MSF, TAC leaders traveled to Brazil and, in defiance of national patent laws, 
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imported generic AIDS drugs and followed with a press conference challenging government’s 
narrative of affordability that gained global attention.  
In response, leaders in the anti-treatment monopoly mobilized the ideas and allies that had 
been supporting their position from the start—claiming the TAC did not understand the complex 
technical issues behind the government’s stance and accused them of being foreign-funded (which 
they significantly were) tools of the pharmaceutical industry (which they were not). Government 
worked hard to undermine the group, including providing funding to the National Association of 
People Living with AIDS (NAPWA), which agreed to support the anti-treatment stance and 
defended government against the TAC, claiming they were an elite group from the urban areas of 
Gauteng and the Western Cape that were “disregarding the real issues of people living with 
HIV/AIDS as experienced by Africans... the fact is, without food the anti-retroviral drugs are more 
of a poison than anything else.”208 Minister Tshabalala-Msimang was even more explicit—claiming 
a small set of white TAC leaders were manipulating the rest, who “come with busses and go to 
commissions where they wait for the white man to tell them what to do. . . . Our Africans say: Let 
us wait for the white man to deploy us; to say to us: toyi-toyi (protest) here.”209  
Progressive civil servants inside government encouraged the campaign from the start—
some providing information and quiet encouragement while others, caught in the middle, said 
more with their silence than anything else.210 A meeting in June of 2001 stands out, in which TAC 
and the pediatricians from the campaign for PMTCT met with the Minister, NDOH Director 
General Ayanda Ntsaluba and Chief Director of HIV/AIDS and STDs Nono Simelela. After the 
abrupt departure of the Minister, the pediatricians demanded to know what they should tell HIV-
positive women who were requesting drugs to stop HIV transition and the civil servants said 
publicly that they simply had no good answer to the dilemma—which TAC seized upon in a press 
release.211 It was later revealed that Simelela had, in fact, crafted a full proposal for rollout of a 
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PMTCT program a year prior, which was rejected by the Minister.212 This vividly illustrated the 
strength of the policy monopoly: despite all the pressure, fractures within the ANC, support among 
technical leaders in government, and international encouragement, government persisted in its 
refusal to roll out ARVs.  
 
Politics of Litigation 
On July 17th, 2001, lawyers for the Treatment Action Campaign sent a formal “letter of 
demand” to the Minister of Health and all provincial MECs for health asking that they “provide us 
with legally valid reasons why you will not make NVP available to patients in the public health 
sector… or alternatively to undertake forthwith to make NVP available in the public health 
sector.”213 TAC had threatened litigation several times, but this letter represented a turning point 
and a critical moment of frame-shifting as the group firmly placed the question before the elected 
government in rights terms. The debates about affordability and feasibility would not disappear in 
the coming litigation, but this re-casting flipped the script, asking the government to justify not 
making AIDS drugs available rather than on making the case for why government should act. The 
Minister’s response three weeks later repeated the technocratic arguments about concerns about 
the efficacy and feasibility of the a large-scale PMTCT program and added a new layer: while they 
understood the ethical challenges for physicians and desires of individual patients, government 
claimed it had to “balance” their desire for the best treatment with “government’s obligation to root 
our public policies in the practical realities of the daily life experiences of all our citizens, equally.”214 
In other words, government could not prioritize the “best” treatment for some over public health 
needs for all—an argument that had carried the day in the recent Soobramoney case dealing with 
dialysis. In this case, of course, the treatment was neither expensive or complex, but this shift in 
argument signaled the Minister was preparing for a legal fight.  
TAC was able to secure some of the leading constitutional lawyers in the country—Bongani 
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Majola who had been legal advisor for the South African Constitutional Assembly, Geoff Budlender 
former director-general of Department of Land Affairs in the Mandela administration and founder 
of the Legal Resources Centre (LRC), and Gilbert Marcus, a longtime Johannesburg senior counsel. 
Attracting this level of legal counsel as allies immediately increased the profile of TAC within the 
legal complex and quickly got the attention of government. “It was immediately impossible to keep 
arguing that these were a fringe group who could not win, and the ANC noticed,” one former senior 
official reported.215  
After years of lobbying, demonstrating, and making the public case, on August 17, 2001, 
the TAC executive committee voted to commence litigation against the state, and was joined by 
150 pediatricians and the Children’s Rights Center. The founding affidavit submitted by TAC’s 
Deputy Chairperson, Sipho Mthathi named the national and provincial ministers of health as 
respondents and laid out the questions:  
“The first issue is whether the Respondents are entitled to refuse to make 
Nevirapine (a registered drug) available to pregnant women who have HIV and 
who give birth in the public health sector, in order to prevent or reduce the risk of 
transmission of HIV to their infants, where in the judgment of the attending 
medical practitioner this is medically indicated.  
The second issue is whether the Respondents are obliged, as a matter of law, to 
implement and set out clear timeframes for a national programme to prevent 
mother-to-child transmission of HIV, including voluntary counselling and testing, 
antiretroviral therapy, and the option of using formula milk for feeding.”216 
 
 Government opposed the litigation, arguing the proposal was unaffordable, not feasible 
given the health system’s capacity, and the drugs unproven and possibly harmful.  
 TAC did not, however, trade social mobilization for the courtroom. Instead, their explicit 
strategy was to build public attention for the court case to raise the stakes in court and to place 
pressure on other political targets who they knew would be required to ensure implementation of 
any decision following a TAC win. On August 24th, a few days after filing the case, TAC picketed 
the provincial departments of health in Gauteng, KwaZulu-Natal and Western Cape, launching a 
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campaign aimed at “Convincing the MECs in all nine provinces not to oppose the court case and 
to start implementing the MTCT programme as widely as possible.”217 These were places where 
TAC was strong and had been pressuring for change for several years—in mounting a litigation 
strategy as well, they hoped to expand their impact but always saw it as synergistic with other types 
of political work. Leaders were cognizant, for example, that the effects of the landmark Grootboom 
decision dealing with housing, handed down just two years earlier, was being limited by the lack of 
political will and TAC was consciously building against that likelihood.218 The mobilization 
culminated on November 25th and 26th when rallies and marches took place around South Africa 
including an all-night vigil with hundreds of TAC members outside the court before the hearing 
began.  
Much has been written about the jurisprudential arguments and course of the case and I 
need not fully reprise it here.219 Suffice it to say that TAC won its case in the High Court on 
December 14th, 2001. In siding with TAC, Judge Chris Botha found that, “prohibiting the use of 
Nevirapine outside the pilot sites in the public health sector is not reasonable and that it is an 
unjustifiable barrier to the progressive realization of the right to health care.” “About one thing 
there must be no misunderstanding,” wrote Judge Botha, “a countrywide MTCT prevention 
programme is an ineluctable obligation of the State.” He thus ordered government to make 
Nevirapine available to all pregnant women and craft “an effective comprehensive national 
programme to prevent or reduce the mother-to-child transmission of HIV, including the provision 
of voluntary counselling and testing, and where appropriate, Nevirapine or other appropriate 
medicine, and formula milk for feeding, which programme must provide for its progressive 
implementation to the whole of the Republic, and to implement it in a reasonable manner.”220 
The litigation process brought to light significant information that had not previously been 
exposed, beginning to undermine the anti-treatment monopoly well before the decision was 
handed down. First, the provinces submitted estimates of the cost of a successful PMTCT program 
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which ranged from R21 million in Western Cape to a likely inflated R71 million in the Northern 
Province.221 Together, it was pointed out that this level of funding was far less than the total left 
unspent in the health budget in 2000/01, exposing the inaccuracies behind government’s arguments 
on affordability. The Western Cape province, which had defied the national government and 
allowed a PMTCT program to begin beyond the pilots, ended up providing clear evidence of what 
was possible when its submission revealed it was drafting plans to reach 90% of HIV-positive 
women by 2002. Government had also long been claiming that Nevirapine, like AZT, was unsafe 
and that even the pilots could not begin because it had not been approved by the MCC—even 
threatening Western Cape officials with legal action for using an unregistered medicine.222 Through 
the court process, however, government documents eventually revealed Nevirapine had been 
approved in April 2001 and, in fact, registration had been recommended in 2000 but inexplicably 
delayed by political hurdles.  
The litigation process also shifted policy before the decision: The “two pilot sites per 
province” rule for the Nevirapine had excluded Johannesburg Hospital, an academic teaching 
hospital with clear capacity to implement. The CEO submitted a letter for inclusion in TAC’s 
founding affidavit pointing out the irrationality of the policy and, shortly thereafter as government 
tried to protect its case, the hospital was added to the list of pilot sites. This opened the floodgates; 
with the two-sites per province rule unenforceable there was an opportunity for pro-treatment 
health officials in Gauteng to act, and they moved aggressively. “With NDOH trying to salvage its 
court case and maintain the idea that all the sites with capacity were implementing PMTCT we 
suddenly had an argument that they couldn’t argue with and we said, ‘now is the time to move’,” 
recalled one senior provincial official.223 By December, when the High Court ruling was handed 
down, Gauteng province already had 12 “pilot” sites covering most of the major hospitals in one of 
the most affected urban provinces.224  
After the high court decision government was faced with a choice—accept legal defeat and 
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move forward with a program that had growing political support or continue to oppose the rollout 
of ARVs in any nationwide form, even to prevent HIV transmission to children. It would not, at 
this point, have been particularly hard to walk away—Mbeki had already declared his official 
“withdrawal” from the public debate, even as his views continued to drive policy, and provincial 
ANC leaders were increasingly agitating for change. A review of the pilot projects by Health 
Systems Trust was nearly complete, which would show they were succeeding.225 There were plenty 
of face-saving avenues that would have had the support of health officials and made for better 
politics. 
Instead, inside government the Minister was forcefully resisting the court ruling and 
pushing to maintain the policy stance. According to one senior ANC leader: 
“At first, in public the decision of the courts was not questioned. But internally the 
court was challenged with the Minister leading saying ‘We aren’t going to allow 
the courts to govern, to tell us what to do.’” (Interview SA-5) 
 
 Dr. Anyanda Ntsaluba, Director General of the National Department of Health reportedly 
stormed out of the MinMEC meeting to discuss appealing the case, saying he could no longer 
“defend the indefensible.”226  
 Just a few weeks before the PMTCT review was completed, the Minister of Health 
announced she would appeal the decision directly to the Constitutional Court. “Government, not 
courts must decide on HIV and other social policy,” she wrote in the Sunday Times.227 That the 
government went ahead speaks to the strength of the commitment to maintaining the policy.  
The litigation combined with social mobilization, however, changed the politics around 
HIV treatment in South Africa. The presidency and Department of Health had succeeded in 
cordoning off HIV treatment policy—securing acceptance by other political players that it was a 
matter appropriately handled by them and successfully fending of challengers. While TAC had 
persuaded COSATU previously to join the cause, TAC now succeeded in “expanding the scope of 
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the conflict” on a major scale. Both the government’s coalition partners—the SACP and 
COSATU—made it publicly known they had opposed the decision to appeal the case, but had not 
carried the day.  
The political pressure TAC had built also bore fruit in the provinces. Even with the appeal 
pending, the lower-court ruling provided an opportunity—action on PMTCT had increased 
legitimacy and many of the national government’s arguments against it had been revealed to be 
nonsensical. This had the effect of empowering those within government who opposed the ruling 
policy who became more active.  
“It communicated to those in the system, within the institution who may have been 
feeling frustrated because there was so much negativity going on in the [National 
Department of Health] to then say ‘the court has ruled, so what I’m doing is wright. 
I’m following what the court has determined. I think it gave strength those of us 
inside and outside the institution.” (Interview SA-5) 
 
In the provinces where TAC had mounted a serious campaign, pro-treatment officials and 
political leaders stepped into the fray and began using their power to move policy—able to move 
out from behind national government’s roadblock and provided with new reasons for action over 
inaction. 
KwaZulu-Natal was and is home to the highest HIV prevalence in the country, as well as 
both some of the stronger TAC branches and the boldest researchers and doctors in the country.228 
The MEC for health was Dr. Zweli Mkhize—an ANC leader who maintained support for the anti-
treatment policy stance despite his personal misgivings.229 As a doctor, Mkhize’s position was 
particularly vexing for the opponents of the anti-treatment monopoly, but neither meetings nor 
protests had changed it. The Premier, Lonel Mtshali, was from the Inkatha Freedom Party and 
disagreed with Mkhize over the issue, though the discord was in private and KZN remained aligned 
with government in allowing only limited pilots of Nevirapine throughout 2001. After the High 
Court ruling, however, Mkhize’s leverage was severely undercut. With evidence that the 
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governments arguments were deeply flawed now backed by the courts in a constitutional claim and 
pressure on the Premier mounting, his incentives to act were significantly higher. Where in October 
he had been deterred by Mkhize’s backing from the national government, after the court ruling 
Mtshali went public with his support for ARVs, applauding the doctors who were implementing 
PMTCT in contravention of official policy.230 In his State of the Province address he announced the 
province would implement a universal PMTCT program despite the objections of the ANC and 
MEC. "Children are dying… We shall not wait any longer, neither will we allow any further excuse, 
delaying tactic or preposterous theory which may get in the way of saving our children," he said.231 
Mtshali followed this by challenging the ANC in court—demanding to replace Mkhize as the voice 
of KZN in the appeal before the Constitutional Court. He won out over the ANC and promptly 
switched sides and submitted an affidavit in support of the Treatment Action Campaign.  
 In Gauteng, a similar story unfolded—this time under an ANC government. With mixed 
signals coming from the ANC leadership about Nevirapine roll out after the initial court loss, 
Mbahzima Shilowa, Premier of Gauteng, announced a plan developed by the provincial health 
department to dramatically expand the PMTCT program to all hospitals and large health centers 
in the province. In many ways, it was finally a public acknowledgement of what they had been doing 
quietly for several years alongside a plan to speed up significantly. One former Gauteng official 
remembers that: 
“After the first court ruling the divisions within government were notable, there 
was no agreement about what to do, though we knew the Minister would to what 
the Minister would do. But we believed there was enough room in what the 
MinMEC agreed for us to go public and go ahead with the programs our doctors 
and our communities were asking for.” (Interview SA-10)  
 
Tshabalala-Msimang, however, publicly rebuked the Gauteng government and her own 
department for initial unapproved positive statements about the move—saying the provincial 
program violated government policy as agreed by the MinMEC. Though at first it seemed the 
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Minister was acting on her own, it quickly became clear she had backing from the ANC leadership, 
and government’s official stance remained opposed to ARV rollout in all its forms.232 Central 
control over HIV policy, however, had broken down enough during the year of litigation that, while 
Shilowa and Tshabalala-Msimang patched over their differences and talk of the program 
disappeared, it continued on the ground even as government was officially declaring to the 
Constitutional Court that it could not, such that by the end of the year the province had nearly 
reached its goal of full coverage across its health facilities.233 
The six other provinces took no such steps and instead continued to support and follow 
the decisions of NDOH and the MinMEC. In Mpumalanga, for example, the ANC-led government 
instituted government policy as strictly as possible—including closing down NGOs that were 
providing antiretrovirals to rape survivors. In Mach 2002, the National Executive Committee of the 
ANC endorsed the decision to appeal the High Court ruling, challenging whether it was really the 
role of the judiciary to order detailed public policy on a specific medicine. With government 
refusing to budge, TAC applied for and received a ruling that the High Court’s order needed to be 
immediately executed, which the state appealed to the Constitutional Court.  
More than 5,000 TAC and COSATU activists marched to the Constitutional Court on April 
3rd to hear the arguments put forth by government about why it should not be required to 
implement the lower court’s decision. According to one observer the Court seemed “at a loss” as to 
what harm was supposed to be done since the government had documented no adverse results from 
the use of Nevirapine over the 11 months of the pilot sites. The Constitutional Court ruled for TAC 
and set down the full appeal to be heard the following month. Mbeki, in a surprise move, put out a 
statement in ANC Today decrying that some “seem very determined to impose the view on all of 
us, that the only health matters that should concern especially the black people are HIV/AIDS, HIV, 
and complex anti-retroviral drugs, including Nevirapine,” and that government would not be 
“intimidated, terrorised, bludgeoned, manipulated, stampeded, or in any other way forced to adopt 
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policies and programmes inimical to the health of our people.”234 
 
By this point the court of public 
opinion shifted quite strongly against the 
ANC’s stance—with Tshabalala-Msimang 
labeled “Dr. NO” by newspapers and 
ridiculed in editorial cartoons for resisting 
the court order.235 Whatever its benefits, 
the anti-treatment stance was not good 
politics or management of the ANC’s 
image—which took hits not just in South Africa, but around the world. Nonetheless, the national 
government persisted and no national rollout of Nevirapine was implemented.  
Two weeks after the interim court ruling, the Cabinet put out a surprise statement, 
seemingly bowing to the pressure brought through the rights mobilization and public attention. 
Ministers had agreed to overrule and out-vote the President and Minister of Health and publicly 
acknowledge the efficacy of ARVs and promised “a universal roll-out plan to be completed as soon 
as possible.” That plan was not soon in coming, having been laid on the Minister of Health to draft, 
but the statement signaled the beginning of the slow destruction of the anti-treatment monopoly.  
By the time the Constitutional Court formally sided with TAC, the decision was an 
expected but welcome relief to those seeking the rollout of PMTCT programs. The landmark ruling 
set a critical precedent that the right to health in the South African Constitution had meaning—
that it was judiciable and that it was the role of the courts to weigh into complex matters of public 
policy to identify whether government had plans that were “reasonable” and moving “progressively 
within available resources” to achieve full realization of health rights. Distinguishing from 
Soobramoney, the Court found the government’s policy failed this test— “it was not reasonable to 
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restrict the use of Nevirapine” and “they failed to implement a comprehensive programme for the 
prevention of mother-to-child transmission of HIV.”236  
 
Impact of Rights Mobilization  
“Without that case and everything around it, probably something gets done on 
ARVs. But maybe not until Mbeki and Manto get sacked. They were still incredibly 
powerful. Or maybe cabinet eventually steps up but I don’t see anything, as I think 
back, that would have done that for at least another few years. I think it helped 
concentrate minds a bit.” –Former Senior Health Official (Interview SA-06) 
 
“Do you know about the adult ARVs case? Where government was taken to court 
for the right to provide antivirals to all South Africans? You can’t because there 
wasn’t a case. That’s the point.” –Former Senior Health Official (Interview SA-54) 
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 Most policy change in a democracy comes from changing the preferences of policymakers 
or replacing the policymakers themselves. In the traditional sense, neither of these happened: 
Mbeki and Tshabalala-Msimang continued in their posts until Mbeki was ousted by Jacob Zuma in 
2008, six years after the Constitutional Court judgement. They also persisted in their opposition to 
the rollout of ARVs. As Bilchitz noted at the time in critiquing the Court’s ruling, “this seems like 
a strikingly bad moment to express good faith in the government's ability to deliver Nevirapine 
expeditiously.”237 Looking only at the court order and government’s willingness to implement at 
that moment, it was hard to see how the case would really have significant impact at the kind of 
population level explored here. Yet beyond the specifics of the court order, what we see is that rights 
mobilization successfully interrupted the anti-treatment policy monopoly. It did so by expanding 
the conflict to include the legal complex, the ANC’s governing coalition partners, and non-health 
cabinet ministers, creating space for health policy change.  
Following the Constitutional Court ruling, government immediately ceased opposition to 
the provision of Nevirapine and many provinces began implementing robust PMTCT programs. 
However, despite the 2002 Cabinet Statement it took another year before the comprehensive plan 
was actually put in place as the Minister continued to put up one roadblock after another. With 
continued national intransigence, TAC returned to court against the Mpumalanga province for 
failing to rollout Nevirapine. The group also engaged in a high-profile civil disobedience campaign 
to push government to fully implement the Court’s orders. Finally, in August 2003, in a “cabinet 
revolt” Senior Ministers, including Minister of Education Kader Asmal and Minister of Public 
Enterprises Jeff Radebe, overruled the Minister of Health, endorsed the long-delayed report of the 
task team charged with examining the treatment options and ordered the Department of Health 
bureaucrats to develop a detailed operational plan and commence ARV rollout. “I am not the one 
making the decisions; the Cabinet decides collectively,” the Minister complained amidst reports she 
was “despondent” over the cabinet decision.238 This was a unique set of developments, to put it 
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mildly, in which the courts and non-health ministers set out national health policy and issued 
orders to the public health system despite the persistent opposition of the sitting President and 
Minister of Health. Still the Minister dragged her feet; indeed, the actual procurement of ARVs was 
nearly derailed again in 2004 until TAC threatened litigation, forcing the Minister’s hand.  
The point in the quote above regarding the lack of a case concerning adult ARVs is an 
important one. It is worth remembering that the landmark TAC case was focused on PMTCT, the 
most palatable of ARV interventions meant to stop the spread of HIV to babies. The Constitutional 
Court ruling completely avoided the broader question of whether ARVs would be made available 
to children and adults for lifelong treatment. Yet that case and the surrounding mobilization shifted 
the power distribution on the issue. Immediately after the case, this was the subject of broader 
negotiation within the ANC and between TAC and civil society groups and government. Relying 
on the Constitutional Court case, the non-health cabinet ministers felt empowered to order a 
sweeping policy shift that went well beyond both what the court had ordered and what the minister 
could support to start a full-fledged triple combination ARV treatment program, of which PMTCT 
was just a small part. The Treatment Action Campaign, for their part, claimed the legitimacy of the 
Constitution and Constitutional Court and, in making what was (at the time) shocking use of anti-
Apartheid tactics of civil disobedience against the ANC, were protected against attacks from the 
anti-treatment cabal by their ability to cloak themselves in the language of law and rights.  
Finally, on April 1st. 2004, ARV initiation began in the public health sector and, as shown 
in Figure 4.9, AIDS deaths quickly fell dramatically. By March 2005, the target of the comprehensive 
plan—to have at least one service point for AIDS-related care and treatment in each of the country’s 
53 districts—had been met.239 HIV prevalence, which had been steadily climbing, finally leveled off 
as people living with HIV stopped dying and ARV treatment also began to cut new infections.  
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Neither Mbeki nor Tshabalala-Msimang backed down. The Minister complained publicly 
that she was being forced to “poison my people” by the courts. She went on to block attempts by 
the provinces to apply to the Global Fund for financing for the ARV program, interrupt 
procurement tenders for ARVs, and to sow confusion among the public by promoting 
“alternatives” to ARVs. Mbeki, for his part, defended his stance as recently at 2016, saying, “it was 
absolutely necessary for ‘the AIDS industry' that South Africa was whipped into line so that it sets 
an example by being an enthusiastic purchaser of ARVs!”240 Constitutionalization, however, created 
opportunities to bypass these powerful actors, undermine their legitimacy, and redistribute 
resources on the basis of an alternative ideational framework.   
Figure 4.10 shows both the rapid expansion of the ARV treatment program and the 
significant shift in funding for HIV treatment and prevention in South Africa. These calculations 
are based on the Treasury expenditure analyses updated by audited-year for the time period. It 
cannot capture all AIDS spending, since data are limited about how provinces spend their 
unconditional transfers, some of which has gone to fight AIDS. The national funding levels, 
however, are comparable across years and show that from 1997 to 2001 HIV funding barely 
registered in the health budgets, even as similar countries like Brazil and Thailand were shifting 
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significant resources into the AIDS response.241 Funding even dropped in 1999 following the 
discovery of effective combination treatment (note that there is a year lag-time between decision 
and funding).  That began to change around the time TAC launched its legal battle and by the year 
following the Constitutional Court decision the country was on an entirely new spending trajectory. 
It is worth noting that the medium-term expenditure framework (MTEF) which laid out planned 
spending included R372 million for AIDS in 2002-2003 period—at a point when the size of the 
epidemic was clear—but the budget was repeatedly revised upward under pressure and, in the end, 
expenditure totaled R1,131 million across the two years. A new program of conditional transfers to 
the provinces was also introduced at the end of 2001 and rapidly expanded after 2003. 
 
 
 
 
 
 
 
 
 
 
The forced investment in building a treatment program paid off and as HIV prevalence, 
which had been growing each year, finally leveled off and the AIDS deaths plummeted after 2005 
as the ARV program gained steam. The impact of rights mobilization on the health of South 
Africans in this context is hard to deny. 
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Conclusion 
 
 Had South African leaders, like their peers in Brazil and Thailand, acted and rapidly 
implemented an HIV treatment program, they might have been able to control the epidemic. Had 
they started alongside other African countries a few years later, millions fewer would have died. 
This failure looms large. But had South Africa waited for a change in leadership or a change of 
heart, it would have been at least several more years still before ARV treatment began, at a cost of 
hundreds of thousands of lives and new infections.  
 It was not until September 2008 that Thabo Mbeki was “recalled” as state President by the 
ANC after losing the election for Presidency of the party to Jacob Zuma at the party’s Polokwane 
conference. Among interim-President Kgalema Motlanthe’s first acts was to move Tshabalala-
Msimang to another post, replacing her with longtime ANC stalwart Barbara Hogan who, in turn, 
welcomed TAC leaders to her home in celebration just hours after her appointment. It was finally 
the end of the anti-treatment era for the ANC. From there, Hogan set out righting South Africa’s 
AIDS policy, re-focusing the department on creating a strong AIDS response, and rebuilding the 
Department’s standing among physicians, scientists, activists, and international leaders. It took 
several more years for her successor, Dr. Aaron Motsoaledi, to finally reach the level of rapid 
expansion needed to get ahead of the now-crushing AIDS epidemic.  
 All of this could have come far earlier with better leadership, but would be far further off 
course without an institutional environment of constitutionalization that opened opportunities to 
challenge that leadership. Several modeling studies have, in fact, shown that the move in 2004 to 
start ARV treatment made it possible to get back on track toward halting the AIDS crisis in the 
country.242 Today South Africa has the largest ARV treatment program in the world. The Gauteng 
health department is piloting a program to provide ARVs through ATM-like dispensing machines 
in the provinces shopping malls. Life expectancy has reversed its decline and has nearly returned 
to where it was in the 1990s. 
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 The effect of constitutionalization, in this context, illustrates both a positive effect and the 
interplay of courts, democracy, and social movements. The legal complex in this case played a 
critical role, but it was not so much the court order that mattered as the way the turn to the courts 
as an additional venue for health policymaking changed the politics around HIV treatment. That 
AIDS activists could mobilize prominent lawyers and draw on the legitimacy of the courts mattered 
more, I would argue, than the order itself—implementation of which was resisted fiercely by the 
Minister of Health. Indeed, the order to implement a PMTCT program was far narrower than the 
eventual impact it had, helping spark a full-blown AIDS program over the objection of the 
President. It only had that effect, however, because it built the power of actors like the AIDS Law 
Project and the Treatment Action Campaign—unique organizations that emerged explicitly to take 
advantage of the constitutionalized environment around health in post-Apartheid South Africa 
and, in that context, were able to break the anti-treatment monopoly on policymaking and take on 
the powerfully dominant African National Congress party. This resulted in significant 
redistribution of resources—pushing billions of Rand into AIDS treatment in the public sector, the 
recipients of whom are mostly poor, black, and a significant majority of whom are women. These 
resources have also, in turn, helped build civil society organizations and legal service organizations 
involved in both the previous example from the Eastern Cape as well as the issues dealt with in the 
coming section—building the support structure needed to translate the constitutional promise into 
meaningful policy change.  
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CHAPTER 4.5: TUBERCULOSIS IN PRISONS 
 
 “They are the power inside and they use safety and control as the reason to oppose 
anything they don’t want to change. More outside time, different cell 
configurations, whatever. They say they’re studying it. There is a culture of 
impunity and rights matter very little across the board. It’s not just health.” –
Attorney (Interview SA-39) 
 
 “No one truly knows a nation until one has been inside its jails," wrote Nelson Mandela in 
Long Walk to Freedom.243 And among the knowledge Mandela acquired while incarcerated was 
that the nation’s prisons provide a perfect environment for the spread of TB—which he acquired 
in 1988 while at the Pollsmoor Prison. Twenty-four years later, the Constitutional Court issued a 
ruling for another Pollsmoor prisoner who had also contracted TB at the prison—a sweeping 
judgment that advanced the right to health jurisprudence in South Africa and drew praise from 
public health leaders around the world.  
 Unfortunately, tracing the policy process on TB in prisons to the present illustrates the 
limits of the impact of constitutionalization. Evidence suggests rights mobilization has had 
significant impacts on the policy space, following the mechanisms I describe, that may yet bear 
fruit—but overall the policy monopoly in corrections in South Africa has been largely able to 
contain and diffuse policy change. The result is that, according to the most recent data from the 
South African National Health Laboratory Service, TB rates are as high now as they were five years 
ago. 
 South Africa has among the highest rates of tuberculosis in the world. It is the leading cause 
of natural death among South Africans in 2015 if you include deaths among those with underlying 
HIV infection.244 Transmitted through the air in conditions of poor ventilation, TB has been a 
                                                
243 Mandela 1994. 
244 Stats SA 2016. Note: this is based on a calculation of cause of death which attributes many deaths that might otherwise be 
attributed to HIV (e.g. in the causes of death chapter 4.1) to TB, the opportunistic infection that lead proximally to death.  
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longstanding problem associated with both the mining sector and substandard housing in the 
country; exploding into a major epidemic as HIV disrupted the immune systems of millions of 
South Africans.245  
 South Africa also has one of the largest prison populations in the world.246 When the ANC 
government took office, South African prisons had an official capacity of just over 96,000 and an 
actual prison population of nearly 117,000—overcrowding at 121% capacity.247 In 2016 the 
imprisoned population had grown to 161,984 and the capacity deteriorated to 133%. Prisons 
worldwide are places of disproportionate risk for TB (as well as HIV) with rates of infection an 
order of magnitude higher due to poor ventilation and nutrition, limited health services, and 
populations with higher risk of TB exposure before prison—risks significantly exacerbated by 
overcrowding.248 South African prisons in particular provide extremely conducive conditions for 
the spread of TB with overcrowding, substandard living conditions, and poorly functioning health 
services resulting in higher rates of TB than both the general public and the mines.249 South African 
prisons may, in fact, be among the most dangerous places in the world when it comes to TB—with 
incidence 5-8 times higher than reported in other studies.250 Little has changed since Mandela 
identified Pollsmoor as a place with a “modern face but a primitive heart with clean staff spaces but 
housing for prisoners that is archaic and dirty.”251 
 The result is TB infection cycles driven by incarceration that spread throughout the 
community—with people leaving prisons (either staff or inmates) infected with TB regularly. 79% 
of prisoners are imprisoned for less than twelve months and the number of people passing through 
the system annually exceeding 368,000.252 Stuckler and colleagues have shown clearly how mass 
incarceration is directly tied to increased rates of TB and South Africa is a prime example.253   
                                                
245 Lawn et al. 2006. 
246 Institute for Criminal Policy Research 2016. 
247 Steinberg 2005. 
248 Baussano et al. 2010. 
249 Johnstone-Robertson et al. 2011; Telisinghe et al. 2014. 
250 Comparing systematic review of data in Baussano et al. 2010 with rates in Johnstone-Robertson et al. 2011. 
251 Mandela 1994. 
252 Johnstone-Robertson et al. 2011, 809. 
253 Stuckler et al. 2008. 
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 This has been a longstanding issue, but public health officials and advocates have struggled 
to address the problem. As with other issues in this study, significant democratic pressure has been 
applied, but has failed to address the problems.  
  The issue has been repeatedly documented by the Judicial Inspectorate and reported to the 
national department and the Presidency. In 2003, for example, the year that Dudley Lee—whose 
case is described below—contracted TB, the Inspectorate documented over 19,000 complaints 
about medical care and noted that there had been a 584% increase in natural deaths in the prisons, 
far faster than the rise in prison population—but had no information about the causes, and little 
was done.254 In 2001, Dr. Steven Craven, one of the doctors at Pollsmoore, sounded the alarm about 
TB—writing to various bodies including the South African Medical Association and eventually 
speaking before the parliamentary portfolio committee on corrections in testimony that appeared 
prominently in the Cape Times.255 The provincial health MEC visited and called it a “scandal.” The 
South African Medical Journal ran a feature article examining the issue in-depth. The Department 
of Health set up a special task team to deal with TB in prisons, but its recommendations were 
followed only temporarily. In 2007, the cycle repeated again when Parliament’s portfolio committee 
and the inspecting judge of prisons described conditions as a “health time bomb.”256 The doctor 
who exposed the health crisis and spoke to the inspecting team was quickly fired by the department, 
and few changes were made.257 
 Three major barriers have long existed: First, prisoners have among the least political 
power in most societies and South Africa is no different. One might imagine that the recent history 
of unjust imprisonment of so many ANC leaders would result in significant public and political 
commitment to improve prison conditions, but the high crime rate in the country means there is 
little sympathy for prisoners.258 As a result, the small group of public health and NGO leaders that 
                                                
254 Inspecting Judge of Prisons 2004. 
255 Crowded Prison a Big Health Risk 2001. 
256 I Got TB in Prison, Former Inmate Tells Court 2012. 
257 Pollsmoor whistle-blower gets his job back 2007. 
258 The U.N. General Assembly even named new international standards for prisoners after Nelson Mandela, UNGA 2015. 
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tried to push for improved conditions and a plan to address TB among prisoners found it very hard 
to garner much support. 
“The reality is that for years we have tried to get people to pay attention to the 
health needs there but people just say ‘ah, well, prisons are not nice places, they are 
punishment for doing wrong. What can you do?’”—NGO leader (Interview SA-
64) 
 
The second major issue was that information was nearly impossible to come by. While many people 
in South Africa recognized there was problem, the Department of Correctional Services largely did 
not test prisoners for TB, and what testing they did was not made public. It was, therefore, nearly 
impossible to assess the size of the problem or understand the degree to which incarceration was 
driving South Africa’s increasingly large TB epidemic.  
“There were previous attempts to address the issue, and even to do so through the 
courts, but there was simply no data. We would ask if they were testing and they 
would say only rarely. We would ask to see the results and they would say no. We 
would ask to come in to provide TB testing and they would say no. There was a 
blockade at the prison gate.” –Physician/Researcher (Interview SA-66) 
 
A quick review of media, as shown in Figure 4.11 below, illustrates the reality intersection of lack 
of information and lack of political priority. While there were occasional articles dealing with the 
TB in prisons—rising a bit as global attention to TB increased in the late 2000s—the most 
significant media before 2012 came from Nelson Mandela acquiring TB in 1988. 
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 Third, and perhaps most importantly, the kinds of changes needed to address TB are 
significant (e.g. changing the conditions and physical construction of prisons) while the governance 
of those prisons in South Africa, as in most places, is a tightly controlled, militaristic enterprise. 
The need for control and power by jailers is considered paramount, power in the system is 
hierarchical, and information is centralized. There is, in theory, statutory power vested differently 
between the political leadership of the system—the Minister of Correctional Services (now the 
Deputy Minister in a consolidated Justice and Corrections Department)—and the civil service 
leadership, vested in the National Commissioner of corrections. The latter has a statutory duty to 
issue standing orders with the force of law behind them, to give effect to existing legislation under 
the Correctional Services Act, including health regulations.  
“The reality we learned was that the Commissioner had issued all sorts of orders but 
they simply ignored them. This is binding law and I have spoken to the leading 
officials in DCS about it but they look at you like it’s another language. They were a 
fig leaf and they would point to them and say ‘yes, yes.’ It took us quite a while to 
figure out how to get past that. Politicians we asked would inquire and be told, yes 
we have all that…” –Attorney (Interview SA-39) 
 
 In 2012, some of these conditions started to shift when public health leaders and attorneys 
decided to mobilize around a court case filed by Dudley Lee, who had been imprisoned in 
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Pollsmoor Prison where Nelson Mandela contracted TB decades earlier. Lee was arrested with four 
others for fraud, counterfeiting and money laundering and sent to Pollsmoor in November 1999 to 
await trial. After over 70 court appearances Lee was eventually acquitted in 2004. Three-and-a-half 
years into his imprisonment awaiting trial, however, Mr. Lee was diagnosed with TB. Pollsmoor 
was beyond 200% of its designated occupancy and Lee was often held for twenty-three hours per 
day in his crowded, damp cell. The Court noted that this represented fairly standard conditions for 
detainees, perhaps better than average since he spent much of his time in a cell designed for a single 
inmate (which he shared with two other prisoners):259   
“The responsible authorities were ‘pertinently aware of the risk’ of inmates 
contracting TB… Pollsmoor is notoriously congested and inmates are confined to 
close contact for as much as 23 hours every day – this providing ideal conditions 
for transmission; on occasion, the lock-up total was as much as 3052 inmates and 
single cells regularly housed three inmates; communal cells were filled with double 
and sometimes triple bunks; the responsible authorities relied on a system of 
inmates self reporting their symptoms upon admission to the prison and during 
incarceration… In Mr Lee’s case, his vulnerability as a prisoner, which meant he 
was unable to put himself out of harm’s way, together with the lack of proper care 
on the part of the prison authorities, makes a similarly powerful case.”260 
 
Upon his diagnosis, Lee was actually sent back to his poorly-ventilated cell with others despite 
having active, infectious TB. The statement of agreed findings submitted to the Court noted that 
Lee then “begged, bullied and bribed” in order to get access to TB drugs and was eventually cured, 
though he suffered ongoing lung damage. Upon his release a year later, he sued the department of 
corrections, and the Western Cape High Court found in his favor—finding the failure to institute 
an effective TB control program in the prison constituted a negligent breach of constitutional and 
statutory duty on the part of the department.261 The court noted in particular that the authorities 
failed to respect their own Standing Correctional Orders on TB and infectious diseases. The 
government appealed and the Supreme Court of Appeal (SCA) found that they were indeed 
negligent and that rights violations had occurred—calling the state’s case “defending the 
                                                
259 Dudley Lee v Minister of Correctional Services 2012, vol. 2013 2 BCLR 129 (CC), para 114. 
260 Ibid., vol. 2013 2 BCLR 129 (CC), para 8, 101. Note quotes from both main and concurring opinion. 
261 Dudley Lee v Minister of Correctional Services 2011, vol. 2011 (6) SA 564 (WCC), para 15. 
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indefensible.”262 However, the SCA nonetheless overturned the lower court decision on narrow 
grounds of factual causation since the case was a question of negligence for previous acts—finding 
that Lee failed to show that “but for” the (in)actions of prison authorities he would not have 
contracted TB, a standard many have argued was impossible to meet in a case such as this.263 
 Lee’s attorneys at the time originally planned not to appeal.264 The SCA’s application of the 
standard would, in many legal contexts, be considered a limited but reasonable interpretation of a 
widely-accepted test of causation. Activists and health rights attorneys, however, took note of the 
case and pushed Lee to challenge this finding at the Constitutional Court based on the 
constitutional right to health, which they believed required greater flexibility in the service of 
justice. The Treatment Action Campaign, the Wits Justice Project (a journalism effort at the 
University of the Witwatersrand), and the Centre for Applied Legal Studies joined the case, 
represented by the NGO SECTION 27. Successfully applying to join as amici, the groups made the 
argument that this case had critical constitutional and public health implications. The TAC did 
more than just engage legally, however—identifying the issue of TB as critical to their work, the 
group held pickets at both the Constitutional Court and at Pollsmoor Prison ahead of the case being 
heard and worked to make the case a political issue. The legal mobilization generated major media 
attention—as seen in Figure 4.11 above, the spike in articles in 2012 was significant—many of which 
came well before the case was announced in December—with continuing growth in 2013.  
 As in other examples, the process of engaging the legal complex opened space for 
information flows. Here, medical and public health actors who had been trying to address TB in 
prisons were able to finally connect the dots. Where previously a physician whistleblower was 
largely sidelined upon speaking out, the legal proceedings in this case opened the door for prison 
doctors to share what they knew and for public health experts to gain access to the facility and the 
data to assess the problem. On appeal, a team of infectious disease experts from the University of 
Cape Town were able to gain access to the prison.  
                                                
262 Minister of Correctional Services v Dudley Lee 2012, vol. 2012 (3) SA 617 (SCA), para 67. 
263 Meerkotter 2015. 
264 Interview SA-38. 
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“Next to HIV, the strongest risk factor we saw in our clinics in the community was 
previous incarceration. But we couldn’t make the link for sure. With this case, they 
finally had to let us in. We were able to look at the size of the rooms and the 
ventilation. They finally gave us the data. And it was shocking.”—Physician 
(Interview SA-51)  
 
  In a submission to the Supreme Court of Appeal that was later published in a medical 
journal, the researchers concluded the annual risk of transmission of the TB bacterium was 
probably 90% per year incarcerated —combined with poor nutrition and health services, the risk 
of developing active TB was quite high.265 An effective program, however, was possible and the 
researchers showed that “active case finding” (meaning seeking out those likely to have TB for 
screening) together with implementation of minimum national and international standards of 
incarceration could reduce transmission by up to 94%.  
 The Constitutional Court agreed with the amici and found for Dudley Lee. “Denying 
recompense, and insulating the prison authorities from responsibility, merely because Mr Lee was 
unable to pinpoint the source of his infection, may have trenched upon his constitutional rights,” 
wrote Justice Cameron.266  The Court split on the question of whether the existing common-law 
standard of causation must be applied more flexibly in cases involving constitutionally protected 
rights (as the majority found) or if a more radical step was needed to further develop the common 
law and develop a new standard. But the Court agreed that the government’s widespread failures 
and practice of “self reporting” were not reasonable policy stances and that, under the SCA’s 
standard, “it is unlikely that any inmate will ever be able to overcome the hurdle of causation and 
further, no effective alternative remedy will be available” to protect the health rights of prisoners.267 
Mr. Lee won damages and the government was handed a high profile loss that was hailed in public 
health and legal circles around the world as a critical advancement in jurisprudence.268  
 Did this matter? 
                                                
265 Johnstone-Robertson et al. 2011. 
266 Dudley Lee v Minister of Correctional Services 2012, vol. 2013 2 BCLR 129 (CC), para 110. Cameron concurring opinion. 
267 Ibid., vol. 2013 2 BCLR 129 (CC), para 65. 
268 Bateman 2014; ConCourt makes landmark TB ruling 2012; South Africa’s notorious Pollsmoor prison joins the global battle 
against TB 2015; Torriente, Tadion, and Hsu 2016. 
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 It did set an important legal precedent—the idea that a long-standing rule in common law 
at the heart of negligence lawsuits the world over had new meaning in a constitutionalized health 
policy context actually opened the courts to the many more people and issues. Dozens of lawsuits 
were filed by others who had contracted TB, which the department claimed was helping it see the 
error in its ways. The decision also shifted the policy space significantly—new guidelines were 
adopted immediately thereafter directing comprehensive and coordinated TB management in 
prisons. These guidelines were issued by the National Department of Health—crossing ministerial 
lines and giving public health actors greater legitimacy to act in a sphere dominated by corrections. 
A new grant from the Global Fund explicitly cited the research done as a result of this case in order 
to make the case for funding a large new investment in TB control in prisons. An NGO called 
TB/HIV care was contracted to assist department of corrections in running the TB program in 
Pollsmoor and ninety-five other corrections facilities. A new body called the “National Task Team 
for the implementation of HIV and TB services” was created and NGO leaders now sit on it.  
 What we would hope and expect to see from this shift in attention is, first and foremost, a 
decrease in TB in South African prisons. Figure 4.12 shows data from the South African National 
Health Laboratory Service on the percent positive among TB tests done in inmates in four cellblocks 
in Pollsmoor prison. A successful TB program should see decreasing outbreaks or spikes in the data 
over time. This data is not publicly available and I have access to only a limited period of time. Yet 
what we see from this data is not promising—outbreaks continue and they seem to move from one 
cell block to the other, with several cell blocks reaching higher levels in 2016 than two years prior.  
 The reason, several different interviewees agreed, is that corrections authorities have not 
made, and have little interest in making, the changes needed to address the problem. In this context, 
medical care is insufficient by itself to address the problem. Instead what is really needed are 
changes in how the prison is built and run—which take both money and shifts in practice by 
corrections officers. To halt TB, for example, critical shifts would include not keeping inmates in 
cells twenty-three hours per day and giving them more access to fresh air through more open cells 
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and fans. Improved nutrition would also help prevent those who have become infected from 
progressing to active disease.  
 
 
  
 Three years after the Lee case, Justice Edwin Cameron of the Constitutional Court visited 
Pollsmoor and wrote a scathing report, suggesting little has changed: 
“Regretfully, my law clerks and I found conditions very far from the standard the 
Constitution and the statute require. The extent of overcrowding, unsanitary 
conditions, sickness, emaciated physical appearance of the detainees, and overall 
deplorable living conditions were profoundly disturbing… inmates are locked in 
their cells 24 hours a day. They cannot leave their cells to exercise, to eat, to use the 
restroom, to shower, or to go to the library... Detainees complain of hunger in the 
evening because they are not given an evening meal. The thickness of the air and 
lack of ventilation was palpable… The air seemed so thick, one felt one could cut 
it with a knife. There seemed to be no air flow... It raises the obvious question 
whether the Department is adhering to its own norms and standards.”269 
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 On the one hand, addressing these issues involves money—and prisoners continue to have 
low priority. Prison health spending did increase significantly—from R664 million to R846 
million.270 Overall, however, spending grew far slower and both staffing and construction were 
significantly constrained in most of the corrections system. There is no sign of significant spending 
to address ventilation or overcrowding. The questions raised in Dudley Lee appear to have been 
cordoned off to an increase in spending on medical care, most especially on TB screening, while 
the wider structures remain untouched. 
  Perhaps far more importantly than money, addressing TB in this way would be a major 
change to the idea guiding the actual practice of jailers—ideas based around maximizing the control 
exercised over prisoners. A variety of feasible changes to the practice of managing prisoners would 
make a big difference for TB. But it would also require corrections officers to do their jobs 
differently in an environment where consistency and predictability is valued and security of the 
prison trumps all. 
 “There is a conflict between health and security in their minds, and security wins. 
If you look at the legislation the importance of security is not higher than health. 
But in their minds, it so obvious it’s not even a starter for a conversation.” –Attorney 
(Interview SA-39) 
 
 Health rights, in this setting, have struggled to counter or complement this idea. The monopoly 
over how prisons are run is incredibly strong by its nature—no person can even observe the 
functioning of the prison without the knowledge and approval of corrections officers. Both the 
practice and the structural ideas that support these practices have not shifted and power remains 
unchanged. The policy monopoly has not been disrupted. Prisoners are still unpopular and wield 
little political power to challenge their conditions. Those from the outside who had put significantly 
energy into change are now part of various committees and advisory boards, but so far these have 
had little power to affect the core conditions of confinement.  
 While forced to open their doors and their policies to examination during the Dudley Lee 
case, the authorities largely seem to have been able to dampen attention and limit the impact of the 
                                                
270 Authors calculations based on the Treasury Department’s 2016 Estimates of National Expenditure.  
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case. Information is a good measure here; during the trial, there was significantly more 
transparency at Pollsmoor, but today data collection and release on prisoner wellbeing, for example, 
has only improved incrementally. The Minister, in his recent budget speech, noted that the auditor 
general “still has serious concerns about the credibility of our records,” in which the data on health 
and care programs did not match actual evidence.271 
 The changes in policy and attention may still bear fruit—Justice Cameron’s very presence 
at the Pollsmoor facility and attention to health issues is an important signal that the judiciary is 
investing in addressing prison conditions. The court order is powerful and precedent-setting. For 
the moment, however, tracing the policy to the present shows evidence of some surface policy 
change without much disruption to the policy monopoly writ large. Impact on population health 
seems unlikely. This is not particularly surprising however—the argument in this project is not that 
constitutionalization is a fix-all. As an incredibly strong policy monopoly, it should be clear that 
even as the mechanisms largely followed the theory outlined in the previous chapter, extremely 
powerful counter-ideas like control of prisoners and strongly structural policy monopolies like 
those in prisons are still capable of defending policy stasis.  
 
 
  
 
 
 
 
 
 
 
 
 
  
                                                
271 Masutha 2016. 
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CHAPTER 4.5: THE SPECTRUM OF HEALTH POLICY & RIGHTS IMPACT  
 
 
“The Constitution gives us leverage at every level, sometimes it’s enough, sometimes not. 
At the end of the day sometimes as a healthcare provider I can say ‘stuff you, the 
constitution says so…” –Physician/Administrator (Interview SA-50) 
 
“The fact is, the constitution became like a mist that permeated everything we were 
doing; it helps give you the moral strength, it gives you the justification to act now 
instead of waiting, it gives you a beacon. That beacon meant we, in the health 
department, had to be differently responsive, we had to talk to a different set of 
people that we might otherwise, and gave us power within government to break 
out of certain patterns—not just from Apartheid but from a very complex, 
fragmented system with lots of interested parties. It’s not like a stitch that you can 
just point to that stopped the bleeding. It’s not a single effect on its own, but there 
is no doubt that it shifted the space we had to make change and address health 
equity.” –Former Senior Health Official (Interview SA-54) 
 
 
 The constitutionalization of health in South Africa has changed political power balances, 
shifted resources, and provided the openings to advance health policy change across a wide swath 
of policy issues. The majority of the impact has not come through judicial orders and apex court 
cases. It has also not been uniform—in some cases the institution shifts under the new constitution 
mattered quite a bit, while in others the impact was not significant. In this chapter I briefly trace 
the other health policy issues—building on the examples in EMS services in the Eastern Cape, HIV 
treatment, and TB in prisons—where the right to health has been mobilized in South Africa. 
Further examining the spectrum of impact through these issues can tell us more about how 
constitutionalization works, which is particularly interesting for those interested in deepening this 
impact. Together with the previous chapters, the additional examples in this chapter illustrate 
relatively well the different ways in which the right to health is instantiated in South Africa. We 
have seen policy entrepreneurs making use of the environment created by constitutionalization to 
counter a classic policy monopoly in the Eastern Cape EMS case, to overcome a monopoly at the 
very apex of politics on HIV treatment, and to directly confront prison authorities through the 
courts with far less success. In this chapter, we see greater engagement of the right to health with 
Chapter	4:	South	Africa		
	
 
190 
private actors including multinational pharmaceutical companies and South African mining 
conglomerates, as well as examples where rights are used to help drive policy change from within 
the state through a resistant bureaucracy and a skeptical international policy environment in the 
user fees case. Together. they suggest a spectrum of impact tied to factors including the strength of 
the policy monopoly, the support structure available to advance rights mobilization, the relative 
power of those seeking to disrupt policy status quo, and the character of the idea that supports 
policy status—some of which are more easily unsettled by the “reasons for action” forwarded by a 
rights framework than others.  
Table	4.09:	Health	Policy	Issues	Subject	to	Rights	
Mobilization	by	Nominal	Level	of	Impact	
Impact	 South	Africa	
High		 HIV	Treatment	
		 Eliminate	User	Fees	
	 Drug	pricing	
	 Eastern	Cape	Emergency	Services	
	 National	Health	Insurance	
	 Private	Sector	Health	Inquiry	
	 Silicosis	&	TB	in	Mines	
		 Migrants	access	to	health	
Low	 TB	in	Prisons	
Source:	Author	estimations.	Impact	level	is	roughly	nominal	based	on	
author	estimation	but	is	not	systematically	measured.	
 
 
 Each of these cases broadly supports the idea that constitutionalization matters—that it 
creates a new politics of health policy that benefits pro-health policy change—but noting the 
differences also illustrates the interplay between constitutionalization and other political 
institutions from electoral rules to the political construction of citizenship.  
 
Eliminating User Fees in Healthcare—Rights and Bureaucratic Initiative 
 
 The Apartheid government embraced a set of neoliberal policy prescriptions in the health 
sector including, in particular, significant point-of-service user fees and promotion of private 
healthcare. By the time of transition, these user fees represented a significant barrier to accessing 
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healthcare—with 20% of Black South Africans in one survey reporting they had not undertaken 
needed medical treatment because they could not afford to pay for it.272 These fees accounted for 
about 9% of health facilities budget at the time, though at the individual facility level fees sometimes 
made up more than half of financing.273 Inspired by the global Alma Ata Declaration, the ANC’s 
health plan focused on building primary care and eliminating barriers to access.274  
 On May 24, 1994, Mandela announced in his State of the Nation Address the new 
government’s policy of free health services for children under the age of 6 years, pregnant and 
nursing women and all women for a period of six weeks after the end of a pregnancy. Free 
healthcare commenced the following week. It was followed by a large and immediate increase in 
healthcare utilization. Patient loads increased by as much as 300% at some primary health facilities, 
with average increases about 60%.275 Figure 4.13 illustrates the typical jump in pediatric and 
antenatal visits in two example cities starting as soon as the user fees were eliminated. There was 
also increased referral to higher level health services including pediatric admissions. In 1996, free 
primary healthcare was extended to all. A clinic infrastructure program was also launched in which 
nearly 1,500 new clinics were built or upgraded to support the new focus on primary care. The 
sharp increase in antenatal visits was almost certainly associated with better health outcomes, 
though the exact effect on wellbeing is obscured by the growing HIV crisis of the time. A survey at 
the time, however, found that “three quarters of the public health sector workers believe that the 
policy was successful in preventing serious illness or death amongst women and children under 6 
years of age.”276 
 
                                                
272 Hirschowitz et al. 1995. 
273 McCoy and Khosa 1996, 157; Heatlh Systems Trust 1996. 
274 African National Congress 1994. 
275 Khosa and Thomas 1995.  
276 Quoted in Gilson et al. 1999, 77. 
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 The new program was incredibly popular—with nearly all Black South Africans showing 
awareness and support for the new policy, though less so among whites.277 However, despite its 
popularity there was significant resistance. The first came from free-market-oriented sources that 
claimed free healthcare would undermine financing of the health system and allocative efficiency 
within the relatively weak system. Government had “not yet faced up to those difficulties 
concerning financing and bureaucracy,” one editorial complained. “The answer lies in setting of 
priorities otherwise [free healthcare] could become a monster.”278 The World Bank at the time in 
particular advocated user fees targeting curative care and drugs, for which people were most likely 
to be willing to pay, to generate revenue and eliminate excessive usage.279 This analysis was 
questioned even at the time and has since been abandoned by most health and development 
agencies.280 At the time, however, it was very influential and even the new ANC government 
received pushback from free-market thinkers, orthodox economists and international 
                                                
277 Kaiser Family Foundation 1999. 
278 Deteriorating Health Services 1994. 
279 Shaw and Ainsworth 1995; Akin, Birdsall, and De Ferranti 1987. 
280 Gilson 1997; McIntyre 1994; Wilkinson, Sach, and Karim 1997. Former WHO DG Margaret Chan, for example, recently 
said, “User fees punish the poor. User fees discourage people from seeking care until a condition is severe and far more difficult and 
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organizations that was hard to ignore for a new government seeking the approval of international 
financiers.  
 More problematic was the surprisingly strong opposition from health workers to the policy. 
Much of the leadership in the public health sector remained staffed by administrators from the 
Apartheid era—both white and Black—who were protected by the negotiated settlement that kept 
the civil servants in their jobs and protected by “sunset” clauses at least through the second election 
in 1999. The abrupt change, especially associated with rapid increases in patient load, were resisted 
by much of the bureaucracy that was simply resistant to change.  
 Physicians had successfully opposed elimination of fees at various points in South African 
history since the 1940s when the Gluckman Report had proposed the creation of free and affordable 
primary care centers—a proposal foreclosed by the election of the National Party in 1948.281 Efforts 
at the provincial level to eliminate or reduce user fees had been thwarted because of this opposition 
and the new initiative aroused similar opposition. 
  Far more important in 1994, though, was opposition from the nation’s nurses. At the time, 
there were about 165,000 registered and enrolled nurses—about 1/3 of whom were white and the 
rest largely Black, with 95% of them women.282 In large parts of the country they were the only 
providers and recent legal changes had increased both their scope of practice and their centrality to 
frontline health services provision in the public sector. For many nurses, the new policy was 
experienced largely as a major shift in both burden and status. Government was committed to 
expanding access to healthcare, but simultaneously influenced by its own Department of Finance 
and external agencies, including the World Bank that maintaining fiscal discipline was critical—
meaning additional resources, especially additions to the wage bill, were more limited. The influx 
of new patients therefore meant far greater patient loads for nurses without significantly more 
human resources. One study found that 85% of nurses experienced an immediate increase in 
workload and about 56% of survey respondents disagreed and strongly disagreed with the 
                                                
281 Marks 1997; Digby 2008. 
282 Marks 2005. 
Chapter	4:	South	Africa		
	
 
194 
statement that ‘implementing free care has been rewarding’ for them personally.283 Wages, 
meanwhile, were starkly disparate at the time of transition between different parts of the 
fragmented health sector. White workers, dominant in certain sectors, started at higher salaries but 
demanded increased pay after a period of starved budgets.284 Addressing this disparity was a 
priority, but limited funds meant it was impossible to increase salaries equitably to avoid racial 
tensions while also expanding infrastructure and commodities to address the influx of patients.285  
 Nurses, meanwhile, perceived the new policy as increasing their workload and 
undermining their working conditions while patients were abusing and overusing the health 
services and that those who were not entitled (e.g. foreigners) were accessing services.286 User fees 
were also sources of funds that provided greater autonomy to clinic administrators (often nurses) 
allowing greater power to set spending priorities.  
 The new government was therefore faced with a choice—expand access by building clinics 
and eliminating user fees or increase the wages and workforce. Complaining about the limited 
options available, Mandela worried that in the previous government’s budgets “ninety-one per cent 
of this was for salaries and administration and only nine percent for the needs of the people.”287 
One can certainly debate which was the more important priority, but health officials focused on 
access as both a symbolic and substantive step that they saw as critical to jumpstarting 
transformation of the post-apartheid health system.  
 The push-back, however, was strong. Leaders in some hospitals announced they would not 
implement the policy or only do so selectively.288 The public health sector was thrown into turmoil 
from periodic nursing strikes throughout the country. In September 1995, 2,000 nurses went on 
strike at Baragwanath Hospital, the country’s largest, and several thousand additional nurses struck 
in Soweto’s clinics paralyzing the city’s health sector. Lawsuits were threatened by disaffected health 
workers. Walker and Gilsen note that, as “street level bureaucrats,” nurses had both significant 
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interest in having a say over policy and capacity to undermine implementation in policies set from 
above.289 Since fees were collected at various points throughout the system in ways that differed 
between provinces and that, in some cases, were idiosyncratic at the facility level and the definition 
of “primary care” was hotly debated, there were plenty of opportunities for resistance at the facility-
level to actually abolishing fees.  
 Political leaders in certain provinces also fought the policy, which was a significant barrier 
given the power granted to provinces over healthcare delivery. The Western Cape and Gauteng 
provinces, for example, resisted the policy for quite a while, dragging their feet on full 
implementation.  
 
“When it came time for implementation suddenly some of the provinces said, ‘No, 
we can’t remove the fees. It’s only where the need arises. We are going to be doing 
a means test.’ They said, ‘Look you know, we don’t have the money’ and others 
were saying ‘well, the unions might not agree.’ Typical of South Africa where 
people argue forever and nothing can move.” –Former Senior Health Official 
(Interview SA-57) 
  
 Early in this process of implementation, the new constitution was publicly announced and 
provided a new tool to health officials seeking to advance full implementation of the new health 
policy and to expand it to provide free primary care to all, as announced in 1996.290 The constitution 
did not dictate the free health policy, which had been a long time ANC promise, but several officials 
from the Mandela administration credit it with helping them push the expansion through a 
skeptical government and helping cut through recalcitrance of civil servants and overcome the 
pressure from both health workers and the neoliberal thinking of the time.  
 When it came to implementation—pushing administrators and frontline health workers to 
respect and follow the new policy in both letter and in sprit, Section 27 of the constitution in this 
context became an ideological reason for action in clear ways:  
 
“Guys like me had to go out and defend this decision. I had to go out into the clinics 
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and hospitals against staff who were not policy people, but were people who saw 
the queues that they had to treat and still get home. I had to market the case and 
the base on which I did that was the Constitution. Here you had a constitutional 
right that you could argue that people were being deprived of under Apartheid.”  
–Former Senior Health Official (Interview SA-54) 
 
 Rollout thus came to include a strong component of meetings and directives between 
central government and frontline health administrators that built from the Constitution as a 
starting point.  
 Countering a strong push from labor unions, the constitution provided a critical idea that 
put government on the side of the realization of people’s rights rather than against the interests of 
labor—which was a critical difference in a governing alliance in which COSATU was a powerful 
member. Indeed, this was part of the justification that kept COSATU-member unions largely on 
the sidelines, even as thousands of local nurses’ unions struck in wildcat actions.291  
 The constitution also shifted the power of health actors inside the state vis-à-vis their 
counterparts in more powerful ministries like the Treasury Department. The initial policy of free 
healthcare for pregnant women and children under six as enacted quickly—a direct promise in the 
ANC platform, it was announced with very little prior debate and relied on Mandela’s political 
capital. When it came time to consider whether to expand the policy, however, the complicated and 
diverse ideology within the Government of National Unity made it a harder. Under pressure from 
international financial institutions, Mandela first kept in place the National Party Finance Minister, 
overseeing the Treasury Department, and then appointed banking CEO Chris Liebenberg to 
succeed him—creating a powerful faction in government dedicated to a more neoliberal policy bent 
focused on maintaining fiscal discipline to drive economic growth.292 In this context, expanding 
free primary healthcare faced a more complicated policy setting. The government had also wrapped 
itself tightly in the new constitutional order, which created a very real ideological commitment and 
political basis for action.  
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 One former health official put it succinctly, remembering back to the debates and the ways 
in which the constitution represented a background political commitment that could be drawn up 
on in policy debates: 
 
“The thing I can remember being like a truly positive move in line with the 
aspirations and those rights was the early years of Nkosazana Zuma when she said, 
‘We’re making healthcare free at the primary care level. Screw it. We’re doing it.’ 
We fought for a constitution that includes health and we are not going back on that 
now was really how we thought about it. –Former Senior Health Official (Interview 
SA-62) 
 
 As a policy anchor, the constitutional right to health in this context created a powerful 
framing process that helped health actors legitimize the push for free healthcare. 
 
“I was sitting on the committee for that and I included treasury in those 
discussions. They kept saying things like, ‘This is fiscal nonsense.’ I remember their 
words, ‘Fiscal nonsense.’ We kept saying to them that the Constitution says this 
and we have to find a way to ensure universal access to primary healthcare, to the 
healthcare system overall. They were not happy.” –Former Senior Health Official 
(Interview SA-57) 
 
 Constitutionalization thus provided an important ideational tool for bureaucratic 
initiative. While the policy goal was driven by apex politics, those charged with implementing the 
program and negotiating the details with the rest of government drew on the institutional 
legitimacy offered by the right to health to advance policy change. By 1998, 86% of those who sought 
care in the public sector reported paying no fees293—a portion that may not seems surprising for a 
presidential priority, but which shows far faster and more thorough uptake in two years than many 
of the Mandela governments’ policy changes amidst an embedded and resistant bureaucracy. 
  
Drug Pricing 
 The issue of drug pricing also started early in the new republic. In 1994, South Africa faced 
a constrained health budget, significant unmet need for medicines, and drug prices that were far 
higher than similar countries. The post-Apartheid government set out a vision in the National Drug 
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Policy of 1996 that included a commitment to lowering drug expenditure through widespread use 
of generic rather than branded drugs.294 The Medicines and Related Substances Control 
Amendment was passed to give effect to the new policy in 1997, which included provisions 
amending the patent act to allow production and importation of generic medicines. Before it could 
go into force, the Pharmaceutical Manufacturing Association (PMA) sued to block its enactment. 
The Treatment Action Campaign was born later that year and immediately took up the issue—
attacking the PMA’s case and noting that “making healthcare more accessible to South Africa’s 
poor is now a constitutional duty facing the government” (original emphasis).295 TAC joined the 
case on the side of government and mobilized global protests. When it came to the High Court in 
March 2001, public outrage in South Africa and abroad was clear, and so too was the legal standing 
of the companies—which stood little chance of blocking a law that met WTO TRIPS standards and 
was framed in the service of constitutional obligation.296 Within six weeks, the case was dropped.  
 Following this victory, and along with public campaigns to push companies to lower ARV 
prices, the AIDS Law Project and others again shifted venues—this time to the Competition 
Commission. In other countries and contexts, the Competition Commission has little to do with 
health policy and advancing health equity, but in a constitutionalized environment, advocates 
successfully used it as a venue to break new ground. Government at this point was still dragging its 
feet on implementing an ARV program, leaving activists and NGOs to take the issue of continued 
high prices up themselves. Alleging that GlaxoSmithKline and Boehringer Ingelheim were violating 
the Competition Act by charging excessive prices Hazel Tau, supported by the ALP, submitted a 
complaint to the Competition Commission. The submission claimed the Competition Act had to 
be understood in context of Section 27 of the constitution and demanded companies be ordered to 
license their drugs for generic production. The commission agreed and, in a striking press release, 
found that in South Africa competition law had to be interpreted toward “advancing social and 
economic welfare and correcting structural imbalances.”297 A settlement quickly followed in which 
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the companies agree to grant licenses to make or import generic versions of their AIDS drugs—a 
practice that has become standard practice in the country for all drug companies making HIV 
medicines.298 With little further support structure, however, the same standard has not extended 
outside of HIV—to additional high priced drugs for heart disease, cancer, etc. where government 
has also shown little appetite to challenge international drug companies and make use of the space 
afforded by the legal context.  
 
Silicosis & TB in Mines  
 The history of South Africa’s economic development is inextricably tied to mining—in 
particular gold mining, on which the city of Johannesburg and much of the South African economy 
was built. It was not just the South African economy built on the gold mines—in the 1930s the 
country produced over 60% of the gold upon which the Western financial system rested.299 By the 
1980s South African gold mines generated half of the country’s exports and employed over 750,000 
people—a small group of unionized white miners and massive numbers of Black migrant workers 
from across the region and the rural parts of South Africa.300  
 Health in South Africa is also deeply tied to mining. Triple epidemics of silicosis and 
tuberculosis, alongside the more recent addition of HIV have been driven by the mines and shape 
the disease profile of South Africans today. Silicosis is the “paradigmatic occupational disease of 
industrialism”—caused by inhaling silica dust from mechanized drilling, it scars the lungs and is 
not only fatal in itself, but it also greatly increases the chances of acquiring tuberculosis.301 TB, for 
its part, is spread incredibly effectively in the confined and poorly ventilated environments in 
mining and, in South Africa, reaches disastrous levels through the crowded communal housing 
where dozens of men share small sleeping spaces with poor nutrition and little opportunity for 
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hygiene. Sex work is common around the all-male hostels, increasing the risk of HIV transmission, 
which in turn increases the risk of active TB.302 
 South Africa was, for decades, seen as a leader in addressing the health of miners. Between 
1912 and 1918 the state enacted the world’s first compensation programs for silicosis and TB, a 
system of regular medial inspections, sanatoriums for white miners, and a system of paid annual 
leave—all for white miners.303 However, Black workers—from Malawi, Lesotho, Mozambique, and 
Botswana as well as South Africa’s Eastern Cape and other rural areas—were labeled temporary 
laborers, not miners, as the companies and the state worked together to craft a labor system 
designed to bring an adequate supply of young men to work. They were covered under a different, 
inferior system that paid lump sums instead of pensions and, instead of sanatoriums, Black men 
were repatriated, absolving mining companies of long term care obligations.304 South African 
scientists nonetheless played a leading role in studies of silicosis and, according to the mine’s self-
reports through the 1980s, achieved lower levels of dust than most of the world. 
 At the time of transition to majority rule, it became clear that industry narratives of 
progress were fiction. The Leon Commission of Inquiry into mine health in 1994 found that death 
rates had not changed substantially between 1940 and 1980 and that “dust levels have remained 
roughly the same over a period of about 50 years. This constitutes a priori evidence that the absence 
of a downward trend in the official figures for certification is correctly interpreted as a failure to 
control dust related disease.”305  
 The compensation system has been the key public health policy in question. This critical 
check on the industry is supposed to pay workers both to address their health issues and to 
incentivize companies toward creating a healthy workplace. It has achieved neither. Repeatedly, 
studies have shown compensation has not been paid to the majority of workers.306 Hundreds of 
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thousands of mine workers and former workers currently suffer from lung disease that remains 
uncompensated in South Africa alone, not even considering nearby countries.307 
 Meanwhile, there is no evidence that interventions have reduced the risk of TB or silicosis 
to acceptable levels.308 While there are many fewer miners than at its heyday, over half a million 
active miners continue to work in the country, representing one of the largest pools of employed 
men in the region.309 Those miners have a greater incidence of TB than do any other working 
population in the world.310 Stuckler and colleagues have studied the region and shown that each 
10% increase in mining activity was associated with a 0.9% higher rate of TB incidence—meaning 
a standard deviation change in mining was linked to 33% more TB.311 With a migratory population, 
even miners who start TB treatment at the mines are unlikely to be able to complete it, which 
generates a disproportionate number of secondary infections, spreading TB (and HIV) throughout 
the region in a manner similar to that of the gulag prisons in the former Soviet Union. Research has 
also shown prevalence of silicosis in miners to be far higher than let on by the companies—between 
22% and 36%, with up to 60% of miners eventually developing silicosis.312  
 The compensation system through the end of Apartheid was both segregated and 
ineffective, designed to overlook the majority of workers and ensure a profitable industry rather 
than protect public health. As Brian Williams and colleagues have shown, companies “conveniently 
externalized the long-term costs of caring for these often-sick former workers” to ex-miners' 
households and governmental health services in their regions of origin after they contracted TB 
and silicosis in the mines.313 Through the twentieth century, the impacts were largely felt in rural 
communities, with the migratory nature of mine work making much of the impact invisible.  
 With majority rule came a new ANC government that included the COSATU union and 
hope for significant reform. Cyril Ramaphosa, founder and head of the National Union of 
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Mineworkers, became general secretary of the ANC (and is today Deputy President of the country). 
The mining companies, however, proved nimble players—exercising power well beyond their share 
of the South African economy. The industry has always been concentrated—in the 1980s nearly 
40% of shares on the Johannesburg Stock Exchange were accounted for by just one mining 
company, Anglo American.314 As McCullough notes, “Anglo American has almost limitless 
resources with which to defend itself, and much of the evidence about dust levels and disease rates 
lies in corporate hands.”315 The concentration of the industry and tight price control has enabled it 
to act as a single, decisive political force. It quickly incorporated Black leadership, including Cyril 
Ramaphosa who soon owned part of several of the companies and, by 2009, was under 
consideration to be chairman of the board of Anglo.316  
 
“There were senior members of the current government leadership who were 
negotiating on [the miners’] behalf. Unfortunately, they were not negotiating with 
good faith. They were actually negotiating their way to being shareholders, and 
ultimately, they are stinking rich. The health of the miners, of communities, it’s not 
what they really want. So, what do we do? Vote DA? I don’t think so.” –NGO leader 
(Interview SA-64) 
 
 This helps explain why, when the compensation law was amended —the Occupational 
Diseases in Mines and Works Act (ODMWA)—the core of the failing system remained intact 
despite the removal of racial clauses.317 Black Miners’ working conditions have changed little. There 
is wide consensus among organized labor, industry, the state, and most recently the judiciary, that 
the century-old system is not working, yet reform has been stopped a sprawling bureaucracy that 
cannot agree to a consensus to fix it and by politicians cautious of upsetting a powerful industry.318 
In place of reform, the industry has built up an impressive set of tertiary medical institutions, which 
they say shows the industry is an actor for good—even critics note that mining employees have 
access to far better medical care than the communities surrounding them. In practice, however, 
only a minority of miners have access to these facilities since they live far from the mines and many 
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are short term contractors. Tertiary care also does little to prevent the underlying conditions of TB 
and silicosis.  
 There have been repeated efforts and ideas to reform the compensation system or merge it 
with the more robust general COIDA worker compensation system—with each push focusing on 
the need to align the incentives behind the system with prevention of TB and silicosis. A decision 
was made in 1996 to merge different compensation systems with this in mind, but it has not yet 
been implemented—blocked at each turn by a narrative that doing so would be too complex, too 
costly, and could undermine a key area of the South African economy.319 
 With health policy intractable in this area, miners have more recently turned to the courts. 
In 2006, human rights lawyer Richard Spoor filed a case on behalf of Thembekile Mankayi, who 
had contracted TB while working for Anglo Gold for nearly 20 years. The High Court and Supreme 
Court of Appeals both rejected his claim on the basis that it was foreclosed by compensation laws, 
but in 2011 the Constitutional Court ruled for Mr. Mankayi, finding that “The golden thread that 
runs throughout ODIMWA and its antecedent legislation is that they address and limit the impact 
and spread of infectious diseases contracted in mines… [these diseases] exacted their toll on not 
only the health of mineworkers and their families, but have posed and continue to pose a danger to 
the health and welfare of the public.”320 Unfortunately, this ruling came too late for Mr. Mankayi, 
who died the week before the ruling. His case opened the door, however, to a broad class action 
lawsuit involving tens of thousands of former miners that is now making its ways through the 
courts—with certification of one of South Africa’s first ever class actions approved in May 2016. 
 While this is a private-law case claiming compensation for a “delict” (aka civil wrong or 
tort) by the mines, the constitutionalization of health has played an important role in broadening 
out the scope and bringing in public health concerns. The health and anti-violence group Sonke 
Gender Justice, along with the Treatment Action Campaign, successfully petitioned the court to 
join the case as amici curiae, represented by the legal services organization SECTION 27. Together, 
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they highlighted a number of issues of constitutional law, pointing to the ways in which the actions 
of the mining companies had been not just negligent but also violated core rights protected by the 
Constitution including the interrelated rights to health (§27), life (§11), bodily integrity (§12), and 
environment necessary for health (§24). They also, importantly, addressed the “right of access to 
any information that is held by another person and that is required for the exercise or protection 
of any rights.”321 The groups raised the public-law policy issues that lay behind the case, including 
the gendered impact of the actions of the mining companies—noting that women in these rural 
areas became the unpaid caregivers for sick miners; lost income when they fell ill, which affected 
the health of the whole family; and themselves were subjected to TB ad HIV due to the conditions 
of the miner’s work. They submitted affidavits from the economist Francis Wilson that outlined 
the implications for broader health policy of not allowing the class action to proceed given the policy 
stalemate and from former UN Special Rapporteur on the Right to Health, Anand Grover, outlining 
the international health rights framework that includes obligations of corporate actors.322 They also 
argued that the common law rules about damages needed to be developed in the context of South 
Africa’s constitutionalization of health to further allow transmissibility of damages to the families 
of those miners who died.  
 
“We have got to strike earlier in the process. Not just at the end of the story where 
people are ill, and now you are trying to get medicine into people’s mouths. You 
want to create a healthy society. To do that you have to strike at the root of the 
system. You have to say that companies conduct themselves in a manner which 
spreads illness. We’ve got to deal with that. We’ve got to deal with TB as an 
underlying issue and use rights and the law to force changes in how people are 
forced to live that results in poor health.” 
—Attorney (Interview SA-01) 
 
 The Court agreed with them in significant part, certifying the class based on both the public 
and private law arguments and agreeing with the amici’s argument to develop the common law and 
allow transmissible damages in the service of public health and justice.323 
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 The rights groups also helped bring the issues out of the courtroom—holding widely-
covered demonstrations outside the High Court and at the offices of the Teba agency, which is 
responsible for much of the recruitment of miners in the Eastern Cape, focused explicitly on the 
argument that private actors have constitutional obligations on health as well. 
 These groups are engaging in such a manner because of the constitutionalization of 
health—mobilizing around a court case and intervening both inside the courtroom and out because 
they see it as a way to change their legitimacy and address power relationships.  
 
“We got involved because we know that on the ground, ordinary women are 
getting the brunt of burden of TB that emanates from the mine houses. Young girls 
have got to vacate and leave schools ungodly early without even thinking about 
that, because there's no one to sustain them at school level not at university level. 
That's the reality. But these are not the ones politicians care about. Many of them 
are even outside the country, though we feel the effects right here… So, we are 
actually trying to entrench ourselves in the constitution of the country, to say this 
actually protects us even if government will not. We will see...” –NGO leader 
(Interview SA-64) 
  
 Whether this intervention will bear fruit is not yet clear. As the court case proceeds public 
health officials expect to once-and-for-all be able to establish the actual size of the problem—
information currently in the sole possession of the mining companies. Government has taken 
notice and, in January 2016 while the parties awaited the High Court judgement, the Deputy 
Minister of Mineral Resources convened a 2-day meeting with the mining houses and unions aimed 
at reforming the compensation system. “We are trying to solve a big problem. The ball was dropped 
before and a process led by labour minister Membathisi Mdladlana stopped,” he was quoted as 
saying.324 So far, however, the new ball seems no less dropped. It thus may be that the best chance 
of reform lies in a coming settlement of the class action—and whether a large payout prompts a 
change in practice, or perhaps whether the settlement itself might mandate reforms as some have 
advocated. 
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Migrants’ Access to Health 
 The economic hub of the region, South Africa is the destination for migrants from 
throughout Southern Africa and it is generally acknowledged that migrant groups experience major 
challenges accessing public healthcare.325 Migrants access to health has been another area of mixed 
impact for the constitutional right to health. Various statutes and policies govern different 
categories of migrants in the country—asylum seekers, refugees, economic migrants, and others all 
have varying status in the country. Different categories of cross-border migrants are granted 
different access to the public health system. By law, refugees and asylum seekers should be treated 
as South African citizens in terms of access to free public healthcare. Others are to be charged a 
foreign fee for certain health services, though the National Health Act (2003) assures everyone in 
the country access to emergency and life-saving care no matter the immigration status. Attorneys 
and activists together won access to ARVs without identity documents—an important policy not 
just for migrants but for public health overall on medicines that help stop the spread of disease. 
 In practice, however, ambiguity prevails. One of the major challenges has been that some 
public health facilities have been found to generate their own guidelines and policies that counter 
national legislation and continue to demand South African identity documents and deny access to 
international migrants no matter their status.326  
 
“It's not pro-migrant in its day-to-day implementation. What they'll say is that, yes 
of course, migrants have the same access to emergency healthcare that everybody 
else does, or we have a very good ARV regulation out there that says that you do 
not need an ID book to access ARVs under Department of Health Policy. But when 
you get to the clinic they don't implement it. They still deny access without the ID 
books.” –Attorney (Interview SA-65) 
 
 Lawyers for Human Rights and the Legal Resource Centre have both been active in 
supporting migrants’ claims for access to care. There has not been a major apex court case ruling 
on the rights of migrants to access health and, in general, there have been relatively few cases that 
make it into court. But on a range of specific issues—from access for children to ARVs—important 
                                                
325 Amon and Todrys 2008; Vearey 2014. 
326 Vearey and Nunez 2010. 
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policies have been set through litigation. On a day-to-day basis, meanwhile, the xenophobia of 
South African Society is often on display in clinics and the major impact of the constitution is that 
national government and public health administrators know they are likely to lose if the request is 
reasonable and they largely settle and grant access to healthcare when challenged. Access therefore 
is possible, but depends directly on the legal support structure.  
  
National Health Insurance and the Private Sector 
 Finally, perhaps paradoxically, I turn now to the policy issue that could well have the 
biggest impact on wellbeing over the long term—the question of public sector and private sector 
health coverage. This is particularly interesting given how much of the international conversation 
on the right to health focuses on the idea of universal health coverage.327 As noted in chapter 4.1, 
one of the biggest issues facing South Africa is the two-tiered health system that remains 
significantly skewed in funding, human resources, and priority toward the 16% of the population 
with private health insurance. With high overall costs, poor clinical outcomes, and massive 
inequities in access, there is broad agreement that something must be done to reform South Africa’s 
health financing and access structures. South Africa has long had a significant tax-funded welfare 
state for white people, with its origins in the 1920s based in the left-right Pact Government of the 
time and rooted in a general strategy of racial segregation in response to the swartgevaar (‘black 
danger’).328 As the U.K. was launching its National Health service, the Gluckman Commission in 
1945 recommended the same for South Africa—built upon establishing primary healthcare centers 
throughout the country. This idea enjoyed only a brief heyday before the National Party election in 
1948 and the rise of the Apartheid state which labeled the idea “socialist.” At the behest of private 
doctors who viewed it as competition, government proceeded to dismantle the nascent primary 
health infrastructure—instead building the fragmented, racially hierarchical system inherited by 
the new government in 1994.329  
                                                
327 Sridhar et al. 2015; Ooms et al. 2013. 
328 Seekings 2007. 
329 Pick, Rispel, and Naidoo 2008. 
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 At the ANC’s 2007 Polokwane national conference, where Mbeki was ousted, a resolution 
was also pushed by KwaZulu-Natal premier Zweli Mkize and others to advance the creation of a 
National Health Insurance (NHI). Rollout has been slow, but in 2017 the final White Paper was 
released—setting policy for a fairly radical reorganization of healthcare through a system designed 
to pool funds for the purchase and provision of healthcare services into a single-payer system 
covering all South Africans. The new policy envisions an increase in public health expenditure from 
roughly 4% of GDP to 6.2% by 2025 through mandatory tax-based payments and the phase out of 
subsidies and tax breaks to private health insurance companies.330 The effort is currently in its pilot 
phase, envisioned to begin in earnest in 2022, and its future is both controversial and uncertain. 
Nonetheless it may augur major changes addressing the heart of some of South Africa’s biggest 
health issues 
 So, what has been the role of the constitutionalization of health in the NHI? First, it is worth 
noting that the heart of the NHI push is directly related to party politics. The ANC has long 
promised an NHI of some sort and the decision in Polokwane to move the policy ahead was clearly 
based on electoral pressures and political dynamics within the governing coalition toward more 
progressive policies and provision of greater public goods. The exact shape of the NHI, however, 
has been hotly contested and subject to significant political pressure. That a single-payer system 
with a commitment to cost containment has been agreed was far from a foregone conclusion; 
private health providers and companies in South Africa are powerful. Private insurance “schemes” 
control 49.9% of health spending in the country and, while they are required to be non-profit, the 
administrators of those programs are largely for-profit entities with strong stakes in the status 
quo.331 Another 12% of health spending is out of pocket, most of it spent in private providers. 
Private providers from physicians to hospital groups are profit-making and they currently have 
access to roughly $16 billion per year in private provision income. Three large hospital groups own 
in excess of 80% of all private hospital beds in the country.332 Previous regulations including the 
                                                
330 South Africa 2017, para 203, 305-309. 
331 Ataguba and McIntyre 2017. 
332 South Africa 2017, para 66. 
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Medical Schemes Act of 1998 that required insurance schemes to cover at cost 270 prescribed 
minimum benefits have led to remarkable growth and profit in this sector that far outstrips 
inflation.333 Government employees including ministers and their staff are covered by these private 
insurance schemes and the plan to eliminate government payments for private insurance has 
worried quite a few.  
 This is an array of powerful interests in the status quo—a grouping and history of path-
dependent processes that have killed health reform in other countries, including the U.S.334 In this 
context health actors have explicitly relied on the legitimacy of the constitution and the ideational 
framework of health as a right and a state obligation to justify the move toward a progressive single-
payer health system and against the lobbying of medical schemes and the private health sector. The 
White Paper States that:  
 
“NHI derives its mandate from Section 27 of the Bill of Rights of the Constitution 
of the Republic of South Africa in which a commitment is made for the State to 
take reasonable legislative and other measures, within its available resources, to 
achieve the progressive realisation of the right to health care.”335  
 
 This reliance has been particularly important in a context in which the Treasury 
Department has actively opposed the move toward a single-payer system in overt and subtle ways. 
The Constitution has been a key part of these debates between Health and Treasury Departments.  
“… very contentious, and the root of the fights between treasury and health is this 
issue of multi-payer and single-payer. Because multi-payer protects the interest of 
the few but it is also less costly and far more favored by the financiers… even 
though it doesn't say in the Constitution that it should be a single-payer, but if you 
want to have everyone to have access to the same services, the same envelope, you 
got to have one single-payer, that would ensure that the standards and everything 
are the same flow-out. So, we made sure that was clear.” –Former Senior Health 
Official (Interview SA-57) 
 
 The second place where Constitutionalization has played a role has been opening space for 
and structuring a “market inquiry in the private healthcare sector” by the competition 
                                                
333 Competition Commission of South Africa 2016. 
334 Hacker and Skocpol 1997; Wilsford 2005; Oberlander 2007. 
335 South Africa 2017, para 8. 
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commission.336 A variety of health actors quietly pushed the competition commission to launch the 
inquiry alongside the push toward the NHI because a great deal of information needed to actually 
launch the NHI and effectively restructure the health financing sector are simply not available—a 
particular challenge for a system meant to use a single public payer but include private service 
provision. Nothing in current legislation compels private medical insurance schemes to share the 
level of information about how their financing systems work and the actual costs, patterns of use, 
and trends over time with Department of Health or the public. However, under 
constitutionalization, the commission was able to combine an inquiry into whether the current 
structures “prevent, distort or restrict competition” with an inquiry into the health utility for 
patients.  
 
“The Panel appreciates that access to healthcare services is a constitutional right 
and that this right also informs the competition assessment that it must 
undertake… Private healthcare provision takes place within the context of a 
constitutional commitment to the provision of healthcare services to everyone.”337  
 
 Activists pushed the commission to both conduct the inquiry and frame it in this way so 
that critical new information about the current functioning of the health system could be placed in 
the public domain. In the end the inquiry was launched under the leadership of former 
Constitutional Court Chief Justice Sandile Ngcobo and has brought in patients to understand their 
experience with private health insurance and made a wide set of data and information available that 
leaders within government say has informed the planning for the NHI.338 “Because this is about 
access, as a constitutional issue, alongside competition between firms they have asked for and 
received data that they did not think they could get and that we have sought for years in the push 
for a real NHI,” reported one NGO attorney.339 
 
  
 
                                                
336 Full details on the market inquiry can be found at http://www.compcom.co.za/healthcare-inquiry/ 
337 Competition Commission of South Africa 2014, para 15, 19. 
338 Interview SA-57, SA-62, SA-68. 
339 Interview SA-42. 
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CHAPTER 4.5: CONCLUSION: South Africa’s Deep Institutionalization  
 
 
 
 
“I think the Right to Health is the indispensable start, it gets things moving that otherwise 
might not. I’m not sure how it matters after that but it does open things up to where we 
can take a look and see…”—Justice, Constitutional Court of South Africa (Interview SA-
03) 
 
‘If we hadn’t had that embedded into the Constitution we would have had just a 
straight political battle, but embedding that into the constitutional gave the court 
the possibility to step in and that truly changed the question.” –Senior ANC 
Official (Interview SA-50) 
 
 
 
 South Africa provides an example of deep institutionalization of the right to health. A great 
deal has been written about South African constitutional jurisprudence on health and the 
transformative role of the Constitutional Court. The contribution this chapter makes is to go 
beyond jurisprudence to the broader policy process and beyond the courtroom to the political 
realm. This exploration touches too on cases of rights mobilization that not received scholarly 
attention like EMS in the Eastern Cape and policy processes like the NHI and user fee elimination 
that have not been analyzed from a constitutional perspective. Taken together, the issues explored 
here show the diversity of contexts in which constitutionalization shifts politics and policy on 
health.  
 The country has faced a fairly clear set of health challenges over the decades since the fall 
of Apartheid—a massive HIV burden that is only now approaching the possibility of epidemic 
control, high mortality rates from causes highly amendable to basic medical intervention like deaths 
in childbirth, a two-tiered health system with a massive misalignment between resources and the 
burden of poor health. The case for policy change on a variety of fronts is clear and, while deeply 
complex, many of the core policy prescriptions have wide agreement among public health actors. 
Not surprisingly, the problems have been political. Post-Apartheid South Africa is characterized by 
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a wide variety of powerful competing interests, many of which have pushed hard against changes 
to the status quo—the whiter, wealthier communities resistant to redistributing health resources; a 
President resistant to introducing medicines to treat an epidemic he believed was overblow; self-
interested private actors or corrupt officials looking to sustain their economic interests; and 
bureaucrats throughout the country resistant to policy changes that upset the usual order and 
threatened their position and authority.  
 Constitutionalization has hardly been a silver bullet, but it has been a positive force. Much 
in the way any shift in the institutions of governance might be, the effect has been slow and 
piecemeal, but taken together it does add up to changes in policy that can be traced back to 
improvements in wellbeing—change that would not have happened or not happened as fast without 
constitutionalization.  
 The right to health has been mobilized by a wide variety of actors—from civil society 
groups like the Treatment Action Campaign that rose specifically in a constitutionalized space to 
take advantage of the context to cause lawyers, judges, bureaucrats, and politicians. By providing 
opportunities to disrupt policy monopolies, the constitutionalized space has helped broaden the 
actors engaged in health policy to break policy stasis. Where Mbeki and Tshabalala-Msimang had 
closed off AIDS treatment policy, local bureaucrats had closed ranks against change in EMS policy, 
and multinational pharmaceutical companies sought to foreclose changes in drug pricing rules, 
constitutionalization gave policy entrepreneurs an opportunity to venue shift. Some examples 
included a shift to the Constitutional Court, but a diverse set of venues have proved responsive to 
rights mobilization on health policy with surprising efficacy, including both the Human Rights and 
Competition Commissions. Repeatedly, we have seen it is the threat of a turn to the courts that 
matters as has often been the case in migrant health.  
 These venue shifts have not always resulted in health benefits—as in the case of TB in 
prisons where, despite a Constitutional Court order, evidence suggests the key matters have not 
significantly changed. This is hardly surprising, however—literature in public policy has long 
shown that some policy monopolies are more resistant than others, and so it is in public health 
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issues. Where constitutionalization was able to break through even the opposition of the State 
President, correctional administrators who exercise great command and control over practices in 
the physical space of the prisons have proved a far harder monopoly to overcome. This point drives 
home a broader reality shown through this case—that apex court orders in themselves have been 
far less important in the scheme of things than the broader bargaining over policy that starts well 
before and continues long after any court order. Constitutionalization improves the bargaining 
endowments of key health actors—as it did even in the case of TB in prisons, where previously-
ignored health actors have been able to access facilities, start new TB programs, and secure greater 
and greater resources to address the disease. That the shift in bargaining endowments has not yet 
been sufficient to also change how prison officials control and house inmates reflects only that the 
relative power of corrections officials remains significantly greater.  
 Constitutionalization has repeatedly helped liberate critical information even as 
democratic mechanisms from media coverage to electoral competition have not. There is an 
ambulance in Xhora Mouth today because of the intervention of the Human Rights Commission, 
which notably lacks enforcement power but brought to light data about underspending and 
planning to fail. Even more importantly, officials were personally compelled to reveal this 
information, explain their actions, and sit and listen to the testimony of communities. With this 
context of force transparency and a different kind of accountability, constitutionalization helped 
win change for some of the poorest and least powerful members of South African society 
 Ideas and information have been key to the changes brought under constitutionalization. 
The South African experience includes several examples where the most important use to which 
the constitution has been put has been as an idea—a “reason for action” that has helped drive policy 
change. At a moment when international consensus supported expansion, not elimination of user 
fees, health leaders in the early ANC government mobilized health as a constitutional right to drive 
elimination through a resistant bureaucracy. In struggles over the NHI, the constitution has had 
powerful legitimating force for health actors to secure a policy commitment to a single payer over 
objections from Treasury. The ideational force of the constitution and the claiming of individual 
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and collective rights has been a powerful ideational counter the dominant ideas that have 
legitimated health policy monopolies—from the nationalist rhetoric of Mbeki to the idea of slow 
“transformation” of health services in the Eastern Cape.  
 The constitutional right to health matters in South Africa—and has its effect because it is 
not just the province of the courts, but has become embedded in the legislative directives at national 
and provincial levels, in the bureaucratic expectations in the health system, in the narratives and 
tactics of civil society, and in the repertoires of pro-health actors within the state. This deep 
institutionalization bodes well for continued impact and, as we will see in the next chapter, explains 
the gamut of impact of constitutionalization can be observed to have in other national contexts.  
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Chapter 5: India—Judicially-Led Constitutionalization  
 
 
 
 
“The orders that are taken seriously are those where somebody reasonably senior 
in the department is facing the threat of contempt and whose presence is being 
demanded, I can vouch for this. Somebody comes running to me saying that, ‘Sir, 
we have to do something. Otherwise on the 13th of next month you have to appear 
before this judge.’ Then all the stops will be pulled out and something would be 
done and we would take a look [at] an issue that maybe was not a priority before 
so we could say to the courts ‘Please don't call the secretary.’ –Former Senior 
Government Official (Interview IN-42) 
 
Supreme court is powerful and the judges can shape policy and they have. It has 
actually opened a lot of doors. But then there are limits where they cannot 
interpret, they can fill some of the most critical gaps but in the end Supreme Court 
cannot legislate. And there is a, within our Indian constitution, there is a limit. –
Physician/Public Health leader (Interview IN-14) 
 
 India, as its leaders like to say, is the world’s largest democracy—a vast, diverse 
subcontinent where policymakers face some of the most complex health and governance challenges 
on the planet. In 1995, in Consumer Education & Research Center v. Union of India, the Supreme 
Court of India established that health and access to public medical care, is a constitutional right. 
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The judiciary has since followed up with a spate of cases at various levels that has firmly enshrined 
that principle in jurisprudence. The effects of this move have cascaded through government and 
civil society. There remains, however, actively conflicting views about whether it is an established 
fact of law and governance, a promising idea requiring further government action to achieve real 
instantiation, or a bad idea advanced by an unaccountable judiciary. My goal here is not to settle 
this debate but instead to identify the impact that this move toward constitutionalization has had 
on health policy.  
 India can thus be identified as an example of partial constitutionalization; there are apex 
court cases and government policies responsive to health as a right and rights mobilization is both 
active and widely recognized by actors throughout the health sector. It is a particular type of 
institutionalization—one led by the judiciary. As such, it can be contrasted to the example in South 
Africa, where constitutionalization occurred in the same period but instead took form in the 
negotiated settlement that established the republic, and was included in far more explicit language 
in the constitutional text. I should note at the outset of this chapter that India is in some ways 
unique—there are few, if any, other examples where the national apex court has newly read a right 
to health in existing text and thus established a constitutionalization process so clearly.1 This, 
however, is what makes India a particularly useful example for to explore qualitatively. It represents 
a textbook example of what critics of the right to health worry about—as Tushnet describes: “how 
could a court describe a better program? And even if we can somehow imagine what a court might 
say… In the end, we would have the courts running everything—raising taxes and deciding how 
the money should be spent.”2 While India’s judicially-led constitutionalization is distinctive, many 
other countries have seen a highly judicially-focused implementation of the right to health.3  
 Meanwhile, understanding India as an example of constitutionalization that differs not just 
in style, but in degree, provides a view into the mechanisms through which health rights act. In 
South Africa, stronger institutionalization has led to wider impacts, and rights mobilization on 
                                                
1 I should note that I include 1995 as the date India moved to a constitutional right in the large N dataset in chapter 2, but a robustness 
check dropping the case as an outlier confirms that the Indian case is not distorting the results.  
2 Tushnet 2000, 169. 
3 Flood and Gross 2014; Rodríguez Garavito 2013. 
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some of the same issues has yielded deeper impact. Nonetheless, as I describe in this chapter, 
constitutionalization in India has had a significant positive impact in several health policy issues 
acting through the same “policy anchor” mechanisms as in South Africa—creating space for policy 
change through disrupting policy monopolies and shifting the ideational frameworks governing 
health.  
 
Health & Health Policy in India 
 
 Like South Africa, India represents a complex 
health environment where health leaders have struggled 
to address the large burden of disease amidst weak 
institutions. This is unlike Thailand, for example, where 
constitutionalization came in a context of strong 
political leadership, innovative approaches to 
addressing limited resources, and an effective medical 
and public health system. In India, health has been a low 
priority and poorly-governed, with few interruptions, 
since the colonial era—the effects of which are clear in 
mortality and morbidity rates in the world’s second 
most populous nation. Constitutionalization has 
mattered in India insofar as it has addressed this 
political context, aiding the formulation and implementation of better health policy.  
 Under the British, health in India had a low priority, even by the standards of colonial rule, 
and focused largely on protecting the British civilians and military. While 4.1% of revenues were 
spent on education in the late 19th century, just 0.15% was spent on health.4 Institutions like the 
                                                
4 Harrison 1994, 196. 
Table	5.1	Leading	Causes	of	Premature	
Death,	India	2015	
1	 Heart	disease	
2	 Preterm	birth	complications	
3	 Neonatal	 brain	 damage	 from	
birth	asphyxia/trauma	
4	 Lower	respiratory	infections	
5	 Emphysema		
6	 Diarrheal	diseases	
7	 Tuberculosis	
8	 Road	injuries	
9	 Hemorrhagic	stroke	
10	 Self-harm	
11	 Chronic	kidney	disease	
12	 Diabetes		
13	 HIV/AIDS	
14	 Typhoid	fever	
15	 Malaria	&	tropical	diseases	
Dark	blue:	infectious	or	childhood	disorders	
Light	blue:	violence/injury	
Gray:	non-communicable	disease	
Source:	Global	Burden	of	Disease,	IHME,	2016.	
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respected Indian Medical Service and Calcutta School of Tropical Medicine were created as well as 
Sanitary Departments at national and provincial levels.5 However, without sufficient resources they 
did little for the health of most Indians. At independence in 1947, the new state inherited a 
significant health burden and little capacity. Life expectancy was estimated at just 26 years, 20 out 
every 1,000 births ended in maternal mortality, and millions of deaths resulted from epidemic 
diseases.6 There was only one nurse for every 43,000 people (goal was 1:500) and there were only 
about 5,000 trained midwives in the country. The Bhore Committee set up in 1943 put forward a 
vision of a national health system built on an ambitious architecture of primary healthcare centers, 
with one doctor for every 4,600 people.7 The post-independence government accepted the report 
but there were significant divisions among provincial leaders about whether and how to implement 
the recommendations and, with just four percent of public expenditures going to health at the time, 
dependence on the Center for financing hobbled the effort from the start.8 The tone was thus set 
early for the decades to come: under-investment in health, weak public policy and institutions, a 
problematic prioritization of impressive tertiary facilities, and disjuncture between states with fiscal 
dependence on the center continue to undermine the health system.  
 
                                                
5 Mushtaq 2009. 
6 Bhore 1946, 7–19. 
7 Bhore 1946. 
8 Rao 2017, 10. 
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 In the 50 years between independence and the Supreme Court’s move to identify health as 
a constitutional right life expectancy in India more than doubled to 60 years.9 A series of disease-
specific campaigns successfully improved health—bringing malaria deaths down from over 100 
million cases to 2 million and eradicating smallpox in 1975.10 Economic growth was a major 
factor—figure 5.1 shows that there has been sustained improvements over the last forty years—as 
we might expect under economic conditions that saw sustained growth of just over six percent per 
year.   
 In the past two decades, India’s economy was one of the fastest growing throughout Asia—
an emerging economic powerhouse, it has exercised increasing political power as well. Yet it is an 
oft-repeated reality that its health indicators fall below those of its neighbors like Bangladesh and 
Nepal. Despite being home to just 17% of the global population, India accounted for 20% of the 
global burden of disease (though this was a slight improvement since 2005).11 This has been a 
consistent trend for decades—Indians face more life years lost due to premature death and greater 
illness and injury than similar countries.12 As seen in Table 5.1, many of the major killers are 
preventable, treatable, or both, through public health interventions and access to basic healthcare. 
Deaths linked to birth and childhood infections still represent a large portion of deaths in India, 
resulting in high infant, child, and maternal mortality. Major epidemics hit the country hard: India 
has more new tuberculosis cases each year than any country in the world—at 2.8 million it is three 
times the number than that in more populous China, with a growing problem of drug-resistant 
strains.13 It is also home to the third-highest number of people living with HIV at two million, 
largely by dint of large population size.14 It is also the only country in Asia in the top-10 list of new 
malaria cases, though high treatment coverage has significantly reduced malaria’s ranking on Table 
                                                
9 World Bank 2017. 
10 Sharma 1996; Bhattacharya 2004. Note malaria cases would later rebound and today India faces a major malaria epidemic.  
11 GBD 2013 Mortality and Causes of Death Collaborators 2015. 
12 Institute for Health Metrics and Evaluation 2010; Institute for Health Metrics and Evaluation 2015. 
13 World Health Organization (WHO) 2016. 
14 UNAIDS 2016. 
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5.1. Meanwhile, a growing portion of deaths and ill health are caused by non-communicable 
diseases linked to smoking and living conditions.  
 Health inequality is unmistakable; most major health indicators are worse in girls, in rural 
populations, in scheduled tribes and castes, and among the (related) poor, with wide variation 
across states.15 Measles provides a good example of how health system limitations and inequalities 
play out: In 2010 India accounted for nearly half of the 139,300 measles-related deaths that occurred 
globally.16 Researchers found that although vaccine cards showed relatively high vaccination rates, 
tens of thousands of deaths still occurred because the health system could not deliver an effective 
cold-storage chain and so vaccines lost potency, the most vulnerable populations had little access 
to healthcare and low vaccination rates, many children were vaccinated at the wrong age or with 
the wrong vaccine, and inadequate medical care for those with signs of measles meant fewer 
infected children survived.17  
Table	5.2:	Health	Financing	in	India	vs.	World	(2014)	
Country	Name	
Total	 health	
expenditure		
(%	GDP)	
Government	
health	expenditure		
(%	GDP)	
Out-of-pocket	
expenditure	 (%	of	 total	
health	expenditure)	
India	 4.7	 1.4	 62.4	
China	 5.5	 3.1	 32.0	
Brazil	 8.3	 3.8	 25.5	
South	Africa	 8.8	 4.2	 6.5	
Mexico	 6.3	 3.3	 44.0	
United	Kingdom	 9.1	 7.6	 9.7	
United	States	 17.1	 8.3	 11.0	
  
 These kinds of health failures are the result of a set of particular factors in the political 
economy of health in India.  
                                                
15 Patel et al. 2015. 
16 Simons et al. 2012. 
17 Awofeso, Rammohan, and Iqbal 2013. 
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 The trend of low political priority and low public spending begun under the British has 
continued uninterrupted. As shown in table 5.2, India spends less of its GDP on health than other 
similar countries, and government spending makes up a particularly small portion. This small 
portion of the public budget going to health drives one of the world’s highest rates of out-of-pocket 
spending. A report by the Reserve Bank of India showed that this low spending for public health 
services is a driver of household debt and poverty—with the interest alone on emergency credit to 
cover medical expenses driving average Indians significantly down the wealth distribution.18 While 
low, public spending as a portion of GDP did increase from 0.98% in 1975 to 1.36% in 1986, only 
to fall back to 1.28% in 1991 and still further to 0.9% in 2000 – among the lowest in the world.19  
 As seen in figure 5.2, in recent years health spending has climbed back up, finally matching 
its previous levels in 2014.20 There are a multitude of factors driving this increase in spending, but 
it is notable that this corresponds to the period of constitutionalization which has arguably (as I do 
below) contributed toward programs like the National Rural health mission.  
Under-resourcing, along with poor management, has left the primary health sector 
chronically weak. One recent study showed that “most facilities fall far short of minimum 
                                                
18 Reserve Bank of India 2017. 
19 Rao 2017, 17. 
20 Reliable and comparable spending and GDP data are not available from international sources before 1995.Graph relies on Rao 2017; 
Reddy and Selvaraju 1994 which report only certain years reflected here.  
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constitutionalization
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standards, with a long tail of facilities which are barely functioning.”21 The authors showed a 
striking variation in the quality of care across states, with districts in the South performing fairly 
well, while care was worse in West Bengal, Uttar Pradesh, and Manipur. Low-quality care was 
correlated to the highest levels of avoidable mortality. The National Rural Health Mission and more 
recent Urban counterpart have sought to reverse address this trend, with some success—adding 
thousands of new clinics and hospital beds in the public sector and investing in quality 
improvement, but much work remains.  
 The combination of steady economic growth, the rapid advances in allopathic medicine, 
and the stagnant public health sector has led to a dramatic expansion of under-regulated private 
sector clinics, pharmacies and hospitals. “In this din of swanky hospitals, modern technology, 
shifting aspirations backed by the willingness to pay, the concept of a family doctor and the 
neighborhood clinic that Bhore had envisioned was lost,” writes Sujatha Rao, former Union 
secretary for health.22 Liberalization in the 1990s sped up this trend as government cut public 
expenditure while subsidizing and facilitating the private 
 sector.  
“Not a single nurse, doctor was added on in some of the weakest districts between 
1993 and 2005. Nobody. Not even to replace those who retired or died in the 
interim.” –former Senior Health Official (Interview IN-36) 
 
At independence, the private sector provided just 5-10% of healthcare, but by the early 2000s it 
accounted for 82% of outpatient visits, 58% of inpatient expenditure, and 40% of births in 
institutions.23 Nearly all of this private spending has been out of pocket—leading the poor to use 
hospitals far less-often and, when they do, to suffer catastrophic financial burden.24 One World 
Bank study showed hospitalized Indians spent 58% of their total annual expenditures on health 
care, and more than 40% had to borrow money or sell assets—including farmland—driving them 
                                                
21 Powell-Jackson, Acharya, and Mills 2013, 58. 
22 Rao 2017, 13. 
23 Sengupta and Nundy 2005. Note this has since reduced to roughly 70% of outpatient care (Patel et al. 2015, 2428). 
24 Reserve Bank of India 2017. 
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into poverty.25 This private sector has remained remarkably unregulated, undermining any sense 
of an effective health “system.” In major urban centers, facilities are increasingly run by large 
corporations that have absorbed smaller providers and become powerful local political and 
economic players. Meanwhile, in slums and rural areas, a large number of underqualified and low-
skilled health providers contribute to such problems as improper immunization.26 The private 
sector context has driven high expenditure on drugs and a major problem with “irrational” use of 
the wrong drugs to treat the wrong symptoms, both of which government refused to tackle until 
recently. All of this has also created a vicious cycle resulting in abandonment of the public health 
sector by anyone who can afford private care, creating a powerful interest group able to resist 
regulation and public-sector encroachment. 
 Governance of the health sector represents a major challenge running throughout all of 
these issues. According to the Constitution, health is a state subject, yet almost two-thirds of health 
funding comes from the center and much of health policy is driven (or not) by central initiatives 
and legislation. Many of the laws and policies that have passed, however, have not been 
implemented—from the 2010 Clinical Establishments Act to the 2006 Medical Devices Regulation 
Bill, health legislation and policies languish. Given India’s size and diversity, there are significant 
limits to what central authority can accomplish and, in 2003, constitutional status was granted to 
local government, providing a key opportunity to improve accountability through decentralization, 
though the effectiveness of these reforms remains in question.27  
 It is into this context—a long history of compounding challenges, huge burden of ill health, 
and weak public institutions—that constitutionalization has been introduced. The question before 
us then is whether this move has mattered and, if so, how? 
 
 
 
                                                
25 Peters et al. 2001. 
26 Das et al. 2012. 
27 Malviya 2014; Seshadri et al. 2015. 
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Constitutionalization 
 
 Constitutionalization of health in India needs to be seen in the light of the specific 
institutions of the Indian judiciary, and the Supreme Court in particular, as an actor in the messy 
political democracy of the country. Pratap Mehta calls the judiciary’s role in India “promiscuous”— 
not only interpreting laws and ruling on the constitutionality of legislation but also formulating 
policy, supervising investigations, and ordering new institutions to be set up.28 The Court itself is a 
sprawling institution with 31 judges who sit in benches of multiple sizes—more of a multi-level 
judicial system in itself, dealing with tens of thousands of cases every year, than an apex court of 
final arbitration.29 The Supreme Court in 1993 even took the remarkable step of interpreting the 
Constitution to mean that Justices of the Supreme Court could only be appointed upon 
recommendation of the other Justices.30 Early in the Court’s history, it was focused largely on 
procedural issues and then on protecting property and first-generation rights. Often more 
conservative than the executive branch and seen as an impediment to social transformation of post-
colonial India, nearly half of the first amendments to the Constitution were aimed at curtailing the 
power of the judiciary.31  
 Following its failure to defend the Constitution during the Emergency period, the Supreme 
Court worked to regain its legitimacy by expanding access to the courts and championing human 
rights and good governance.32 Relaxing rules on standing gave far wider access to the Supreme 
Court, which began to expand its remit to a far wider range of policy issues, giving rise to a new 
class of public interest litigation (PIL) cases. The judiciary has thus become far more “inventive and 
activist” and a substantial political force as developments like the PIL transformed both the form 
                                                
28 Mehta 2015, 233. 
29 Robinson 2013 shows that the total number of cases has risen in recent year but constitutional benches have become increasingly 
rare. 
30 Choudhry, Khosla, and Mehta 2016, 83–4. 
31 Mehta 2005, 168. 
32 See Baxi 1985; Desai and Muralidhar 2004.During “The Emergency” 1975-77, the government declared a state of emergency in 
what is regarded as a dark period in Indian democracy, and the Supreme Court ruled the government could suspend even fundamental 
rights. In the period that followed, the Court needed to fix its tarnished image and turned toward more populist measures.  
Chapter	5:	India	
	
	
225	
and substance of the courts..33 The Supreme Court has established court-appointed commissions 
and crafted a practice of “continuing mandamus” in order to monitor implementation of judicial 
orders as it has in cases on food, the environment, education, and more.34 These moves have been 
highly debated. Some hail the PIL as a critical accountability mechanism to issues no other part of 
government will tackle, while others have argued that, while addressing critical shortfalls, “the 
growth of PIL has also taken its toll on the apex court, which spends increasingly less time deciding 
important questions of a constitutional nature and more on populist posturing.”35 Still others 
suggest the PIL is funneling policy issues into a binary between state and marketplace that fails to 
reflect the true needs of the poor.36 It is clear to all, however, that the Court exercises significant 
power that comes, in significant part, from the vacuum created by the weakening of India’s 
legislative and executive institutions.37  
Analysts have thus described the Court as a “good governance court”38 and “accountability 
court” an “embedded negotiator” court among many other adjectives—in other words a a far more 
complex institution than typically imagined in a “court.”39 
 
Constitutionalizing Health—Courts and State Action 
 
 The Indian Constitution directs that “the State shall regard the… improvement of public 
health as among its primary duties.”40 This is a directive principle of state policy (DPSP), however, 
distinguished from Part III of the Constitution which enshrines a series of civil and political rights 
as “fundamental rights.” The former is not enforceable by courts, and in the early years this 
                                                
33 Galanter and Krishnan 2003; Suresh and Narrain 2014. 
34 See e.g. PUCL vs Union of India & Others 2001, the "right to food" case in which the Court ordered the creation of an office of 
Supreme Court Commissioners to "track side-by-side hunger and the implementation of interim orders relevant to the Right to Food 
Case across the country." (www.sccommissioners.org)  
35 Kapur, Mehta, and Vaishnav 2017, 9. But see Gauri 2014, 102 arguing PILs take up only a small part of the Supreme Court's overall 
caseload, idnetified by Robinson (2013, 572) as about 1% of the overall workload.  
36 Rajagopal 2007. 
37 Khosla and Padmanabhan 2017. 
38 Robinson 2009; Mehta 2015; Shankar 2013. 
39 Robinson 2009. 
40 Article 47. 
Chapter	5:	India	
	
	
226	
prohibition on judiciability was strictly enforced by the courts.41 With the post-Emergency 
expansion into social issues, however, the Court began to unite the two sections of the Constitution. 
In Francis Coralie Mullin v. Delhi, the Court formally set aside the barrier between civil and political 
rights and socioeconomics rights, using the idea of dignity as a prism through which to interpret 
the right to life, originally construed as a classic negative right against unfair state action, as a 
positive right conferring duties on the state.42  
 In 1995, the Supreme Court ruled in Consumer Education & Research Center v. Union of 
India that health was a judiciable right under Article 21 of the Constitution—the right to life. In a 
PIL seeking the protection of workers against the health hazards associated with asbestos exposure, 
the petitioners sought to fill gaps in the compensation systems and medical services available to 
workers suffering from asbestosis. “The expression ‘life’ assured in Art. 21 of the Constitution does 
not connote mere animal existence or continued drudgery through life…” the Court ruled. 
“Therefore, it must be held that the right to health and medical care is a fundamental right 
under Article 21…”43 In its 1996 decision of a case involving a man who had been turned away from 
six different government hospitals after falling from a train, the Supreme Court of India articulated 
its understanding of the right to health as one that includes a state duty to provide medical care. 
“Failure on the part of a Government hospital to provide timely medical treatment to a person in 
need of such treatment results in violation of his right to life guaranteed under Article 21.”44 
Reading access to healthcare into the right to life also addressed the Court’s desire to give meaning 
to Article 38 of the Constitution, which designates the Indian Union as a welfare state. The 
following year, the Supreme Court affirmed, “It is now settled law that right to health is integral to 
right to life. Government has constitutional obligation to provide the health facilities.”45 While 
doing so just a decade before would have been a relatively innovative act in global perspective, by 
                                                
41 Article 37. 
42 Francis Coralie Mullin v. The Administration, Union Territory of Delhi 1981. 
43 Consumer Education & Research Center v. Union of India 1995, para 24, 26. 
44 Paschim Banga Khet Mazdoorsamity v. State of West Bengal and Anr., 1996 SCC (4) 37. 
45 State of Punjab and Ors. v. Mohinder Singh Chawala, 1997 2 SCC 83 at 2. 
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the mid-1990s it was becoming commonplace for constitutions to include an explicit right to health, 
and it continued the Court’s moves to read the DPSPs into the Constitution’s fundamental rights.  
 India’s constitutionalization thus came not from a negotiated political settlement, but from 
a set of court cases. Various governments since have accepted this move and incorporated 
recognition thereof in pieces of policy (e.g. draft National Health Policy, 2015). There is no clearer 
evidence that institutionalization of heath as a right is only partial, however, than the continuing 
conversations over whether the government should legislate a right to health. There was much talk 
in the first UPA government (led by the Congress party) about a right to health bill—a version of 
which was finally introduced near the end of the first UPA government in 2009 on the way into 
elections. The bill recognized the Supreme Court’s jurisprudence in its preamble and moved on to 
structure a judicially enforceable right to health and outline the core responsibilities of the state 
around public health and medical care.46 The bill, however, never passed.  
“Mostly we just ran out of time. UPA-I we had a lot on our plate and during UPA-
II there was far less left support. The energy went into the Food Security Act and 
there was a sense that UPA-III would have done the Right to Health Act but there 
was no UPA-III.” –Senior Congress Party Leader (Interview IN-39) 
 
The NDA government’s first pass at a draft Health Policy directly engaged with the rights 
discussion—acknowledging the Court’s finding, yet noting there remained debate about the best 
way to give shape and form to the constitutional obligation. “To break the deadlock and this 
vacillation and move forwards with determination- the draft national health policy proposes the 
following formulation- the Center shall enact, after due discussion and on the request of three or 
more States a National Health Rights Act, which will ensure health as a fundamental right, whose 
denial will be justiciable.” After significant internal debate, however, the final Health Policy 
dropped the idea of health rights.  
“To be honest I was surprised to see that in there the first time. Health Assurance 
is this government’s framework and that is certainly not rights. In fact, no one is 
quite sure what it will mean. It is not hard to see that the Supreme Court will have 
its say though, we will see.” –Public Health Leader (Interview IN-44)  
 
                                                
46 The National Health Bill, 2009 (GoI Working Draft) 2009. 
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 On the side of the judiciary, though, development of a robust jurisprudence on health as a 
right has continued apace. Between 1996 and 2016, the Supreme Court and the next level High 
Courts addressed Article 21 alongside health in 2,771 cases.47 This includes cases that did not turn 
on the right to health, but it indicates that health quickly became recognized as part of the 
fundamental rights in Indian Constitutional jurisprudence. Figure 5.3 shows the growth in these 
cases which happened quickly after 1995. As seen here, a more recent increase in these cases since 
2010 might be attributable to the dramatic spike in cases overall in the High and Supreme Courts, 
but throughout the 1990s and 2000s the number of these cases rose even as overall cases did not.  
 
  Charles Epp documented the weakness of the early Indian “rights revolution” through the 
early 1990s, and the limited utility of the judge-created PIL opportunities due to the limited support 
structure in India.48 In more recent years, however, there are signs of a strengthening infrastructure 
and use of the courts—the right to health is one of these areas. While hardly a panacea, several 
                                                
47 Based on a boolean search using the Indian Kanoon database for “‘Article 21’ and health” in Supreme Court and High Court. Note 
article 21 is the right to life, discussed infra, which the Indian Supreme court identified as the source of the right to health and around 
which the jurisprudence was built.  
48 Epp 1998. 
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important right to health cases have come to the courts through PIL, as described below. Shankar 
and Metha note that still few poor people approach the court, but the not-insignificant number of 
cases that have come illustrate an eagerness of the courts to act.49  
 
Subjects of Litigation 
 
 The key questions for this project is whether constitutionalization of health is good, bad or 
indifferent—which in India hinges significantly on how the right to health is mobilized around the 
courts. As the case studies later in this chapter illustrate, even in India’s judicially-driven context, 
the most important aspects of the right to health come in the bargaining over policy outside the 
courtroom, not from court orders. Nonetheless, the question of whether litigation is touching on 
important public health issues or instead driving a distorted policy likely to undermine effective 
public health is a key starting point. One of the worries is that with the Supreme Court offering low 
barriers to access and a robust—but not always coherent—legal analysis, that it will be captured by 
individualist or middle-class interests. In Latin America, this apprehension has been most clearly 
focused around medicines as large numbers of cases for access to specific medicines for individuals 
has been a driver of much of the court attention.  
 In the case of India, there is at least some evidence that courts are navigating a path to avoid 
this pitfall and have focused on what many experts agree are the main challenges in the Indian 
system—low investment and poor implementation. In 224 cases, the highest courts in the country 
drew upon the right to health explicitly—from which I was able to draw a sample of at least 121 
cases that I could clearly identify as rulings in which the right to health was central to the decision.50 
These ranged from ordering the state to provide antiretroviral AIDS drugs and health facilities to 
religious pilgrims, to considering health impact as a factor in denying patents on life-saving drugs, 
                                                
49 Shankar and Mehta 2008. 
50 I drew the sample by drawing on the cases included in the Global Health & Human Rights Database, Georgetown University 
O’Neill Institute and Lawyers Collective n.d. alongside a subset of cases mentioned specifically in one of several sources including 
Shankar and Mehta 2008; Parmar and Wahi 2011; Muralidhar 2008. 
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to ensure affordable generic versions were available. They collectively show a very active court 
addressing far-reaching policies, despite expectations to the contrary. As previous research has 
shown, plaintiffs in right to health cases are highly successful—nearly 70% win.51 Figure 5.4 shows 
the categories into which the 121 cases in our sample of significant Supreme Court and High Court 
rulings fall.  
  
 A number of the cases fall into the category of individual remedies for government workers. 
These cases are the most traditional adjudication cases in the model of the courts as neutral third-
party conflict resolvers.52 The court has ruled that government must fulfill its healthcare obligations 
to current and former state workers,53 cannot arbitrarily change the rules, and must reimburse 
employees that seek urgent care.54 The litigants are often relatively privileged government 
employees seeking higher reimbursements and so could be seen as the type of adjudication critics 
                                                
51 Shankar and Mehta 2008. 
52 Shapiro 1986. 
53 State of Punjab and Ors. v. Mohinder Singh Chawala 1996, vol. 1997 2 SCC 83.  
54 State of Punjab v. Ram Lubhaya Bagga, 1998 1 SCR 1120. 
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have worried about. Importantly, though, these cases can largely be understood as the Court 
enforcing and interpreting obligations already taken on by the state—not creating new and costly 
obligations on behalf of an advantaged group. Indeed, when recently asked to do just this by ex-
servicemen, the Court declined to do so.55 
 Meanwhile, much of the Court’s work has been in tackling core problems of health system 
performance and public health—the work that Nick Robinson has labeled part of a “good 
governance court.”56 The Court has built out the idea of a minimum core of health services to which 
people are entitled, including emergency medical care, without creating a specific court-mandated 
set of requirements, largely leaving this to government.57 The Court’s work has included using the 
right to health to hold state officials responsible for denying poor people access to services to which 
they were entitled,58 prevent unregistered and unqualified individuals from practicing medicine,59 
enforce agreements by hospitals to provide free treatment in exchange for land,60 require regulation 
of blood banks,61 enforce minimum health obligations of companies involved in dangerous 
businesses,62 and many other issues. Recently the court, on its own motion, took note of deaths of 
Amarnath pilgrims and ordered authorities to create proper medical and other facilities for the 
pilgrims.63 
 As the bulk of the courts work, these kinds of cases have shown a thoughtful and restrained 
engagement in which the courts respond to failures in the system. Rather than order individual 
remedies, court engagement has focused on “catalyzing changes in law and policy” (Muralidhar 
2008, 117). While the court has refused to accept financial constraints as an absolute response, it 
has also not ordered costly individual remedies in large numbers, instead primarily identifying state 
and private obligations to be addressed more broadly. It has focused largely on raising unaddressed 
                                                
55 Confederation of Exe Servicemen Associations v. Union of India, 2006 (4) SCR 872; (8) SCC 399. 
56 Robinson 2009. 
57 Mahendra Pratap Singh v. State of Orissa and Ors. AIR 1997 Ori 37; Paschim Banga Khet Mazdoorsamity v. State of West Bengal 
and Anr., 1996 SCC (4) 37. 
58 Laxmi Mandal v. Deen Dayal Harinagar Hospital and Ors., 2010 HC-Delhi 2983. 
59 D.K. Joshi v. State of U.P., 2000 5 SCC 80; Rajesh Kumar Srivastava v. A.P. Verma, AIR 2005 All 175. 
60 Social Jurist v. Government of NCT of Delhi and Ors. 140 2007 HC-Delhi DLT 698 
61 M. Vijaya v. Chairman and Managing Director, Singareni Collieries Co. Ltd., Hyd. And Ors., AIR 2001 AP 502; 
62 Consumer Educ. & Research Ctr. v. Union of India, 1995 S.C.C. (3) 
63 Court On Its Own Motion vs Union Of India & Ors. Suo Motu Writ Petition (Civil) No 284 of 2012. 
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issues and setting benchmarks for progress toward improved health service delivery. Worries that 
the courts will end up running everything have not shown themselves in Indian RtH cases. 
 Concerns that the courts will simply go from case to case without ever affecting real change 
are also being addressed, if imperfectly. As former Chief Justice Bhagwati noted,  
 
“The orders made by the Court are obviously not self-executing. They have to be 
enforced through State agencies and if the State agencies are not enthusiastic in 
enforcing the court orders, the object and purpose of [Social Action Litigation] 
would remain largely unfulfilled. The consequence of the failure of State machinery 
to secure the enforcement of court orders in SAL cases would not only result in the 
denial of effective justice to the disadvantaged groups but would also have a 
demoralizing effect on further attempts at litigation.”  
 
The courts have responded to this concern with a series of innovations that go beyond the 
broadened standing requirements in the PIL, to using a range of innovative structures in an attempt 
to both help it understand the full scope of the health system issues and enable better enforcement. 
Parmar and Wahi document the use(s) of many of these elements in right to health cases.64 To 
increase its understanding, the court has established expert committees and external investigative 
commissions —efforts designed to specifically address the limitations of the courts. In order to try 
to deal with the enforcement issues inherent in such cases, the court has exercised continuing 
mandamus in which the courts have issued interim decisions but retained supervisory jurisdiction 
over a number of cases in order to continue to monitor them. In addition to mandatory orders, the 
courts have set up oversight committees appointed for a range of purposes—to fill vacancies of 
health professionals, to report back to the court on the conditions of mental hospitals, and even to 
identify which pharmaceutical drugs should be banned. Whether these bodies are helpful 
innovation or harmful parallel systems, however, has to be judged in the context of the policy cycle 
as a whole. 
 These actions do not well-conform to the concerns about courts in the literature. Courts 
are still, without question, imperfect vehicles by which to set health policy—but the Indian courts 
seem to be navigating a different role and instead creating an accountability function on the right 
                                                
64 Parmar and Wahi 2011, 172–4. 
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to health where failure of other public and private actors is clear and significant. Its focus seems 
designed, in part, to have the improved service delivery that the large-N regression in chapter 2 
suggests. 
 As I have repeatedly argued here, though, to understand the impact of constitutionalization 
we must look well-beyond court orders in isolation and trace policy issues from before rights 
mobilization to well-afterward to see how power, ideas, and actors shift. Therefore, I turn now to a 
set of such policy issues. I begin by going into depth on three policy issues—HIV treatment, where 
the mechanisms of action of constitutionalization are perhaps most clear; clinical trials, where court 
intervention has been highly contentious in public health circles and I suggest is misunderstood in 
snapshot depictions in the West; and the implementation of the National Rural Health Mission 
where we begin to see the outlines of constitutionalization beyond the court.  I then turn to briefer 
examination of issues dealing with the safety and affordability of medicines, maternal healthcare, 
LGBT rights, and the unsuccessful effort to legislate a right to health. In each of these issues we see 
the mechanisms outlined in chapter 3 at play—the shifts in institutional environment under 
constitutionalization, in actors, venues and ideas, has a significant effect on policy. However we 
also see the limits of judicially driven constitutionalization. 
 
 HIV Treatment  
 
“The Constitution is a tool we have learned how to use to push through issues that 
politicians ignore and bureaucrats want to just take their time on and then say they 
are still considering it while people drop dead around them. The Constitution says 
no, do it now.” –PLHIV leader (Interview IN-08) 
 
 The story of the refusal to roll out HIV treatment in South Africa described in chapter 4.3 
garnered significant global attention—but in India the timelines were nearly identical, with 
government standing in the way until years after other countries had rolled out treatment. 
Mobilizing a different set of ideas centering affordability, the Indian policy monopoly was at least 
as strong as that in South Africa  
 HIV was first detected in India in 1986 among female sex workers in Tamil Nadu, and was 
further revealed throughout significant swaths of the country. By the early 2000s it had been 
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detected in 29 of India’s (at the time) 32 states and union territories. The exact size and trajectory 
of the epidemic in India has been hotly debated for years. In the early 2000s, opinions verged from 
a “disaster in the making” or, from the U.S. CIA, dire warnings of potentially tens of millions living 
with HIV, to the more sober estimates that nonetheless recognized that millions in India were living 
with HIV by the turn of the century.65 More recent estimates show over 2 million people living with 
HIV in India in 2015—making it the third-largest epidemic in the world behind South Africa and 
Nigeria.  
 Taking India as a whole, 2 million is not a large number—translating to just 0.3% 
prevalence in 2015, down from closer to 0.5% around 2000. Compared to Southern Africa, these 
are low rates. However, comparing India as a whole gives a distorted epidemiologic picture since 
the HIV epidemic has been concentrated in a subset of states, and many states in India have 
populations far larger than many 
countries.66 Maharashtra, Karnataka, 
Andhra Pradesh, and Tamil Nadu have 
all had “generalized” epidemics (i.e. 
more than 1% of women attending 
antenatal clinics were HIV-positive) 
largely driven by heterosexual 
transmission. Together these states 
have a population roughly the same as 
the United States and larger by a third 
than Brazil, but have two-to-four times 
the HIV prevalence respectively.67 At 
the height of the U.S. epidemic 41,000 
people were dying of AIDS per year, 
                                                
65 Kadiyala and Barnett 2004; National Intelligence Council 2002; NACO 2003b. 
66 NACO 2003a; NACO 2006a; NACO 2017. 
67 UNAIDS n.d. 
Figure 5.5 India HIV Prevalence  
Source: 2012 data, Antenatal prevalence NACO 2015, John et. al. 2011 
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while more than twice that number died in these four Indian states. Meanwhile on the Myanmar 
border in Manipur, Nagaland, and Mizoram, most districts report well over 1% antenatal 
prevalence and HIV infection largely linked to intravenous drug use—rates higher than Myanmar 
or Thailand. Suffice it to say the AIDS problem in India has been significant. Meanwhile sub-
populations have been particularly hard hit—including sex workers, intravenous drug users, men 
who have sex with men, and truck drivers. In some areas, these populations have had between 30% 
and 55% prevalence.68 
 Indian and international public health experts raised the alarm early in the epidemic. The 
few who were getting tested for HIV including sex workers in Mumbai and injecting drug users in 
Manipur had well over 5% prevalence. The WHO warned India had just a few years to get its HIV 
epidemic under control or it could risk dramatically rising prevalence.69 
 In the early response to HIV, as in many parts of the world, blame of marginalized groups 
and foreigners for spreading the disease undermined an effective early response.70 Instead the 
programmatic effort was punitive and coercive, which was not particualry effective. The National 
AIDS Prevention Bill of 1989 would have mandated medical providers to identify “high risk” people 
and bring in authorities to institute compulsory HIV testing and isolation for those found HIV-
positive.71 State bills passed in Goa in 1987 required quarantine, and in Maharashtra allowed arrest 
and segregation camps.72 While media reports about chained and jailed addicts in Manipur created 
outrage, the coercive instincts of the state were only contained after sustained pressure from human 
rights and public health experts who decried such steps as ineffective.73 The first AIDS bill was 
eventually withdrawn, but the government’s instinct toward basing its HIV strategy on identifying 
and changing the behavior of a small subset of the population perceived as driving the epidemic 
                                                
68 Brahme et al. 2006; Boily et al. 2013; Chandrasekaran et al. 2006; NACO 2006b. 
69 Mangla 1992. 
70 Blaming foreigners has been “among the earliest and the most enduring responses to the HIV/AIDS epidemic.” Amon and Todrys 
2008. In India some observers “blamed it on Sri Lankan militants, promiscuous African students, and the West for selling 
condoms.”(Kadiyala and Barnett 2004). This is hardly unique. In the U.S. see Farmer 2001 on the blame of Haitians and far more 
recently see the comments of Nigel Farage in “Nigel Farage’s HIV claim criticised by leaders’ debate rivals" 2015. 
71 The AIDS Prevention Bill of 1989 1989; Dhanda 1989.  
72 Padmavati 1991. 
73 Aids Is A Blessing, Says Keeper Of The Chained Addicts 1991. 
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(through varying degrees of incentive and coercion) has persisted.74 The identification of “high risk” 
groups in the Indian strategy has not only focused far more exclusively on groups like sex workers 
and men who have sex with men than is warranted by the epidemiology, but it has carried shades 
of ethnic and caste mapping.75  
 The government did take early steps to build an AIDS response. It started a National AIDS 
Control Program in 1987, but lacking both resources and leadership, it did little to stop disease 
progression and did a lot to expand quackery by deputizing poorly trained health workers across 
the country to fight AIDS. As one doctor distributing homeopathic pills she hoped would cure 
AIDS put it, “I admit we are working in crude ways. But we have almost no money budgeted for 
this programme. The government is too busy in meetings to realise what is going on. So I'm taking 
the initiative. I believe in miracles.”76  
 By 1992, the government began a program in earnest—taking out an $84 million loan from 
the World Bank to create the National AIDS Control Organization and launch an effort that 
actually made the AIDS program the second-largest in the center’s health budget behind malaria.77 
But that too faced significant challenges in the absence of political leadership—left largely to a 
technocratic group within the Ministry of Health and Family Welfare, the new central program 
seeking to address issues largely left to state-level government faced an uphill battle.78 “Stimulating 
states’ commitment to HIV-related work generally failed, resulting in an uneven response, 
particularly among those with high incidence and weak health systems.”79 Head of UNAIDS, Peter 
Piot, reported attending meetings in India where he “heard great speeches, but as for action, zero.”80 
 These dynamics—lack of political attention, technocratic governance, complex federalism, 
and a disease enmeshed with caste politics—are not unique to HIV, even as some particularly 
                                                
74 Chatterjee 2006; Chandrasekaran et al. 2006. 
75 Lieberman 2009, 204. 
76 Losing the battle with Aids. 1990. 
77 Mangla 1992. 
78 By the end of the loan there remained significant unspent funds, which had to be spent down quickly in an extension period—
largely programmed through NGOs for large “communication” campaigns that were never evaluated for efficacy (Chhabra 2007). 
79 Rao 2017, 203. 
80 Worldwide war on AIDS/HIV still coming up way short 2003. 
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exceptional conditions distinguish the epidemic. A similar deep malaise can be seen across various 
parts of the under-funded, under-capacitated Indian health system. See, for example, the TB 
program has been struggling for fifty years between optimism and failure.81 The argument here is 
not that these factors  are distinctive, but instead too-common and that rights mobilization had to 
address these factors to be effective. In particular these factors explain, in part, one of the major 
failings of the AIDS response through the early 2000s: a lack of any public antiretroviral treatment 
program.  
 
Failing to Roll out ARV Treatment 
 
 The year after HIV was revealed in India, the Food and Drug administration approved the 
drug AZT as the first treatment for AIDS, though it was only partially effective.82 By 1991, the Indian 
generic drug company Cipla had produced a version of the drug, which was soon selling for one 
quarter of the price offered by multinational drug companies.83 By 1996, the breakthrough of 
combination antiretroviral (ARV) therapy was proven effective and, from the U.S. and Europe to 
Brazil and Thailand, hospitalization and deaths plummeted where ARVs were rolled out.84 As seen 
in Figure 5.7, however, no such roll out happened in India.  
 Instead, the Indian HIV program remained exclusively focused on prevention strategies, 
with a sharp focus on the “high risk groups.” The 1998 National AIDS Policy set forth a program 
with the chief aim to prevent the further spread of HIV “by making the people at large and specially 
the high-risk groups, aware of its implications and provide them with the necessary tools for 
protecting themselves from getting infected.”85 The main strategy was to use nongovernmental 
organizations (NGOs) to deliver HIV prevention interventions—with over 660 NGOs engaged 
                                                
81 Sharma 2017; John 2014. 
82 FDA 2014. 
83 Flynn 2014, vol. 11, 119; Hakansta 1998. 
84 Zuniga et al. 2008; Palella et al. 1998. 
85 National Aids Policy 1998. 
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across different states.86 Treatment was identified as too expensive and “still in the initial trial 
stage.” By 2002 National Health Policy had little more to say—with only passing mention of HIV 
except for a pledge to “bring about a behavioural change to prevent HIV/AIDS and other life-style 
diseases.”87  
 
 Not starting an HIV treatment program had three broad and negative effects in India: First, 
of course, people living with HIV had no access to medicines to sustain their health. Figure 5.6 
shows that, until 1995, Brazil had more AIDS deaths than India, but after the advent of effective 
ARVs Brazil implemented a national program that quickly reversed the trend of AIDS deaths. India, 
on the other hand, did not act for another eight years and deaths continued to climb. There is 
significant debate about the exact mortality numbers from this period, given poor data on mortality 
overall in the country and HIV prevalence in particular, as well as the challenge of separating AIDS 
deaths from other causes. This debate is illustrated in Figure 5.7 by the large uncertainty bounds 
around the AIDS mortality figures. Overall, likely somewhere between 150,000 to 270,000 people 
were dying each year at the height of the epidemic. Second, the lack of rollout significantly  
                                                
86 Over et al. 2004, 18. 
87 National Health Policy 2002, Sec 2.14.1. 
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exacerbated stigma and undermined prevention activities. With no treatment available, HIV was a 
near certain death sentence, which undercut Indians’ motivation to get tested and engage with HIV 
programs overall. Finally, HIV treatment to suppress the virus is among the best HIV prevention 
strategies—as or more effective than condoms in practice—and the lack of a treatment program 
ensured many thousands of additional HIV infections that could have been averted.  
 
 
There was also a vicious political cycle associated with the lack of a treatment program. HIV stigma 
intersected with stigma toward marginalized people (e.g. sex workers, transgender people) which 
is deeply intertwined with caste, region, and ethnolinguistic identities. The lack of a public 
treatment program transformed this complex politics of social exclusion and hierarchy into a 
politics of “blame” with the most visible AIDS deaths among those without the money or social 
standing to hide their illness—which then further undercut the political will to act.88  
                                                
88 Lieberman 2009 makes this point in chapter 5, but does not connect it with the stigma dynamics of an untreatable disease vs. one 
that can be managed—see, for example, Biehl 2007; Comaroff 2010 on the critical role that treatment availability plays in the shaping 
political power and interpretive frameworks for HIV.  
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 Government justified its opposition to creating a public treatment program largely based 
on the idea that it was too expensive. Early on this argument had a clear foundation—while AZT 
had been made somewhat less expensive, the full combination “cocktail” cost more than $10,000 
per patient per year from the multinational pharmaceutical companies.89 In the private sector, 
ARVs became available but were far too expensive for most Indians—leaving just a handful of 
wealthy Indians with access to drugs. The Brazilian government’s response to this was to focus on 
negotiating far lower prices and building the capacity for generic production within Brazil that 
made treatment cost effective. The Indian government, after a decade of liberalization and with a 
very limited public health strategic capacity, instead left it to the private sector to solve the problem.  
 In September 2000, that happened. Drugs suddenly became far more affordable when 
Indian company Cipla offered a full course of ARVs to the world for just $800 per patient per year.90 
Cipla’s colorful CEO Yusuf Hamied made headlines around the world just five months later when 
he announced an even bolder gesture—a price cut to less than $1 per day and an offer of the 
company’s ARV drug production technology totally free to any developing country government 
which wanted to produce its own drug against AIDS. This was good news, but for the average 
Indian this still left treatment out of reach. In the private sector that meant about Rs 15,050 for the 
ARV drugs, plus Rs. 5,585 for initial tests, and Rs 5,155 every six months for monitoring tests—
totaling just about $2 per day before transportation or provider fees.91 According to UNDP, 86% of 
Indians lived on less than $2/day in 2000.92  
 However, it did make treatment cost effective for a public-sector program. Nonetheless, 
the 2002 National AIDS Prevention Policy, adopted after a great deal of public consultation and 
what NACO identified as deep engagement with people living with HIV, again did not include HIV 
treatment and instead doubled down on a prevention-only approach. The policy repeated, almost 
exactly, the stance from four years before:  
 
                                                
89 MSF Access Campaign 2012. 
90 Hamied 2006. 
91 Over et al. 2004, 30. 
92 UNDP 2002. 
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“The treatment options are still in the initial trial stage and are prohibitively 
expensive. While there is no vaccine in sight, multi-drug antiretroviral therapy, 
popularly known as ‘cocktail therapy’, is not a cure to the disease and may help 
only in prolonging the life of the patient. Standardisation of treatment regimens 
for these drugs is still evolving and there are fears of patients developing drug 
resistance and side effects if the therapy is not administered under proper medical 
supervision.”  
 
 At this point, there were parts of this policy that were demonstrably false. ARVs were no 
longer in a “trial stage”—in 2002 well over a million people worldwide were on HIV treatment—
many tens of thousands throughout Asia, and even 50,000 in Sub-Saharan Africa, which lagged 
furthest behind.93 Treatment regiments were well-established after six years of use across the world, 
and had been quickly incorporated into HIV treatment programs in both the rich and poorer 
countries. And while the costs were not insignificant, the new Global Fund had launched that 
January to support ARV treatment costs and the country already had a major concessional loan 
from the World Bank that it was spending on HIV—just not on treatment.  
“Government, everyone knew that after 2000 the piece about how expensive it was, 
that was just an excuse. They just did not want to get stuck with the bill and they 
did not want to be forced to put more in the health budget. So they said we are still 
thinking about it but someday it will be affordable. How do you argue with that?” 
–Community based organization leader (Interview IN-13) 
 
 By 2001, roughly R10 billion ($225 million) per year was being spent on the AIDS response 
by government, international aid, and philanthropic sources—but almost none of it was going to 
treatment programs.  
 The decision was taken inside a classic policy monopoly made up of technocrats inside 
NACO, from other parts of the Ministry, and from the international financial institutions. These 
bureaucratic policy structures focused not only on the idea of cost effectiveness,94 but also on a 
narrative of “indigenization” of HIV medicine. The National AIDS Policy said it would “pursue all 
available means to encourage indigenous drug manufacturers to take up manufacture of 
antiretroviral drugs within the country”—ironic, since at the time those drugs were not only already 
                                                
93 UNAIDS n.d. 
94 In this they had an ally in World Bank staff, who issued reports backing the idea that treatment was not cost effective (Over et al. 
2004). That work was later discredited as both inflating the costs and underestimating the impacts, but helped maintain policy status 
by advising government to “proceed cautiously.”  
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available from Indian companies, but being shipped across the world to treat people living with 
HIV programs in countries with public-sector AIDS programs. The policy also included an 
extensive section on the use of alternative remedies that, when read in the context of the South 
Africa case study, are notable for their similarities to the arguments from the Minister of Health 
there at the same time—seeking “cost-effective alternatives to antiretroviral drugs.”95 Perhaps 
because it was wrapped in technocratic language and delivered by far more sober bureaucrats than 
Manto Tshabalala-Msimang, this push never received the attention that focused on the similar 
South African move, but stalled ARV roll out just as effectively.  
 
Breaking Policy Stasis—Rights & Democracy 
 
 There were numerous efforts to break the stalemate on HIV treatment.  There was 
significant public attention to the issue in the media—reports of people turned away from hospitals 
because they were HIV-positive, of the mounting death toll including young children who lacked 
access to treatment, and some on the disconnect between a robust generic industry offering ARVs 
to the world while Indians could not access them. Throughout all of this attention, however, the 
narrative of unaffordability went largely unchallenged. The generic company Cipla helped 
underwrite a public information campaign aimed at pushing for a government supported ARV 
program called “You don’t have to die of HIV/AIDS,” which included well-produced ads that aired 
in major TV markets.96 The effort generated significant attention, but not action, as NACO 
responded that the cost of drugs was not the only factor in a treatment program and citing 
diagnostics, human resources, and other barriers.  
 The issue was not one of party ideology since between 1996 and 2006 India had five changes 
of government with all of the ideological perspectives represented in the central government at 
                                                
95 National Aids Prevention and Control Policy 2002, 5.12.1. 
96 You Don’t Have to Die of HIV/AIDS 2001. Of course the ad campaign was also aimed at the small private market for ARVs and so 
served the economic interests of Cipla in multiple ways. See example add at https://www.youtube.com/watch?v=CfKcCu0L9Xo 
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some point. In addition, since health is a state subject any state could have taken the lead and 
proceeded with the aggressive HIV treatment program health leaders were urging.   
 A set of politicians did push for a bill in the parliament that could have replaced the more 
conservative AIDS policy with a broader long-term vision and framework. Introduction was 
repeatedly delayed however as jockeying between politicians derailed each effort. Drafting of a bill 
started in August 2002, inspired by an international policy conference held in Delhi and led by 
Kapil Sibal, Rajya Sabha MP. Civil society groups including the Lawyers Collective—a prominent 
legal and advocacy NGO—and networks of people living with HIV, mobilized input and support. 
It struggled to get attention and support, however—undermined by the negative stigma associated 
with HIV and burdened by various problematic proposals from politicians against which public 
health leaders had to push back. The question of ART was central in debates but NACO and others 
continued to suggest it was unaffordable which further hamstrung the process. People living with 
HIV and their allies largely lacked sufficient political power to ensure treatment was guaranteed, or 
that the bill was prioritized. Two years later, announcing that the bill was finally to be tabled, Sibal 
acknowledged the delay. “Undue delay in responding to the wakeup call will result in adverse 
consequences of unmanageable proportions,” he said.97 It never came. In fact, it waited 15 years 
until April 2017 before any HIV bill was actually passed.  
 
“Indian politicians, they are supposed to represent the people but the day they are 
elected is the last day they see us. It is impossible to meet them. Too much 
bureaucracy. We don’t have a large enough portion of the population in any one 
place to threaten their vote, so we are marginalized.” –PLHIV leader (Interview 
IN-08) 
 
 Indian people living with HIV (PLHIV) increasingly organized in this period—forming 
groups in Manipur, Delhi, and eventually throughout most of the country under the banner of the 
Indian Network of People Living with HIV (INP+) in the late 1990s.98 In 2001, these groups came 
together with other civil society organizations to launch a public campaign titled the “Affordable 
                                                
97 Draft Bill on HIV/AIDS soon 2004. 
98 Bhardwaj 2009. 
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Medicines and Treatment Campaign” (AMTC). The founding statement read “the right to life and 
health is a fundamental right, guaranteed to every person living in India and is non-negotiable.”99 
This framework helped mobilize not just HIV-oriented groups but also legal aid organizations like 
the Lawyers Collective and the Alternative Law Forum to support. The effort pushed for both a 
publicly-funded HIV treatment program and for the protection of space within the Indian 
intellectual property regime for generic AIDS drug production—which was threatened as India 
joined the WTO TRIPS agreement. Campaigners went on to hold public meetings in a half-dozen 
cities, put up information stalls in the main Mumbai railway station, held marches in Mumbai, 
Delhi, and Banaglore, a candle light vigil in Delhi with signs reading “Sirf rok tham adhuri hai, 
Chikitsa Bhi zaroori hai” (Only prevention is incomplete, treatment is also necessary), and a 
nationwide signature campaign. A similar campaign was launched in Tamil Nadu the following 
year led by advocates for orphans and children living with AIDS.  
 These pressures began to weigh on government, including the availability of external 
resources which they began to consider more seriously—but leaders remained concerned that any 
life-long AIDS treatment program would eventually fall on Government, which the Finance 
Ministry was reluctant to take on. In the 2002 budget statement the best the Minister of Finance 
would commit to was to exempt HIV drugs from the excise duty.100  
 Things began to change more quickly when the Courts began to engage. A set of PILs was 
filed by two organizations working with intravenous drug users—Sahara House in Delhi and 
Sankalp Trust in Mumbai—and wound their way slowly through the courts.101 Filed with support 
of the Lawyers Collective in 1998 and 1999, the cases were not originally about ART but instead 
sought to address the common denial of access to basic medical care due to their HIV status, 
arguing government needed to have a comprehensive policy on HIV.  
 
“People were just dying, we could see our clients just die. But government was 
delaying and delaying on really addressing anything besides prevention…. I think 
it was just apathy. And bureaucracy.”–Attorney (Interview IN-27)  
                                                
99 Divan 2002, 21. 
100 Budget Speech 2002-2003 of Shri Yashwant Sinha, Minister of Finance 2002, para 123. 
101 Sahara House v. Union of India 1998; Sankalp Rehabilitation Trust v. Union of India 1999. 
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 For years the case languished in procedural motions as the court was reluctant to set policy, 
and government issued a series of promises that it was working on a new policy.102 As the need for 
ARV treatment became increasingly within reach, however, the Supreme Court took note of the 
news and treatment campaigning. When the 2002 policy failed to address treatment, the Court 
began to push government—bringing members of NACO before the court and demanding 
affidavits about exactly what their plan was. A third PIL was filed by the Human Rights Law 
Network on behalf of the Voluntary Health Association in October 2003, which was joined to the 
initial petitions and added to pressure on government.103 One exchange from this time was 
particularly memorable:  
 
“There was a particular interaction with the Chief Justice, and it was a particularly 
rough exchange. But, we told the Chief Justice that this case is pending for quite a 
long time and the policy of the central government is to allow people to die. Then, 
we gave some rough figures. Then he turned to the other, to the attorney general, 
and he said, ‘put an affidavit in now from [Health Minister] Swaraj.’ They are 
making a very serious allegation, that you people have a policy of letting people 
die.”–Attorney (Interview IN-28) 
 
 Within a few months of this exchange Union Minister for Health & Family Welfare in the 
BJP led NDA government, Sushma Swaraj, announced a new policy aimed at providing free 
antiretroviral treatment to 100,000 people living with HIV in six high-burden states. The Indian 
government planned to provide treatment for 100,000 people in the first year, at a cost of 2 billion 
rupees (US$40 million). There are differing opinions about just how important the court 
intervention was in this decision—several of those interviewed for this project note that initial 
preparations were underway for some time.104 Political pressures from campaigners and a few high-
profile stories seem to have moved Minister Swaraj to act, surprising many.105 What all agree on, 
                                                
102 See, for example, the year after year of orders relisting the case at 
http://courtnic.nic.in/supremecourt/caseno_listed_1.asp?cno=535&ctype=3&cyear=1998&frmname=querycheck&petname=SAHARA 
103 Voluntary Health Association of Punjab v Union of India Ors. 20003. 
104 Interviewees each with direct knowledge of government thinking differed. One noted moves had already been undertaken to get 
funding from the Global Fund and the timing with the court case was incidental, two others suggested the Minister was very keen not 
to have her name tied to something the Chief Justice was implying was a “policy of letting people die.” Interviews IN-01, IN-42, IN-
41.  
105 Help for Benson and Bency 2003; Plan To Provide Treatment to HIV-Positive Mothers, Children 2003. 
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however, is that judicial engagement played a critical role in transforming this initial 
announcement into a true national program. The ART program did not reach 100,000 people—
instead a year and a half later the program was running in only a handful of hospitals and only 
10,000 patients were enrolled. The new Minister for Health & Family Welfare (now in the 
Congress-led UPA coalition) inexplicably reported to parliament that Government's goal had never 
been to treat 100,000 by 2005.106 
 The Supreme Court had not closed its case—instead it had continued it and re-listed the 
case every few months. When it became clear that government was still failing to fully implement 
its original plan, the Court stepped up the pressure.  
 
“I remember after the judges had all been quite happy about the initial plan, when 
we came in with our documented evidence to show them what was wrong with the 
program, and the denial of treatment in practice, they called in the head of NACO 
who was subjected to a bit of scathing criticism and a threat that the Minister would 
next have to answer.” –Attorney (Interview IN-25) 
 
 From there, the Court kept the case open and it became essentially a bargaining platform. 
At regular intervals government and the plaintiffs would come to court and make public arguments 
about how the ART program was functioning. By November 2005, the head of NACO was replaced 
by Sujata Rao who was widely seen as far more effective and who built the capacity and 
professionalism of the organization. She and her team increasingly used the Court as an 
opportunity for dialogue.  
“She's literally sat on our side and said, ‘Let’s take this from the top and say what 
are the things we need to do and what can we do before the next time in court…’ 
We were on opposite sides but Sujata Rao had this beautiful way of saying it so the 
government spoke to us and a lot of it was done without any animosity.”-NGO 
leader (Interview IN-13) 
 
 At this point the treatment program finally got underway in earnest—with a big jump in 
treatment numbers in 2006 that finally reversed the trajectory of AIDS deaths as seen in Figure 5.7 
above.   	
                                                
106 Jain and Stephens 2008, 3. 
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 Constitutionalization also facilitated intra-bureaucratic bargaining. NACO strategically 
used the Court’s intervention as justification to advance the ART program faster than political 
leaders might had planned or than the ministry of Finance preferred. The Court provided not just 
a reason but a venue, since it continued to monitor and issue periodic order, to continue to advance 
the policy over time. Federalism was a particular challenge as it is with many health issues in India 
since, while drugs were procured centrally, the program required staffing and other supports that 
were state responsibilities and not all wanted to make the investment.  
“We used it. Completely. We kept fighting with different parts that did not want 
[the ART program]—with Finance, with the states, who would be saying ‘no, no, 
no’ and I would say ‘lets use the case. We are doing this.’ 
 
In fact, we encouraged the whole dialogue with Supreme Court so that if any state 
does not give ... since it was not an adversarial, it was political.  We needed to get 
state governments on board. We insisted that the Secretary of Health must 
constitute a committee at the state level where he periodically once a month or 
once in three months to review what the Court had ordered.” –Former Senior 
Health Official (Interview IN-01) 
 
This is not to say, however, that NACO and activists were in agreement or that NACO became 
immune to the bureaucratic inefficiency and conservativism that mark other parts of the state. Over 
the course of the years that followed, a series of issues came up including the expansion in the 
number of treatment centers, use of newer drugs, introduction of earlier treatment, and 
programming to address the living conditions of people living with HIV. Some NACO agreed with 
and Court orders proved helpful in overcoming resistance in other parts of the state. In other cases, 
NACO officials resisted change and build strong narratives that justified their stance. Second line 
treatment—providing an additional set of drugs for those who, in the normal course of disease, 
developed resistance to their first drug regimen—was the most prominent example that became 
central in the cases as activists pushed for what was widely recognized as standard practice but 
NACO leaders felt was beyond the system’s capacity. In the end a negotiated solution was reached 
at the behest of the Supreme Court to this and other issues and the plans were entered as orders.  
“You could really see that every time the Court heard the matter and submissions 
were made, someone in the government obviously in the AIDS program was 
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reading them, and said, ‘Okay, now we have to adapt the guidelines because when 
we go to court we have to say that we could respond to the problem by this and yes 
we have a real plan. You want the court case to go away, so just move faster... we 
kept moving the goal posts and we finally had the power…”—NGO Leader 
(Interview IN-43) 
 
 Indeed, the official National AIDS Policy was, for the first decade of the ARV program, 
never as science-based or comprehensive as the set of agreements reached in these negotiations and 
enshrined in court orders from the Supreme Court.  
 The unregulated private sector came into the picture too. Both NACO and the PLHIV 
groups agreed the private sector was presenting a problem—offering poor-quality services, 
prescribing ARVs in combinations that were more profitable but that did not work and produced 
drug resistance, and allowing quack remedies. Despite a push by NACO, there was huge resistance 
to formal regulation and the Ministry could not be moved to act against the powerful private 
physicians sector opposed to regulation in all forms. 
 
“Then standard protocols and all were developed, but we haven’t built a system 
where you can legally enforce them. It is still very much professional organization, 
self-regulation, that kind of a thing, but there is no legally enforceable regulation 
where we can penalize you for not doing it. We were hamstrung, but we had this 
opportunity at the Supreme Court.” –Former Senior Health Official (Interview IN-
01) 
 
 The Supreme Court ordered the Medical Council of India to immediately disseminate and 
enforce NACO protocols for treatment programs in the private sector—directing the Council and, 
if not, then directing the Consumer Courts to “take a strict view of private practitioners who take 
advantage of the illiteracy and poverty to prescribe wrong or unnecessary medicines or charge 
exorbitant amounts.”107 According to a senior official, “The private sector complied immediately. 
We found a lot of patients shifting from the private sector into the public and, if they did treatment, 
private sector treated them ethically or they were actually threatened and punished.” (Interview IN-
01). 
                                                
107 Ibid., 58. 
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 Finally, the Court also waded into federalism to address the huge challenges there. PLHIV 
had low political power and were rarely able to move politicians—which meant that at state level, 
where implementation happened, they were low-priority and NACO officials were not able to call 
on strong political backing to push recalcitrant states to act. For example, PLHIV in several states 
regularly reported that they were denied treatment on the grounds that equipment was not 
functional while in other states healthcare workers refused to give injections to PLHIV because 
“post exposure prophylaxis” or PEP was not available for cases of needle sticks. The Supreme Court 
issued orders addressing these pieces and ordered states and NACO to separately report back on 
progress on each—which gave NACO and PLHIV networks far more leverage and sped policy 
change at that level.  
 By 2008, 172 HIV treatment centers were functional and new second-line drugs were being 
brought into the program. Funding to the HIV program had grown both from the government of 
India and from international sources such that treatment programs were no longer restricted. The 
Court did eventually close the case and issue final orders and, in so doing, the effect of having the 
Court as a venue for health policymaking has actually become quite obvious to some HIV 
advocates.  
 
“For example, I know the drug Dolutegravir to be so much better than Efavirenz. 
And I'm like, my god, this is so much better than having to put people on treatment 
that you know will fail in 5 years, and so on. We want to move that goal posts, but 
we can't. We don't have the court case to move the goal posts with and we have to 
present our arguments to bureaucrats who can act as slow as they want. Of course, 
they’re still a little worried we will go back to court, so they still take us seriously. 
We’ll see, maybe we go back to court or maybe we just threaten…” —NGO Leader 
(Interview IN-43) 
 
Courts, Activists, and AIDS Treatment 
 
 The interplay between political freedoms and constitutionalization of health is on clear 
display in case of HIV treatment in India. The legislature, for all intents and purposes, never acted 
on HIV treatment. Meanwhile civil servant policy entrepreneurs in favor of treatment inside 
government had a hard time breaking through the powerful technocratic arguments about cost. 
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Constitutionalization created an environment that brought together networks of people living with 
HIV with rights groups to frame demands for treatment as a constitutional right in both public 
campaigns and in court filings. The Supreme Court in this case perhaps most clearly embodies the 
idea of a venue for policymaking. It is not that the Court is “making” policy per-se, but instead it is 
providing a platform for discussion while putting its legitimacy behind action over inaction. This 
empowered activists who had been stymied by limited political power as well as a set of health actors 
within government vis-à-vis their more reluctant counterparts, who together took apart the existing 
policy monopoly and, in the course of a few years, transformed the HIV policy landscape in India.  
 Khosla makes a key observation about the way in which the Supreme Court’s 
socioeconomic rights jurisprudence takes, as its departure point, the policy and programs 
government actually puts forward—arguing the Court makes social rights like health “conditional 
upon the nature of state action undertaken.”108 We can see important echoes of that here—the 
Court did not act for several years, while government prevaricated about HIV treatment with no 
policy. In the framing and the asking, however, I would argue it was less that the right was 
conditional than that the court itself was more venue than adjudicator. Rather than ordering 
particular policy, the Court forced government to justify its choices, demanded information, and 
provided an opportunity for a group with limited political power and clout to demand action. 
Constitutionalization engaged rights actors and provided a framework in which a decision to “allow 
people to die” was not legitimate. Of course, in reality all health policy includes weighing competing 
priorities and some people will die. But as an idea, the rights framework in this case forced 
Government to defend its choices and, in that way, moved an issue that had been bureaucratized 
into one of public politics. Bargaining over policy, of course, continues. In 2017 the NDA 
government passed the long-lingering HIV bill that includes a robust treatment commitment, 
including a policy change allowing immediate treatment for all PLHIV (rather than restricting it to 
only the sick)—placing India as a leader in HIV treatment policy. While it is not possible to identify 
                                                
108 Khosla 2010. 
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the exact contribution of constitutionalization to these decisions, some of the same players who 
scoffed at an ARV program in the early 2000s today frame access to ARVs as a core right.  
 
Clinical Trials 
 
 Another recent area where constitutional rights have been central in the policy debates is 
the issue of clinical trials. There, however, the picture has been far less clear—exposing the 
limitations of judicial constitutionalization.   
 Starting in the 1990s, pharmaceutical companies began to “outsource” clinical trials from 
the U.S. and Europe to the rest of the world, both because of an increasing need for research subjects 
and the increasing cost and regulatory environments.109 India has been a significant destination for 
this “globalization” of clinical trials by multinational companies (MNCs). It is particularly attractive 
given the large, genetically diverse population who have not been exposed to many medications 
and the large burden of diseases from infectious to chronic. Meanwhile, a large pool of English-
speaking physicians, many of whom trained in the US or UK, is available and the costs are a fraction 
of what they would be in the U.S. or Europe—less than one tenth.110 Multinationals came to see 
India as an appealing location, particularly after India joined the WTO and began protecting 
product patents in 2005. The Indian government saw potential to both position the country as 
leader in drug discovery and to help drive economic growth through what the Planning 
Commission in 2006 identified as a $60 billion industry, of which India had just $ 100 million but 
could grow at the rate of 80% per year.111 Government thus introduced a series of legal measures to 
facilitate access to MNCs, including cancelling the 12% service tax on clinical trials and amending 
Schedule Y of the Drugs and Cosmetics Act of 1945 to make trials easier to conduct. 112  
 Public health leaders, however, expressed concern as large clinical trials—sponsored by 
both multinationals and local Indian companies—rapidly expanded without what they saw as 
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sufficient safeguards.113 Press reports regularly came to support this view. In 2008 alone, the deaths  
of 49 children were linked to a nutritional supplement study in Delhi;114 the drug company Wyeth 
was revealed to be violating study protocols by recruiting children with serious illnesses for a 
pneumonia vaccine study when one died in Bangalore; 115 and a young man making his living off 
clinical trials in Hyderabad died from effects of a blood pressure medicine under study.116 It was 
argued by advocates that these represented just the “tip of the iceberg” (Interview IN-02). Given 
limitations in records it is nearly impossible to tell with certainty what portion of these or any other 
deaths while in a clinical trail were caused by the trial itself. As noted, Indians face high mortality 
risks overall and those engaged in many trials are explicitly seeking treatment for illness and thus 
are at higher risk. That said, there was plenty of evidence that at least some trial participants were 
being given drugs and other treatments of suspect quality, were not properly screened and 
monitored, or were subjecting themselves to harm in the service of quack medicine.  The point is 
that, in the largely unregulated environment of the time, it was essentially impossible to know what 
portion of trials were well-run and which represented reckless experimentation on human beings 
that not only harm participants but provide questionable evidence for the treatments they are 
supposed to evaluate.  
 Clinical trials, by their nature, include a trade-off between elevated risks for participants 
and the potential for benefit to both the participant and the wider community if the treatments are 
successful.  Protection from harm is never absolute but is supposed to come through three channels: 
government regulation, within-study ethics review, and a system of compensation that incentivizes 
trial sponsors to protect the safety of participants.117 In the context of the time, however, none of 
these functioned properly. Prior to 2005, the main regulatory hurdle was the requirement for a 
“phase lag” in trials of drugs and other interventions developed outside India, which ensured they 
showed some level of efficacy and safety before they were brought to India. Phase 1 trials were only 
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allowed for drugs developed fully in India. In India’s weak regulatory environment and limited 
capacity to monitor, this acted as a check that in part outsourced the regulation to foreign 
environments. When this requirement was lifted in 2005, little regulatory infrastructure was in 
available to replace it. While the Indian Council of Medical Research had put out guidelines, there 
was no legal requirement to follow them, to sufficiently train researchers in good clinical practice 
(GCP), or to fully register trials and ethics reviews. The Drugs Controller General of India (DCGI), 
responsible for monitoring trials and reviewing complex protocols had just five qualified staff as of 
October 2008.118 While state governments had responsibility for the public health system where 
much of the research was happening, they had no authority to regulate research trials. The Indian 
Council of Medical Research (ICMR) set up a Clinical Trials Registry but there was no legal 
requirement to register trials. In the broader context of poor quality, under-resourced public health 
system and patients desperate for better-quality affordable care, there was particular concern as 
private contract research organizations (CROs) set up shop in the public sector offering free 
medicines and potential cures.119 The requirement for internal ethics review was similarly weak. In 
theory all trials needed to be subjected to evaluation by a local ethics review committee (ERC) at 
each site that met international standards. In practice, however, there was no central register of 
these ERCs—many were never set up properly, members were not sufficiently trained, and little 
support was provided to conduct thorough reviews.  An ICMR survey found that only 40 of 179 
institutional ethical committees follow the legal provisions to avoid conflict of interest and properly 
use ethical guidelines.120 There was also no mechanism to prevent a protocol rejected by a an ERC 
from simply being submitted to a different, more friendly ERC. Finally, the last check in the system 
to incentivize good practice is a compensation system, yet the self-regulating system was largely 
non-existent—of several thousand deaths between 2007 and 2010 just 22 were compensated and 
those only after MP Maneka Gandhi probed the matter.121 Essentially no real regulatory or legal 
action was taken against any company, committee, or sponsoring organization before 2012.  
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 Activists documented widespread violation of ethical standards, lack of informed consent, 
conflict of interests among physicians who recruited their patients into trials, and too many 
incentives for low-quality trials and low-quality medicines to be tested. Participants who had been 
harmed or misled in clinical trials submitted hundreds of complaints through various government 
agencies with no follow up.122 
  Despite significant media attention, the issue was very low on the priority list of the 
government of the time, which was focused on incentivizing trials. Activists and public health 
leaders began raising concerns in the late 2000s as the explosion in the number of clinical trials and 
reports of ethical violations increased, but struggled to get attention.123 Basic information about 
how many people were dying in trials was unavailable and responsible parliamentarians were 
largely unconcerned. This changed in 2010, when deaths of seven girls in a massive Gates 
Foundation-funded trial of HPV vaccination by the NGO PATH sparked a media frenzy and 
allegations that the group had not followed proper ethics and consent procedures. The case was 
hugely controversial with both sides claiming the moral and public health high ground—activists 
and parliamentarians citing ethical lapses that treated the rights and health of poor, rural girls as 
unimportant, and questioning the motive of pharmaceutical MNC co-sponsors, while PATH and 
Gates accused their critics of ignoring the huge potential value of the HPV vaccine.124 What is quite 
clear is that Parliament’s response was ineffective—a series of reports and hearings featured a 
questionable understanding of science but also effective fact-finding and dramatic rhetoric.125 A 
scathing report of the Standing Committee On Health and Family Welfare provided evidence of 
illegal collusion between drug companies, CROs, and physicians to skirt safety rules in clinical trials 
and drug approval processes—but resulted in little action.126 Government seemed to be living up to 
its image as a “flailing state.”127 
                                                
122 Clinical Trials: Regulating Chaos 2012. 
123 Sunder Rajan 2007; Bhatt 2004. 
124 Shetty 2011; Bagla 2013. 
125 It’s a PATH of violations, all the way to vaccine trials: House panel 2013. 
126 Department-Related Parliamentary Standing Committee On Health And Family Welfare 2012. 
127 Pritchett n.d. 
Chapter	5:	India	
	
	
255	
 A number of civil society groups responded by filing a set of PILs on the basis of the 
constitutional right to health. The most significant of these was filed by Indore-based NGO 
Swasthya Adhikar Manch (SAM) in 2012 with support of legal aid organizations.128 
 
“After all the campaigns and media, the Parliament took it up, but it was just talk, 
there was no substance. For that, to really get their attention, that took the court.” 
–NGO leader (Interview IN-02) 
 
  The court demanded information from government and, in an affidavit submitted by the 
Ministry of Health and Family Welfare, they revealed that they had only analyzed the data upon 
the court’s request. It showed at least 2,868 people died in clinical trials between 2005 and 2012—
of which 89 were definitively linked to the trial, but with limited information to ensure whether 
most of the others were related or not. This finding was widely covered in the media, sparking 
further outrage. Through a series of hearings, the Court pushed government for action rather than 
further committees, delays in regulation, and promises to respond to the court after further 
consideration. “You can get back to the court but what about those people who are losing their lives 
in such clinical trials. People who lost their lives can't get their lives back,” the Bench observed in 
one interaction.129  
 There were seven different hearings over the year, with the Court expressing increasing 
frustration over the failure to regulate. “You have to protect health of citizens of the country. It is 
your obligation,” the court pleaded.130 After several months of back and forth, the Supreme Court 
finally made good on a threat it had issued and banned all new clinical trials in the country in 
January 2013. It issued a series orders that put all drug trials under the direct supervision of the 
Union Secretary for Health and ordered that a new regulatory framework be developed before any 
further trials be approved. It later put 162 existing trials on hold, exempting those explicitly 
approved by the Ministry. The Court also directed the Ministry of Health and Family Welfare to 
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organize a meeting of all state-level Secretaries to discuss the legal framework for strengthening the 
regulation of clinical trials.  
 This sent a shockwave through the research community and was covered in media around 
the world.131 Building on the perception from the HPV trial that India was not a welcoming place 
for biomedical research, a ban was a very blunt instrument that was easily attacked by industry as 
out-of-touch on the value of medical research. However, it did get ministry’s attention and they 
finally responded—issuing new policies within two months and then passing a series of new 
regulations in 2014 for patient consent (including audiovisual recording of consent), patient 
reimbursement, and adverse events, and issued a directive that clinical trials could only be carried 
out at accredited centers. In March 2013, the DCGI set up an expert committee to examine reports 
of deaths in clinical trials, and further rules have been put in place requiring stronger independent 
ethics committees. The government also began regulating compensation to those who experience 
adverse effects rather than leaving it up to the companies.132 
 For public health, this has been largely positive. It is difficult to know exactly how the new 
regulations have affected the safety of clinical trials because there is not reliable data before 2013 on 
which deaths during clinical trials were actually linked to the trial rather than due to unrelated 
causes.133 Based on data released through a right-to-information request, year-on-year the number 
of total deaths among those in clinical trials does seem to have fallen from 670 in 2010 to 443 deaths 
in 2014, and 302 deaths in 2015.134 Of course, these numbers provide only very weak evidence given 
we lack causal connections. Deaths in clinical trials also reflect a tiny fraction of mortality in India 
but the indicator is a harbinger for the safety of the drugs regulation system as well since poorly-
run clinical trials have been directly linked to major safety problems and poor-quality drugs in both 
the public and private sector.135 Perhaps equally important, the regulations triggered by court 
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intervention also seem to be helping to rebuild a more robust clinical trials environment in the 
country. The number of clinical trials conducted in India dropped precipitously before the Supreme 
Court ruling—with industry and international funders pulling back from the country after 2010 
when 500 trials were conducted to fewer than 50 in 2012 due to uncertainty about both the quality 
and regulatory environment after the HPV trials scandal.136 Since then, trials have grown back to 
several hundred with continued growth predicted.137 This reflects a return of several major industry 
players and, tentatively, of funders like NIH, and improved quality of trials overall as the lowest 
quality have largely not returned. It was, to say the least, a less-than-ideal way to reach a point of 
regulation—undermining the credibility of India’s scientific community in the global imagination. 
The Court, however, had few tools at its disposal after cajoling, and more limited orders had failed. 
There are also concerns among some that the improvements in regulation and quality will not stick. 
With the Supreme Court less engaged and health rights not reflected in any of the core regulatory 
documents, many public health advocates have raised concerns that these changes will be 
increasingly watered down in practice.138 Together, this case thus illustrates both the power of 
constitutionalization and the limitations of judicially driven instantiation—where courts drive 
without backstop from other branches, reform is both harder and more tenuous.  
 
Rights & the National Rural Health Mission 
“The early cases were all about a certain urgent medicine or what you should have 
access to if you are covered under a government insurance of a certain kind. Okay 
fine. But it got translated into some kind of a political demand during the push for 
National Rural Health Mission saying you must define the package of service under 
the right to health…” Physician/Public Health Leader (Interview IN-14) 
 
Constitutionalization also played a part in the initiation of a set of the National Rural Health 
Mission (NRHM) through the rise of a set of health rights organizations and hearings by the 
National Human Rights Commission (NHRC). Founded in response to the failure to achieve the 
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Alma Ata declaration goal of “health for all by 2000,” the umbrella organization Jan Swasthya 
Abhiyan (JSA; people’s health movement) was created at an assembly in Kolkata of over 2,000 
health activists from nineteen states representing physicians and health worker groups, NGOs 
providing health services, feminist and science-based policy organizations, and trade unions.139 The 
group highlighted the deterioration of public health services and stagnated budgets through the 
1990s, as well as the sharp rise of the unregulated private sector. A few years later, in September of 
2003, the group launched the “Right to Healthcare Campaign” out of a national consultation held 
in Mumbai where Justice AS Anand, chair of the National Human Rights Commission, spoke to 
the assembled health leaders. 
 
“There was an openness and then we thought let us bring in our Constitution 
because you could see the collapsing of the public health systems has already 
started. The structural adjustment programs had opened the doors for the new 
economic policies that focused on private health over public. We thought let us use 
this opportunity how we can push government to stay in the public health [sic].” –
Health Activist (Interview IN-03) 
 
The group organized a series of Jan Sunwais or “health tribunals” to test the idea of documenting 
denial of access to services as a rights violation—holding events throughout the country from 
Adivasi areas to Bangalore. These “let hundreds of ordinary people testify about what they faced in 
the health sector and gave us a new way to talk about things through a violations lens. It worked 
quite well.” (Interview IN-02). JSA formally requested the help from the NHRC, which agreed to 
support a series of hearings the following year including funding of Rs. 834,000 (about $19,000) 
and using the convening power of the commission.140  Shortly thereafter, the UPA government 
came to power with support of the left, though without a particularly clear vision for what the 
government would do on health. There was nothing resembling what became the NRHM, for 
example, in the Congress elections manifesto and the Prime Minister, Manmohan Singh, had 
previously presided over significant disinvestment in the public sector as finance minister in the 
1990s. The hearings took on a different tone in this context, however, because there were factions 
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in government who were both interested in rights and committed to a reinvigorated public health 
sector. On the other hand, there was a clear push both by international aid agencies and by many 
within government to continue the focus of many years on narrow investments in reproductive and 
child health (RCH) along with certain vertical disease programs. Indeed, this was the first proposal 
developed by the Ministry in 2004. 
 
“You had the UPA government having the Common Minimum Program where 
one of the things that they said is that they would increase health care expenditure 
to two to three percent of GDP... Now when called upon to actually act on that 
promise the initial predilection was to do the minimum, to just leave an RCH 
Program. But there was an opening with the Sonia Gandhi faction who stood in 
favor of investment in the social sector and so we were active on many fronts trying 
to influence and the stamp of the Human Rights Commission helped…” –JSA 
leader (Interview IN-37) 
 
 Four regional hearings were held between August and November, framed around the idea 
of documenting “denial of the right to health care” with 200 people from every state testifying and 
a host of local politicians attending. In December 2004, a national hearing was held in Delhi which 
managed to attract far more political attention to health as a right than any previous gathering, 
especially in a context of strengthening of the public health sector. It was attended by the Union 
Health Minister, Anbumani Ramadoss along with the NHRC chair Justice Anand, the Union 
Secretary for health and the health secretaries from most of the states.141 
 The hearings did several important things. First, they framed health in the context of the 
constitution and rights, which indicated a particular obligation of the state to both provide and 
regulate healthcare. Second, they focused clearly on the public sector and revealed in human terms 
how the failures of the system as a whole were driving poor outcomes—far beyond interventions 
that could be fixed by vertical programs or limited intervention—which helped broaden the vision 
of the policy change needed outside of what was originally imagined by the Congress. Third, it 
added the clout of the Human Rights Commission—which, while not particularly powerful, is 
headed by a former Chief Justice of India and brings a not-insignificant sense of political 
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legitimacy—to this broader focus on public sector health reform. The NHRC produced a set of 
recommendations for a “National Action Plan to Operationalize the Right to Health Care.”142 The 
plan called for delineating essential health services and strengthening the public sector to ensure 
quality and availability, integrating national health programs into a broader primary health care 
system reform, implementing a universal community health worker program, building a system of 
monitoring of health services to document realization of the right to health, creation of a Charter 
of Patients’ Rights at the local level to increase transparency and accountability on what is supposed 
to be provided and what is to be free, and other key concepts. 
 When, in 2005, the UPA government announced the National Rural Health Mission it 
moved actively away from the original idea of simply building out RCH programs and instead 
focused on many of the priorities identified through the NHRC/JSA process. The NRHM vision 
focused on provision of quality healthcare to rural populations throughout the country, beginning 
with a focus on 18 states which had weak public health indicators and infrastructure. To be clear, 
there were multiple pressures and processes that shaped the NRHM including active engagement 
from left political leaders in the ruling coalition and a wide set of expert committees. The claim here 
is not that the rights hearings were definitive. Government officials interviewed, however, directly 
credited the right to health hearings with opening space for broader thinking and 
constitutionalization of health broadly with increasing the opportunities to focus on strengthening 
the public health sector.  
 
“We used [the right to health] extensively to explain to people inside why we 
needed to build the NRHM in the way we did, looking to the Court cases like the 
one from West Bengal to overcome objection and explain why it needed a base set 
of essential services and new accountability structures.”—Former Senior Health 
Official (Interview IN-36)  
 
Looking to the NHRM Framework for Implementation seems to bear this out. The document 
explicitly recognizes the constitutional right to health as “brought out” by the relevant rulings of 
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the Supreme Court. “Therefore, providing basic Health services to all the citizens as guaranteed 
entitlements will be attempted under the NRHM.”143 It is notable that this was hardly the consensus 
view in government—as one senior official from the time told me directly: “right to health is not a 
part of the constitution.”144 Yet it runs nonetheless through the document this official had to sign 
off on, including a long list of examples of, taking the frame of the hearings, as “denial of the right 
to healthcare” experienced by Indians in the public sector.145 This is used as a basis to justify a variety 
of policy moves that were also controversial within the bureaucracy including identifying specific 
core packages of services, requiring local patients’ rights charters, supporting community based 
monitoring, etc.  
 While the NRHM failed to achieve quite a few of its targets on time, it has been widely 
praised as one of the more effective health initiatives in India in recent decades.146 Several 
components called for in the NHRC hearings (as well as elsewhere) have proven effective (though 
in need of improvement) including wide expansion of Accredited Social Health Activists147 and the 
Village Health Sanitation and Nutrition Committees, Patient Welfare Committees, and community 
monitoring mechanisms148 have increased not just service delivery but accountability in rural health 
settings. Overall the program was shown to increase utilization, quality, and equity.149 That said, in 
many ways the program has proved better at diagnosing the problems than ameliorating them—
public health spending has increased but remains well below what is necessary and and, after a 
decade, little of the rural public health infrastructure has reached a level of quality service delivery 
where it can radically shift the public-private dynamic. Like many programs implementation is 
uneven geographically and it is not yet clear how the new health policy will affect progress. As 
incremental change, though, NHRM stands out as clear progress and constitutionalization helped 
in that achievement.   
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 Leaders in the NRHM inside government who found the health rights framework useful 
also tried to build on their success and use the Constitution as a reason for action in building a 
wider Health Bill which, as described below, was released in draft in January 2009, but never acted 
upon.  
 
“We almost got away with it in justifying why we needed a bill.	We had legal experts 
on it. We had paid people to get a viewpoint on that. But…” Former Senior Health 
Official (Interview IN-36) 
 
 On the NRHM, however, constitutionalization helped provide a key framework and 
opportunity to engage new actors—bringing the human rights commission into health policy, 
providing the Jan Swasthya Abhiyan with an opportunity to shift venues, and buoying the idea of 
public sector investment with additional reasons for action. A handful of key NRHM provisions 
can be traced back to this process. That said, it also shows the implications of limited health rights 
institutionalization in India since, as described more below, the framework met its limits at the end 
of the UPA-1 government when macro political forces undercut the rights-based push.  
 
Other Health Issues: From Affordable Medicines and Maternal Health to the Health Bill That 
Wasn’t 
 In total, at least eleven different policy processes in India have seen significant mobilization 
of the right to health across the last two decades. These ranged from HIV treatment where, as 
described above, the effect was clear and large, to the issue of drug pricing where rights mobilization 
has struggled to have an impact. Below, I briefly touch on a set of these further issues to highlight 
the ways in which they tell us about different aspects of constitutionalization.  
 
Medicines 
 Three issues on medicines highlighted the complexity of constitutionalization and the 
varying impact it has in India. India is often referred to as the “pharmacy of the world”—home to 
the world’s largest generic drug industry, which supplies both the global North and South with 
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(mostly) high quality generic versions of key medicines.150 This is a sea change since the 1970s, when 
India had among the most expensive medicine prices in the world. Then-Prime Minister Indira 
Gandhi made building a domestic industry a national priority and the pre-World Trade 
Organization patent system enabled the industry to reverse engineer a wide range of medicines. 
Today the industry is one of India’s most important—accounting for 20% of the global drug market 
and slated to cross $20 billion in exports by 2020.151 In a context of a highly privatized health sector 
with low regulation and low public-sector investment, generic drug production has a complicated 
effect on health. On the whole, availability of low-cost, quality drugs has helped blunt some of the 
deficits of the health system by enabling Indians to access medicines that are often unavailable in 
other low- and middle-income countries.152 While it is nearly impossible to disentangle a particular 
effect, affordable generic medicines have helped enable the limited public sector budgets to go 
further than they would and out-of-pocket access to a greater portion of the population than in 
many other countries.153 Lack of regulation of the Indian Pharmaceutical industry, however, has 
undercut this benefit. Constitutionalization has played a part in how each of these policy processes 
have played out—helping ensure the continued availability of generic drugs, but having far less 
effect on struggles to ensure drugs are truly affordable for the poor and to address dangerous and 
“irrational use” of medicines.  
 The Indian system of drug production depends significantly on the national patent system. 
Since liberalization, the government itself plays little role in direct production, but private 
companies that grew out of the initial public investment now compete on the international market. 
Following a broad consensus at the time that monopolies on medicines and other essential goods 
were not in the public interest, the 1970 Patent Act provided for patents only on processes but not 
products, meaning reverse engineering medicines could be encouraged. The multinational 
pharmaceutical companies (MNCs), of course, opposed the policy and succeeded in their own bit 
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of venue shifting to make patents into a trade issue in WTO negotiations over the objection of 
Indian negotiators.154 Seeking to protect both industry and health budgets, India strategically 
adopted the “flexibilities” allowed under WTO rules as it revised its patent laws to comply, seeking 
to maintain as much space as possible for continued generic production. Section 3(d) of the new 
patent law, the most strongly opposed by multinationals, requiring new drugs to show increased 
“efficacy” to get a patent, which undercut a key MNC strategy of seeking new patents for new uses 
and cosmetic changes to a medicine. Generic companies and several of the key health rights 
organizations have since used those flexibilities to challenge pharmaceutical company patents on 
drugs for HIV, cancer, and other diseases. MNCs, for their part, have made overturning these 
provisions a key political priority—lobbying up to the level of the prime minister, lining up rich 
country governments to pressure India for change, and using litigation.  
 Constitutionalization mattered on two fronts: First, it had had enabled the rise of new set 
of alliances between legal aid organizations and PLHIV groups linked to an international treatment 
activist movement that were key in pushing to keep the flexible laws. In much of the rest of the 
world the ideational frame used by the MNCs—of innovation and advancement in the service of 
public health—has been very effective in justifying very liberal patenting of drugs.155 In India, 
however, groups like the HIV/AIDS Unit at the Lawyers Collective developed legal expertise in 
intellectual property while PLHIV groups and Doctors Without Borders/Medecins Sans Frontiers 
mounted a strong public lobby, backed by this legal expertise, to push a different framework focused 
on the public health benefits of limiting patent rights and the “TRIPS compliant” laws India had 
enacted. These arguments carried the day in both court and with government.156 That the Indian 
government has not (yet) acceded to such significant pressure is surprising—especially so in an era 
of increasing buy-up of Indian generic companies by MNCs, which has undercut the political 
power of efforts to maintain the current law. Beyond the alliance of groups, however, 
constitutionalization has provided an important legal basis for the current laws.  
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 The key test of this came when the Swiss pharmaceutical company Novartis brought suit 
against the Indian government for denying its patent on a highly profitable drug—
Gleevec/Imatinib used to treat leukemia. Strong mobilization by health rights groups was critical 
to raising the profile of the case and setting out a framework of debate that centered on health—
notable because this was led by PLHIV groups even as the case dealt with cancer, not HIV.157 
Meanwhile, the Lawyers Collective was admitted as amicus curiae to argue on the side of 
government. This turned out to be critical as weak representation of government meant at various 
times the case was in danger of being lost, but Lawyers Collective mobilized a key set of arguments, 
respected expert testimony, and submissions from public health leaders around the world. This 
included strong argumentation that Section 3(d) had to be read in the context of the constitutional 
right to health. The Madras High Court agreed in a decision upheld by both the Supreme Court 
and the Intellectual Property Appellate Board:  
 
“We have borne in mind the object which the amending Act wanted to achieve 
namely, to prevent evergreening; to provide easy access to the citizens of the 
country to life saving drugs and to discharge their constitutional obligation of 
providing good health care to its citizens.”158  
 
 While the final Supreme Court case which upheld India’s patent law turned on a series of 
highly technical matters, there is a strong argument it would have turned out quite differently 
without both the jurisprudential bases of the right to health used early in the case and the 
institutional capacity built out directly in response to constitutionalization.159  
“Now with the Supreme Court judgment it's been made very clear that health and 
the constitution cannot be separated from IP [intellectual property], which would 
not have happened without Anand Grover [of the lawyers collective] and others. 
That makes Indian unique and makes health a consideration where it often is not. 
The pharmaceutical companies worked hard to ensure otherwise, to keep it unclear 
and technical and out of the public, but now there is clarity.” –Senior Government 
Official (Interview IN-38)  
 
                                                
157 HIV+ People and Health groups Protest Outside Novartis Headquarters 2012. 
158 Novartis AG v. Union of India & Others 2006, para 19. 
159 Analyzing the case see, e.g. Grover 2013; Chaudhuri 2013; ‘t Hoen 2013. And see Gostin and Sridhar 2014 arguing this is an 
example of the balancing of different norms of rights and IP inside health law.  
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 In two other areas, however, constitutionalization has had arguably little effect. I argue this 
is because the venue shifting that has occurred has resulted in only very weak new allies to public 
health and that the nature of the program is so complex that judicially-driven constitutionalization 
reaches its limits.  
 First is the issue of regulation of dangerous and “irrational” drugs. The flip side of the 
ascendency of the pharmaceutical industry in the Indian context has been a continued lack of 
effective regulation, which has led to a proliferation of medicines that are have either unproven 
efficacy or have been shown to be actually dangerous. This has been an issue that has concerned 
public health activists and experts for decades. “It is the never-ending saga of a state that simply 
refuses to use its considerable power to protect the health of citizens,” as one health leader put it 
(Interview IN-18). 
 In 2012, a scathing Parliamentary report found that regulation had for “been according 
primacy to the propagation and facilitation of the drugs industry, due to which, unfortunately, the 
interest of the biggest stakeholder i.e. the consumer has never been ensured.” As many as 85,000 
different formulations are available in India, many of which have never received central approval 
for marketing.160 By comparison there are fewer than 500 drugs on the WHO’s essential medicines 
list.161 “Fixed dose combinations” (FDCs) of multiple drugs in one pill have been of particular 
worry. While many FDCs are safe and helpful to patients, like those in HIV that reduce large pill 
counts, others are ineffective or dangerous due to drug interactions or potential to compound side 
effects.   
 This issue too has been taken up extensively by legal mobilization including a set of 
campaigns by groups like the All India Drug Action Network (AIDAN), the Drug Action Forum 
in Karnataka, and others. A series of PILs dates back to the early 1980s when Vincent 
Panikurlangara asking the Supreme Court to break a political stalemate and order the government 
to use its powers to ban “harmful and injurious” medicines.162 While the Court issued a decision 
                                                
160 Chaudhury 2013. 
161 WHO 2017. 
162 Vincent Panikurlangara v. Union of India and Ors n.d. 
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that would lead to recognizing health as a right, it largely declined to force the state to ban particular 
medicines. A campaign followed by women’s groups focused on dangerous (but profitable) 
prescription and sale of high dose estrogen and progesterone in which a PIL triggered a series of 
Supreme Court-ordered regional public meetings and eventually a series of Supreme Court and 
High Court orders banning the product. However, in the absence of an effective communications 
and surveillance system, sales continued for years.163 In 1993 another PIL was filed by a set of NGOs 
that again sought an order for state action on irrational drugs after an advisory committee had met 
for 2 years without any success in advancing the issue. The case was heard over the course of 8 years 
and many drugs were banned under the direction of Chief Justice J.S. Varma—and these bans 
proved more effective and did pull dangerous drugs off the shelves.  
 But in many ways, it proved a drop in the bucket. The 2013 Choudhury Committee report 
found that many of the 85,000 formulations available in the country should not have been allowed 
on the market and that many banned drugs were still available. A 2015 study showed while most 
diabetes drugs were approved for sale, 69% of anti-depressants and 28% of pain relievers sold were 
not centrally approved, and pills including internationally banned/restricted drugs made up 12% 
of pain reliever sales.164  
 Most recently government has finally stepped in more aggressively on the issue—banning 
344 fixed-dose combinations deemed irrational or unsafe. In a deeply unfortunate turn of events, 
however, the High Court stayed the governments regulation at the behest of multinational 
pharmaceutical companies—undermining what small bit of progress seemed to have been made by 
the judiciary in addressing this issue.165 This points to a key point: the argument here is not that 
courts never act as critics worries—serving the interests of economic elites over public health. In 
this example they clearly did. It is notable, however, that such actions have been rare. For this 
reason, the argument of this dissertation is that constitutionalization has beneficial effects “on 
balance.” 
                                                
163 Wass 2011, 51. 
164 McGettigan et al. 2015. 
165 Pfizer Limited & Anr vs Union Of India & Anr 2016. 
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 Price controls, meanwhile, have travelled a slightly more direct path with a series of judicial 
interventions that essentially acted as a check on government when it moved to deregulate 
pharmaceutical pricing without a rational alternative strategy to address affordability. Most major 
market economies (the U.S. being the outlier exception) have some more of price control on 
medicines to counter a widely recognized market failure.166 This is particularly important in India 
since, given low wages, even “affordable” medicines are out-of-reach to many poor public health 
system users. Until recently there was also no major public sector initiative to subsidize drugs—a 
reality that changed some with the advent of free-drug programs in states like Tamil Nadu and 
Rajasthan, extended nation-wide in 2012, and the Jan Aushadhi (Medicine for the Masses) Scheme 
to provide cheaper generic medicines through public stores.167 Prior to these programs, however, 
the major strategy to deal with this was a system of price controls that even supporters agree are 
not ideal as a public health strategy but without which medicines would be further out of reach.  
 India has a long tradition of controlling the price of drugs. A series of drug pricing orders 
beginning in the 1960s under the Essential Commodities Act sought to regulate the price of drugs—
with an explicit policy that paired price controls with the 1970 Patent Act to build an affordable 
drug ecosystem. Through much of the 1980s, 347 essential medicines were subject to price control 
under a 1978 policy that set up the National Drug Authority.168 Industry, however, unsurprisingly 
pushed against price controls—one place where MNCs and domestic firms have agreed. Under 
liberalization in the 1990s, there was a push to gradually roll back price controls and, by the early 
2000s, government announced its intention to list just 30 or so drugs for price control (Interview 
IN-10).  
 After significant negotiation back and forth, the All-India Drug Action Network and others 
filed a PIL in 2003 challenging these moves at the point where just 74 drugs were under price 
control—which included several unimportant drugs and excluded many critical ones. They asked 
                                                
166 WHO 2015; Maynard and Bloor 2003. 
167 See e.g. discussions in Maiti et al. 2015; Mukherjee 2017. 
168 Srinivasan and Bhargava 2009, 14. 
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the Court to institute price controls on a series of drugs. The Court declined to do so, kicking the 
question back to the Ministry, but directed the government to bring all essential medicines under 
price control.169 In 2011, government agreed and listed all 348 drugs on the National List of 
Essential Medicines, writing, “It is the considered view of the respondents that to make affordable 
healthcare a reality, all the medicines included in the NLEM, 2011 need to be brought within the 
ambit of price control, considering that cost of medicines constitutes over 60% of the total cost of 
healthcare.”170 The subsequent policy, however, came under further criticism for setting the price 
ceilings too high, excluding critical drugs, and for using a “market-based” mechanism that critics 
argue is set up to undercut true affordability.171  
 
“I think there is no precedent for something like this. Maybe you've heard of 
something like this in other parts of the world, but we've never heard of... our 
calculations were that for a lot of key drugs it would have an impact of less than 2% 
of the total market value, which worked out to less than, I think, 10 rupees per 
person per year in India, which is like, nothing. It's insignificant. So, it's a bit of an 
eye-wash. –Health Activist (Interview IN-10) 
 
 The court, however, declined to micromanage the details of the policy. That changed when 
the new NDA government moved to do away with even this price control policy. AIDAN and others 
were soon back in court challenging a plan to get rid of the National Drug Authority entirely.172 
The Court called the government’s policy “unreasonable and irrational” and sent them back to 
negotiations with AIDAN.173 Just a few days before this writing, government produced a new policy 
which maintains and even strengthens price controls with policies that may actually make greater 
use of international best practice standards and encourage use of generic over branded drugs.  
 Medicines policy in India thus provides an important insight into the functioning of the 
right to health: it has been most effective when the policy in question is responsive to a fairly blunt 
intervention, but the judicially-led model struggles where detailed pro-active steps are needed by a 
                                                
169 Union of India vs KS Gopinath and Ors 2003. 
170 Prices of 348 essential drugs to be controlled 2011. 
171 Jain 2013; Srinivasan and Bhargava 2009. 
172 Is the govt mulling a surgical strike on medicines? 2016. 
173 Supreme Court seeks review of drug pricing policy 2015. 
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bureaucracy that is not actually under the control of the judiciary. Unlike in Latin America, there 
is little evidence of the Judiciary ordering government to provide high priced medicines or issuing 
detailed orders that undercut balanced public health policymaking. On the other hand, the impact 
of India’s judicially-driven constitutionalization has also varied—from fairly strong in ensuring the 
maintenance of perhaps India’s most important medicines policy embedded in its patent law to 
very little impact on ensuring safety of the medicines that exist. Drug pricing has fallen in between.  
 
Maternal Health  
 One of the clearest areas where right to health mobilization has thus far had a lower level 
of impact is in the area of maternal health. With one of the highest burdens of maternal mortality 
in the world, India has crafted quite a few national programs and schemes to support pregnant and 
lactating women like the Janani Suraksha Yojana (JSY) promoting institutional delivery through 
the NRHM and the National Maternity Benefit Scheme (NMBS), providing women below the 
poverty line financial assistance for pre- and post-pregnancy care. The problem, however, has come 
in the implementation of the programs, which are often inaccessible to the very women who need 
them most. Constitutionalization of health has provided an opportunity for a unique partnership 
between the legal aid organization Human Rights Law Network (HRLN) and the international 
NGO Center for Reproductive Rights, who have partnered in a research and litigation effort to 
address the issue. Perhaps the most well-known case has been Laxmi Mandal, the consolidated case 
of two women—one of whom died shortly after childbirth, the other of whom was forced to give 
birth outside a hospital; both denied access to healthcare and financial support because they lacked 
Poverty Line (BPL) cards.174 The Court found that despite the existence of services there was as 
“systemic failure resulting in denial of benefits to two mothers below the poverty line (BPL) during 
their pregnancy and immediately thereafter.”175 In an internationally noted decision, the Court 
ordered compensation and significant changes to the schemes to ensure they were portable between 
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states and actually faithfully implemented. Shortly thereafter, the same Court took heard a case of 
a woman who, homeless and pregnant, died on the streets of Delhi while giving birth. The Delhi 
High Court took the case suo moto after a high-profile article in the Hindustan Times176 caught the 
judges’ attention and ordered the NCT Delhi government to create at least two homeless shelters 
for pregnant and lactating women.177  
 Implementation of both orders has been challenging. While the Court has made a rather 
scathing statement, the bureaucracy has not embraced it and few politicians have taken up the rights 
based framework in thinking about the maternity schemes. Compensation has been paid in full, 
which theoretically should act as an incentive to change policy. Years afterward, however, the Delhi 
government was still dragging its feet implementation of the Laxmi Mandal case with respect to the 
maternal health schemes, with the Court finding government in contempt, and the policy changes 
ordered have largely not been implemented.178 Meanwhile, a fact-finding mission by the HRLN 
found that while there were technically two shelters functioning, they were terribly managed and 
failed to meet basic standards.179 A similar predicament faces a set of cases in Madhya Pradesh.180  
 In this way, maternal health issues reflect a limitation to judicially-driven 
constitutionalization—in which a recalcitrant government facing complex policy change does have 
the ability to wave off the judicial branch with only limited ability of courts to control the 
bureaucracy via court order. In the coming years, it will be interesting to see if the Court moves 
toward using some of its more creative mechanisms to address the issue or if further venue shifting 
to the Supreme Court changes that dynamic.  
 
Regulating Private Health and Private Lives 
 Without belaboring the point, constitutionalization has mattered in a range of other 
issues as well that run the gamut. PILs have been brought out to try to address other areas of 
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regulation of the private health sector and to force rules about hospitals reserving a portion of their 
beds for the poor to be enforced. Neither has been particularly effective. Rights mobilization has 
been slightly more effective in forcing the issue on emergency access to healthcare—which is among 
the clearest constitutional rights. While there have been some successful PILs, the very nature of 
emergency need largely means the cases are about restitution rather than policy change, which has 
meant little change in the system as a whole.  
 On the other hand, the right to health was a piece of the argumentation in the case the 
overturned the ban on sodomy. Arguing that the constitutional protection of health meant that 
infamous section 377 of the Indian penal code banning gay sex had the effect of driving LGBT 
communities underground and away from healthcare, with particular effect on HIV. This piece was 
an important part of the background arguments in what would become the landmark decision to 
strike down the section in the Delhi High Court in 2009.181 However, in a sign of both the limits of 
judiciaries and the particular challenges of the Indian judiciary, a two-judge bench of the Supreme 
Court in 2013 overturned the lower court ruling and reinstated the law—with no reference to the 
health effects. In 2016 Chief Justice TS Thakur led a decision to revisit the case with a 5-judge 
constitutional bench, which may yet reinstate the lower court’s ruling. In a landmark Supreme 
Court judgement in 2017, a 9-judge constitutional bench ruled unanimously that privacy is a 
fundamental right under Article 21 of the Constitution—which lays a path for a constitutional 
bench to overturn the smaller bench ruling. One key argument on the part of petitioners is likely to 
be the way in which the previous bench ignored the health implications of section 377. 
 
A Right to Health Bill 
 Finally, I turn to the “issue” of whether to enact a broader health bill that might include a 
legislatively recognized judiciable right to health. During the UPA 1 government a bill was drafted 
by leaders in public health inside and outside the Ministry that would have sought to provide a new 
overarching framework to the Indian health system. Constitutionalization was a key rationale. 
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“We almost got away with using [the Constitution] in justifying why we needed a 
bill. We had to actually build the rationale and justification on right to health. This 
is one of the major justifications that we did use. We had legal experts on it. We 
had paid people to get a viewpoint on that. One justification was that it in effect 
was required by Supreme Court judgments, and we read a number of judgments 
together that the right to life implies a right to health. This was one key argument. 
 
The National Health Bill was tabled in parliament in 2009. It included language recognizing that 
“the Constitution of India places obligations on the Government to ensure protection and 
fulfilment of right to health for all” and noting:  
“And whereas the Honorable Supreme Court of India has, in several judgments, 
exhorted the Government of India to accord legal recognition to the health rights 
as vital component of the fundamental right to life; and the National Human 
Rights Commission has also directed the Government of India to enact a health 
law;” (p.7) 
 
The bill would have created a substantive cause of action for multiple levels of judicial intervention 
and made denial of quality health services a clearly legalized question.  
“But… UPA 1, it was on the agenda. UPA 2 came, it fell off.”  –Former Senior 
Health Official (Interview IN-36) 
 
 In India, constitutionalization does provide ideational reasons for action and it does enable 
venue shifting which opens room for policy change. New actors are engaged. But this only goes so 
far; with the Left in government there was a strong “interaction effect” with constitutionalization—
making several things possible and making the rights frame powerful. When the Left Front pulled 
out during UPA-2, it had less power. This is the reality of partial constitutionalization.  
 In 2015 the Modi government circulated a draft National Health Policy that proposed some 
of the same key elements from the previous government’s bill including formally recognizing health 
as a judiciable right in legislation. By 2017, however, this did not make it into the bill.  
 Thus for the time being it will continue to be true that social science researchers, when 
asking whether India has a constitutional right to health, will most often hear an answer that begins 
“It depends…” 
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Conclusion 
 India reflects one of the most complex health policy environments in the world—with 
massive health needs and distinct political and institutional weaknesses alongside remarkable 
human capacity and pockets of excellence. The particular political history of the country has driven 
decades of under-investment in the public sector and growth of a powerful, unregulated private 
sector. It is in this context the Indian Supreme Court has led a move toward constitutionalization 
that has shifted the institutional environment for health policy. To understand if and how this has 
mattered for health policy we have to start with this reality and resist decontextualizing the poor 
health outcomes in the country, which leads to quickly to a conclusion that constitutionalization 
matters not at all.  By instead tracing policy issues where the right to health has been mobilized 
through time we can understand how this institutionalization of the right to health has impacted 
policy. Overall, we can see the key elements outlined in chapter 3 at work in India as 
constitutionalization provides an increasingly strong anchor from which policy entrepreneurs push 
for change. This includes those inside government like NACO leaders engaging the 
constitutionalized environment for bureaucratic bargaining and those outside government like 
public health leaders pushing for greater regulation on medicines and clinical trials that engaged 
the judiciary as one part of a broader policy change effort. Venue shifts to the courts and to the 
Human Rights Council have been accompanied by the mobilization of the ideational power of 
rights to interrupt the intransigent and negligent status quo.  For the most part the issues that have 
seen rights mobilization reflect neglect rather than avarice—policy monopolies on HIV unwilling 
to reconsider assumptions about treatment cost-effectiveness or those on maternal health unwilling 
or unable to address the disconnect between policy and practice. In the background, however, the 
interests of the Indian private health sector—providers, pharmaceutical companies—discourage 
disruption of this status quo in overt and covert ways. Constitutionalization has had an agenda-
setting function—attracting the attention of Ministers and Union Secretaries to the actions of those 
below and beside them and reframing the health policy question in ways that prevent dismantling 
drug price controls without an alternative or empower those promoting strengthening the rural 
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public health infrastructure and building new accountability structures.     There are some limited 
examples of the courts acting counter to public health—as in the recent High Court decision to stay 
government action against ineffective drug formulations. But these are few and, on balance, the 
impact of this constitutionalization has been positive.  
 The Indian policy issues explored also illuminate the mechanisms through which 
constitutionalization matters by illustrating the limits of only partial constitutionalizing. Because 
the right to health comes through judicial interpretation rather than an overt political bargain, it 
has a more limited impact. Issues like the complex health system failures in maternal health, where 
the right has struggled to achieve impact, show how the right works—drawing attention and briefly 
disrupting the status quo, but struggling to maintain that attention long enough to resettle on an 
improved policy space without clearer and wider recognition of the right. Judges are, of course, 
political actors and constitutionalizes. The issues explored here, however, give us reason to believe 
that not passing the right to health bill and removing the right to health from the National Health 
Policy were missed opportunities that might have deepened the efficacy of constitutionalization.  
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CHAPTER 6:  CONCLUSION 
 
 
 
 
 Constitutionalizing health is a significant development in the institutions of health 
governance and can contribute to improved wellbeing. Over forty years of global health data, we 
can observe a small but significant health dividend for countries that have adopted the right to 
health, when controlling for the major alternative explanations of cross-national variation in 
mortality. Tracing health policy issues in South Africa and India reveals a right that operates as a 
policy anchor—tying health to the fundamental national political bargain and providing an 
innovation in the institutions of governance that helps policy entrepreneurs gain a foothold from 
which to drive policy that expands health capabilities. These findings contribute to literature on law 
and rights, improves understandings of the public policy process, and responds to the need for 
understanding the broader set of institutions in the political economy of development that drive 
improvements in population health. In a broader context, this study suggests that greater attention 
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to constitutions and the substance and process of health rights is warranted in global health, but 
with implications for the U.S. and other countries of the global North as well.  
 In the conclusion I will review the contributions to these three key literatures and then 
conclude with the important scope conditions for my findings and other limitations and the 
potential for future extensions.  
 
Contributions to the Literature: Rights, Policy, and Political Economy of Development 
 
Politics of Rights (Or, why rights are not trumps; Norway may not need rights but South Africa does)  
 
 This study contributes to debates about rights and their realization in law—analyzing the 
move from a right to health as an ethical claim and normative framework1 into the form of a 
constitutionalized right. Two prominent ideas in law and political science scholarship have 
encouraged what I label the “skeptical” and the “pessimistic” views on this move—the 
conceptualization of rights as trumps and veneration of development paths epitomized by Nordic 
countries. I argue that both of these views misunderstand the impact of the constitutionalization of 
health. Based on the empirical analysis above—both quantitative and qualitative—we should 
instead understand the right to health as a “policy anchor” that functions as a part of the political 
economy of health policy, not apart from it. In so doing, we can better understand both why 
constitutionalization can be beneficial on balance, and how its impact can be deepened.  
 First, the view of “rights as trumps” associated with Ronald Dworkin suggests that 
constitutionally protected rights are best understood as an attempt to protect certain individual 
interests, even if some social aim would be served by doing otherwise.2 This implies that rights have 
a power to supersede political bargaining, cutting through processes aimed at balancing the 
interests of the different segments of society to focus in the individual rights holder. On 
																																																						
1 e.g. Ruger 2006; Sen 2008. 
2 See Dworkin 1978. This conceptualization has been hotly debated and Waldron argues that, in its simplest form, this is actually a 
misrepresentation of Dworkin’s conceptualization (Waldron 2000). The idea, however, lies explicitly or implicitly behind many of the 
critiques of socioeconomic rights. Justice Albie Sachs reports Dworkin himself was against adding such rights to the South African 
Constitution (Sachs 2009, 169). 
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consequentialist grounds, this has led Dworkin and others to argue against inclusion of 
socioeconomic rights in constitutions. Enforced by courts, if rights are primarily aimed at shielding 
individuals from the intrusion of social forces, then case-by-case intervention into health policy on 
behalf of individuals is understandably worrying. This “pessimistic” view of constitutionalization 
reflects a rightly worrying possibility that applying such a rights-based framework might 
undermine effective policymaking and could actually worsen the health of populations by diverting 
resources and hobbling public health officials’ capacity. Legal scholar Amy Kapczynski has argued 
for a right to health, but against instantiations she labels a “neoliberal right to medicines” through 
judicial intervention in favor of those who demand access to high priced drugs.3 This could deliver 
on long-held goals of multinational pharmaceutical companies to capture a larger share of health 
budgets, without regard to the impact on budgets for other public health issues or even the 
effectiveness of the treatments in question.  
 The second “skeptical” set of ideas is best epitomized in the influential work of Ran Hirschl 
who challenges the proclivity in South Africa, India, and other countries to pin hopes for 
improvements in wellbeing on courts and constitutional frameworks, when the most successful 
countries in health and development (e.g. Nordics, Canada) have explicitly avoided 
constitutionalization.4 In his view, the turn toward constitutional rights frameworks and judicial 
empowerment serves primarily to preserve the power of hegemonic elites against the growing 
demands of mass publics for redistribution under democracy.5 This suggests rights are largely a 
distraction from the “government policy—shaped, in turn, by political factors” that matter most 
for improving wellbeing. “In addition to moderate population size and stable electoral processes, 
the existence of a developed market economy combined with centralized planning that cherishes 
public investment in science, education, and health care appears to be the winning formula here. A 
large middle class and a well-developed civil society—precisely what the Nordic countries 
																																																						
3 Kapczynski 2018. Note, Kapczynski ultimately spells out a tentatively optimistic view of the potential for a progressive right to 
health to address the intellectual property issues that drive pricing and accessibility, citing cases in India and Kenya as potential 
exemplars.  
4 Hirschl 2014, 181–5. 
5 Hirschl 2004. 
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exemplify—are key societal factors. And what is the net impact of the variance on the 
constitutionalism axis? Quite negligible, frankly.”6 This matches a concern, more nuanced in the 
political economy of the global South, that political leaders may turn to rights talk and constitutions 
to project progressive commitments and garner support from human rights actors to distract from 
their failures to address the core drivers of poor public goods provision.7 
 If rights functioned only or primarily as trumps it might well be bad for health. But in the 
context of health, I show that rights function in a far more complex way as a part of the health policy 
cycle—opening new opportunities for policy change. This is not to say problematic instantiations 
never occur or that those expressing concern about certain judicial decisions and/or the potential 
for neoliberal capture are wrong. On balance, however, there is evidence that supports the benefits 
of constitutionalization. Similarly, I take only minor issue with the idea that wellbeing is driven by 
complex issues of state capacity, social structures, and effective institutions—and my claim here is 
certainly not that constitutionalization is a silver bullet. Courts are, indeed, often conservative 
forces in society and unlikely to spark change on their own. However, in taking up Hirschl’s call to 
move “beyond idealistic normative accounts or insular case law discourse to understand social 
rights as part of larger matrix of public policy, economics, and politics…” I find that his claims 
about constitutionalization do not hold up. In the complex, thorny worlds of health policy in South 
Africa, India, Thailand, and Malawi—far from the Nordic realities in more ways that can be 
discussed here—Constitutionalization is beneficial precisely because it affects policy and 
governance rather than acting through judicial order divorced from them. Perhaps Norway and 
Sweden, with their particular assets, have no need for constitutionalization, which I note below has 
risen in the context of the failure of successive development paradigms to drive better health and 
accountability. But in the environments explored in this study it is helpful.  
 The quantitative analysis in chapter 2 supports these views. If hegemonic preservation were 
the only function of constitutionalization, which served primarily as a check against the demands 
																																																						
6 Hirschl 2011, 455. 
7 Kapur 2013. 
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of the poor, we would expect to see better provision of public health goods where 
constitutionalization has been avoided. If rights functioned as trumps, we would expect to see that 
skewed priorities undermine public health. Wealthy, homogenous countries like the Nordics, of 
course, have the benefit of resources and social cohesion that make direct comparisons 
misleading—many of the non-constitutional assets of such countries are neither quickly nor easily 
emulated by others. To truly consider the impact of constitutionalization we need to control for 
such factors; when I do so in chapter 2, we see that countries with a right to health have better health 
outcomes. Constitutionalizing countries also show better service delivery—higher rates of births 
attended by a skilled health worker, higher immunization rates, and wider availability of essential 
medicines in the public sector. This is the opposite of what we would expect if constitutionalization 
were skewing priorities and encouraging widespread diversion of resources.  
 Meanwhile, a central claim rising from the qualitative findings of this project is that 
constitutionalizing health can act, through a clear set of mechanisms, to address long-recognized 
realities that inhibit policy change. As a “policy anchor,” the constitutional right roots health in the 
fundamental legal and political bargain governing the state.  
 This changes the institutional environment in which policy is made—creating the 
opportunity for policy entrepreneurs to shift the venue of policymaking to new settings like courts 
and human rights commissions or to threaten to do so. Clinicians and people living with HIV in 
both India and South Africa, for example, shifted away from intransigent bureaucracies in the 
Ministries of Health to the nations’ apex courts. If constitutionalization only happened in 
constitutional courts, however, it would be hard for it to have significant broader effect on health 
policy. Instead, we see a variety of other venues coming into play: Health activists and public health 
leaders in South Africa shifted to the Competition Commission to gain access to information about 
private healthcare and access to key medicines. In the Eastern Cape, the shift was to the Human 
Rights Commission on emergency medical care. And in India, substantial use of the lower courts 
was key to policies on affordable medicines. In Thailand, the constitutional right to health helped 
create an entirely new venue in the National Health Security Office’s adjudication structures, which 
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illustrates how constitutionalization can enable venue shifting even in the absence of judicialization 
of health. This possibility of venue shift enables policy entrepreneurs to expand the conflict in the 
classic political science sense—bringing in new, powerful allies. In the United States, legal service 
organizations are rarely involved in health policy in the ways that SECTION 27 in South Africa or 
the Lawyers Collective in India are. As judges, lawyers, human rights commissioners, and the legal 
complex become involved in key health issues, consequential health policy issues that have 
previously been stuck begin to move.  
 To understand this effect requires insights from both law and public policy scholarship. 
Rights and constitutions interact with well-known phenomena in public policy where, as policy 
questions are settled at one point in time, a policy monopoly (or “iron triangle” or “sub-system”) 
develops around that issue to defend the status quo going forward, even as policy change may be 
sorely needed. What I show here is that a primary function of the right to health is the enabling of 
disruption of policy monopolies on key issues through expanding the conflict. None of the policy 
issues I trace here start in the courts, contrary to the concerns of those who are worried about 
judicial activism. Courts are, it is worth noting, hardly ideal venues for policy entrepreneurs given 
the cost, ethos, and uncertain outcomes. Instead, the issues start with moves by policy 
entrepreneurs inside or outside government to shift policy that come up against a wall. Silicosis and 
TB in the mines of South Africa has been a century-long issue. Key policy questions have shifted to 
the judicial space only after hopes it could be addressed through increased miner organizing, 
majority rule, and COSATU’s role in government were not realized and the ANC government 
proved unwilling to act on urgent reforms that would better protect public health. Unregulated 
clinical trials in India were agreed to be a problem, even within the Ministry, but the issue was stuck 
in a series of commissions and bureaucratic exercises across several governments that gave the 
illusion of progress without actual reform until the Supreme Court order temporarily halted trials 
and shocked the system. One of the key functions here is to capture the attention of macro political 
actors—interrupting the impression (or excuse) that the expert/bureaucratic/interest group 
monopoly currently setting policy is handling things appropriately. 
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 Importantly, much as courts do not start the policy issue, court orders also do not end it. 
The concern that inexpert inference by judges in key health policy issues will harm or simply 
distract from health policymaking does not capture the complexity of what is happening in practice. 
Instead, bargaining begins well before the case and continues well afterward. The clinical trials case 
in India, for example, has been among the most criticized decisions as high-profile actors like the 
Gates Foundation and prominent universities raised alarm that the Court was not properly 
considering the public health benefit of clinical trials. The halt was quickly lifted, however, as the 
ministry rapidly moved to address the competing concerns of pharmaceutical companies, 
researchers, public health officials, and activists with new systems and regulations that were long 
overdue. Bureaucratic resistance to changing the status quo inside the Ministry, interested parties 
among pharmaceutical companies, researchers concerned over regulation, and limited capacity to 
coordinate were each overcome. Though sparked by judicial intervention, the policy outcome was 
the subject of bargaining. There are also multiple examples in which courts are not involved, yet 
rights matter nonetheless—like in the Eastern Cape example—with policy change sometimes 
driven by other rights bodies like the human rights commission and other times by the threat of 
litigation alone.  
 On several issues, the intervention of the legal complex served a primarily information and 
accountability function—raising attention to, and spurring actors to make good on, promises and 
intentions that might be held up by the many frictions that inhibit policy change. The promise of 
ambulances to Xhora Mouth and other rural parts of the Eastern Cape were repeated over years, 
but zero-sum budgets and self-interested actors maintained the status quo. Change came after the 
Human Rights Commission made it evident that the health department was essentially planning to 
fail, and forced officials to justify irrational resource allocation. 
  Again and again this cycle repeats in the issues studied here—judicial orders are a part of 
the story, but focusing too closely on them misses the broader impact of constitutionalization.  
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 Understanding the right to health as a policy anchor helps focus attention on the ways in 
which constitutionalization centers health policy on the health capabilities of people8—including 
both the opportunities individuals in a society have to achieve wellbeing and the process through 
which health policy is made. Indeed, some of the concern about the focus on the individual in legal 
contexts from skeptics seems to help here—allowing individuals to raise concerns about how health 
policies may be undermining their health capabilities and those of similarly situated individuals; 
creating opportunities to address those issues where monopolistic policy ideas deflected attention 
from them. This policy anchor grounds a long-term commitment by the state to the achievement 
of wellbeing and an institutional change that enables realization. Following the metaphor, there is 
room for the policy process to drift with the current in multiple directions as the state considers the 
particular health realities of the society at a given moment and reaches agreement on the necessary 
requirements for “flourishing” that all people must be afforded. The anchor, however, provides 
both ideational and institutional mechanisms to return health policy debates to the individual, and 
force reconsideration of whether policy is effectively oriented toward this agreement. Facing 
opposition, post-Apartheid South African health officials used the Constitution to focus attention 
of health workers on the individual to drive user fee abolition and push forward a single-payer 
health system. People living with HIV were able to challenge those same officials’ decisions on HIV 
policy and be heard by the state, identifying the anti-treatment stance as contrary to the health 
capabilities the state committed to support. 
 Perusing the health issues that have seen rights mobilization reveals a variety of issue 
areas—addressing both healthcare and public health. More of issues in which constitutionalization 
matters most deal with healthcare. This is not particularly surprising since these are both the more 
straightforward issues in terms of complexity and the issues which do not require overcoming 
powerful, coordinated, cohesive opponents to change (e.g. South African mining companies). 
While healthcare is not the only driver of wellbeing and, in most wealthy countries differences in 
																																																						
8 See Ruger 2010; Sen 1999 for a fuller discussion of capabilities. 
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health are decreasingly due to differential access to healthcare, modern medicine remains 
important. The prominent McKeown thesis suggested that vast improvements in health in the 
North had little to do with healthcare, but this dismissal of the value of modern medicine has since 
been convincing challenged and the translation of germ theory into effective public health 
interventions remain an important path to improving health in much of the world.9 As documented 
in chapters 4 and 5, most of the major drivers of death in South Africa and India are amenable to 
basic medical intervention—as are those in many countries in the global South, especially among 
the poor. As such, the dominance of healthcare is understandable and may also be an artifact of 
case selection in the qualitative section here. A handful of issues—legalization of sodomy or Silicosis 
& TB in mines for example—have begun to expand the focus to broader issues affecting health 
capabilities. With just two decades of experience, it is hard to assess the degree to which the broader 
conceptualization will take hold, though for truly addressing health capabilities it is necessary.  
 One thing that is clear is that Epp’s finding that support structures are necessary for 
triggering a “rights revolution” holds true for socioeconomic rights as well. As the Malawi case 
makes clear, moving beyond a core government commitment to health and to a constitutionalized 
space requires a threshold level of legal aid and financial support to rights-based organizations—
without that venue shifting is not possible, even where the constitutional language is good and the 
courts are willing. That said, as seen in the cases here, the legal complex is an important, but not 
isolated, piece of the constitutionalization matrix. Activists, social movements, public health 
officials, politicians, and others all operate within a different opportunity structure when health is 
constitutionalized. The Indian case illustrates how judicially-driven constitutionalization has limits 
and, while providing significant and beneficial impact, has been smaller and less systemic than in 
South Africa where a broader politics of constitutionalization drives political action. 
 Many authors have written on social and economic rights, including the right to health—
several tackling key empirical questions about the function of courts that challenge both the 
																																																						
9 McKeown 1988; Guha 1994; Easterlin 1999; Colgrove 2002; Deaton 2013. 
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Dworkin and the Hirschl conceptualizations.10 By focusing on constitutionalization as a broader 
phenomenon, of which litigation is just one piece, and tracing health policy issues before and after 
rights mobilization  (most over at least a decade) I build on that work to show that a consistent 
“policy anchor” model can help describe the mechanisms of action for health as a right in 
constitutions. This might help us think as well about how to increase the efficacy of these 
mechanisms for greater impact.  
 
Public Policy—Constitutionalization Matters 
 
 This project also contributes to literature on the process of public policymaking. Within 
the public policy frame we can also understand when and how the right to health has an impact and 
explain why some issues see a high level of impact while others see a lower level.  
 A core question in public policy studies is, to put it simply: how and when do policies 
change? I have traced the process of a wide set of health policy issues that demonstrate significant 
alignment with leading theories of the policy process. Missing from many previous accounts, 
however, is the role of constitutionalization. I show that constitutional recognition of health as a 
right has an important function and facilitates health policy change through mechanisms that have 
not been explored to this point.  
 Rights largely do not figure into political science theories of the public policy process. An 
influential recent article by Baumgartner et al., for example, starts with the question of how 
constitutional design affects the public policy process, but then does not consider rights as a 
relevant part of the constitution in relation to policymaking.11 This seems to stem, in part, from the 
reality described by Béland and Powell that “much of the scholarship on social policy continuity 
and change focuses on one policy area, one country, one continent (mainly Europe), or one welfare 
																																																						
10 E.g. Yamin and Gloppen 2011; Brinks and Gauri 2014; Fukuda-Parr, Lawson-Remer, and Randolph 2015; Langford, Rodríguez-
Garavito, and Rossi 2017. 
11 Baumgartner et al. 2009. 
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regime.”12 The antipathy to socioeconomic rights in the global North has contributed to 
undertheorizing rights impact in policy. Insofar as civil and political rights are the model for 
political scientists, this is not surprising. The impact of free speech or religious exercise rights, for 
example, on the issues studied by most policy scholars (e.g. welfare state spending) is minimal. 
Meanwhile, as an institution that has emerged largely from the global South, the over-reliance on 
cases from the U.S. and Europe has also contributed to the studies that miss the impact of 
constitutionalization as a phenomenon.  
 If we look South, however, we can see that constitutionalization matters.  
 Debates around policy change and continuity in the literature have largely centered around 
the question of how best to characterize change. Peter Hall’s seminal work on policy change 
described three orders of magnitude—changes to the settings of policy instruments, changes to the 
instruments themselves, and changes to the hierarchy of goals behind policy.13 Pierson’s 
exploration of path dependence built on a long literature that drew attention to the relative stability 
of policy over time and helped focus attention on the need to explain continuity and change 
together.14 Scholars have since come to some agreement that policy change takes the shape of a 
broadly punctuated equilibrium, as the theory pioneered by Baumgartner and Jones explains.15 
Some historical institutionalists, though, have challenged this theory with Thelen, Hacker, and 
others arguing that more common than big punctuations is gradual change or “cumulative, but 
transformative” change in both policy and institutions with seemingly small adjustments adding 
up to transformation.16 This analysis has been criticized, however, as more descriptive than 
explanatory and the distinction between path-departing change and incremental change as perhaps 
overplayed.17  
																																																						
12 Béland and Powell 2016. 
13 Hall 1993. 
14 Pierson 2004. 
15 Baumgartner and Jones 1993; Baumgartner et al. 2009. 
16 Thelen 2004; Hacker 2004. 
17 Béland and Powell 2016. 
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 In tracing over twenty health policy processes in two global South country contexts, this 
study finds examples that might fit multiple definitions and magnitudes of change. Path-dependent 
processes are found in abundance. The decision under Apartheid to focus on tertiary medical 
services and a variety of facilities in white areas made it nearly impossible to shift resources later, as 
white residents protested curtailing of services and specialty physicians opposed lay-offs or 
relocation to Black areas. In a constrained budget environment, these prior choices inhibited 
expansion of emergency health services in the Eastern Cape to reach Black rural residents and prior 
placement of clinics meant the infrastructure to support ambulances was missing as well—resulting 
in the need for rights mobilization.  
 Indeed, nearly all of the policy processes in which health rights were mobilized in India and 
South Africa can be described as examples where policy stasis was the reality, even as it inhibited 
public health improvement. This consistency across issues is interesting, perhaps even surprising, 
since the issues were chosen based on initial interviews identifying where rights mobilization took 
place. I did not set out to develop a set of cases of policy stability. It seemed just as possible, at the 
outset, that some significant portion of issues where the right to health might be mobilized would 
be defensive. In the context of the U.S. and other OECD countries, health and welfare state 
retrenchment is often the question under study.18 In the global North, Scheppele’s work on 
socioeconomic rights in Eastern Europe focuses on defense against retrenchment.19 Meanwhile, a 
significant portion of the theoretical work on the right to health as well as some of the most 
celebrated cases deal with rules of “non-retrogression” (backsliding).20 Yet while I identified a few 
cases of constitutionalization affecting questions of pull-backs in policy (e.g. struggles over price 
controls in India) these are the exception in the sample of issues studied here. This surely stems in 
part from case selection—focusing mostly on a set of middle-income countries in Africa and Asia. 
However, as Rudra, Haggard & Kauffman, and MacLean have all shown, struggles over 
																																																						
18 Pierson 2004; Hacker 2004; Böhm 2016. 
19 Scheppele 2005. 
20 UN Committee on Economic, Social and Cultural Rights 2000, 14; Chapman 2009; Yamin and Parra-Vera 2009. 
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retrenchment in health and welfare have been part to the politics of neoliberal reforms in the South 
from the late 1990s to the present.21 Further study is needed to fully understand this 
phenomenon—whether it is particular to the cases or part of the nature of health rights. Overall, 
however, the reality of rights being mobilized in a context of policy stasis makes a great deal of sense 
from a policy process perspective that understands continuity is far more common than change, 
even in the face of urgent needs and new information. In this way, the health issues traced here 
support the punctuated equilibrium theory, though with greater suggestion that punctuations will 
be more mundane than grand and dramatic.  
 Policy change in health, however, is especially important given the close alignment 
explained by Deaton between the progress of both medical and public health science and 
improvements in wellbeing.22 I show here that constitutionalization changes the institutional 
terrain of policy change. By providing policy entrepreneurs the opportunity to shift the venue of 
policymaking into legal spaces, constitutionalization encourages policy change. This too supports 
the idea of punctuated equilibrium—as this venue shift pierces the kinds of policy monopolies 
expected to maintain the status quo in the theory. Understanding this shift, however, is impossible 
without considering the constitutional rights context. Again and again on these issues, I show that 
the expected mechanisms from social movements to electoral change fail to bring about health-
enhancing policy change—a reality that will surprise few observers of health policy—but that rights 
mobilization shifts the political power dynamics and opens space for change. The issue of 
emergency health services in the Eastern Cape received front page media coverage and politicians 
raced to pledge change—yet the policy monopoly there was strong and the beneficiaries of policy 
change were comparatively weak. When the HRC entered the conflict, however, power dynamics 
shifted and new information came out about the budgets, officials were forced to justify the policy, 
and the monopoly was undercut. This mechanism holds in both incremental change (drug price 
controls in India, for example) and in some more paradigm-shifting changes in which the 
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22 Deaton 2003. 
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instruments and the levels of policy shifted such as the move to an ARV treatment program in both 
India and South Africa or removal of user fees in primary healthcare in South Africa.  
 Policy entrepreneurs make these venue-shifting moves—turning to courts and rights 
bodies—largely as a fallback position when issues get “stuck.” This stems in part from the very 
significant investment needed to use these rights bodies as venues for change. Given this reality, it 
seems likely that the right to health will continue to play a similar role—that even as 
constitutionalization deepens, it will continue to be a second-order choice for policy entrepreneurs. 
It may, on the other hand, become more important—with rights mobilization on a wider range of 
issues and with increased frequency if it proves efficacious and avoids backlash from powerful 
political actors. However, the likelihood of courts running everything, as critics worry, seems very 
far off.  
 The existence of that second-order option, however, needs to be better considered in 
models of how policy works, because it changes the power structures of policymaking. Public health 
leaders fighting “irrational” medicines in India, for example, had neither a powerful social 
movement behind them nor significant political support, yet their ability to move to the courts 
changed how they structured their campaigns, constructed their arguments, and interacted with 
the bureaucracy. In that case, rights mobilization bore only limited fruit—and considering why and 
how in relation to the rest of the policy cycle helps us understand the relative strength of the policy 
monopoly on that issue and has bearing for how the entire policy cycle has functioned over a decade 
through back-and-forth negotiations with the Court. In clinical trials, on the other hand, policy 
change was directly sparked because a set of very small NGOs that were unable to break through 
bureaucratic deadlock were able to secure the sustained attention of the Supreme Court, through 
which policy change was then brokered, significantly changing the players and the power on 
different sides of the issue.  
 What we see is that the constitutional context shifts but does not fundamentally disrupt the 
policy process. Neither bureaucrats nor public health experts become irrelevant in our cases, and 
bargaining within the public health policy infrastructure does not end. Policies are not in a state of 
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constant disruptions, but instead they return to a state of continuity much as the literature would 
expect. Today in South Africa, the courts have very little to do with the HIV treatment program 
despite its high-profile role in the programs birth—and complex negotiations over how the 
program is run, which drugs are used, who is eligible to start treatment, etc. are largely negotiated 
through a set of bureaucratic structures in the National AIDS Council and the Ministry. Instead, I 
would argue that the health system becomes more nimble and responsive to information. The 
“politics of attention” and “information process” described by Jones & Baumgartner now includes 
new and different players that, in some cases, help speed the translation of information and 
evidence into state action.23 My findings predict, for example, that constitutionalization is likely to 
lead to more and more frequent punctuations—an empirically testable hypothesis that could be 
explored in future work using the tools developed by policy scholars like budget tracking and media 
content analysis.24 
 Meanwhile, a growing body of literature has identified the key role of ideas in promoting 
policy change—yet rights rarely figure in this analysis.25 The beliefs and conceptual frameworks of 
political actors shape both the range of policy options they can imagine and the degree to which 
they see policy change as feasible and necessary. Constitutions, in this light, are as much ideational 
instruments as they are institution-building. I argue that constitutionalizing health provides a 
particularly robust constellation of ideas— “reasons for action” — that I show have real power in 
the policy process. These reasons for action provide three key functions: First, they provide a 
counter to ideas that support the monopolistic policymaking processes and deflect the attention of 
macro political actors. People living with HIV in India countered the powerful idea of 
unaffordability and cost effectiveness while rural residents in South Africa countered the ANC’s 
narrative of slow but steady progress toward liberation—both with rights claims. Second, the rights 
framework is particularly oriented toward action over inaction—important in a health policy 
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24 Green-Pedersen and Walgrave 2014. 
25 Béland and Cox 2010; Carstensen and Schmidt 2016; Campbell 2004; Schmidt 2008. 
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context in which the question is often whether or not to change the current status quo in light of 
new information or insights. Not providing HIV treatment had to be justified in both India and 
South Africa after rights mobilization, which flipped the script from the previous debates in which 
resistant leaders had sustained inaction by continually raising questions about the effectiveness of 
an anti-retroviral program and offering more study. Finally, rights act as what Béland and Cox call 
“coalition magnets”—attracting a set of partners for policy change.26 This is related to, but distinct 
from the point about engaging the legal complex noted previously. Some allies that are part of, and 
needed for, the venue shift into rights bodies are directly attracted by the rights framing. In 
addition, some allies are attracted by the framing of the issue as a rights issue. In the Eastern Cape, 
for example, the human rights group Black Sash was attracted through the rights framing to the 
EMS issue and proved an important ally that brought anti-Apartheid struggle legitimacy to help 
counter the ANC resistance.  
 In these ways, this study contributes to moving scholarship from description to causality 
in studying policy change. The constitutional framework plays a causal role and needs to be 
considered as part of the framework within which policy is made. This study also provides a 
corrective to research that rarely includes the legal complex as a key player in health and social 
policy, helping update the theories developed in OECD countries in a time before significant moves 
on socio-economic rights to reflect the current political context in comparative perspective.  
 
Constitutionalization—Public Policy Explains When Constitutionalization Matters  
 
 Table 3.1 in Chapter 3 arrays the list set of health policy issues covered in this project from 
low- to high-impact. This is a notional order, not meant to be exact, but instead to reflect the reality 
that some issues saw greater impact than others. While this study was not set up to compare policy 
																																																						
26 Béland and Cox 2016. 
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issues to each other, in the end, a notional rank order was clearly discernable in the issue case 
studies.  
 For most of the issues we see a clear policy monopoly in operation in one form or another—
with monopoly actors ranging from the reaches of apex politics as in HIV treatment in South Africa 
to the technocrats of the small subsystem engaged in policy debates on medicines’ quality and 
rational use in India. What matters most for impact, however, is the character of the policy 
monopoly and the policy entrepreneurs. The opportunity to venue shift, new allies, and ideational 
power that are available under constitutionalization change the opportunity structure for policy 
change—but it is not assured. When monopoly actors are strong and cohesive or when the ideas 
backing the policy monopoly are particularly powerful then policy change with major impact is less 
likely to occur. The archetypal example here is Tuberculosis in prisons in South Africa. Justice 
Cameron’s visit to Pollsmoor prison and the data on TB infections described in chapter 4 showed 
that little has changed in practice, despite the intervention of the Constitutional Court and 
continued bargaining by pro-health actors in recent years that has been similar to that in other 
cases. Prison authorities represent a paramilitary authority over what happens in the prison and 
thus their monopoly over policy is simple and nearly incontestable, while the paradigmatic idea 
that security in the prisons trumps all other concerns has proved resistant to challenge. The 
character of the policy entrepreneurs is also critical. Constitutionalization created a critical 
opportunity for the small group of public health actors and ex-prisoners concerned about the issue 
to attract new allies—from the Treatment Action Campaign to leading lawyers. Nonetheless, the 
main beneficiaries—prisoners—remained among the least powerful political actors in the country 
and, as the policy process settled back into bargaining, even the backing of the Constitutional Court 
was insufficient to increase their political power enough to counter resistance from prison 
authorities. Finally, the nature of the policy change needed matters—Peter Hall’s three levels of 
change are illustrative.27 To truly address TB in prisons requires more than just changing the 
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“levels” of change (e.g. better health services) or the instruments (e.g. bringing in a whole new set 
of actors and programs like the NGO-led TB program). Instead, it truly required changing the 
underlying goals of the policy—with changes like vastly more time outside, renovating prisons with 
new designs and layouts, or reducing overcrowding by imprisoning fewer people each requiring 
prioritizing health over (or at least alongside) control and punishment. These kinds of changes need 
more power and sustained attention than was marshalled by policy entrepreneurs, even under 
constitutionalization. This does not mean this level of change is not impenetrable to rights 
mobilization. I would argue changes like the shape of the National Health Insurance in SA or 
National Rural Health Mission in India are paradigm-shifting as were some of the drug pricing 
cases in South Africa. It does seem fair to say, however, that where a strong, coherent policy 
monopoly faces off against a relatively weak entrepreneurial coalition demanding paradigm-
shifting change, the mechanisms of constitutionalization are unlikely to foster change. On the other 
hand, most health policy issues do not face such odds—there are usually dissenting voices inside 
the monopolistic structures (e.g. officials in the SA Department of Health who opposed the 
Minister’s stance on AIDS), health policy monopolies are rarely so strong as control over prisons, 
and often an entrepreneurial coalition can be crafted that is able to make use of opportunities under 
constitutionalization. Where this is true, the right to health provides the anchor they can grasp as 
they work toward policy change.  
 
Political Economy of Development & Democracy 
 
 Finally, the third set of literature to which this project contributes is in the political 
economy of development. When applied to the global South, debates over the determinants of 
mortality are fundamentally about theories of development. Despite remarkable economic growth 
rates in some countries, market-driven development models that dominated the 1980s and 1990s 
did little to help countries in the global South catch up to the global North—with disparities in 
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health and mortality growing rather than shrinking between countries.28 The move toward 
constitutionalization needs to be seen, therefore, in light of the failure of both neoliberal 
development and its statist predecessor to globalize the kind of revolutions in wellbeing seen in the 
North in the post-war period. Meanwhile, while the “wealthier is healthier” paradigm still holds 
some explanatory power, in recent decades a growing number of countries reached the top of the 
Preston curve in which increasing national income does not drive increases in population health. 
In this context, the institutional turn in political economy helps make sense of some of these 
realities, though the “Northian” over-focus on institutions related to private property and markets 
risks providing little more leverage over the institutions that drive wellbeing than previous work.29 
Evans, in this context, calls for a “successful societies institutionalism” capable of exploring a far 
wider set of socio-political institutions to understand when and how improvements in health are 
produced.30 
 This project is, in part, and attempt to do just that. Our case studies show that the right to 
health is more than a conceptual frame and that embedding such a right in a national constitution 
has the power to shift the institutional environment in ways that foster health. When health is 
constitutionalized, the new “rules of the game” change what constitutes appropriate action for 
different actors—judges and lawyers, human right commissions, and even the Competition 
Commission all take part in health policy in South Africa and India. In Thailand, the NHSO adopts 
an adjudicative model that allows individuals to petition for inclusion of drugs and services in the 
national health system. New organizations arise to take advantage of the institutional shifts and 
existing organizations respond to shifting incentives. The Treatment Action Campaign is born as a 
rights-based organization wrapping itself in the Constitution so tightly that learning the 
Constitution becomes a key activity of grassroots members and a relationship with the AIDS Law 
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Project becomes integral to the organizations functioning. The Lawyers Collective in India, a 
decades old legal organization, becomes a leading actor in HIV policy.   
 Democracy, meanwhile, has been arguably the leading political institution studied with 
respect to health. While many scholars have little expectation that electoral democracy will drive 
health policy (especially those focused on the global North), the political economy literature 
includes robust debates over whether democracy drives wellbeing.31 This links to Hirschl’s concern 
that constitutionalization might be a distraction, diverting focus from building strong social 
democratic institutions that are far more likely to drive redistributive policies than courts, which 
serve hegemonic interests. Yet Peter Hall and Michele Lamont note that “the deliberative processes 
fostered by democratic institutions have a role to play but are insufficient to generate large 
improvements in health.”32 The issues examined here support this contention. In the subset of 
issues here, there is little evidence of robust electoral democracy and related political freedoms, 
even engaging avowed social democratic actors, fostering redistribution or addressing obvious 
barriers to improvements in health. These issues are, of course, identified based on where rights 
mobilization occurs in order to understand its impact—so it is not surprising these would be issues 
where other forms of politics have not produced results. They nonetheless suggest the clear 
limitations of electoral democracy alone. In the Eastern Cape neither competitive elections nor 
criticism from opposition politicians, front-page headlines, nor demonstrations broke through the 
policy inertia to expand emergency health services—but the constitutionalized environment 
created alternative paths to policy change. 
 The quantitative findings in Chapter 2 support this—suggesting only a weak relationship 
between electoral democracy and wellbeing, but with a clear interaction between democracy and 
health rights that enhances impact. That the TAC can engage in mass protest and win over public 
opinion through strategic use of media mattered for addressing the AIDS treatment policy 
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Pieters et al. 2016; Welander, Lyttkens, and Nilsson 2015. 
32 Hall and Lamont 2009, 15. 
Chapter	6:	Conclusion	
	
296	
debacle—but it was not enough. By going to court, the TAC created a different opening, reframed 
the issue, and gained important allies that helped amplify the other pieces of their activism.  
 I show here that constitutionalization actually mobilized many of the mechanisms 
suggested by Sen and other political economists as the keys to democratic impact on wellbeing. It 
fosters information flows both to and from government about health issues—whether exposing the 
failure to plan for success in the Eastern Cape or exposing and politicizing rural health issues in 
India, the “discovery” power of rights bodies can compel information flows. Accountability is a key 
function of rights bodies that can augment the far blunter power of elections—forcing decision-
makers in the Eastern Cape Department of Health to justify their plan to fail, for example. And 
while elections and free media can shift the incentives of politicians to deliver on public goods—so 
too can the reality or threat of being hauled into court or human rights body.  
 One of the most important findings of this work relates to this interaction and the power 
of constitutionalization where there is nothing approaching a strong social movement on the issue. 
Health-related social movements have had powerful effects in some countries and transformed 
health politics.33 Critiques from the left worry that moving toward a rights framework will defang 
these movements—diverting time and energy to the law. It is clear from the case studies here that 
engaging in litigation is expensive, time-consuming, and while rights frameworks can help provide 
reasons for actions, judges need not take them up amidst the myriad alternative frameworks within 
the law. However, on most of the issues examined here there is nothing approaching a movement. 
The People’s Health Movement in India used the human rights commission to help drive policy 
change on broad health system changes, but on the issues of regulating medicines or clinical trials 
the key actors were not movements but small groups, NGOs, and civil servants inside government 
acting in traditional policy entrepreneur form. Up against more powerful interests dedicated to the 
status quo, their uses of democratic pressures were largely unable to break through. Here, 
																																																						
33 See e.g. Brown et al. 2010. 
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institutionalization of health as a right structured the opportunity for policy change—new rules of 
the game changed the possibilities and the power for change.  
 Understanding constitutionalization thus expands our understanding of the political 
economy of health policy and seeing rights in institutionalist terms helps us better understand how 
it is possible that words in the constitution might matter for population health.  
 
Limitations & Extensions 
 
 This study seeks to combine multiple levels of analysis and types of data to understand how 
and when constitutionalization matters for wellbeing. The quantitative analysis in chapter 2 uses 
40 years of health data to show it matters and the qualitative case studies augment this with process 
tracing in two countries and two short shadow cases. There is, however, a clear limitation to how 
far these findings can be said to travel.  
 
Scope Conditions 
 
 The findings of this study are driven by work in a set of middle-income countries—with 
the main paired comparison centered on countries with strong electoral democracies and relatively 
robust civil society. While the quantitative data presented in Chapter 2 is global, further work will 
be needed to understand the degree to which the effect and mechanisms travel.  
 Middle-income status matters because these countries share elements of a political 
economy in which limited capital undercut early visions of a universal health system akin to those 
in Europe, but recent rapid economic growth has expanded both the resources available to address 
health and the expectations of the population. Both the growing middle class in India and South 
Africa and the increasing living standards of the poor have created complex pressures on the health 
system—driving growth in the private sector as well as demands for transformation in the public 
sector. Constitutionalization in this context has, not surprisingly, been enmeshed in that process 
and so the particular mechanisms and effects I find cannot be separated from them. It is possible, 
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therefore, that constitutionalization in a context of middle-income growth is far different than it is 
elsewhere. While these mechanisms travel well to Thailand and they might do so as well in Nigeria 
or Malaysia, they may not travel to upper-income Korea or to North American and European 
powers. Low-income countries, as noted, are also less likely to see the benefits of 
constitutionalization—though more work is needed to understand how these dynamics play out 
outside of places like Malawi that are at the very bottom of the least-developed-country list. Even if 
these results only travel to middle-income countries, however, they are still significantly worth 
paying attention to—5 of the worlds 7 billion people live here and they represent many of the 
world’s rising powers and most dynamic economies.34  
 In terms of the higher-income countries often prized for their institutions and successful 
health systems, it may well be that they simply do not need rights mobilization to address challenges 
in health. As we have seen, most of the health issues where rights have been effective in mobilizing 
positive policy change are not the kind of deeply complex questions where there is genuine scientific 
equipoise about how to improve mortality. Instead, constitutionalization generally seems to work 
by driving policy change toward where evidence is relatively uncontroversial, pushing expansion 
of effective programs through intransigent bureaucracies, increasing accountability for planning to 
succeed, and shifting resources toward the health needs of those who may not be well served by the 
extant distributive politics. Where these are not at issue, then, it is not clear whether 
constitutionalization would help. I would note, however, that it is a relatively rare polity in which 
these are not the issue—certainly the U.S. is not on that optimal list. Hungary, Spain, several post-
Soviet states, and others among high-income countries have adopted a right to health, but very little 
is written about the effects and future work looking at how the right to health plays out in the global 
North would be worthwhile.  
 The main comparison countries here are also atop the democratic spectrum and, while my 
findings travel well to Thailand, which has far more mixed democratic institutions, the 
																																																						
34 World Bank 2017. 
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instantiation is different. Some level of democratic space is clearly necessary for the exact 
mechanisms I describe here since, by their very nature, fully autocratic states have no possibility for 
venue shifting. Independent courts play an important role in the story too, as does a threshold level 
of freedom of association that enables civil society and media to engage as key actors in policy 
change. That said, one can make too much of the distinction between democracy and non-
democracy. Ginsburg and collaborators have shown that courts can be highly consequential even 
where elections are far from free and media has limited freedom.35 Political science has also long 
shown that the most countries, especially in recent decades, are characterized by complicated 
degrees of political freedom such that even countries that may not meet the threshold scores on 
various indexes as democracies might well allow venue shifting, conflict expansion, and the 
mobilization of rights as ideas.36 Health policy in many cases is driven more by bureaucratic politics 
than by macro politics and, as I show here, on the issues where rights are mobilized, democratic 
pressures have largely failed to secure change. Nonetheless, further research is needed before we 
can know how far the effects I describe here travel along the relative democracy spectrum.  
 Finally, this study does not touch on Latin America—which is worthy of note since there 
has been significant debate over the effect of constitutionalization in the region.37 With a very 
different model of judicial engagement with the right to health (driven in part by the civil law 
systems), Brazil and Colombia have both seen tens of thousands of cases brought before the courts 
for access to medicines and other health issues through low-barrier petitions that make 
judicialization easy. Several scholars have raised serious concerns about this—worrying that some 
of the concerns which I have countered here, including diversion of resources and individualist 
decision-making raise their heads in these countries. Ferraz argues that litigation is harming the 
poor in Brazil by favoring privileged litigants over the rest of the population and undercutting 
balanced public health funding.38 Biehl’s work, however, challenges some of Ferraz’s findings—
																																																						
35 Ginsburg and Moustafa 2008. 
36 O’Donnell 1993; Collier and Levitsky 1997; Levitsky and Way 2010. 
37 E.g. Yamin and Parra-Vera 2009; Rodríguez Garavito 2013; Barcellos 2014; Hoffmann and Bentes 2008; Lamprea 2014; Norheim 
and Wilson 2014. 
38 E.g. Ferraz 2010. 
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showing that litigants are largely poor and often litigating to gain access to drugs that government 
has already committed to funding.39 Tracing the Colombian Supreme Court’s T-760/08 decision 
that examined systemic failures in the health system and called for significant restructuring, Yamin 
and Parra-Vera depict a court seeking ways to focus on the macro-level issues over the 
individualist.40 These researchers’ work fits, at least broadly, with the findings from my case studies 
that a shift in the political economy of health policy is at the heart of constitutionalization and that 
venue-shifting may well be functioning to address accountability deficits in the existing system. 
That said, there are clearly different political forces at work in Latin American and it is hard to 
know without replicating the same kind of process tracing on health policy over time whether the 
mechanisms I see here would travel to Latin America.  
 
The Role of International Politics 
 
 This story has been primarily one of domestic politics and domestic institutions—drawing 
on the literature in comparative politics to ground an analysis of constitutionalization; this has to 
significant degree been by design. While much of the work in health and human rights is focused 
at the international level—analyzing global norms and engaging with UN processes—the goal here 
was to understand far better how the increasingly common move to include right to health in 
national constitutions affects the actors, ideas, and institutions of national health policy. I did, 
however, expect that international forces would be come into my qualitative data far more strongly 
than it has. Throughout my interviews, with the significant exception of the international 
pharmaceutical industry, international actors were often absent or background players in the 
processes described to me—even when multiple interview participants described the same 
processes. In retrospect, this reflects far more on my research design and interview protocols than 
it does on the actual influence of international actors. The UN and international structures, for 
																																																						
39 Biehl 2015; Biehl et al. 2012. 
40 Yamin and Parra-Vera 2009. 
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example, have played a critical role in facilitating constitution-making processes around the 
world—with international advisors working alongside (and occasionally in place of) national 
leaders in the drafting of written constitutions. Since I did not focus on the constitution-writing 
process, however, these important actors are absent from my analysis. Meanwhile, public and 
private international funding agencies like the Global Fund to Fight AIDS, TB, and Malaria, and 
the Bill & Melinda Gates Foundation have played an outsized role in health policy in low- and 
middle-income countries in the last decade—including on key health issues like HIV, tuberculosis, 
maternal health, and several other issues explored here.  
 In a story significantly about agenda-setting, the absence of these players and processes like 
the Millennium Development Goals is a weakness in this analysis. In retrospect this reflects the 
reality that they act not as principles in policy negotiation but far more in the background—and 
thus are less visible in my data. Finally, the international financial institutions including the IMF, 
World Bank, and regional development banks play another key, but background role, in setting the 
stage for what is possible in health policy. While the pressures of IFIs can sometimes be 
exaggerated—including by domestic actors looking to blame external forces for unpopular 
decisions they themselves are taking—there is no doubt that structural adjustment programs and 
related ideas and instruments of the IFIs have had major impact on the development of welfare 
states and health systems. Their primary interaction, however, is with finance ministers. Thus, 
while I interviewed with high-level government leaders including the former or current Ministers 
of Health of each country, by focusing on health actors my design failed to draw out data on the 
IFIs and other international economic pressures. More work is therefore needed to build an 
additional layer of analysis at the international level to ensure this work is not seen as 
decontextualizing health from the very processes of globalization that have helped diffuse the idea 
of health as a right into national constitutions.  
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Extensions & Future Work 
 
 As I have mentioned, further work in understanding the constitutionalization of health is 
worthwhile on a number of fronts—some of which I propose to take forward in future adaptations 
of this project and future projects. First and foremost, as I move this project into a book project I 
will focus on fleshing out the shadow cases on Malawi and Thailand—which the limitations of time 
and brain-space have left insufficiently dealt with. Interviews conducted for this project will allow 
me to expand these to include several mini-issue studies that illuminate the ways in which the right 
to health functions under conditions of more limited democracy, limited judicial engagement, and 
limited national income.  
 I will also expand the shadow cases to include at least one Latin American case—likely 
Brazil, which could be conducted through secondary sources and a few primary interviews. For all 
the reasons described above, bringing Latin America into the analysis would strengthen it and 
provide an important further test to the theory. At this stage, I do not foresee seeking to bridge 
further into advanced industrial countries for this study—and so my scope conditions will remain 
largely the same. The dynamics, issues, and processes of health policy are distinct enough in AICs 
that they warrant a separate examination. It is one that is worthwhile, however, and in a later project 
I will seek a research partner with greater knowledge of AIC politics to look at those countries it the 
global North that have adopted the constitutional right like Hungary to see if and how it matters.  
 Finally, I will seek to address the international issues by expanding my research design with 
another set of interviews in at least one of my cases that focus in on international actors. Interviews 
with actors in the finance ministry would improve the analysis overall by giving a second 
perspective on the bureaucratic negotiations like those over financing HIV treatment described in 
chapter 5. They would also help bring into greater clarity the role of international forces in these 
key policy areas. Meanwhile interviews with officials at the Global Fund, World Bank, Gates 
Foundation, and elsewhere will help clarify how they saw constitutionality and will be paired with 
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second interview with a few of my original sources with new questions focused at this international 
level.  
 
Implications for Global and U.S. Health 
 
 Finally, I turn to the question of what this work suggests for those whose core interest is in 
improving population health. The clearest finding in this work is that constitution-making is public 
health policymaking. In the long term, building a nimble, accountable health system able to adapt 
to changes is helped by constitutionalizing health. This suggests that far more attention from public 
health actors to the constitution is warranted. Since globally the average constitution lasts fewer 
than 20 years before it is replaced or substantially revised, there are actually far more opportunities 
for this attention than might be suggested by observing the U.S. context.41 Yet public health actors 
are rarely involved in constitution-writing and I am aware of only a few campaigns at the national 
level for the adoption of a right to health. This is a missed opportunity to improve wellbeing 
through building a policy anchor that can help drive health policy toward better and more equitable 
impact. 	
 Meanwhile, each year billions of dollars are spent by foundations and aid agencies on 
improving health outcomes in low- and middle-income countries—from the Global Fund to Fight 
AIDS, TB, and Malaria to the Gate Foundations’ high-profile efforts to eradicate polio and address 
a host of other health issues to the European efforts through the International Health Partnership. 
Perhaps even more important than the external funding, governments put large portions of their 
budgets into building and regulating health systems. In all of this, however, only a smattering of 
resources has been dedicated to building the kind of support structures that I show are critical for 
maximizing the impact of constitutionalization. There is no Section 27 or Lawyers Collective in 
Malawi—which is a question of resources rather than will. I suggest that public- and private-sector 
resources need to be invested in building the nexus between the health system and the legal 
complex—supporting non-governmental organizations and public-sector legal aid efforts that 
																																																						
41 Elkins, Ginsburg, and Melton 2009. 
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enable utilization of the right to health. Human Rights Commissions too could be better connected 
and resourced to engage with health systems—as I show here in both India and South Africa, this 
has helped improve the accountability of and vision for health.  
 Finally, while this study does not touch on the U.S., it does hold potential lessons. As of this 
writing it seems rather hard to imagine a constitutional amendment on the right to health. Yet there 
is reason to believe that this is not the only opportunity to realize some of the benefits I document 
here. The mechanisms through which constitutionalization works—venue shifting, expansion of 
actors, ideational tools, etc.—might also be realized in some form through legislated rights. There 
were proposals for including fuller substantive and procedural rights as part of the Affordable Care 
Act in 2010. It seems few took them seriously, perhaps because even sympathetic leaders did not 
see the issue as particularly important compared with other priorities in the bill. Today, as the 
debate continues over the potential repeal of the ACA, the case studies here suggest that too was a 
missed opportunity. Perhaps structuring some sort of enforceable right thought legislation could 
have more effectively harnessed the legal complex and other actors toward pro-health aims beyond 
simply rejecting (so far) challenges seeking to strike down the law.  
 Rights matter. Constitutionalizing those rights—moving them from ethical demands 
toward political institutions with sufficient substance to change the environment in which health 
policy is made—is both increasingly common and increasingly complex. This is a relatively new 
phenomenon—with just a few decades to show impact. As this institutionalization deepens, it will 
become layered with different meanings, practical instantiations, and be used by new actors in the 
service of increasingly complex interests. We can see some of this already. The early policy issues 
where rights were mobilized in South Africa were far more straightforward than the multifaceted 
issues of more recent mobilization from migrants’ rights to National Health Insurance. Time will 
tell how this complexity will drive what is, today, an important emerging institutional option for 
addressing health and health equity in the twenty-first century.  
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Annex C: Variables  
 
Variable Description/Transformation Source 
Right to 
Health 
Text of constitutions in answer to 
the question, “Does the 
constitution mention the right to 
health care?” 
Transformed to 0/1 and all “other” 
or “unable to determine” cases 
identified in original dataset were 
examined and recoded by the 
author.  
The Comparative Constitutions 
Project: A Cross-National 
Historical Dataset of 
Written Constitutions. 2011. 
Available from: 
http://www.comparativecon
stitutionsproject.org 
Country/year data received, 
personal correspondence, 
Tom Ginsburg, 25 March 
2013. 
 
Under-5 
mortality 
The probability of death between 
birth and age 5 years, expressed 
per 1,000 live births, using logged 
data for estimation.  
Institute for Health Metrics and 
Evaluation Estimates published in 
(Rajaratnam et al. 2010) 
 
GDP per 
capita (log) 
Published GDP estimates in dollar 
conversions, using logged data for 
estimation. 
Institute for Health Metrics and 
Evaluation Estimates published in 
(James et al. 2012) 
Democracy Polity-IV score ranging from -10 
to 10, with 0 being transition from 
non-democracy to democracy 
Marshall MG, Jaggers K. Polity IV 
Project: Political Regime 
Characteristics and Transitions, 
1800-2011. Available from: 
http://www.systemicpeace.org/polit
y/polity4.htm  
Women’s 
Education  
A-standardized mean years of 
education for men and women 
aged 25 years or older 
Institute for Health Metrics and 
Evaluation Estimates published in 
(Gakidou et al. 2010) 
Inequality 
(gini) 
The gini coefficient represents 
how far countries deviate from a 
perfectly equitable distribution of 
income among individuals or 
households, ranging from 0 
(perfect equality) to 100 (perfect 
inequality). 
World Income Inequality Database, 
http://website1.wider.unu.ed
u/wiid/wiid-
documentation1.php 
Ethno-
Linguistic 
Fractionalizati
on 
Probability that two randomly 
selected individuals in a country 
belong to different ethnolinguistic 
groups, based on the 1985 measure 
as recalculated 2005. 
Montalvo and Reynal-Querol 2005 
supplmented by Alesina et al. 2003  
 
Urbanization People living in urban areas as 
defined by national statistical 
offices. It is calculated using 
World Bank. World Development 
Indicators, 2013 
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World Bank population estimates 
and urban ratios from the United 
Nations World Urbanization 
Prospects. 
 
Population 
Density 
Midyear population divided by 
land area in square kilometers.  
 
World Bank. World Development 
Indicators, 2013. 
 
Conflict Magnitude score of episode(s) of 
civil and ethnic violence and 
warfare in a state  
 
Center	for	Systemic	Peace,	Major	
Episodes	of	Political	
Violence,	1946-2013,	Total	
(Marshall	2014) 
Legal 
Tradition 
Categorization based on seven 
options: Muslim, Common, 
Civil, Customary, Mixed 
Common, Mixed Civil, or 
Mixed Common/Civil.  
Collapsed mixed categories 
into the civil or common 
category.  
University of Ottawa 
Government 
Expenditure 
General government expenditure 
on health as % of GDP 
 
World Health Organization. Global 
Health Expenditure 
Database.  
Out of Pocket 
Expenses 
Out of pocket expenditure as % of 
total health expenses 
 
World Health Organization. Global 
Health Expenditure 
Database.  
Skilled Birth 
Attendance 
Births attended by skilled health 
personnel (%) 
World Bank. World Development 
Indicators, 2013. 
Immunization  Diphtheria-tetanus-pertussis 
(DTP3) immunization coverage 
among 1-year-olds (%) 
World Health Organization, Global 
Health Observatory 
Availability 
of Medicines-
Pub Sector 
Median availability of selected 
generic medicines (%) in the 
public sector. 
 World Health Organization, Global 
Health Observatory 
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Annex D.1 
 
MALAWI: Missing The Support Structure To Constitutionalize Health 
 
 
 The drafting of a new, democratic Constitution in Malawi in 1994 was reason for 
celebration. For thirty years prior, Malawi had been under one-party rule by Hastings Banda and 
the new Constitution reflected a progressive shift toward protection of human rights and the rule 
of law. The new Constitution includes in Section 30 a right to development that states: 
 
“All persons and peoples have a right to development and therefore to the 
enjoyment of economic, social, cultural and political development …  [which] 
include, amongst other things…health services…. The State shall take measures to 
introduce reforms aimed at eradicating social injustices and inequalities. The State 
has a responsibility to respect the right to development and to justify its policies in 
accordance with this responsibility.” 
 
 There is some debate amongst legal scholars about how to interpret this provision. Chirwa 
notes that the Constitution, on its face, is not particularly coherent and bifurcates entrenched rights 
that are judiciable from Directive Principles of State Policy which are not, with health rights in both 
sections.1 Others, however, have argued that even a marginally creative legal team could easily make 
the case that the combination of the directive principle and right to development grant Malawians 
a judiciable right to health.2  
 Yet there have been no substantive rulings supporting a right to health to date from 
Malawian courts and the right to health plays very little role in the politics of health in the country. 
Why?  
 There is a clearly a need—Malawians have one of the lowest life expectancies in the world 
at just 64 years, with high rates of HIV, child mortality, and maternal mortality driven by causes 
that are clearly amenable to medical intervention.3 Of particular note is the situation of access to 
																																																								
1 Chirwa 2005. 
2 Kapindu 2013; Gloppen and Kanyongolo 2007. 
3 World Bank 2017. 
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medicines in the country. Malawi has seen a documented drug shortage crisis that is going on five 
years now. It started in 2013 when it was revealed that some public sector facilities had just 5% of 
the essential medicines they needed. Health service delivery at public hospitals and clinics came to 
a near standstill and there were widespread reports of deaths in hospitals due to lack of basic 
medicines.4 Doctors at Kamuzu Central Hospital in Lilongwe sent the President at the time Joyce 
Banda a letter calling their workplace a “waiting rooms for death.”5 Years later, however, the 
situation remains a problem that is not simply attributable to insufficient funds as donors have 
stepped in to ensure money is available. Instead widespread corruption and mismanagement have 
been revealed but little action has been taken under two different presidents.6 So why no rights 
mobilization?  
 It is tempting to simply assume that Malawi, the second poorest country in the world, lacks 
an independent judiciary capable of tackling the issue, but this is not the case. The Malawian 
judiciary, which had been marginal and lacking independence under Banda’s authoritarian rule, 
quickly gained a reputation as a surprisingly strong institution—asserting independence and 
weighing in on contentious political issues. One indicator of the judiciary’s independence can be 
seen in one study that showed Malawi’s high court ruled against the government more than half 
the time and was no less likely to do so even if the President was involved in the case. 7 The courts 
have weighed in strongly and effectively on civil and political rights—overruling executive rules 
designed to stop demonstrations, ordered the Electoral Commission (MEC) to register prisoners as 
voters, and played an important role in preventing the amendment of the constitution to allow the 
sitting president to stand for a third term.8 They have also shown willingness to wade into question 
of fraud and the intervene directly in the executive’s function—most recently effectively suspending 
of the Minister of Agriculture over the objection of the president in the so-called Maize-gate 
scandal. As one commentator notes with relatively surprise, “Malawi's judges appear relatively 
fearless.”9  
																																																								
4 Malawi drug shortage still high: Now at 80 percent 2013. 
5 Stop mass murder of poor people 2013. 
6 Drug shortage now at 65% 2015; Goodall silent on drug shortages 2016. 
7 Vondoepp 2006. 
8 Gloppen and Kanyongolo 2012; VonDoepp 2013. 
9 Vondoepp 2006. 
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 Another explanation is that the judiciary simply does not see the right to health as 
judiciable. Interviews conducted with judges on the Supreme Court of Appeals and the High Court 
suggest otherwise, however. I conducted semi-structured interviews with eight justices and each 
voiced their sense that there was a judicially enforceable right to health in the Malawi Constitution.  
 
“Yes, that’s in the Constitution. I think if government was seen to be really violating 
the right of the people in terms of this provision, it's a matter that could be taken 
up, and which the court should be able to enforce. Say assuming they had the ability 
to give higher quality health service, but they were prioritizing things other than 
that. One was able to demonstrate to the court that the only shortfall in terms of 
the provision of quality healthcare, is because government is concentrating on 
wrong things, and not on this area, is a thing which I think, as courts, we should 
be able to come in to help the citizens to enforce.” –Justice, Supreme Court of 
Appeals (Interview MW-13) 
 
 Yet while a few cases have touched on the right to health but have not explicitly ruled on a 
positive right to health. The court, in the 2007 Masango case explicitly rejected the argument that 
socio-economic rights were not judiciable in a case dealing with denial of healthcare, among other 
rights, for a prisoner.10 The grounding, however, for the litigation was not in a positive social right 
and Section 30 but instead based on violations of dignity of prisoners. In another prisoner related 
case, Chimwemwe Mphembedzu v. The Republic, the court directly identified the constitutional 
provisions protecting health rights and placing a duty on the state to ensure health when deciding 
whether to release a sick person on bail.11 But the courts have not ruled firmly on an affirmative 
right to health not because they are unwilling but because they have not been asked to do so by any 
plaintiff.  
 There is also a growing civil society willing to take up both health and rights cases. Groups 
like the Malawi Health Equity Network have challenged government’s decision to require payment 
for some health services and the Center for the Development of People (CEDEP) have challenged 
the government’s criminalization of men who have sex with men on health grounds. Some of these 
groups have even gone to court—but only on political rights grounds, as when they fought to ensure 
the right to demonstrate against corruption on the National AIDS Commission. In their health 
																																																								
10 Gable Masango and Others v Attorney-General and Another 2007. 
11 Chimwemwe Mphembedzu v The Republic 2011. 
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work, these groups rarely make rights claims and they have never approached the court to address 
their health policy claims. 
 The missing link is what Epp labels the “support structure”—the lawyers, legal aid groups, 
and funding sources—to support litigation.12 There had previously been a donor-funded effort to 
support lawyers to work with NGOs on rights claims through the Civil Liberties Committee. At its 
height around 2000 that attracted roughly 40 lawyers to work on rights cases. All of these cases were 
civil and political rights as driven by the mission of the CLC and the donor interest. Today, however, 
even that initiative has gone due to “donor fatigue” and an estimate by the head of the Malawi Law 
Society is that there are no more than 10 lawyers in the country engaged in rights litigation of any 
type—and all do so part time (Interview MW-11). None of the major health groups have attorneys 
on staff or on their main boards.  
 This limited engagement by the legal complex together with the relatively formal locus 
standi rules and lack of a mechanism for public interest litigation that lowers the barriers to entry 
is what is driving the lack of judicial action. In the absence of that support structure, the 
constitutional structure means nothing for health or health policy in Malawi. It is worth noting, 
however, that support structure is something that can be built and funded.  
 
  
																																																								
12 Epp 1998. 
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Annex D.2 
 
 
THAILAND: Non-Judicial Constitutionalization of Health 
 
 
 Thailand has had twenty constitutions, interim constitutions and charters since the end of 
absolute monarchy in 1932. This high number reflects the political instability of the country, with 
most of the constitutions being replaced due to a coup or upon return to democratic rule. The 1997 
“people’s constitution” was the first to be drafted through an inclusive process led by an elected 
drafting assembly. The new constitution introduced a host of reforms that led directly to a variety 
of health reforms that have been widely lauded in the country.  
 The new constitution mattered most directly because it introduced a new electoral system 
that dramatically changed the landscape of parties in the country. The new 1997 electoral 
framework included a mix of proportional representation and single member districts, which 
Selway credits for shifting the way parties formulated and targeted their health policies.13   Opening 
the door for the birth of the Thai Rak Thai (TRT) Party led by billionaire Thaksin Shinawatra, these 
new electoral rules also incentivized Thaksin’s party to support a sweeping new Universal Health 
Care (UHC) program known as the “30-baht scheme” for the low price charged for each visit.14 
This system bucked the advice of international financial institutions and has since been widely 
praised as a bold and effective expansion of access for the poor.15 Even as the era of open democracy 
and populist politics in Thailand has waned the 30-baht scheme (now free) has remained.  
 Less explored is the other change to the constitution—the introduction of a right to health. 
The 1997 constitution included an explicit right to health:  
 
Article 52: A person shall enjoy an equal right to receive standard public health 
service, and the indigent shall have the right to receive free medical treatment from 
public health centers of the State, as provided by law. The public health service by 
the State shall be provided thoroughly and efficiently and, for this purpose, 
participation by local government organizations and the private sector shall also 
be promoted insofar as it is possible. The State shall prevent and eradicate harmful 
contagious diseases for the public without charge, as provided by law.  
																																																								
13 Selway 2015. 
14 Siriwan Pitayarangsarit 2010; Phongpaichit and Baker 2004. 
15 Thaiprayoon and Wibulpolprasert 2017. 
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 Since 1997 there have been a series of new constitutions—two interim constitutions and 
the full constitutions of 2007 and 2017. Each of these has retained similar language, keeping the 
right to health in place even as the electoral rules that gave rise to the universal health system have 
long since passed and both the Thai Rak Thai party and its successors are no more.  
 On the one hand, one struggles to identify the impact of the Thai constitution. As one 
interviewee noted: 
“Constitutions come and go. What does the King want? What will the military 
allow? These are the key questions. Only then do we get to the constitution.” 
(Interview TH-16) 
 
 It is certainly true that the right to health has not had the kind of impact on macro politics 
in Thailand as it has in India or South Africa.  
 Even more notable is that the courts in Thailand have no role in socioeconomic rights to 
speak of. On the one had the judiciary seems quite powerful—it has twice dissolved the ruling party 
and has been highly active in politics. They represent, however, a classic example of a conservative 
power focused on hegemonic preservation in the clearest sense—leading scholars to refer to the 
apex Thai courts as practicing ‘rule by law’.16  
 However, as Harris has documented the actual story of the expansion of health policy in 
Thailand has as much to do with bureaucratic entrepreneurialism and the initiative of a set of 
progressive doctors inside government as it did with the TRT party per se.17 Leaders from the Rural 
Doctors Society and the subsequently formed Sampran Forum have become critical players in the 
health politics of Thailand by securing key positions of technocratic leadership in the country and 
using those to launch progressive health policies on several levels. They helped set in place the 
dynamics that led to the UHC system—having sought for years the political leadership needed to 
make it happen without success until the appearance of Thaksin who adopted their platform based 
on a political instinct and personal connections (Interview TH-24, TH-28 & Harris 2015). It was 
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these doctors and their associates who helped craft and push for the inclusion of the right to health 
in the 1997 constitution and they have played a central role in defending it since then.  
 While far less visible, these doctors and other policy entrepreneurs inside and outside 
government have strategically used the constitution to help drive critical parts of the UHC system.  
It was not a mistake that article 52 of the constitution includes the language “as provided by law.” 
Having pushed for the right to health provision, public health leaders proceeded to draft a bill to 
enact the law it called for, which took shape well before Thaksin came to power. While TRT was 
building its platform and before the new elections that would bring the party to power was called, 
health activists and physicians together started drafting a bill. With explicit reference to the 
constitution, the bill fleshed out what a system would look like based in principles of universalism 
that directly challenged the advice of the World Bank and others at the time. Then, with funding 
from the ministry of public health itself, secured by leaders from the Rural doctors, civil society 
groups began a petition drive to support a new National Health Security Bill which eventually 
garnered over 60,000 signatures.18 They then used a provision from Section 170 of the 1997 
constitution that required any bill introduced with 50,000 or more signatures to move to a vote 
automatically. By this point Thaksin had been elected and the external bill was joined by a series of 
other bills on the issue submitted by cabinet and from other parties and, in the end, what was passed 
reflected a mix of the proposals with strong influence from the original externally drafted bill.  
 One of the key elements it created was the National Health Security Office—a separate body 
charged with financing the UHC system. Inside this new institution was created a set of rights-
based processes aimed at identifying what should be covered under the UHC system and providing 
accountaibliy for services. The first unique feature—built into the institutional design and justified 
explicitly on the grounds that health was now a constitutional right—is an adjudication system in 
which individual Thais and NGOs can petition for coverage of different drugs, laboratory tests, and 
medical interventions that may not be already covered. Originally, for example, antiretroviral drugs 
to treat HIV were not covered under the NHSO scheme. After a complex process of review sparked 
by a formal petition, today they are covered—which in part later spared an important push to lower 
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the price of these drugs as well as expand spending on not just HIV but a small handful of deadly 
but neglected diseases. This system is not adversarial but it is adjudicative—mobilizing the key 
mechanisms of a court—and allows petitioners to challenge the decisions of the NHSO directly. A 
second similar system has also been set up to allow petitions for redress when the right to health 
has not been met by the health system for individual Thais. As the 2008 NHSO annual report notes, 
“following the declaration in the Thai constitution several measures to guarantee the right to health 
for all Thais have been developed.” These include an investigative team and sub-committee to 
adjudicate claims where core health services are not provided for free, substandard services are 
provided, or access to care is not meaningfully available because of distance, accessibility issues, or 
discrimination. These adjudication mechanisms have been used by drug users to get access to 
treatment and harm reduction services, by rural women to push for maternal health services closer 
to where they live, and by advocates for the urban poor to call attention to corrupt providers who 
charged extra fees to customers. Even as space for electoral politics has closed and the courts have 
become less and less reliable, especially for poor Thais, these processes have continued—shifting 
how health services are governed in the country.  
  
 
 
References	
	
318	
Primary	Sources	
Newspaper	Articles	&	Court	Cases	
(alpha	by	title)	
	
	
2008.	49	babies	die	during	clinical	trials	at	AIIMS.	Times	of	
India.	
2002.	A	Bold	Move	on	AIDS	in	South	Africa.	New	York	Times.	
2003.	Aids	activists	take	on	one	of	their	own.	Mail	&	
Guardian.	
1991.	Aids	Is	A	Blessing,	Says	Keeper	Of	The	Chained	Addicts.	
Reuters	News.	
2003.	Aids:	Ministers	revolt.	Mail	&	Guardian.	
2004.	Ambulance	Blaimed	for	Boys	Death.	Daily	Dispatch.	
2007.	Ambulance	shortages	exaggerated	-	state.	South	
African	Press	Association.	
2002.	ANC	and	IFP	square	up	in	‘volley	of	assaults’.	The	
Independent	Online.	Available	at	
<http://www.iol.co.za/news/politics/anc-and-ifp-
square-up-in-volley-of-assaults-82392>.	
2002.	ANC	Closes	Ranks.	Mail	&	Guardian.	
2000.	ANC	takes	Mbeki	to	task.	Cape	Times.	September	14.	
2009.	Anglo	chairperson	list	includes	Ramaphosa.	Mail	&	
Guardian.	
2003.	Baby	stillborn	after	40-hour	wait	for	help.	Daily	
Dispatch.	
2004.	Bisho	blamed	for	ambulance	crisis.	Daily	Dispatch.	
2002.	Budget	Speech	2002-2003		of	Shri	Yashwant	Sinha,	
Minister	of	Finance.	Government	of	India.	
Available	at	<http://indiabudget.nic.in/ub2002-
03/bs/speech_b.htm>.	
2004.	Call	for	probe	into	6-hour	ambulance	wait.	Daily	
Dispatch.	
1996.	Can	we	afford	new	Aids	drugs?	Mail	&	Guardian.	
November	08.	
2011.	Chimwemwe	Mphembedzu	v	The	Republic	Bail	Case	
No	70	of	2011	MWHC	12.	
2008.	Clinical	Drug-Test	Claims	Volunteer’s	Life	in	
Hyderabad.	DNA.	
2013.	Clinical	trials	of	untested	drugs	creating	‘havoc’:	
Supreme	Court.	The	Hindu.	Available	at	
<http://www.hrln.org/hrln/peoples-health-
rights/pils-a-cases/1170-clinical-trials-of-
untested-drugs-creating-havoc-
sc.html#ixzz4q9XlmWrC>.	
2012.	Clinical	Trials:	Regulating	Chaos.	Mint.	
2012.	ConCourt	makes	landmark	TB	ruling.	Mail	&	Guardian.	
n.d.	Constitution	of	the	Treatment	Action	Campaign.	
Available	at	
<http://www.tac.org.za/Documents/Constitution
/Constitution.htm>.	
1995.	Consumer	Education	&	Research	Center	v.	Union	of	
India	1995	SCC		(3)	 	42.	
2012.	Cope	calls	for	national	intervention	in	key	Eastern	
Cape	departments.	Algoa	FM.	Available	at	
<http://www.algoafm.co.za/Article/37215/cope-
calls-for-national-intervention-in-key-eastern-
cape-departments->.	
2010.	Court	of	its	own	Motion	v.	Union	of	India	W.p.	(C)	
5913/2010.	
2001.	Crowded	Prison	a	Big	Health	Risk.	Cape	Times.	
	
	
	
2013.	Cutting	the	McCord:	Durban’s	hospital	finally	loses	the	
battle.	Daily	Maverick.	Available	at	
<http://www.dailymaverick.co.za/article/2013-
01-23-cutting-the-mccord-durbans-hospital-
finally-loses-the-battle/#.UipEzrzXE_p>.	
1994.	Deteriorating	Health	Services.	The	Star,	14	July	1994	
edition.	
2004.	Draft	Bill	on	HIV/AIDS	soon.	The	Hindu.	
2015.	Drug	shortage	now	at	65%.	The	Nation.	
2011.	Dudley	Lee	v	Minister	of	Correctional	Services,	2011	(6)	
SA	564	(WCC).	
2012.	Dudley	Lee	v	Minister	of	Correctional	Services,	2013	2	
BCLR	129	(CC).	
2012.	Eastern	Cape	EMS	wildcat	strike	could	be	over	by	next	
week.	Algoa	FM.	Available	at	
<http://www.algoafm.co.za/Article/37270/easter
n-cape-ems-wildcat-strike-could-be-over-by-next-
week>.	
2009.	EMS	Blues.	Stu.d.jo	Productions.	
2014.	Founding	Affidavit,	Anele	Yawa	in	re:	Nkala	and	others	
v.	Harmony	Gold	and	Others.	
2001.	Founding	Affidavit,	TAC	v	Minister	of	Health.	High	
Court	of	South	Africa,	Transvaal	Provincial	
Division.	
1981.	Francis	Coralie	Mullin	v.	The	Administration,	Union	
Territory	of	Delhi.	
2007.	Gable	Masango	and	Others	v	Attorney-General	and	
Another	2009	AHRLR	353	(MHC	2009).	
2013.	Generic	cancer	drug	-	access	not	guaranteed.	Mail	&	
Guardian.	Available	at	
<http://bhekisisa.org/article/2013-09-09-cancer-
drug-pricing-debacle-leaves-patients-unsure>.	
2016.	Goodall	silent	on	drug	shortages.	The	Nation.	
2012.	Government	wins	battle	for	cheaper	AIDS	drugs.	
Business	Day.	Available	at	
<http://www.bdlive.co.za/articles/2010/12/15/g
overnment-wins-battle-for-cheaper-aids-
drugs;jsessionid=9B99F69BB76E8DE0869D5F156
DC78C19.present1.bdfm>.	
2003.	Help	for	Benson	and	Bency.	The	Hindu.	
2012.	HIV+	People	and	Health	groups	Protest	Outside	
Novartis	Headquarters.	Don’t	Trade	Away	Our	
Lives.	Available	at	
<https://donttradeourlivesaway.wordpress.com/
2012/12/21/hiv-people-and-health-groups-
protest-outside-novartis-headquarters-in-
mumbai-ahead-of-verdict-in-novartis-vs-india-
supreme-court-case/>.	
2012.	I	Got	TB	in	Prison,	Former	Inmate	Tells	Court.	City	
Press.	
2000.	I	will	not	apologise,	vows	John	Robbie.	South	African	
Press	Association.	
2013.	Illegal	Clinical	Trials:	India	Poor	‘Duped’	Into	Taking	
Untested	Drugs.	Agence	France	Presse.	
2016.	Is	the	govt	mulling	a	surgical	strike	on	medicines?	The	
Hindu.	
2013.	It’s	a	PATH	of	violations,	all	the	way	to	vaccine	trials:	
House	panel.	The	Hindu.	
2010.	Laxmi	Mandal	v.	Deen	Dayal	Harinagar	Hospital	&	Ors	
W.p.	(C)	No.	8853/2008.	
1990.	Losing	the	battle	with	Aids.	The	Guardian.	
1999.	Make	AZT	affordable	to	all.	Cape	Argus.	April	28.	
2013.	Malawi	drug	shortage	still	high:	Now	at	80	percent.	
Malawi	Nyasa	Times	-	Malawi	breaking	news	in	
Malawi.	
References	
	
319	
1994.	Mandela	on	Reassuring	Whites,	People’s	Needs.	South	
African	Press	Association.	
2011.	Mankayi	v	Anglogold	Ashanti	Ltd	6	BLLR	527	(CC).	
2004.	Manto	punts	‘eccentric’	Aids	plan	once	more.	Cape	
Times.	February	9.	
2000.	Mbeki	digs	in	heels	over	HIV/Aids.	Sunday	
Independant.	March	25.	
2001.	Mbeki	in	Bizarre	AIDS	Outburst.	Mail	&	Guardian.	26	
October.	
2004.	Mbeki	slams	soothsayers	of	doom.	South	African	Press	
Association.	February	6.	
1999.	Mbeki	sparks	row	over	Aids	drug.	Independent.	
October	30.	Available	at	
<http://www.iol.co.za/news/south-africa/mbeki-
sparks-row-over-aids-drug-17874>.	
2012.	Medical	strike	stalls	SOS	line.	Grocotts	Mail.	Available	
at	<http://www.grocotts.co.za/content/patients-
stranded-strike-22-11-2012>.	
2016.	Mining	sector	to	reform	worker	compensation	system.	
Cape	Times.	
2012.	Minister	of	Correctional	Services	v	Dudley	Lee,	2012	(3)	
SA	617	(SCA).	
2002.	Minister	of	Health	and	Others	v	Treatment	Action	
Campaign	and	Others	(10)	BCLR	1033	(CC).	
1998.	National	Aids	Policy.	Government	of	India.	
2002.	National	Aids	Prevention	and	Control	Policy.	National	
AIDS	Control	Organization.	
2002.	National	Health	Policy.	New	Delhi:	Ministry	of	Health	
and	Family	Welfare.	
2009.	Naz	Foundation	v.	Govt.	of	NCT	of	Delhi	WP(C)	
No.7455/2001.	
2016.	New	government	regulations	water	down	clinical	trial	
safety	norms.	Scroll.in.	
2015.	Nigel	Farage’s	HIV	claim	criticised	by	leaders’	debate	
rivals.	The	Guardian.	
2016.	Nkala	and	others	v.	Harmony	Gold	Mining	Company	
Limited	and	others	(7)	BCLR	881	(GJ).	
2003.	Notable	quotes	from	the	year	that	was...	South	African	
Press	Association.	15	December.	
2006.	Novartis	AG	v.	Union	of	India	&	Others	Writ	Petition	
No	24759	and	24760	of	2006.	
2002.	Now	I	must	poison	my	people,	says	Dr	No.	South	
African	Press	Association.	
2016.	Pfizer	Limited	&	Anr	vs	Union	Of	India	&	Anr	W.P.(C)	
No.2212/2016.	
2003.	Plan	To	Provide	Treatment	to	HIV-Positive	Mothers,	
Children.	Times	of	India.	
2007.	Pollsmoor	whistle-blower	gets	his	job	back.	Mail	&	
Guardian.	
2011.	Prices	of	348	essential	drugs	to	be	controlled.	Times	of	
India.	
2000.	Pseudoscience	Can	Damage	Your	Health.	Sunday	
Times.	May	21.	
1995.	Public	services	still	on	the	boil.	Mail	&	Guardian.	06	
Jan	1995.	
2001.	PUCL	vs	Union	of	India	&	Others	Writ	Petition	(Civil)	
196	of	2001.	
2001.	Puzzling	delay	in	nevirapine	programme.	South	African	
Health	News	Service	(Health-e).	
1998.	Sahara	House	v.	Union	of	India	Supreme	Court	No.	535	
of	1998.	
1999.	Sankalp	Rehabilitation	Trust	v.	Union	of	India	Supreme	
Court	No.	(C)	513	of	1999.	
2013.	SA’s	newspapers	‘under	pressure’	as	circulation	drops.	
Business	Day.	
2010.	She	gave	birth,	died.	Delhi	walked	by...	Hindustan	
Times.	
1994.	Shortage	of	Funds	Threatens	Province’s	Health	
Projects.	South	African	Press	Association.	
2015.	South	Africa’s	notorious	Pollsmoor	prison	joins	the	
global	battle	against	TB.	The	Guardian.	
1996.	State	of	Punjab	and	Ors.	v.	Mohinder	Singh	Chawala,	
1997	2	SCC	83	1997	2	SCC	83.	
2013.	Stop	mass	murder	of	poor	people.	The	Nation.	
2015.	Supreme	Court	seeks	review	of	drug	pricing	policy.	
Reuters.	
2012.	Swasthya	Adhikar	Manch,	Indore	&	Anr.	vs.	Ministry	of	
Health	and	Family	Welfare	&	Ors.	Writ	Petition	
(Civil)	No(s).	33/2012	Supreme	Court.	
1989.	The	AIDS	Prevention	Bill	of	1989.	Gazette	of	India	18-
8-1989	S.2.	43.	
2004.	‘The	ANC	has	broken	its	promises	on	Aids’.	The	
Independent	Online.	Available	at	
<http://www.iol.co.za/news/politics/the-anc-has-
broken-its-promises-on-aids-210152>.	
2000.	The	Durban	Declaration.	Nature	(406):	15–16.	
2009.	The	National	Health	Bill,	2009	(GoI	Working	Draft).	
Ministry	of	Health	and	Family	Welfare.	
1997.	The	new	Randlord.	The	Economist.	Available	at	
<http://www.economist.com/node/90685>.	
2000.	The	XIII	International	AIDS	Conference.	The	Body.	July	
14.	Available	at	
<http://www.thebody.com/content/art16083.ht
ml>.	
2002.	Treatment	Action	Campaign	&	others	v.	Minister	of	
Health	and	others,	(4)	BCLR	356	(T).	
2003.	Union	of	India	vs	KS	Gopinath	and	Ors	Civil	Appeal	NO.	
9219	of	2003.	
1987.	Vincent	Panikurlangara	v.	Union	of	India	and	Ors	1987	
SCC	(2)	165.	
20003.	Voluntary	Health	Association	of	Punjab	v	Union	of	
India	Ors.	Supreme	Court	No.311	of	2003.	
2015.	Where	there	are	no	ambulances.	Daily	Maverick.	
2007.	Why	Frere’s	Babies	Die.	Daily	Dispatch.	
2003.	Worldwide	war	on	AIDS/HIV	still	coming	up	way	short.	
Associated	Press.	Available	at	<http://www.post-
gazette.com/news/health/2003/09/21/Worldwid
e-war-on-AIDS-HIV-still-coming-up-way-
short/stories/200309210048>.	
2008.	Wyeth	drug	tests	fall	foul	of	watchdog.	LiveMint.	
Available	at	<http://www.livemint.com/Home-
Page/j4W7C2aW2imlLjKZPUSfNM/Wyeth-drug-
tests-fall-foul-of-watchdog.html>.	
2001.	You	Don’t	Have	to	Die	of	HIV/AIDS.	Cipla	Archives.	
1998.	Zuma	defends	AZT	policy.	Mail	&	Guardian.	October	
16.	
	
	
	
	
	
	
References	
	
320	
Literature	
	
Acemoglu,	Daron.	2012.	The	World	Our	Grandchildren	Will	
Inherit:	The	Rights	Revolution	and	Beyond.	NBER	
Working	Paper	(17994).	
Acemoglu,	Daron,	Simon	Johnson,	and	James	A.	Robinson.	
2005.	Institutions	as	a	fundamental	cause	of	long-
run	growth.	In	Handbook	of	economic	growth,	
edited	by	Phillipe	Aghion	and	Stephen	Durlauf,	
385–472.	Amsterdam:	Elsevier.	
Acemoglu,	Daron,	Suresh	Naidu,	Pascual	Restrepo,	and	James	
A.	Robinson.	2014.	Democracy	does	cause	growth.	
National	Bureau	of	Economic	Research.	
Acemoglu,	Daron,	and	James	A.	Robinson.	2005.	Economic	
origins	of	dictatorship	and	democracy.	Cambridge	
University	Press.	
Achen,	Christopher	H.	2000.	Why	lagged	dependent	variables	
can	suppress	the	explanatory	power	of	other	
independent	variables.	In	Annual	Meeting	of	the	
Political	Methodology	Section,	American	Political	
Science	Association,	1001:.	Vol.	1001.	Chicago.	
Achmat,	Zackie.	2003.	Building	Branches	to	Organise	for	
Treatment.	TAC	Electronic	Newsletter.	Available	at	
<http://www.tac.org.za/newsletter/2003/ns01_07
_2003.htm>.	
Adams,	Gordon.	1981.	The	Iron	Triangle:	the	politics	of	
defense	contracting.	Transaction	Publishers.	
African	National	Congress.	1992.	A	Bill	of	Rights	for	a	New	
South	Africa-A	Working	Document	by	the	ANC	
Constitutional	Committee.	
African	National	Congress.	1994.	A	National	Health	Plan	for	
South	Africa.	Available	at	
<http://www.anc.org.za/content/national-health-
plan-south-africa>.	
African	National	Congress.	1990.	Maputo	statement	on	HIV	
and	AIDS	in	southern	Africa.	Health	Policy	and	
Planning	5	(4):	386–88.	
African	National	Congress.	1995.	Preliminary	ANC	Submission,	
Theme	Committee	4	-	Further	Socio-Economic	
Rights.	
Ahmad,	Omar	B.,	Alan	D.	Lopez,	and	Mie	Inoue.	2000.	The	
decline	in	child	mortality:	a	reappraisal.	Bulletin	of	
the	World	Health	Organization	78:	1175–1191.	
Ainsworth,	Martha,	Chris	Beyrer,	and	Agnes	Soucat.	2003.	
AIDS	and	public	policy:	the	lessons	and	challenges	
of	‘success’	in	Thailand.	Health	Policy	64	(1):	13–
37.	
Aísa,	Rosa,	Jesús	Clemente,	and	Fernando	Pueyo.	2014.	The	
influence	of	(public)	health	expenditure	on	
longevity.	International	journal	of	public	health	59	
(5):	867–875.	
Akin,	John	S.,	Nancy	Birdsall,	and	David	M.	De	Ferranti.	1987.	
Financing	health	services	in	developing	countries:	
an	agenda	for	reform.	World	Bank.	
Alabi,	Adeyinka	A.,	Don	O’Mahony,	Graham	Wright,	and	
Mohlomi	J.	Ntsaba.	2015.	Why	are	babies	born	
before	arrival	at	health	facilities	in	King	Sabata	
Dalindyebo	Local	Municipality,	Eastern	Cape,	
South	Africa?	A	qualitative	study.	African	Journal	
of	Primary	Health	Care	&	Family	Medicine	7	(1):	9	
pages.	
Alesina,	Alberto,	Reza	Baqir,	and	William	Easterly.	1999.	
Public	goods	and	ethnic	divisions.	The	Quarterly	
Journal	of	Economics	114	(4):	1243–1284.	
Alesina,	Alberto,	Sule	Özler,	Nouriel	Roubini,	and	Phillip	
Swagel.	1996.	Political	instability	and	economic	
growth.	Journal	of	Economic	growth	1	(2):	189–
211.	
Alexander,	Peter,	Carin	Runciman,	and	Trevor	Ngwane.	2016.	
South	Africa’s	rebellion	of	the	poor.	In	3rd	
International	Conference	Strikes	and	Social	
Conflicts:	combined	historical	approaches	to	
conflict.,	148–161.	CEFID-UAB.	
Amon,	Joseph	J.,	and	Katherine	W.	Todrys.	2008.	Fear	of	
foreigners:	HIV-related	restrictions	on	entry,	stay,	
and	residence.	Journal	of	the	International	AIDS	
Society	11	(1):	8.	
Associated	Chamber	of	Commerce	&	Industry.	2016.	India’s	
pharma	exports	may	reach	$20	bn	by	2020:	Study.	
ASSOCHAM.	
Ataguba,	John	E.,	James	Akazili,	and	Di	McIntyre.	2011.	
Socioeconomic-related	health	inequality	in	South	
Africa:	evidence	from	General	Household	Surveys.	
International	journal	for	equity	in	health	10	(1):	48.	
Ataguba,	John	E.,	and	Di	McIntyre.	2017.	The	incidence	of	
health	financing	in	South	Africa:	findings	from	a	
recent	data	set.	Health	Economics,	Policy	and	Law:	
1–24.	
Ataguba,	John	Ele-Ojo,	and	Olufunke	Alaba.	2012.	Explaining	
health	inequalities	in	South	Africa:	a	political	
economy	perspective.	Development	Southern	
Africa	29	(5):	756–764.	
Ataguba,	John	Ele-Ojo,	and	Di	McIntyre.	2013.	Who	benefits	
from	health	services	in	South	Africa?	Health	
Economics,	Policy	and	Law	8	(01):	21–46.	
Auvert,	Bertran,	Ron	Ballard,	Catherine	Campbell,	Michel	
Caraël,	Matthieu	Carton,	Glenda	Fehler,	Eleanor	
Gouws,	Catherine	MacPhail,	Dirk	Taljaard,	and	
Johannes	Van	Dam.	2001.	HIV	infection	among	
youth	in	a	South	African	mining	town	is	associated	
with	herpes	simplex	virus-2	seropositivity	and	
sexual	behaviour.	Aids	15	(7):	885–898.	
Awofeso,	Niyi,	Anu	Rammohan,	and	Kazi	Iqbal.	2013.	Age-
appropriate	vaccination	against	measles	and	DPT-3	
in	India–closing	the	gaps.	BMC	public	health	13	(1):	
358.	
Bachmann,	Max	O.,	and	Bupendra	Makan.	1997.	Salary	
inequality	and	primary	care	integration	in	South	
Africa.	Social	Science	&	Medicine	45	(5):	723–729.	
Backman,	Gunilla,	Paul	Hunt,	Rajat	Khosla,	Camila	Jaramillo-
Strouss,	Belachew	Mekuria	Fikre,	Caroline	Rumble,	
David	Pevalin,	David	Acurio	Páez,	Mónica	Armijos	
Pineda,	and	Ariel	Frisancho.	2008.	Health	systems	
and	the	right	to	health:	an	assessment	of	194	
countries.	The	Lancet	372	(9655):	2047–2085.	
Bagcchi,	Sanjeet.	2015.	Thousands	die	in	clinical	trials	in	India,	
but	compensation	is	rarely	paid.	BMJ:	British	
Medical	Journal	351.	
Bagla,	Pallava.	2013.	Indian	Parliament	comes	down	hard	on	
cervical	cancer	trial.	Science.	
Ballard,	Richard,	Adam	Habib,	and	Imraan	Valodia.	2006.	
Voices	of	protest:	Social	movements	in	post-
apartheid	South	Africa.	University	of	KwaZulu-
Natal	Press.	
Ban,	Cornel.	2016.	Ruling	Ideas:	How	Global	Neoliberalism	
Goes	Local.	Oxford	University	Press.	
References	
	
321	
Barber,	Ryan	M.,	Nancy	Fullman,	Reed	JD	Sorensen,	and	GBD	
2015	Healthcare	Access	and	Quality	Collaborators.	
2017.	Healthcare	Access	and	Quality	Index	based	
on	mortality	from	causes	amenable	to	personal	
health	care	in	195	countries	and	territories,	1990–
2015:	a	novel	analysis	from	the	Global	Burden	of	
Disease	Study	2015.	Lancet.	
Barcellos,	Ana	Paula	de.	2014.	Sanitation	Rights,	Public	Law	
Litigation,	and	Inequality:	A	Case	Study	from	Brazil.	
Health	and	human	rights	16:	2.	
Bartels,	Larry	M.	2009.	Unequal	democracy:	The	political	
economy	of	the	new	gilded	age.	Princeton	
University	Press.	
Bateman,	Chris.	2014.	Breaching	the	chasm	between	what’s	
law	and	what’s	done.	South	African	Medical	
Journal	104	(9):	600–601.	
Batniji,	Rajaie,	Lina	Khatib,	Melani	Cammett,	Jeffrey	Sweet,	
Sanjay	Basu,	Amaney	Jamal,	Paul	Wise,	and	Rita	
Giacaman.	2014.	Governance	and	health	in	the	
Arab	world.	The	Lancet	383	(9914):	343–355.	
Baumgartner,	F.	R.,	and	B.	D.	Jones.	1993.	Agendas	and	
instability	in	American	politics.	Chicago:	University	
Of	Chicago	Press.	
Baumgartner,	Frank	R.,	Petra	Bishtawi,	Marcello	Carammia,	
Derek	A.	Epp,	Ben	Noble,	Beatriz	Rey,	and	Tevfik	
Murat	Yildirim.	2015.	Budgeting	in	Authoritarian	
and	Democratic	Regimes.	In	Comparative	Agendas	
Project	Conference.	Lisbon.	
Baumgartner,	Frank	R.,	Christian	Breunig,	Christoffer	Green-
Pedersen,	Bryan	D.	Jones,	Peter	B.	Mortensen,	
Michiel	Nuytemans,	and	Stefaan	Walgrave.	2009.	
Punctuated	equilibrium	in	comparative	
perspective.	American	Journal	of	Political	Science	
53	(3):	603–620.	
Baumgartner,	Frank	R.,	Bryan	D.	Jones,	and	John	Wilkerson.	
2011.	Comparative	studies	of	policy	dynamics.	
Comparative	Political	Studies	44	(8):	947–972.	
Baussano,	Iacopo,	Brian	G.	Williams,	Paul	Nunn,	Marta	
Beggiato,	Ugo	Fedeli,	and	Fabio	Scano.	2010.	
Tuberculosis	incidence	in	prisons:	a	systematic	
review.	PLoS	medicine	7	(12):	e1000381.	
Bawa,	Ahmed,	Daniel	Herwitz,	and	Hoosen	Coovadia.	2000.	
Leave	Science	to	the	Scientists	Mr.	Mbeki.	Sunday	
Independant.	June	25.	
Baxi,	Upendra.	1985.	Taking	suffering	seriously:	Social	action	
litigation	in	the	Supreme	Court	of	India.	Third	
World	Legal	Studies:	107.	
Bazzle,	Timothy.	2010.	Pharmacy	of	the	developing	world:	
Reconciling	intellectual	property	rights	in	India	
with	the	right	to	health:	TRIPS,	India’s	patent	
system	and	essential	medicines.	Georgetown	
Journal	of	International	Law	42:	785.	
Beck,	Nathaniel,	and	Jonathan	N.	Katz.	1995.	What	to	do	(and	
not	to	do)	with	time-series	cross-section	data.	
American	political	science	review	89	(03):	634–647.	
Beckfield,	Jason,	and	Nancy	Krieger.	2009.	Epi+	demos+	cracy:	
linking	political	systems	and	priorities	to	the	
magnitude	of	health	inequities—evidence,	gaps,	
and	a	research	agenda.	Epidemiologic	Reviews	31`	
(1):	152–177.	
Beitz,	Charles	R.	2009.	The	idea	of	human	rights.	Oxford	
University	Press.	
Béland,	Daniel.	2005.	Ideas	and	social	policy:	An	
institutionalist	perspective.	Social	Policy	&	
Administration	39	(1):	1–18.	
Béland,	Daniel.	2010.	Policy	change	and	health	care	research.	
Journal	of	health	politics,	policy	and	law	35	(4):	
615–641.	
Béland,	Daniel,	and	Robert	Henry	Cox.	2010.	Ideas	and	politics	
in	social	science	research.	Oxford	University	Press.	
Béland,	Daniel,	and	Robert	Henry	Cox.	2016.	Ideas	as	coalition	
magnets:	coalition	building,	policy	entrepreneurs,	
and	power	relations.	Journal	of	European	Public	
Policy	23	(3):	428–45.	
Béland,	Daniel,	and	Martin	Powell.	2016.	Continuity	and	
Change	in	Social	Policy.	Social	Policy	&	
Administration	50	(2):	129–147.	
Bennett,	Andrew,	and	Jeffrey	T.	Checkel.	2014.	Process	
tracing.	Cambridge	University	Press.	
Beracochea,	Elvira,	Corey	Weinstein,	and	Dabney	Evans.	2010.	
Rights-based	approaches	to	public	health.	Springer	
Publishing	Company.	
Berger,	Jonathan.	2008.	Litigating	for	social	justice	in	post-
apartheid	South	Africa:	a	focus	on	health	and	
education.	In	Courting	social	justice:	Judicial	
enforcement	of	social	and	economic	rights	in	the	
developing	world,	edited	by	Varun	Gauri	and	
Daniel	M.	Brinks,	38–99.	Cambridge:	Cambridge	
University	Press.	
Berry,	Christopher	R.,	and	William	G.	Howell.	2007.	
Accountability	and	local	elections:	Rethinking	
retrospective	voting.	Journal	of	Politics	69	(3):	
844–858.	
Berry,	Jeffrey	M.	1989.	Subgovernments,	issue	networks,	and	
political	conflict.	Westview	Press.	
Besley,	Timothy.	2006.	Principled	agents?:	The	political	
economy	of	good	government.	Oxford	University	
Press	on	Demand.	
Besley,	Timothy,	and	Masayuki	Kudamatsu.	2006.	Health	and	
democracy.	The	American	economic	review	96	(2):	
313–318.	
Beyrer,	Chris,	Juan	Carlos	Villar,	Voravit	Suwanvanichkij,	Sonal	
Singh,	Stefan	D.	Baral,	and	Edward	J.	Mills.	2007.	
Neglected	diseases,	civil	conflicts,	and	the	right	to	
health.	The	Lancet	370	(9587):	619–627.	
Bhardwaj,	Kajal.	2009.	Persons	living	With	HIV	and	Access	to	
Generic	Medicines	in	India.	In	Our	Health	Our	
Right:	The	roles	and	experiences	of	PLHIV	networks	
in	securing	access	to	generic	ARV	medicines	in	Asia.	
Bangkok:	Asia	Pacific	Network	of	People	Living	
with	HIV/AIDS	(APN+).	
Bhatt,	A.	2004.	Clinical	trials	in	India:	Pangs	of	globalization.	
Indian	Journal	of	Pharmacology	36	(4).	
Bhattacharya,	Sanjoy.	2004.	Uncertain	advances:	a	review	of	
the	final	phases	of	the	smallpox	eradication	
program	in	India,	1960–1980.	American	journal	of	
public	health	94	(11):	1875–1883.	
Bhave,	Amita,	and	Suresh	Menon.	2017.	Regulatory	
environment	for	clinical	research:	Recent	past	and	
expected	future.	Perspectives	in	clinical	research	8	
(1):	11.	
Bhore,	Joseph.	1946.	Report	Of	The	Health	Survey	And	
Development	Committee.	Calcutta:	Government	of	
India	Press.	
Bickel,	Alexander	M.	1962.	The	Least	Dangerous	Branch:	The	
Supreme	Court	at	the	Bar	of	Polilics.	Yale	University	
Press.	
Biehl,	João.	2015.	The	Juridical	Hospital.	In	Living	and	Dying	in	
the	Contemporary	World:	A	Compendium,	edited	
by	Veena	Das,	251–269.	University	of	California	
Press.	
References	
	
322	
Biehl,	João,	Joseph	J.	Amon,	Mariana	P.	Socal,	and	Adriana	
Petryna.	2012.	Between	the	court	and	the	clinic:	
Lawsuits	for	medicines	and	the	right	to	health	in	
Brazil.	Health	and	Human	Rights:	An	International	
Journal	14	(1):	E36-52.	
Biehl,	João	Guilherme.	2007.	Will	to	live:	AIDS	therapies	and	
the	politics	of	survival.	Princeton	University	Press.	
Biehl,	João,	Adriana	Petryna,	Alex	Gertner,	Joseph	J.	Amon,	
and	Paulo	D.	Picon.	2009.	Judicialisation	of	the	
right	to	health	in	Brazil.	The	Lancet	373	(9682):	
2182–2184.	
Biehl,	João,	Mariana	P.	Socal,	and	Joseph	J.	Amon.	2016.	The	
Judicialization	of	Health	and	the	Quest	for	State	
Accountability:	Evidence	from	1,262	Lawsuits	for	
Access	to	Medicines	in	Southern	Brazil.	Health	and	
human	rights	18	(1):	209–220.	
Biggs,	Brian,	Lawrence	King,	Sanjay	Basu,	and	David	Stuckler.	
2010.	Is	wealthier	always	healthier?	The	impact	of	
national	income	level,	inequality,	and	poverty	on	
public	health	in	Latin	America.	Social	science	&	
medicine	71	(2):	266–273.	
Bilchitz,	David.	2003a.	South	Africa:	Right	to	health	and	access	
to	HIV/AIDS	drug	treatment.	International	Journal	
of	Constitutional	Law	1	(3):	524–534.	
Bilchitz,	David.	2003b.	Towards	a	reasonable	approach	to	the	
minimum	core:	laying	the	foundations	for	future	
socio-economic	rights	jurisprudence.	South	African	
Journal	on	Human	Rights	19	(1):	1–26.	
Birn,	Anne-Emanuelle,	Yogan	Pillay,	and	Timothy	H.	Holtz.	
2009.	Textbook	of	international	health:	Global	
health	in	a	dynamic	world.	Oxford	University	Press.	
Böhm,	Katharina.	2016.	The	Transformation	of	the	Social	
Right	to	Healthcare:	Evidence	from	England	and	
Germany.	Routledge.	
Boily,	Marie-Claude,	Michael	Pickles,	Catherine	M.	Lowndes,	
Banadakoppa	M.	Ramesh,	Reynold	Washington,	
Stephen	Moses,	Kathleen	N.	Deering,	Kate	M.	
Mitchell,	Sushena	Reza-Paul,	and	James	Blanchard.	
2013.	Positive	impact	of	a	large-scale	HIV	
prevention	programme	among	female	sex	workers	
and	clients	in	South	India.	AIDS	27	(9):	1449.	
Boix,	Carles.	2011.	Democracy,	development,	and	the	
international	system.	American	Political	Science	
Review	105	(04):	809–828.	
Bond,	Patrick.	2014a.	Constitutionalism	as	a	Barrier	to	the	
Resolution	of	Widespread	Community	Rebellions	
in	South	Africa.	Politikon	41	(3):	461–482.	
Bond,	Patrick.	2014b.	Elite	transition:	From	apartheid	to	
neoliberalism	in	South	Africa.	Chicago:	University	
of	Chicago	Press.	
Bond,	Patrick.	2010.	South	Africa’s	bubble	meets	boiling	
urban	social	protest.	Monthly	Review	62	(2):	17.	
Booysen,	Susan.	2017.	The	African	National	Congress	and	the	
regeneration	of	political	power.	Wits	University	
Press.	
Boyko,	Ryan,	Seyward	Darby,	R.	Carmen,	and	Zorka	Milin.	
2014.	Fulfilling	broken	promises:	reforming	the	
century-old	compensation	system	for	occupational	
lung	disease	in	the	South	African	mining	sector.	
New	Haven:	Yale	Law	School	and	Yale	School	of	
Public	Health;	2014.	New	Haven:	Yale	Global	
Health	Justice	Project.	
Brahme,	Radhika,	Shruti	Mehta,	Seema	Sahay,	Neelam	
Joglekar,	Manisha	Ghate,	Smita	Joshi,	Raman	
Gangakhedkar,	Arun	Risbud,	Robert	Bollinger,	and	
Sanjay	Mehendale.	2006.	Correlates	and	trend	of	
HIV	prevalence	among	female	sex	workers	
attending	sexually	transmitted	disease	clinics	in	
Pune,	India	(1993–2002).	Journal	of	acquired	
immune	deficiency	syndromes	(1999)	41	(1):	107.	
Braveman,	Paula,	Susan	Egerter,	and	David	R.	Williams.	2011.	
The	social	determinants	of	health:	coming	of	age.	
Annual	review	of	public	health	32:	381–398.	
Brehm,	John,	and	Scott	Gates.	1999.	Working,	shirking,	and	
sabotage:	Bureaucratic	response	to	a	democratic	
public.	University	of	Michigan	Press.	
Brinks,	Daniel	M.,	and	Varun	Gauri.	2014.	The	law’s	majestic	
equality?	The	distributive	impact	of	judicializing	
social	and	economic	rights.	Perspectives	on	Politics	
12	(02):	375–393.	
Brown,	Julian.	2015.	South	Africa’s	insurgent	citizens:	on	
dissent	and	the	possibility	of	politics.	Zed	Books	
Ltd.	
Brown,	Phil,	Crystal	Adams,	Rachel	Morello-Frosch,	Laura	
Senier,	and	Ruth	Simpson.	2010.	Health	social	
movements.	Handbook	of	Medical	Sociology:	380.	
Brunetti,	Aymo,	Gregory	Kisunko,	and	Beatrice	Weder.	1997.	
Institutional	obstacles	to	doing	business:	region-by-
region	results	from	a	worldwide	survey	of	the	
private	sector.	1759.	World	Bank	Publications.	
Bump,	Jesse	B.,	and	Michael	R.	Reich.	2013.	Political	economy	
analysis	for	tobacco	control	in	low-and	middle-
income	countries.	Health	policy	and	planning	28	
(2):	123–133.	
Burgess,	Susan	R.	1993.	Beyond	Instrumental	Politics:	The	
New	Institutionalism,	Legal	Rhetoric,	&	Judicial	
Supremacy.	Polity	25	(3):	445–459.	
Bustreo,	Flavia,	and	Paul	Hunt.	2013.	The	right	to	health	is	
coming	of	age:	Evidence	of	impact	and	the	
importance	of	leadership.	Journal	of	public	health	
policy	34	(4):	574–579.	
Butler,	Anthony.	2005.	South	Africa’s	HIV/AIDS	policy,	1994–
2004:	How	can	it	be	explained?	African	Affairs	104	
(417):	591–614.	
Cabal,	Luisa,	and	Suzannah	Phillips.	2017.	Reproductive	Rights	
Litigation:	From	Recognition	to	Transformation.	In	
Social	Rights	Judgments	and	the	Politics	of	
Compliance:	Making	It	Stick,	399.	Cambridge	
University	Press.	
Cairney,	Paul.	2007.	A	‘Multiple	Lenses’	Approach	to	Policy	
Change:	The	Case	of	Tobacco	Policy	in	the	UK1.	
British	Politics	2	(1):	45–68.	
Caldwell,	John	C.	1990.	Cultural	and	social	factors	influencing	
mortality	levels	in	developing	countries.	The	
Annals	of	the	American	Academy	of	Political	and	
Social	Science	510	(1):	44–59.	
Caldwell,	John	C.	1986.	Routes	to	low	mortality	in	poor	
countries.	Population	and	development	review:	
171–220.	
Cameron,	Edwin.	2015.	Report:	Pollsmoor	Correctional	Centre	
–	Remand	Centre	and	Women’s	Centre.	
Constitutional	Court	of	South	Africa.	
Cameron,	Edwin.	2003.	The	dead	hand	of	denialism.	
Cambridge,	MA.	
Cameron,	Edwin.	2005.	Witness	to	AIDS.	IB	Tauris.	
Cameron,	Edwin,	and	Jonathan	Berger.	2005.	Patents	and	
Public	Health:	Principle,	Politics	and	Paradox.	
Proceedings	of	the	British	Academy	(131):	331–
369.	
Camp	Keith,	Linda.	2002.	Constitutional	provisions	for	
individual	human	rights	(1977-1996):	Are	they	
References	
	
323	
more	than	mere	“window	dressing?”	Political	
Research	Quarterly	55	(1):	111–143.	
Camp	Keith,	Linda.	2012.	Political	Repression:	Courts	and	the	
Law.	University	of	Pennsylvania	Press.	
Camp	Keith,	Linda,	C.	Neal	Tate,	and	Steven	C.	Poe.	2009.	Is	
the	law	a	mere	parchment	barrier	to	human	rights	
abuse?	The	Journal	of	Politics	71	(2):	644–660.	
Campbell,	Catherine,	and	Brian	Williams.	1999.	Beyond	the	
biomedical	and	behavioural:	towards	an	integrated	
approach	to	HIV	prevention	in	the	southern	
African	mining	industry.	Social	Science	&	Medicine	
48	(11):	1625–1639.	
Campbell,	John	L.	2004.	Institutional	change	and	
globalization.	Princeton	University	Press.	
Carstensen,	Martin	B.,	and	Vivien	A.	Schmidt.	2016.	Power	
through,	over	and	in	ideas:	conceptualizing	
ideational	power	in	discursive	institutionalism.	
Journal	of	European	Public	Policy	23	(3):	318–337.	
Case,	Anne,	and	Angus	Deaton.	2005.	Health	and	wealth	
among	the	poor:	India	and	South	Africa	compared.	
American	Economic	Review:	229–233.	
Chamber	of	Mines.	2017.	Facts	and	Figures	2016.	Chamber	of	
Mines	of	South	Africa.	
Chambers,	Dave.	2007.	National	emergency,	says	minister	
after	visit	to	Eastern	Cape	hospital.	Weekend	
Argus,	sec.	A.	
Chan,	Kwan	Nok,	and	Shuang	Zhao.	2016.	Punctuated	
Equilibrium	and	the	Information	Disadvantage	of	
Authoritarianism:	Evidence	from	the	People’s	
Republic	of	China.	Policy	Studies	Journal	44	(2):	
134–155.	
Chan,	Margaret.	2016.	Address	to	the	Sixty-ninth	World	
Health	Assembly.	Available	at	
<http://www.who.int/dg/speeches/2016/wha-
69/en/>.	
Chandrasekaran,	Padma,	Gina	Dallabetta,	Virginia	Loo,	Sujata	
Rao,	Helene	Gayle,	and	Ashok	Alexander.	2006.	
Containing	HIV/AIDS	in	India:	the	unfinished	
agenda.	The	Lancet	infectious	diseases	6	(8):	508–
521.	
Chang,	Ha-Joon.	2011.	Institutions	and	economic	
development:	theory,	policy	and	history.	Journal	of	
Institutional	Economics	7	(04):	473–498.	
Chang,	Ha-Joon,	and	Peter	Evans.	2005.	The	role	of	
institutions	in	economic	change.	In	Reimagining	
Growth:	towards	a	renewal	of	development	theory.	
London:	Zed.	
Chapman,	Audrey	R.	1997.	Conceptualizing	the	right	to	
health:	a	violations	approach.	Tennessee	Law	
Review	65:	389.	
Chapman,	Audrey	R.	2009.	Globalization,	human	rights,	and	
the	social	determinants	of	health.	Bioethics	23	(2):	
97–111.	
Chatterjee,	Patralekha.	2006.	AIDS	in	India:	police	powers	and	
public	health.	Elsevier.	
Chaudhuri,	Sudip.	2013.	The	larger	implications	of	the	
Novartis-Glivec	judgment.	Economic	and	Political	
Weekly	48	(17):	10–12.	
Chaudhury,	Ranjit	Roy.	2013.	Expert	committee	to	formulate	
policy	and	guidelines	for	approval	of	new	drugs,	
clinical	trials	and	banning	of	drugs.	Ministry	of	
Health	and	Family	Welfare.	
Chhabra,	Rami.	2007.	National	AIDS	control	programme:	a	
critique.	Economic	and	Political	Weekly:	103–108.	
Chigwedere,	Pride,	George	R.	Seage	III,	Sofia	Gruskin,	Tun-
Hou	Lee,	and	Max	Essex.	2008.	Estimating	the	lost	
benefits	of	antiretroviral	drug	use	in	South	Africa.	
JAIDS	Journal	of	Acquired	Immune	Deficiency	
Syndromes	49	(4):	410–415.	
Chilton,	Adam	S.,	and	Mila	Versteeg.	2016a.	Do	Constitutional	
Rights	Make	a	Difference?	American	Journal	of	
Political	Science	60	(3):	575–589.	
Chilton,	Adam	S.,	and	Mila	Versteeg.	2016b.	Rights	Without	
Resources:	The	Impact	of	Constitutional	Social	
Rights	on	Social	Spending.	
Chirwa,	Danwood	Mzikenge.	2005.	A	full	loaf	is	better	than	
half:	The	constitutional	protection	of	economic,	
social	and	cultural	rights	in	Malawi.	Journal	of	
African	Law	49	(2):	207–241.	
Chopra,	Mickey,	Emmanuelle	Daviaud,	Robert	Pattinson,	
Sharon	Fonn,	and	Joy	E.	Lawn.	2009.	Saving	the	
lives	of	South	Africa’s	mothers,	babies,	and	
children:	can	the	health	system	deliver?	The	Lancet	
374	(9692):	835–846.	
Chopra,	Mickey,	Joy	E.	Lawn,	David	Sanders,	Peter	Barron,	
Salim	S.	Abdool	Karim,	Debbie	Bradshaw,	Rachel	
Jewkes,	Quarraisha	Abdool	Karim,	Alan	J.	Flisher,	
and	Bongani	M.	Mayosi.	2009.	Achieving	the	
health	Millennium	Development	Goals	for	South	
Africa:	challenges	and	priorities.	The	Lancet	374	
(9694):	1023–1031.	
Choudhry,	Sujit.	2012.	Method	in	Comparative	Constitutional	
Law:	A	Comment	on	Law	and	Versteeg.	Journal	of	
International	Law	and	Politics	87:	2078.	
Choudhry,	Sujit,	Madhav	Khosla,	and	Pratap	Bhanu	Mehta.	
2016.	The	Oxford	Handbook	of	the	Indian	
Constitution.	Oxford	University	Press.	
Chuang,	Ying-Chih,	Pei-Wei	Sung,	Hsing	Jasmine	Chao,	Chyi-
Huey	Bai,	and	Chia-Jung	Chang.	2013.	A	
longitudinal	ecological	study	of	the	influences	of	
political,	economic,	and	health	services	
characteristics	on	under-five	mortality	in	less-
developed	countries.	Health	&	place	23:	111–121.	
Clark,	Nancy	L.,	and	William	H.	Worger.	2016.	South	Africa:	
The	rise	and	fall	of	apartheid.	Routledge.	
Cleland,	John	G.,	and	Jerome	K.	Van	Ginneken.	1988.	
Maternal	education	and	child	survival	in	
developing	countries:	the	search	for	pathways	of	
influence.	Social	science	&	medicine	27	(12):	1357–
1368.	
Cobb,	Roger	W.,	and	Charles	D.	Elder.	1971.	The	politics	of	
agenda-building:	An	alternative	perspective	for	
modern	democratic	theory.	The	Journal	of	Politics	
33	(04):	892–915.	
Cohen,	Myron	S.,	Ying	Q.	Chen,	Marybeth	McCauley,	Theresa	
Gamble,	Mina	C.	Hosseinipour,	Nagalingeswaran	
Kumarasamy,	James	G.	Hakim,	Johnstone	
Kumwenda,	Beatriz	Grinsztejn,	and	Jose	HS	Pilotto.	
2011.	Prevention	of	HIV-1	infection	with	early	
antiretroviral	therapy.	New	England	Journal	of	
Medicine	365	(6):	493–505.	
Colgrove,	James.	2002.	The	McKeown	Thesis:	A	Historical	
Controversy	and	Its	Enduring	Influence.	American	
Journal	of	Public	Health	(92):	725.	
Collier,	David,	Henry	E.	Brady,	and	Jason	Seawright.	2010.	
Sources	of	Leverage	in	Causal	Inference.	In	
Rethinking	Social	Inquiry,	161–200.	Rowman	&	
Littlefield	Publishers.	
Collier,	David,	and	Steven	Levitsky.	1997.	Democracy	with	
adjectives:	Conceptual	innovation	in	comparative	
research.	World	politics	49	(3):	430–451.	
References	
	
324	
Collier,	Ruth	Berins,	and	David	Collier.	1991.	Shaping	the	
Political	Arena:	Critical	Junctures,	the	Labor	
Movement,	and	Regime	Dynamics	in	Latin	
America.	Princeton	University	Press.	
Colm,	Allan,	Zama	Somhlaba,	Vuyo	Tetyana,	and	Lucas	Zepe.	
2004.	The	Crisis	of	Public	Health	Care	in	the	
Eastern	Cape:	The	post-apartheid	challenges	of	
oversight	and	accountability.	The	Public	Service	
Accountability	Monitor	(PSAM).	
Colomer,	Josep.	2016.	The	handbook	of	electoral	system	
choice.	Springer.	
Comaroff,	Jean.	2010.	Beyond	Bare	Life:	AIDS,(Bio)	Politics,	
and.	In	Morality,	Hope	and	Grief:	Anthropologies	of	
AIDS	in	Africa,	21.	Berghahn	Books.	
Competition	Commission.	2003.	Competition	Commission	
finds	pharmaceutical	firms	in	contravention	of	the	
Competition	Act.	
Competition	Commission	of	South	Africa.	2016.	Report	on	
analysis	of	medical	schemes	claims	data	–	
descriptive	statistics.	Pretoria:	Comptetition	
Commission.	
Competition	Commission	of	South	Africa.	2014.	Statement	of	
Issues:	health	market	inquiry.	
Connor,	Edward	M.,	Rhoda	S.	Sperling,	Richard	Gelber,	Pavel	
Kiselev,	Gwendolyn	Scott,	Mary	Jo	O’Sullivan,	
Russell	VanDyke,	Mohammed	Bey,	William	
Shearer,	and	Robert	L.	Jacobson.	1994.	Reduction	
of	maternal-infant	transmission	of	human	
immunodeficiency	virus	type	1	with	zidovudine	
treatment.	New	England	Journal	of	Medicine	331	
(18):	1173–1180.	
Coovadia,	Hoosen,	Rachel	Jewkes,	Peter	Barron,	David	
Sanders,	and	Diane	McIntyre.	2009.	The	health	and	
health	system	of	South	Africa:	historical	roots	of	
current	public	health	challenges.	The	Lancet	374	
(9692):	817–834.	
Coovadia,	Hoosen	Mahomed.	1999.	Sanctions	and	the	
struggle	for	health	in	South	Africa.	American	
journal	of	public	health	89	(10):	1505–1508.	
Cordner,	Alissa,	Phil	Brown,	and	Rachel	Morello-Frosch.	2014.	
Health	Social	Movements.	The	Wiley	Blackwell	
Encyclopedia	of	Health,	Illness,	Behavior,	and	
Society.	
Correa,	Carlos	María.	2000.	Integrating	public	health	concerns	
into	patent	legislation	in	developing	countries.	
South	Centre	Geneva.	
Correa,	Carlos	María,	and	World	Health	Organization	(WHO).	
2002.	Implications	of	the	Doha	Declaration	on	the	
Trips	Agreement	and	Public	Health.	World	Health	
Organization.	Available	at	
<http://apps.who.int/medicinedocs/en/d/Js2301e
/>.	
Council	for	Medical	Schemes.	2015.	Annual	Report	
2014/2015.	Hatfield:	CMS.	
Cross,	Frank	B.	2000.	The	Error	of	Positive	Rights.	UCLA	Law	
Review	48:	857.	
Cross,	Frank	B.	1999.	The	relevance	of	law	in	human	rights	
protection.	International	Review	of	Law	and	
Economics	19	(1):	87–98.	
CSDH.	2008.	Closing	the	gap	in	a	generation:	health	equity	
through	action	on	the	social	determinants	of	
health.	Final	Report	of	the	Commission	on	Social	
Determinants	of	Health.	Geneva:	World	Health	
Organization.	
Cullinan,	Kerry,	and	Anso	Thom.	2009.	The	virus,	vitamins	and	
vegetables:	the	South	African	HIV/AIDS	mystery.	
Jacana	Media.	
Cutler,	David	M.,	Angus	S.	Deaton,	and	Adriana	Lleras-Muney.	
2006.	The	determinants	of	mortality.	Journal	of	
Economic	Perspectives	20	(3):	97–120.	
Dahl,	Robert	Alan.	1957.	Decision-making	in	a	democracy:	The	
Supreme	Court	as	a	national	policy-maker.	Journal	
of	Public	Law	6:	279.	
Dahl,	Robert	Alan.	1971.	Polyarchy:	Participation	&	
Opposition.	Yale	University	Press.	
Daniels,	Norman.	2001.	Is	there	a	Right	to	Health	Care	and,	if	
so,	what	Does	it	Encompass?	In	A	Companion	to	
Bioethics,	edited	by	Helga	Kuhse	and	Peter	W.	
Singer,	362–73.	Wiley-Blackwell.	
Daniels,	Norman.	2008.	Just	health:	meeting	health	needs	
fairly.	Cambridge	University	Press.	
Das,	Jishnu,	Alaka	Holla,	Veena	Das,	Manoj	Mohanan,	Diana	
Tabak,	and	Brian	Chan.	2012.	In	urban	and	rural	
India,	a	standardized	patient	study	showed	low	
levels	of	provider	training	and	huge	quality	gaps.	
Health	affairs	31	(12):	2774–2784.	
Davenport,	Christian	A.	1996.	‘	Constitutional	Promises’	and	
Repressive	Reality:	A	Cross-National	Time-Series	
Investigation	of	Why	Political	and	Civil	Liberties	are	
Suppressed.	The	Journal	of	Politics	58	(3):	627–654.	
David,	Richard	J.,	and	James	W.	Collins.	2014.	Layers	of	
inequality:	power,	policy,	and	health.	American	
journal	of	public	health	104	(S1):	S8–S10.	
Davis,	Dennis	M.	1992.	The	Case	Against	the	Inclusion	of	
Socioeconomic	Demands	in	a	Bill	of	Rights	Except	
as	Directive	Principles.	South	African	Journal	on	
Human	Rights	8	(4):	475–490.	
De	Boef,	Suzanna,	and	Luke	Keele.	2008.	Taking	time	
seriously.	American	Journal	of	Political	Science	52	
(1):	184–200.	
De	Jong,	Joop	TVM.	2010.	A	public	health	framework	to	
translate	risk	factors	related	to	political	violence	
and	war	into	multi-level	preventive	interventions.	
Social	Science	&	Medicine	70	(1):	71–79.	
De	Mesquita,	Bruce	Bueno,	James	D.	Morrow,	Randolph	M.	
Siverson,	and	Alastair	Smith.	2002.	Political	
institutions,	policy	choice	and	the	survival	of	
leaders.	British	Journal	of	Political	Science:	559–
590.	
De	Soto,	Hernando.	2000.	The	mystery	of	capital:	Why	
capitalism	triumphs	in	the	West	and	fails	
everywhere	else.	Basic	books.	
De	Waal,	Alex.	2013.	AIDS	and	power:	why	there	is	no	political	
crisis–yet.	Zed	Books	Ltd.	
Deaton,	Angus.	2003.	Health,	Inequality,	and	Economic	
Development.	Journal	of	economic	literature	41	
(1):	113–158.	
Deaton,	Angus.	2013.	The	great	escape:	Health,	wealth,	and	
the	origins	of	inequality.	Princeton	University	
Press.	
Department	of	Health.	2015.	District	Health	Information	
System	(DHIS).	Pretoria:	Statistics	South	Africa.	
Department-Related	Parliamentary	Standing	Committee	On	
Health	And	Family	Welfare.	2012.	Fifty-	Ninth	
Report	On	The	Functioning	Of	The	Central	Drugs	
Standard	Control	Organisation.	Rajya	Sabha.	
Desai,	Ashok	H.,	and	S.	Muralidhar.	2004.	Public	Interest	
Litigation:	Potential	and	Problems.	In	Supreme	but	
not	Infallible	–	Essays	in	Honour	of	the	Supreme	
Court	of	India,	159.	Oxford	University	Press.	
References	
	
325	
Dhanda,	Amita.	1989.	The	Aids	Preventive	Bill	of	1989:	An	
Agenda	for	the	Joint	Select	Committee.	Journal	of	
the	Indian	Law	Institute	33	(1).	
Digby,	Anne.	2008.	‘Vision	and	Vested	Interests’:	National	
Health	Service	Reform	in	South	Africa	and	Britain	
during	the	1940s	and	Beyond.	Social	history	of	
medicine	21	(3):	485–502.	
Divan,	Vivek.	2002.	Medicines	for	All:	The	Launch	of	a	
Campaign.	From	The	Lawyers	Collecive	17	(1):	21–
2.	
Dixon,	Rosalind,	and	Tom	Ginsburg.	2011.	The	South	African	
Constitutional	Court	and	socio-economic	rights	as’	
insurance	swaps’.	Constitutional	Court	Review	4	
(1):	1–29.	
Doucouliagos,	Hristos,	and	Mehmet	Ali	Ulubaşoğlu.	2008.	
Democracy	and	economic	growth:	a	meta-analysis.	
American	Journal	of	Political	Science	52	(1):	61–83.	
Dressel,	Björn.	2010.	Judicialization	of	politics	or	politicization	
of	the	judiciary?	Considerations	from	recent	
events	in	Thailand.	The	Pacific	Review	23	(5):	671–
691.	
Dreze,	Jean,	and	Amartya	Sen.	1989.	Hunger	and	public	
action.	Oxford	University	Press.	
Dworkin,	Ronald.	1978.	Taking	rights	seriously.	Harvard	
University	Press.	
Easterlin,	Richard	A.	1999.	How	beneficent	is	the	market?	A	
look	at	the	modern	history	of	mortality.	European	
Review	of	Economic	History	3	(3):	257–294.	
Easterly,	William.	2001.	The	middle	class	consensus	and	
economic	development.	Journal	of	economic	
growth	6	(4):	317–335.	
Eastern	Province	Herald.	2004.	Granny	dies	waiting	for	
ambulance.	Eastern	Province	Herald.	
ECDoH.	2013.	Annual	Performance	Plan	for	2013/15-2015/16.	
Eastern	Cape	Department	of	Health.	
ECDoH.	2005.	Eastern	Cape	Department	of	Health	Budget,	
2005/06	Financial	Year	Presented	to	the	National	
Portfolio	Committee.	Cape	Town,	South	Africa:	
ECDoH.	
ECDoH.	2015.	Eastern	Cape	Department	of	Health	Budget	and	
Policy	Speech	2015.	
ECDoH.	2007.	Eastern	Cape	Health	on	Port	Elizabeth	
Emergency	Medical	Services.	Press	Statement.	
Economist	Intelligence	Unit.	2017.	Democracy	Index.	Available	
at	<http://www.eiu.com/topic/democracy-index>.	
Ehrlich,	Rodney,	and	David	Rees.	2016.	Reforming	Miners’	
Lung	Disease	Compensation	in	South	Africa—Long	
Overdue	but	What	Are	the	Options?	NEW	
SOLUTIONS:	A	Journal	of	Environmental	and	
Occupational	Health	Policy	25	(4):	451–468.	
Elkins,	Zachary.	2010.	Diffusion	and	the	Constitutionalization	
of	Europe.	Comparative	Political	Studies	43	(8–9):	
969–999.	
Elkins,	Zachary,	Tom	Ginsburg,	and	James	Melton.	2009.	The	
endurance	of	national	constitutions.	Cambridge	
University	Press.	
Elkins,	Zachary,	Tom	Ginsburg,	and	James	Melton.	2016.	Time	
and	Constitutional	Efficacy.	In	Assessing	
Constitutional	Performance.	New	York:	Cambridge	
University	Press.	
Elkins,	Zachary,	Tom	Ginsburg,	and	Beth	Simmons.	2013.	
Getting	to	Rights:	Treaty	Ratification,	
Constitutional	Convergence,	and	Human	Rights	
Practice.	Harvard	International	Law	Journal	54:	
61–219.	
Englebert,	Pierre.	2000.	Solving	the	Mystery	of	the	AFRICA	
Dummy.	World	development	28	(10):	1821–1835.	
Epp,	Charles	R.	1998.	The	rights	revolution:	Lawyers,	activists,	
and	supreme	courts	in	comparative	perspective.	
Cambridge	University	Press.	
Epstein,	Richard.	1997.	Mortal	Peril:	Our	Inalienable	Right	to	
Health	Care?	Basic	Books.	
Epstein,	Richard	A.,	and	Paula	M.	Stannard.	2012.	
Constitutional	Ratemaking	and	the	Affordable	Care	
Act:	A	New	Source	of	Vulnerability.	American	
Journal	of	Law	&	Medicine	38:	243.	
Evans,	Peter.	2009.	Population	Health	and	Development:	An	
Institutional-Cultural	Approach	to	Capacity	
Expansion.	In	Successful	societies:	How	institutions	
and	culture	affect	health.	Cambridge	University	
Press.	
Fariss,	Christopher	J.	2016.	The	Changing	Standard	of	
Accountability	and	the	Positive	Relationship	
between	Human	Rights	Treaty	Ratification	and	
Compliance.	British	Journal	of	Political	Science.	
Farmer,	Paul.	2001.	Infections	and	Inequalities:	The	Modern	
Plagues.	Univ	of	California	Press.	
Farmer,	Paul.	2005.	Pathologies	of	Power:	Health,	Human	
Rights,	and	the	New	War	on	the	Poor.	University	of	
California	Press.	
Fassin,	Didier,	and	Helen	Schneider.	2003.	The	politics	of	AIDS	
in	South	Africa:	beyond	the	controversies.	British	
Medical	Journal	326	(7387):	495.	
FDA.	2014.	HIV/AIDS	Historical	Time	Line	1981-1990.	
Available	at	
<https://www.fda.gov/forpatients/illness/hivaids/
history/ucm151074.htm>.	
Feldman,	Eric	A.	2000.	The	ritual	of	rights	in	Japan:	law,	
society,	and	health	policy.	Cambridge	University	
Press.	
Ferraz,	Octavio	Luiz	Motta.	2014.	Between	Usrupation	and	
Abdiation?	The	right	To	Health	in	the	Courts	of	
Brazil	and	South	Africa.	In	Transformative	
Constitutionalism.	New	Delhi:	National	Law	
University	Press.	
Ferraz,	Octavio	Luiz	Motta.	2010.	Harming	the	Poor	Through	
Social	Rights	Litigation:	Lessons	from	Brazil.	Texas	
Law	Review	89:	1643.	
Ferraz,	Octavio	Luiz	Motta.	2016.	Moving	the	debate	forward	
in	right	to	health	litigation.	Health	and	Human	
Rights	18	(2):	265.	
Ferraz,	Octavio	Luiz	Motta.	2009.	The	right	to	health	in	the	
courts	of	Brazil:	Worsening	health	inequities?	
Health	and	human	rights:	33–45.	
Filmer,	Deon,	and	Lant	Pritchett.	1999.	The	impact	of	public	
spending	on	health:	does	money	matter?	Social	
science	&	medicine	49	(10):	1309–1323.	
Finnemore,	Martha,	and	Kathryn	Sikkink.	1998.	International	
norm	dynamics	and	political	change.	International	
organization	52	(4):	887–917.	
Fioretos,	Orfeo,	Tulia	G.	Falleti,	and	Adam	Sheingate.	2016.	
The	Oxford	Handbook	of	Historical	Institutionalism.	
Oxford	University	Press.	
Flood,	Colleen	M.,	and	Aeyel	Gross.	2014.	The	Right	to	Health	
at	the	Public/Private	Divide:	A	Global	Comparative	
Study.	Cambridge	University	Press.	
Flynn,	Matthew	B.	2014.	Pharmaceutical	autonomy	and	public	
health	in	Latin	America:	State,	society	and	industry	
in	Brazil’s	AIDS	program.	Vol.	11.	Routledge.	
Forman,	Lisa.	2008.	Justice	and	justiciability:	advancing	
solidarity	and	justice	through	South	Africans’	right	
References	
	
326	
to	health	jurisprudence.	Medicine	and	law	27	(3):	
661.	
Forman,	Lisa,	Gorik	Ooms,	and	Claire	E.	Brolan.	2015.	Rights	
language	in	the	sustainable	development	agenda:	
Has	right	to	health	discourse	and	norms	shaped	
health	goals?	
Foster,	George	K.	1998.	Opposing	forces	in	a	revolution	in	
international	patent	protection:	the	US	and	India	
in	the	Uruguay	round	and	its	aftermath.	UCLA	J.	
Int’l	L.	&	Foreign	Aff.	3:	283.	
Fourie,	Pieter.	2006.	The	Political	management	of	HIV	and	
AIDS	in	South	Africa:	one	burden	too	many?	New	
York:	Palgrave	Macmillan.	
Fox,	Ashley	M.,	and	Michael	R.	Reich.	2015.	The	Politics	of	
Universal	Health	Coverage	in	Low-and	Middle-
Income	Countries:	A	Framework	for	Evaluation	and	
Action.	Journal	of	health	politics,	policy	and	law	40	
(5):	1023–1060.	
Fox,	Daniel	M.	2014.	Health	policies,	health	politics:	The	
British	and	American	experience,	1911-1965.	
Princeton	University	Press.	
Franco,	Álvaro,	Carlos	Álvarez-Dardet,	and	Maria	Teresa	Ruiz.	
2004.	Effect	of	democracy	on	health:	ecological	
study.	BMJ:	British	Medical	Journal	329	(7480):	
1421.	
Freedom	House.	2014.	Freedom	in	the	World	2014:	The	
Annual	Survey	of	Political	Rights	and	Civil	Liberties.	
Rowman	&	Littlefield.	
Friedman,	Steven,	and	Shauna	Mottiar.	2005.	A	rewarding	
engagement?	The	treatment	action	campaign	and	
the	politics	of	HIV/AIDS.	Politics	&	Society	33	(4):	
511–565.	
Fukuda-Parr,	Sakiko,	Terra	Lawson-Remer,	and	Susan	
Randolph.	2015.	Fulfilling	social	and	economic	
rights.	Oxford	University	Press,	USA.	
Fuller,	Lon	L.	1960.	Adjudication	and	the	Rule	of	Law.	In	
Proceedings	of	the	American	Society	of	
International	Law	at	Its	Annual	Meeting,	54:1–8.	
Vol.	54.	
Gakidou,	Emmanuela,	Krycia	Cowling,	Rafael	Lozano,	and	
Christopher	JL	Murray.	2010.	Increased	
educational	attainment	and	its	effect	on	child	
mortality	in	175	countries	between	1970	and	
2009:	a	systematic	analysis.	The	Lancet	376	(9745):	
959–974.	
Galanter,	Marc.	1983.	The	radiating	effects	of	courts.	
Empirical	theories	of	courts:	117–42.	
Galanter,	Marc,	and	Jayanth	K.	Krishnan.	2003.	Bread	for	the	
Poor:	Access	to	Justice	and	the	Rights	of	the	Needy	
in	India.	HAStIngS	lJ	55:	789.	
Galea,	Sandro.	2002.	Urbanization,	urbanicity,	and	health.	
Journal	of	Urban	Health	79	(1):	S1–S12.	
Galvão,	Jane.	2005.	Brazil	and	access	to	HIV/AIDS	drugs:	a	
question	of	human	rights	and	public	health.	
American	journal	of	public	health	95	(7):	1110–
1116.	
Gauri,	Varun.	2011.	The	cost	of	complying	with	human	rights	
treaties:	The	convention	on	the	rights	of	the	child	
and	basic	immunization.	The	Review	of	
International	Organizations	6	(1):	33–56.	
Gauri,	Varun,	and	Daniel	M.	Brinks.	2008.	Courting	social	
justice:	judicial	enforcement	of	social	and	economic	
rights	in	the	developing	world.	Cambridge	
University	Press	Cambridge.	
Gauri,	Varun,	and	Daniel	M.	Brinks.	2015.	The	Impact	of	Legal	
Strategies	for	Claiming	Economic	and	Social	Rights.	
Closing	the	Rights	Gap:	From	Human	Rights	to	
Social	Transformation:	87.	
Gauri,	Varun,	and	Siri	Gloppen.	2012.	Human	Rights-Based	
Approaches	to	Development:	Concepts,	Evidence,	
and	Policy.	Polity	44	(4):	485–503.	
Gauri,	Varun,	and	Peyvand	Khaleghian.	2002.	Immunization	in	
developing	countries:	its	political	and	
organizational	determinants.	World	Development	
30	(12):	2109–2132.	
GBD	2013	Mortality	and	Causes	of	Death	Collaborators.	2015.	
Global,	regional,	and	national	age–sex	specific	all-
cause	and	cause-specific	mortality	for	240	causes	
of	death,	1990–2013:	a	systematic	analysis	for	the	
Global	Burden	of	Disease	Study	2013.	The	Lancet	
385	(9963):	117–171.	
Geddes,	Barbara.	2003.	Paradigms	and	sand	castles:	Theory	
building	and	research	design	in	comparative	
politics.	University	of	Michigan	Press.	
Geffen,	Nathan.	2010.	Debunking	delusions:	the	inside	story	of	
the	Treatment	Action	Campaign.	Jacana	Media.	
George,	Alexander	L.,	and	Andrew	Bennett.	2005.	Case	
studies	and	theory	development	in	the	social	
sciences.	Mit	Press.	
Georgetown	University	O’Neill	Institute,	and	Lawyers	
Collective.	n.d.	Global	Health	and	Human	Rights	
Database.	Available	at	
<http://www.globalhealthrights.org/about-us/>.	
Accessed	20	December	2013.	
Gerdtham,	Ulf-G.,	and	Bengt	Jönsson.	2000.	International	
comparisons	of	health	expenditure:	theory,	data	
and	econometric	analysis.	Handbook	of	health	
economics	1:	11–53.	
Gerring,	John.	2007.	Is	there	a	(viable)	crucial-case	method?	
Comparative	Political	Studies	40	(3):	231–253.	
Gerring,	John,	Carl	Henrik	Knutsen,	Svend-Erik	Skaaning,	Jan	
Teorell,	Michael	Coppedge,	Staffan	I.	Lindberg,	and	
Matthew	Maguire.	2016.	Electoral	Democracy	and	
Human	Development.	V-Democracy	Working	
Paper	9.	
Gerring,	John,	Strom	C.	Thacker,	and	Rodrigo	Alfaro.	2012.	
Democracy	and	human	development.	The	Journal	
of	Politics	74	(01):	1–17.	
Giliomee,	Hermann,	and	Charles	Edward	Wickens	Simkins.	
1999.	The	awkward	embrace:	One-party	
domination	and	democracy.	Taylor	&	Francis.	
Gilson,	Lucy.	1997.	The	lessons	of	user	fee	experience	in	
Africa.	Health	policy	and	planning	12	(3):	273–285.	
Gilson,	Lucy,	Jane	Doherty,	Di	McIntyre,	Stephen	Thomas,	
Vishal	Brijlal,	and	Chris	Bowa.	1999.	The	Dynamics	
of	Policy	Change:	Health	Care	Financing	in	South	
Africa,	1994-1999.	In	The	Dynamics	of	Policy	
Change:	Lessons	from	Health	Financing	Reform	in	
South	Africa	and	Zambia.	Partnerships	for	Health	
Reform.	
Ginsburg,	Tom,	Zachary	Elkins,	and	Justin	Blount.	2009.	Does	
the	Process	of	Constitution-Making	Matter?	
Annual	Review	of	Law	and	Social	Sciences	5	(5).	
Ginsburg,	Tom,	and	Aziz	Huq.	2016.	Assessing	Constitutional	
Performance.	New	York:	Cambridge	University	
Press.	
Ginsburg,	Tom,	and	Tamir	Moustafa.	2008.	Rule	by	law:	the	
politics	of	courts	in	authoritarian	regimes.	
Cambridge	University	Press	Cambridge.	
Giollabhuí,	Shane	Mac.	2017.	The	fall	of	an	African	president:	
How	and	why	did	the	ANC	unseat	Thabo	Mbeki?	
African	Affairs:	1–23.	
References	
	
327	
Givel,	Michael.	2006.	Punctuated	equilibrium	in	limbo:	The	
tobacco	lobby	and	US	state	policymaking	from	
1990	to	2003.	Policy	Studies	Journal	34	(3):	405–
418.	
Glendon,	Mary	Ann.	2008.	Rights	talk:	The	impoverishment	of	
political	discourse.	Simon	and	Schuster.	
Glickman,	Seth	W.,	John	G.	McHutchison,	Eric	D.	Peterson,	
Charles	B.	Cairns,	Robert	A.	Harrington,	Robert	M.	
Califf,	and	Kevin	A.	Schulman.	2009.	Ethical	and	
scientific	implications	of	the	globalization	of	clinical	
research.	Mass	Medical	Soc.	
Gloppen,	Siri,	Roberto	Gargarella,	and	Elin	Skaar.	2004.	
Democratization	and	the	judiciary:	the	
accountability	function	of	courts	in	new	
democracies.	Psychology	Press.	
Gloppen,	Siri,	and	Fidelis	Edge	Kanyongolo.	2007.	Courts	and	
the	poor	in	Malawi:	Economic	marginalization,	
vulnerability,	and	the	law.	International	Journal	of	
Constitutional	Law	5	(2):	258–293.	
Gloppen,	Siri,	and	Fidelis	Edge	Kanyongolo.	2012.	Judicial	
independence	and	judicialization	of	electoral	
politics	in	Malawi	and	Uganda.	In	Accountable	
Government	in	Africa:	Perspectives	from	Public	
Law	and	Political	Studies,	43–69.	
Godoy,	Angelina.	2013.	Of	Medicines	and	Markets:	
Intellectual	Property	and	Human	Rights	in	the	Free	
Trade	Era.	Stanford	University	Press.	
Goertz,	Gary.	2006.	Social	science	concepts:	A	user’s	guide.	
Princeton	University	Press.	
Gostin,	Lawrence	O.,	Eric	A.	Friedman,	Paulo	Buss,	Mushtaque	
Chowdhury,	Anand	Grover,	Mark	Heywood,	
Churnrurtai	Kanchanachitra,	Gabriel	Leung,	Judith	
Mackay,	and	Precious	Matsoso.	2016.	The	next	
WHO	Director-General’s	highest	priority:	a	Global	
Treaty	on	the	Human	Right	to	Health.	The	Lancet	
Global	Health	4	(12):	e890–e892.	
Gostin,	Lawrence	O.,	and	Devi	Sridhar.	2014.	Global	health	
and	the	law.	New	England	Journal	of	Medicine	370	
(18):	1732–1740.	
Gostin,	Lawrence	Ogalthorpe,	and	Zita	Lazzarini.	1997.	Human	
rights	and	public	health	in	the	AIDS	pandemic.	
Oxford	University	Press,	USA.	
Goudge,	Jane.	2015.	Catastrphic	Expenditure	on	Health,	
Submission	to	the	South	African	Human	Rights	
Commission.	In	Emegency	Medical	Services	in	the	
Eastern	Cape.	Section	27.	
Graber,	Mark	A.	1993.	The	Nonmajoritarian	Difficulty:	
Legislative	Deference	to	the	Judiciary.	Studies	in	
American	Political	Development	7	(01):	35–73.	
Granich,	Reuben,	Charles	F.	Gilks,	Christopher	Dye,	Kevin	M.	
De	Cock,	and	Brian	G.	Williams.	2008.	Universal	
voluntary	HIV	testing	with	immediate	antiretroviral	
therapy	as	a	strategy	for	elimination	of	HIV	
transmission:	a	mathematical	model.	The	Lancet	
373	(9657):	48–57.	
Green-Pedersen,	Christoffer,	and	Stefaan	Walgrave.	2014.	
Agenda	setting,	policies,	and	political	systems:	a	
comparative	approach.	University	of	Chicago	
Press.	
Grodin,	Michael	A.,	Daniel	Tarantola,	George	J.	Annas,	and	
Sofia	Gruskin.	2013.	Health	and	Human	Rights	in	a	
Changing	World.	New	York:	Routledge.	
Grover,	Anand.	2013a.	Analysing	the	Supreme	Court	
Judgment.	Economic	and	Political	Weekly	48	(32):	
46–49.	
Grover,	Anand.	2013b.	Report	of	the	Special	Rapporteur	on	
the	right	of	everyone	to	the	enjoyment	of	the	
highest	attainable	standard	of	physical	and	mental	
health:	the	right	to	health	and	migrant	workers.	
Geneva:	UN	Human	Rights	Council.	
Gruskin,	Sofia,	Edward	J.	Mills,	and	Daniel	Tarantola.	2007.	
History,	principles,	and	practice	of	health	and	
human	rights.	The	Lancet	370	(9585):	449–455.	
Guha,	Sumit.	1994.	The	importance	of	social	intervention	in	
England’s	mortality	decline:	the	evidence	
reviewed.	Social	History	of	Medicine	7	(1):	89–113.	
Habib,	Adam,	and	Rupert	Taylor.	2001.	Political	Alliances	and	
Parliamentary	Opposition	Post-Apartheid	South	
Africa.	Democratization	8	(1):	207–226.	
Hacker,	Jacob	S.	2004.	Privatizing	risk	without	privatizing	the	
welfare	state:	The	hidden	politics	of	social	policy	
retrenchment	in	the	United	States.	American	
Political	Science	Review	98	(2):	243–260.	
Hacker,	Jacob	S.	2002.	The	divided	welfare	state:	The	battle	
over	public	and	private	social	benefits	in	the	United	
States.	Cambridge	University	Press.	
Hacker,	Jacob	S.,	and	Paul	Pierson.	2010.	Winner-take-all	
politics:	How	Washington	made	the	rich	richer--
and	turned	its	back	on	the	middle	class.	Simon	and	
Schuster.	
Hacker,	Jacob	S.,	and	Theda	Skocpol.	1997.	The	new	politics	of	
US	health	policy.	Journal	of	Health	Politics,	Policy	
and	Law	22	(2):	315–338.	
Hafner-Burton,	Emilie.	2013.	Making	human	rights	a	reality.	
Princeton	University	Press.	
Hafner-Burton,	Emilie	M.,	and	Kiyoteru	Tsutsui.	2005.	Human	
Rights	in	a	Globalizing	World:	The	Paradox	of	
Empty	Promises.	American	journal	of	sociology	110	
(5):	1373–1411.	
Haggard,	Stephan,	and	Robert	R.	Kaufman.	2008.	
Development,	democracy	and	welfare	states:	Latin	
America,	East	Asia,	and	Eastern	Europe.	Princeton	
University	Press.	
Haggard,	Stephan,	Andrew	MacIntyre,	and	Lydia	Tiede.	2008.	
The	rule	of	law	and	economic	development.	
Annual	Review	of	Political	Science	11:	205–234.	
Hakansta,	Carin.	1998.	The	battle	on	patents	and	AIDS	
treatment.	Biotechnology	and	Development	
Monitor	34:	17–19.	
Hall,	Peter	A.	1993.	Policy	paradigms,	social	learning,	and	the	
state:	the	case	of	economic	policymaking	in	
Britain.	Comparative	politics:	275–296.	
Hall,	Peter	A.	1997.	The	role	of	interests,	institutions,	and	
ideas	in	the	comparative	political	economy	of	the	
industrialized	nations.	Comparative	politics:	
Rationality,	culture,	and	structure:	174–207.	
Hall,	Peter	A.,	and	Michèle	Lamont.	2013.	Social	resilience	in	
the	neoliberal	era.	Cambridge	University	Press.	
Hall,	Peter	A.,	and	Michèle	Lamont.	2009.	Successful	societies:	
How	institutions	and	culture	affect	health.	
Cambridge	University	Press.	
Hall,	Peter	A.,	and	David	W.	Soskice.	2001.	Varieties	of	
capitalism:	The	institutional	foundations	of	
comparative	advantage.	
Hall,	Peter	A.,	and	Rosemary	CR	Taylor.	1996.	Political	science	
and	the	three	new	institutionalisms*.	Political	
studies	44	(5):	936–957.	
Hamied,	Y.	K.	2006.	Trading	in	Death.	Health	Administrator:	
Journal	of	the	Indian	Society	of	Health	
Administrators	14	(1):	53–59.	
References	
	
328	
Hamilton,	Alexander.	1788.	The	Federalist	No.	78:	The	
Judiciary	Department.	
Harrington,	John,	and	Maria	Stuttaford.	2010.	Global	health	
and	human	rights:	legal	and	philosophical	
perspectives.	Global	health	and	human	rights:	
legal	and	philosophical	perspectives.	
Harris,	Joseph.	2015.	“Developmental	Capture”	of	the	State:	
Explaining	Thailand’s	Universal	Coverage	Policy.	
Journal	of	Health	Politics,	Policy	and	Law	40	(1).	
Harrison,	Mark.	1994.	Public	Health	in	British	India:	Anglo-
Indian	Preventive	Medicine	1859-1914.	Cambridge	
University	Press.	
Hassim,	Adila,	Mark	Heywood,	and	J.	Berger.	2014.	Health	
and	democracy:	a	guide	to	human	rights,	health	
law	and	policy	in	post-apartheid	South	Africa.	
Hathaway,	Oona	A.	2002.	Do	human	rights	treaties	make	a	
difference?	The	Yale	Law	Journal	111	(8):	1935–
2042.	
Hatt,	Laurel	E.,	and	Hugh	R.	Waters.	2008.	Determinants	of	
child	morbidity	in	Latin	America:	a	pooled	analysis	
of	interactions	between	parental	education	and	
economic	status.	Social	science	&	medicine	62	(2):	
375–386.	
Health	Policy	Project.	2016.	Health	Financing	South	Africa.	
Washington	DC:	Health	Policy	Project.	
Health	Systems	Trust.	1996.	Free	health	care	for	pregnant	
women	and	children	under	six	in	South	Africa:	an	
impact	assessment.	Health	Systems	Trust.	
Health	Systems	Trust.	2002.	Interim	findings	on	the	national	
PMTCT	pilot	sites:	lessons	and	recommendations.	
Health	Systems	Trust.	
Heywood,	Mark.	2003.	Preventing	Mother-to-Child	HIV	
Transmission	in	South	Africa:	Background	
Strategies	and	Outcomes	of	the	Treatment	Action	
Campaign	Case	against	the	Minister	of	Health.	S.	
Afr.	J.	on	Hum.	Rts.	19:	278.	
Heywood,	Mark.	2009.	South	Africa’s	treatment	action	
campaign:	combining	law	and	social	mobilization	
to	realize	the	right	to	health.	Journal	of	Human	
Rights	Practice	1	(1):	14–36.	
Hill,	Daniel	W.,	and	Zachary	M.	Jones.	2014.	An	empirical	
evaluation	of	explanations	for	state	repression.	
American	Political	Science	Review	108	(03):	661–
687.	
Hill,	Kenneth,	and	Dawn	M.	Upchurch.	1995.	Gender	
differences	in	child	health:	evidence	from	the	
demographic	and	health	surveys.	Population	and	
Development	Review:	127–151.	
Hirschl,	Ran.	2014.	Comparative	Matters:	The	Renaissance	of	
Comparative	Constitutional	Law.	Oxford	University	
Press.	
Hirschl,	Ran.	2011.	The	Nordic	counternarrative:	Democracy,	
human	development,	and	judicial	review.	
International	journal	of	constitutional	law	9	(2):	
449–469.	
Hirschl,	Ran.	2004.	Towards	juristocracy:	the	origins	and	
consequences	of	the	new	constitutionalism.	
Harvard	University	Press.	
Hirschl,	Ran,	and	Evan	Rosevear.	2011.	Constitutional	Law	
Meets	Comparative	Politics:	Socio-Economic	Rights	
and	Political	Realities.	In	The	Legal	Protection	of	
Human	Rights:	Sceptical	Essays.,	edited	by	Tom	
Campbell,	K.D.	Ewing,	and	Adam	Tomkins,	207–
228.	Oxford:	Oxford	University	Press.	
Hirschowitz,	Ros,	Mark	Orkin,	Joan	de	Castro,	S.	Hirschowitz,	
K.	Segel,	and	L.	Taunyane.	1995.	A	national	
household	survey	of	health	inequalities	in	South	
Africa.	Overview	report.	Henry	J.	Kaiser	
Foundation.	
Hitiris,	Theo,	and	John	Posnett.	1992.	The	determinants	and	
effects	of	health	expenditure	in	developed	
countries.	Journal	of	health	economics	11	(2):	173–
181.	
Hobolt,	Sara,	James	Tilley,	and	Susan	Banducci.	2013.	Clarity	
of	responsibility:	How	government	cohesion	
conditions	performance	voting.	European	journal	
of	political	research	52	(2):	164–187.	
’t	Hoen,	Ellen.	2015.	Access	to	Cancer	Treatment:	A	study	of	
medicine	pricing	issues	with	recommendations	for	
improving	access	to	cancer	medication.	Oxfam	
Report.	
’t	Hoen,	Ellen.	2016.	Private	Patents	and	Public	Health:	
Changing	intellectual	property	rules	for	access	to	
medicines.	Health	Action	International.	
Hoffman,	Steven	J.,	and	John-Arne	Røttingen.	2015.	Assessing	
the	expected	impact	of	global	health	treaties:	
evidence	from	90	quantitative	evaluations.	
American	journal	of	public	health	105	(1):	26–40.	
Hoffmann,	Florian,	and	Fernando	Bentes.	2008.	Accountability	
for	social	and	economic	rights	in	Brazil.	In	Courting	
social	justice:	Judicial	enforcement	of	social	and	
economic	rights	in	the	developing	world,	edited	by	
Varun	Gauri	and	Daniel	M.	Brinks,	100–45.	
Cambridge	University	Press.	
Hogerzeil,	Hans	V.,	Melanie	Samson,	Jaume	Vidal	Casanovas,	
and	Ladan	Rahmani-Ocora.	2006.	Is	access	to	
essential	medicines	as	part	of	the	fulfilment	of	the	
right	to	health	enforceable	through	the	courts?	
The	Lancet	368	(9532):	305–311.	
Horowitz,	Donald	L.	1977.	The	courts	and	social	policy.	
Brookings	Institution	Press.	
Horton,	Richard,	and	Pam	Das.	2011.	Indian	health:	the	path	
from	crisis	to	progress.	The	Lancet	377	(9761):	
181–183.	
Huber,	Evelyn,	and	John	D.	Stephens.	2001.	Development	and	
Crisis	of	the	Welfare	State:	Parties	and	Policies	in	
Global	Markets.	Chicago:	University	Of	Chicago	
Press.	
Huber,	Evelyne,	and	John	D.	Stephens.	2012.	Democracy	and	
the	left:	social	policy	and	inequality	in	Latin	
America.	Chicago:	University	Of	Chicago	Press.	
Hughes,	David,	and	Songkramchai	Leethongdee.	2007.	
Universal	coverage	in	the	land	of	smiles:	lessons	
from	Thailand’s	30	Baht	health	reforms.	Health	
Affairs	26	(4):	999–1008.	
Human	Rights	Law	Network.	2013.	Fact-Finding	Report	on	
Night	Shelters	in	New	Delhi:	The	Status	of	Pregnant	
and	Lactating	Women.	Available	at	
<http://www.hrln.org/hrln/reproductive-
rights/reports/1627-fact-finding-report-on-night-
shelters-in-new-delhi-the-status-of-pregnant-and-
lactating-women.html>.	
Hunt,	Paul.	2003.	The	right	of	everyone	to	the	enjoyment	of	
the	highest	attainable	standard	of	physical	and	
mental	health.	Geneva:	UN	Commission	on	Human	
Rights.	
Hunt,	Sharon	A.	2006.	Taking	heart-cardiac	transplantation	
past,	present,	and	future.	The	New	England	journal	
of	medicine	355	(3):	231.	
Immergut,	Ellen	M.	1992a.	Health	politics:	interests	and	
institutions	in	Western	Europe.	Cambridge	
University	Press.	
References	
	
329	
Immergut,	Ellen	M.	1992b.	The	rules	of	the	game:	The	logic	of	
health	policy-making	in	France,	Switzerland,	and	
Sweden.	Structuring	politics:	Historical	
institutionalism	in	comparative	analysis:	57–89.	
Imran,	Mohammed,	Abul	K.	Najmi,	Mohammad	F.	Rashid,	
Shams	Tabrez,	and	Mushtaq	A.	Shah.	2013.	Clinical	
research	regulation	in	India-history,	development,	
initiatives,	challenges	and	controversies:	Still	long	
way	to	go.	Journal	of	pharmacy	&	bioallied	
sciences	5	(1):	2.	
India	Brand	Equity	Foundation.	2017.	Indian	Pharmaceutical	
Industry.	Available	at	
<https://www.ibef.org/industry/pharmaceutical-
india.aspx>.	
Inspecting	Judge	of	Prisons.	2004.	Annual	Report	for	the	
period	1	April	2003	to	31	March	2004.	Cape	Town:	
Judicial	Inspectorate	of	Prisons.	
Institute	for	Criminal	Policy	Research.	2016.	World	Prison	
Brief.	London:	University	of	London.	Available	at	
<http://www.prisonstudies.org/>.	
Institute	for	Health	Metrics	and	Evaluation.	2010a.	GBD	
Profile:	India	(2010).	Seattle,	WA:	IHME.	
Institute	for	Health	Metrics	and	Evaluation.	2015.	GBD	Profile:	
India	(2015).	Seattle,	WA:	IHME.	
Institute	for	Health	Metrics	and	Evaluation.	2017.	Global	
Burden	of	Disease.	Available	at	
<http://www.healthdata.org/results>.	
Institute	for	Health	Metrics	and	Evaluation,	(IHME).	2010b.	
Building	Momentum:	Global	Progress	Toward	
Reducing	Maternal	and	Child	Mortality.	
Institute	for	Health	Metrics	and	Evaluation,	(IHME).	2016.	
Global	Burden	of	Disease	Study	2015.	Available	at	
<http://www.healthdata.org/gbd>.	
Institute	of	Medicine.	2004.	Scaling	up	treatment	for	the	
global	AIDS	pandemic:	challenges	and	
opportunities.	National	Academies	Press.	
Integrated	Support	Team.	2009.	Eastern	Cape	Department	of	
Health:	Report	of	the	Integrated	Support	Team.	SA	
National	Department	of	Health.	
Jacobs,	Sean,	and	Richard	Calland.	2002.	Thabo	Mbeki’s	
world:	the	politics	and	ideology	of	the	South	
African	president.	Zed	Books.	
Jain,	Dipika.	2013.	Is	the	National	Pharmaceutical	Policy,	2012	
Really	Cheering	the	Pharma.	Indian	Journal	of	Law	
&	Technology	9:	92.	
Jain,	Dipika,	and	Rachel	Stephens.	2008.	The	struggle	for	
access	to	treatment	for	HIV/AIDS	in	India.	Socio	
Legal	Information	Cent.	
James,	Spencer	L.,	Paul	Gubbins,	Christopher	JL	Murray,	and	
Emmanuela	Gakidou.	2012.	Developing	a	
comprehensive	time	series	of	GDP	per	capita	for	
210	countries	from	1950	to	2015.	Population	
Health	Metrics	10:	12.	
Jan	Swasthya	Abhiyan.	2000.	People’s	Health	Charter.	Kolkata:	
First	National	Health	Assembly.	
Jayaraman,	Killugudi.	2014.	India’s	top	drug	regulator.	Nature	
Medicine	20	(8):	802–805.	
Jenkins,	Stephen	P.	2014.	World	Income	Inequality	Databases:	
An	Assessment	of	WIID	and	SWIID.	￼￼Institute	
for	Social	&	Economic	Research.	
Jinabhai,	Champak	C.,	Hoosen	M.	Coovadia,	and	Salim	S.	
Abdool-Karim.	1986.	Socio-medical	indicators	of	
health	in	South	Africa.	International	journal	of	
health	services	16	(1):	163–178.	
John,	T.	Jacob.	2014.	Tuberculosis	control	in	India:	Why	are	
we	failing?	Indian	pediatrics	51	(7):	523–527.	
Johnstone-Robertson,	Simon,	Stephen	D.	Lawn,	Alex	Welte,	
Linda-Gail	Bekker,	and	Robin	Wood.	2011.	
Tuberculosis	in	a	South	African	prison:	a	
transmission	modelling	analysis.	SAMJ:	South	
African	Medical	Journal	101	(11):	809–813.	
Jones,	Bryan	D.,	and	Frank	R.	Baumgartner.	2012.	From	there	
to	here:	Punctuated	equilibrium	to	the	general	
punctuation	thesis	to	a	theory	of	government	
information	processing.	Policy	Studies	Journal	40	
(1):	1–20.	
Jones,	Bryan	D.,	and	Frank	R.	Baumgartner.	2005.	The	politics	
of	attention:	How	government	prioritizes	problems.	
University	of	Chicago	Press.	
Jones,	Peris,	and	Nyasha	Chingore.	2014.	Health	Rights:	
Politics,	Places	and	the	Need	for	‘Sites	for	Rights’.	
In	Socio-Economic	Rights	in	South	Africa,	226–52.	
Cambridge	University	Press.	
Joseph,	Reji	K.	2016.	Pharmaceutical	Industry	and	Public	
Policy	in	Post-reform	India.	Routledge.	
Judge,	Ken,	Jo-Ann	Mulligan,	and	Michaela	Benzeval.	1998.	
Income	inequality	and	population	health.	Social	
Science	&	Medicine	46	(4):	567–579.	
Kable	Intelligence.	2017.	India’s	2016	clinical	trials	activity	
back	to	2008	levels.	Pharmaceutical	Technology.	
Available	at	<http://www.pharmaceutical-
technology.com/researchreports/researchreportin
dias-2016-clinical-trials-activity-back-to-2008-
levels-5773915/>.	
Kadiyala,	Suneetha,	and	Tony	Barnett.	2004.	AIDS	in	India:	
Disaster	in	the	making.	Economic	and	political	
weekly:	1888–1892.	
Kahneman,	Daniel,	and	Amos	Tversky.	2000.	Choices,	values,	
and	frames.	Cambridge	University	Press.	
Kaiser	Family	Foundation.	1999.	Second	Kaiser	Family	
Foundation	National	Household	Survey	on	Health	
Care.	CASE/Kaiser	Family	Foundation.	
Kamat,	Vinay	R.	2014.	Fast,	cheap,	and	out	of	control?	
Speculations	and	ethical	concerns	in	the	conduct	
of	outsourced	clinical	trials	in	India.	Social	Science	
&	Medicine	104:	48–55.	
Kapczynski,	Amy.	2018.	The	Right	to	Medicines	in	an	Age	of	
Neoliberalism.	Humanity.	
Kapczynski,	Amy,	and	Jonathan	M.	Berger.	2009.	The	story	of	
the	TAC	Case:	The	potential	and	limits	of	socio-
economic	rights	litigation	in	South	Africa.	In	
Human	Rights	Advocacy	Stories,	47:.	Vol.	47.	New	
York:	Foundation	Press.	
Kapindu,	Redson	E.	2013.	Courts	and	the	enforcement	of	
socio-economic	rights	in	Malawi:	Jurisprudential	
trends,	challenges	and	opportunities.	African	
Human	Rights	Law	Journal	13	(1):	01-27.	
Kapstein,	Ethan,	and	Joshua	Busby.	2013.	AIDS	Drugs	For	All:	
Social	Movements	and	Market	Transformations.	
Cambridge	University	Press.	
Kapur,	Devesh.	2013.	The	wrongs	of	rights.	Business	Standard.	
New	Delhi.	Available	at	<http://www.business-
standard.com/article/opinion/the-wrongs-of-
rights-113070800015_1.html>.	Accessed	27	July	
2014.	
Kapur,	Devesh,	Pratap	Bhanu	Mehta,	and	Milan	Vaishnav.	
2017.	Rethinking	Public	Institutions	in	India.	Oxford	
University	Press.	
Karim,	Salim	S.	Abdool,	Gavin	J.	Churchyard,	Quarraisha	
Abdool	Karim,	and	Stephen	D.	Lawn.	2009.	HIV	
References	
	
330	
infection	and	tuberculosis	in	South	Africa:	an	
urgent	need	to	escalate	the	public	health	
response.	the	Lancet	374	(9693):	921–933.	
Karpik,	Lucien,	and	Terence	C.	Halliday.	2011.	The	legal	
complex.	Annual	Review	of	Law	and	Social	Science	
7:	217–236.	
Katznelson,	Ira.	2009.	Structure	and	configuration	in	
comparative	politics.	Comparative	politics:	
Rationality,	culture,	and	structure:	81–112.	
Kaufmann,	Daniel,	Aart	Kraay,	and	Massimo	Mastruzzi.	2004.	
Governance	matters	III:	Governance	indicators	for	
1996,	1998,	2000,	and	2002.	The	World	Bank	
Economic	Review	18	(2):	253–287.	
Kavanagh,	Matthew	M.	2016.	The	Right	to	Health:	
Institutional	Effects	of	Constitutional	Provisions	on	
Health	Outcomes.	Studies	in	Comparative	
International	Development	51	(3):	328–364.	
Kaye,	Neil.	1989.	The	Right	to	Health	Care.	New	England	
Journal	of	Medicine	321	(10):	693–693.	
Keck,	Margaret	E.,	and	Kathryn	Sikkink.	1998.	Activists	beyond	
borders:	Advocacy	networks	in	international	
politics.	Cambridge	Univ	Press.	
Kende,	Mark	S.	2003.	The	South	African	Constitutional	Court’s	
Construction	of	Socio-Economic	Rights:	A	
Response	to	Critics.	Conn.	J.	Int’l	L.	19:	617.	
Kersh,	Rogan,	and	James	Morone.	2002.	The	politics	of	
obesity:	seven	steps	to	government	action.	Health	
Affairs	21	(6):	142–153.	
Khosa,	Solani,	and	Elmar	Thomas.	1995.	‘Free	health	care’	
policies.	In	South	African	Health	Review	1995.	
Health	Systems	Trust.	
Khosla,	Madhav.	2010.	Making	social	rights	conditional:	
Lessons	from	India.	International	journal	of	
constitutional	law	8	(4):	739–765.	
Khosla,	Madhav,	and	Ananth	Padmanabhan.	2017.	The	
Supreme	Court.	In	Rethiking	Public	Instiutitons	in	
India,	105–138.	New	Delhi:	Oxford	University	
Press.	
Kijtiwatchakul,	Kannikar.	2007.	The	right	to	health.	Thailand:	
Medecins	Sans	Frontiéres-Belgium	(MSFB),	
Pharmacy	network	for	Health	Promotion	(PNHP),	
Thai	health	Promotion	Foundation	and	Third	
World	Network.	
Kim,	Jim	Yong,	Paul	Farmer,	and	Michael	E.	Porter.	2013.	
Redefining	global	health-care	delivery.	The	Lancet	
382	(9897):	1060–1069.	
King,	Gary,	Robert	O.	Keohane,	and	Sidney	Verba.	1994.	
Designing	social	inquiry:	Scientific	inference	in	
qualitative	research.	Princeton	University	Press.	
Kingdon,	John	W.	2003.	Agendas,	alternatives,	and	public	
policies.	2nd	ed.	Pearson	Longman.	
Klug,	Heinz.	2002.	Access	to	Health	Care:	Judging	
Implementation	in	the	Context	of	Aids:	Treatment	
Action	Campaign	v.	Minister	of	Health	TPD	
21182/2001	(Unreported).	South	African	Journal	
on	Human	Rights	18:	114.	
Klug,	Heinz.	2000.	Constituting	Democracy:	Law,	Globalism	
and	South	Africa’s	Political	Reconstruction.	
Cambridge	University	Press.	
Knight,	David,	Rodney	Ehrlich,	Katherine	Fielding,	Hannah	
Jeffery,	Alison	Grant,	and	Gavin	Churchyard.	2015.	
Trends	in	silicosis	prevalence	and	the	healthy	
worker	effect	among	gold	miners	in	South	Africa:	a	
prevalence	study	with	follow	up	of	employment	
status.	BMC	Public	Health	15	(1):	1258.	
König,	Thomas,	George	Tsebelis,	and	Marc	Debus.	2010.	
Reform	processes	and	policy	change:	veto	players	
and	decision-making	in	modern	democracies.	Vol.	
16.	Springer	Science	&	Business	Media.	
Krieger,	Nancy.	2001.	Theories	for	social	epidemiology	in	the	
21st	century:	an	ecosocial	perspective.	
International	journal	of	epidemiology	30	(4):	668–
677.	
Kriesi,	Hanspeter,	Anke	Tresch,	and	Margit	Jochum.	2007.	
Going	public	in	the	European	Union:	Action	
repertoires	of	Western	European	collective	
political	actors.	Comparative	Political	Studies	40	
(1):	48–73.	
Krikorian,	Gaëlle.	2009.	The	politics	of	patents:	conditions	of	
implementation	of	public	health	policy	in	Thailand.	
Politics	of	intellectual	property:	contestation	over	
the	ownership,	use,	and	control	of	knowledge	and	
information,	Cheltenham,	Edward	Elgar	Publishing	
Limited:	29–56.	
Kudamatsu,	Masayuki.	2012.	HAS	DEMOCRATIZATION	
REDUCED	INFANT	MORTALITY	IN	SUB-SAHARAN	
AFRICA?	EVIDENCE	FROM	MICRO	DATA.	Journal	of	
the	European	Economic	Association	10	(6):	1294–
1317.	
La	Porta,	Rafael,	Florencio	Lopez-de-Silanes,	Andrei	Shleifer,	
and	Robert	Vishny.	1999.	The	quality	of	
government.	Journal	of	Law,	Economics,	and	
Organization	15	(1):	222–279.	
Lam,	Wai	Fung,	and	Kwan	Nok	Chan.	2015.	How	
authoritarianism	intensifies	punctuated	
equilibrium:	The	dynamics	of	policy	attention	in	
Hong	Kong.	Governance	28	(4):	549–570.	
Lamprea,	Everaldo.	2014.	Colombia’s	right-to-health	litigation	
in	a	context	of	health	care	reform.	In	The	Right	to	
Health	at	the	Public/Private	Divide:	A	Global	
Comparative	Study.	Cambridge	University	Press.	
Landau,	David.	2012a.	The	Reality	of	Social	Rights	
Enforcement.	Harvard	International	Law	Journal	
53	(1):	190–247.	
Landau,	David.	2012b.	The	Reality	of	Social	Rights	
Enforcement.	Harvard	International	Law	Journal	
53	(1):	190–247.	
Langford,	Malcolm,	ed.	2008.	Social	rights	jurisprudence:	
emerging	trends	in	international	and	comparative	
law.	Cambridge	University	Press.	
Langford,	Malcolm,	César	Rodríguez-Garavito,	and	Julieta	
Rossi.	2017.	Social	Rights	Judgments	and	the	
Politics	of	Compliance:	Making	It	Stick.	Cambridge	
University	Press.	
Law,	David	S.,	and	Mila	Versteeg.	2013.	Sham	Constitutions.	
California	Law	Review	101	(4):	863.	
Law,	David,	and	Mila	Versteeg.	2012.	Sham	Constitutions.	
Available	at	SSRN	1989979.	
Lawn,	Stephen	D.,	Linda-Gail	Bekker,	Keren	Middelkoop,	
Landon	Myer,	and	Robin	Wood.	2006.	Impact	of	
HIV	infection	on	the	epidemiology	of	tuberculosis	
in	a	peri-urban	community	in	South	Africa:	the	
need	for	age-specific	interventions.	Clinical	
Infectious	Diseases	42	(7):	1040–1047.	
Lena,	Hugh	F.,	and	Bruce	London.	1993.	The	political	and	
economic	determinants	of	health	outcomes:	A	
cross-national	analysis.	International	journal	of	
health	services	23	(3):	585–602.	
Leon	Commission.	1995.	Report	Of	The	Commission	Of	Inquiry	
Into	Safety	And	Health	In	The	Mining	Industry.	
References	
	
331	
Levitsky,	Steven,	and	Lucan	A.	Way.	2010.	Competitive	
authoritarianism:	Hybrid	regimes	after	the	cold	
war.	Cambridge	University	Press.	
Lieberman,	Evan	S.	2009.	Boundaries	of	contagion:	how	ethnic	
politics	have	shaped	government	responses	to	
AIDS.	Princeton	University	Press.	
Lieberman,	Evan	S.	2007.	Ethnic	politics,	risk,	and	policy-
making	a	cross-national	statistical	analysis	of	
government	responses	to	HIV/AIDS.	Comparative	
Political	Studies	40	(12):	1407–1432.	
Lieberman,	Evan	S.	2005.	Nested	analysis	as	a	mixed-method	
strategy	for	comparative	research.	American	
Political	Science	Review	99	(03):	435–452.	
Lijphart,	Arend.	1971.	Comparative	politics	and	the	
comparative	method.	The	american	political	
science	review:	682–693.	
Lin,	Ro-Ting,	Ya-Mei	Chen,	Lung-Chang	Chien,	and	Chang-
Chuan	Chan.	2012.	Political	and	social	
determinants	of	life	expectancy	in	less	developed	
countries:	a	longitudinal	study.	BMC	Public	Health	
12	(1):	1.	
Lipton,	Merle.	1986.	Capitalism	and	Apartheid:	South	Africa,	
1910-1986.	New	Africa	Books.	
Liu,	Chun,	and	Krishna	Jayakar.	2012.	The	evolution	of	
telecommunications	policy-making:	Comparative	
analysis	of	China	and	India.	Telecommunications	
Policy	36	(1):	13–28.	
Long,	Lawrence	C.,	Matthew	P.	Fox,	Celeste	Sauls,	Denise	
Evans,	Ian	Sanne,	and	Sydney	B.	Rosen.	2016.	The	
high	cost	of	HIV-positive	inpatient	care	at	an	urban	
hospital	in	Johannesburg,	South	Africa.	PloS	one	11	
(2):	e0148546.	
Lurie,	Mark	N.,	and	Brian	G.	Williams.	2014.	Migration	and	
health	in	Southern	Africa:	100	years	and	still	
circulating.	Health	Psychology	and	Behavioral	
Medicine:	an	Open	Access	Journal	2	(1):	34–40.	
Lynch,	Julia.	2006.	Age	in	the	welfare	state:	The	origins	of	
social	spending	on	pensioners,	workers,	and	
children.	Cambridge	University	Press.	
Mackenbach,	Johan	P.,	and	Martin	McKee.	2013.	A	
comparative	analysis	of	health	policy	performance	
in	43	European	countries.	The	European	Journal	of	
Public	Health	23	(2):	195–201.	
MacLean,	Lauren	M.	2011.	State	retrenchment	and	the	
exercise	of	citizenship	in	Africa.	Comparative	
Political	Studies	44	(9):	1238–1266.	
Mahoney,	James.	2007.	Qualitative	methodology	and	
comparative	politics.	Comparative	Political	Studies	
40	(2):	122–144.	
Mahoney,	James.	2012.	The	logic	of	process	tracing	tests	in	
the	social	sciences.	Sociological	Methods	&	
Research	41	(4):	570–597.	
Mahoney,	James,	and	Kathleen	Thelen.	2009.	Explaining	
institutional	change:	ambiguity,	agency,	and	
power.	Cambridge	University	Press.	
Maiphetlho,	Lerato,	and	Rodney	Ehrlich.	2010.	Claims	
experience	of	former	gold	miners	with	silicosis–A	
clinic	series.	Occupational	Health	Southern	Africa	
16	(2):	10–16.	
Maiti,	Rituparna,	Vikas	Bhatia,	Biswa	Mohan	Padhy,	and	
Debasish	Hota.	2015.	Essential	Medicines:	An	
Indian	Perspective.	Indian	Journal	of	Community	
Medicine	40	(4):	223–232.	
Maleche,	Allan,	and	Emma	Day.	2014.	Right	to	Health	
Encompasses	Right	to	Access	Essential	Generic	
Medicines:	Challenging	the	2008	Anti-Counterfeit	
Act	in	Kenya.	Health	and	human	rights	16:	2.	
Malviya,	A.	2014.	Assessment	of	functioning	of	Village	Health	
and	Sanitation	Committees	(VHSCs)	of	Indore	
District.	Online	Journal	of	Health	and	Allied	
Sciences	12	(4).	
Mandela,	Nelson.	1994.	Long	Walk	to	Freedom.	Little	Brown	
and	Company.	
Mangla,	Bhupesh.	1992.	India:	disquiet	about	AIDS	control.	
the	Lancet	340	(8834–8835):	1533–1534.	
Mann,	Jonathan	M.	1996.	Human	rights	and	AIDS:	the	future	
of	the	pandemic.	J.	Marshall	Law	Review	30:	195.	
Mann,	Jonathan	M.,	Lawrence	Gostin,	Sofia	Gruskin,	Troyen	
Brennan,	Zita	Lazzarini,	and	Harvey	V.	Fineberg.	
1994.	Health	and	human	rights.	Health	and	human	
rights:	6–23.	
Marais,	Hein.	2000.	To	the	edge:	AIDS	review	2000.	University	
of	Pretoria,	Pretoria,	ZA.	
March,	James	G,	and	Johan	P.	Olsen.	2008.	Elaborating	the	
‘New	Institutionalism’.	In	The	Oxford	handbook	of	
political	institutions.	Oxford	University	Press.	
March,	James	G.,	and	Johan	P.	Olsen.	1983.	The	new	
institutionalism:	organizational	factors	in	political	
life.	American	Political	Science	Review	78	(03):	
734–749.	
Marks,	S,	and	N	Andersson.	1987.	Issues	in	the	political	
economy	of	health	in	South	Africa.	Journal	of	
Southern	African	Studies:	179–86.	
Marks,	Shula.	1997.	South	Africa’s	early	experiment	in	social	
medicine:	its	pioneers	and	politics.	American	
journal	of	public	health	87	(3):	452–459.	
Marks,	Shula.	2005.	The	Legacy	of	the	History	of	Nursing	for	
Post	Apartheid	South	Africa.	In	Nursing	history	and	
the	politics	of	welfare.	Routledge.	
Marks,	Shula.	2006.	The	silent	scourge?	Silicosis,	respiratory	
disease	and	gold-mining	in	South	Africa.	Journal	of	
Ethnic	and	Migration	Studies	32	(04):	569–589.	
Marmor,	Ted,	Richard	Freeman,	and	Kieke	Okma.	2005.	
Comparative	perspectives	and	policy	learning	in	
the	world	of	health	care.	Journal	of	Comparative	
Policy	Analysis:	research	and	practice	7	(4):	331–
348.	
Marmor,	Theodore	R.,	and	Morris	L.	Barer.	2012.	The	Politics	
of	Universal	Health	Insurance.	Politics,	Health,	and	
Health	Care:	Selected	Essays:	127.	
Marmor,	Theodore,	and	Claus	Wendt.	2012.	Conceptual	
frameworks	for	comparing	healthcare	politics	and	
policy.	Health	policy	107	(1):	11–20.	
Marmot,	Michael.	2005.	Social	determinants	of	health	
inequalities.	The	Lancet	365	(9464):	1099–1104.	
Marmot,	Michael,	Jessica	Allen,	Ruth	Bell,	Ellen	Bloomer,	and	
Peter	Goldblatt.	2012.	WHO	European	review	of	
social	determinants	of	health	and	the	health	
divide.	The	Lancet	380	(9846):	1011–1029.	
Marmot,	Michael,	Sharon	Friel,	Ruth	Bell,	Tanja	AJ	Houweling,	
Sebastian	Taylor,	and	Commission	on	Social	
Determinants	of	Health.	2008.	Closing	the	gap	in	a	
generation:	health	equity	through	action	on	the	
social	determinants	of	health.	The	Lancet	372	
(9650):	1661–1669.	
Marmot,	Michael,	and	Richard	Wilkinson.	2005.	Social	
determinants	of	health.	Oxford	University	Press.	
Marshall,	Monty	G.	2014.	Major	Episodes	of	Political	Violence,	
1946-2013.	Center	for	Systemic	Peace.	Available	at	
<http://www.systemicpeace.org/inscrdata.html>.	
Accessed	24	April	2015.	
References	
	
332	
Marshall,	Monty	G.,	and	Keith	Jaggers.	n.d.	Polity	IV	Project:	
Political	Regime	Characteristics	and	Transitions,	
1800-2011.	Available	at	
<http://www.systemicpeace.org/polity/polity4.ht
m>.	Accessed	6	March	2013.	
Marten,	Robert,	Diane	McIntyre,	Claudia	Travassos,	Sergey	
Shishkin,	Wang	Longde,	Srinath	Reddy,	and	
Jeanette	Vega.	2014.	An	assessment	of	progress	
towards	universal	health	coverage	in	Brazil,	Russia,	
India,	China,	and	South	Africa	(BRICS).	The	Lancet	
384	(9960):	2164–2171.	
Massyn,	Naomi,	Candy	Day,	Nazia	Peer,	M.	Dombo,	Peter	
Barron,	Rene	English,	and	Ashnie	Padarath.	2014.	
District	health	barometer.	Durban:	Health	Systems	
Trust.	
Massyn,	Naomi,	Nazia	Peer,	Rene	English,	Peter	Barron,	and	
Candy	Day.	2016.	District	Health	Barometer	
2015/16.	Durban:	Health	Systems	Trust.	
Masutha,	Michael.	2016.	Budget	Vote	Speech	by	Minister	of	
Justice	and	Correctional	Services.	Cape	Town:	
Parliament	of	South	Africa.	
Maynard,	Alan,	and	Karen	Bloor.	2003.	Dilemmas	in	
regulation	of	the	market	for	pharmaceuticals.	
Health	Affairs	22	(3):	31–41.	
Mayosi,	Bongani	M.,	and	Solomon	R.	Benatar.	2014.	Health	
and	health	care	in	South	Africa—20	years	after	
Mandela.	New	England	Journal	of	Medicine	371	
(14):	1344–1353.	
Mbali,	Mandisa.	2013.	South	African	AIDS	Activism	and	Global	
Health	Politics.	New	York:	Palgrave	Macmillan.	
Mbeki,	Thabo.	1999.	Address	to	the	National	Council	of	
Provinces.	Cape	Town,	South	Africa.	Available	at	
<http://www.dirco.gov.za/docs/speeches/1999/m
bek1028.htm>.	
Mbeki,	Thabo.	2002.	Health,	human	dignity	and	partners	for	
poverty	reduction.	ANC	Today.	
Mbeki,	Thabo,	and	Peter	Mokaba.	2002.	Castro	Hlongwane,	
Caravans,	Cats,	Geese,	Foot	&	Mouth	and	
Statistics:	HIV/Aids	and	the	Struggle	for	the	
Humanisation	of	the	African.	African	National	
Congress.	
McCann,	Michael.	2006.	Law	and	social	movements:	
Contemporary	perspectives.	Annu.	Rev.	Law	Soc.	
Sci.	2:	17–38.	
McCann,	Michael	W.	1994.	Rights	at	work:	Pay	equity	reform	
and	the	politics	of	legal	mobilization.	University	of	
Chicago	Press.	
McCoy,	David,	and	Solani	Khosa.	1996.	‘Free	Health	Care’	
Policeis.	In	South	African	Health	Review	1996,	157–
165.	Health	Systems	Trust.	
McCulloch,	Jock.	2012.	South	Africa’s	gold	mines	&	the	politics	
of	silicosis.	Boydell	&	Brewer	Ltd.	
McGettigan,	Patricia,	Peter	Roderick,	Rushikesh	Mahajan,	
Abhay	Kadam,	and	Allyson	M.	Pollock.	2015.	Use	of	
fixed	dose	combination	(FDC)	drugs	in	India:	
central	regulatory	approval	and	sales	of	FDCs	
containing	non-steroidal	anti-inflammatory	drugs	
(NSAIDs),	metformin,	or	psychotropic	drugs.	PLoS	
medicine	12	(5):	e1001826.	
McGuire,	James	W.	2006.	Basic	health	care	provision	and	
under-5	mortality:	a	cross-national	study	of	
developing	countries.	World	Development	34	(3):	
405–425.	
McGuire,	James	W.	2013.	Political	regime	and	social	
performance.	Contemporary	Politics	19	(1):	55–75.	
McGuire,	James	W.	2010.	Wealth,	health,	and	democracy	in	
East	Asia	and	Latin	America.	New	York:	Cambridge	
University	Press.	
McIntyre,	Di.	1994.	User	fees	for	public	sector	health	services	
in	South	Africa:	Revenue	generating	potential	and	
equity	implications.	University	of	Cape	Town,	Dept.	
of	Community	Health.	
McIntyre,	Di,	and	John	E.	Ataguba.	2012.	Modelling	the	
affordability	and	distributional	implications	of	
future	health	care	financing	options	in	South	
Africa.	Health	policy	and	planning	27	(suppl	1):	
i101–i112.	
McIntyre,	Diane,	Anderson	Bloom	Gerald,	Jane	Doherty,	and	
Prem	Brijlal.	1995.	Health	Expenditure	and	Finance	
in	South	Africa.	Health	Systems	Trust	and	the	
World	Bank.	
McKeown,	Thomas.	1988.	The	Origins	of	Human	Disease.	
Oxford:	Blackwell.	
McNeil,	Donald.	1997.	Report	of	South	African	AIDS	
‘Breakthrough’	Angers	Experts.	New	York	Times.	
Meents,	E,	and	T	Boyles.	2010.	Emergency	medical	services	–	
poor	response	time	in	the	rural	Eastern	Cape.	
South	African	Medical	Journal	100	(12):	790.	
Meerkotter,	Anmari.	2015.	The	Dudley	Lee	Case:	A	new	
approach	to	factual	causation	and	its	implications	
for	transformative	jurisprudence.	Southern	African	
Public	Law	30	(1):	273–289.	
Mehta,	Jal.	2010.	The	varied	roles	of	ideas	in	politics.	In	Ideas	
and	politics	in	social	science	research,	23–46.	
Oxford	University	Press.	
Mehta,	Pratap	Bhanu.	2005.	India’s	Judiciary:	The	Promise	of	
Uncertainty.	In	Public	Institutions	in	India:	
Performance	and	Design,	158–93.	New	Delhi:	
Oxford	University	Press.	
Mehta,	Pratap	Bhanu.	2015.	The	Indian	Supreme	Court	and	
the	Art	of	Democratic	Positioning.	In	Unstable	
Constitutionalism:	Law	and	Politics	in	South	Asia,	
233–60.	New	York:	Cambridge	University	Press.	
Meier,	Benjamin	Mason,	Kristen	Nichole	Brugh,	and	Yasmin	
Halima.	2012.	Conceptualizing	a	Human	Right	to	
Prevention	in	Global	HIV/AIDS	Policy.	Public	health	
ethics	5	(3):	263–282.	
Melton,	James.	2014.	Do	constitutional	rights	matter?	The	
relationship	between	de	jure	and	de	facto	human	
rights	protection.	Working	Paper.	
Melton,	James,	Zachary	Elkins,	Tom	Ginsburg,	and	Kalev	
Leetaru.	2013.	On	the	Interpretability	of	Law:	
Lessons	from	the	Decoding	of	National	
Constitutions.	British	Journal	of	Political	Science	43	
(02):	399–423.	
Meltzer,	Allan	H.,	and	Scott	F.	Richard.	1981.	A	rational	theory	
of	the	size	of	government.	The	Journal	of	Political	
Economy:	914–927.	
Mercer,	Jonathan.	2005.	Prospect	theory	and	political	science.	
Annu.	Rev.	Polit.	Sci.	8:	1–21.	
Michelman,	Frank	I.	2008.	Socioeconomic	rights	in	
constitutional	law:	Explaining	America	away.	
International	journal	of	constitutional	law	6	(3–4):	
663–686.	
Million	Death	Study.	2010.	Causes	of	neonatal	and	child	
mortality	in	India:	a	nationally	representative	
mortality	survey.	The	Lancet	376	(9755):	1853–
1860.	
Mine	Health	and	Safety	Inspectorate.	2003.	Executive	
Summary	of	the	Review	of	Mine	Health	and	Safety,	
References	
	
333	
Post-Leon	Commission.	Department	of	Minerals	
and	Energy.	
Ministry	of	Health	and	Family	Welfare.	2005.	NATIONAL	
RURAL	HEALTH	MISSION:	Meeting	people’s	health	
needs	in	rural	areas.	Framework	for	
Implementation	2005-2012.	Government	of	India.	
Mishkin,	Frederic	S.	2007.	Monetary	policy	strategy.	MIT	
press.	
Mkhize,	Zweli.	2016.	Dear	Mbeki,	now	is	the	time	to	apologise	
for	Aids	denialism.	Sunday	Times.	
Mkokeli,	Sam.	2002.	Goqwana	Denies	That	There	is	Any	Crisis.	
East	Cape	News.	
Mnookin,	Robert	H.,	and	Lewis	Kornhauser.	1979.	Bargaining	
in	the	shadow	of	the	law:	The	case	of	divorce.	The	
Yale	Law	Journal	88	(5):	950–997.	
Moe,	Terry	M.	1990.	Political	institutions:	The	neglected	side	
of	the	story.	Journal	of	Law,	Economics,	&	
Organization	6:	213–253.	
Moe,	Terry	M.	2005.	Power	and	political	institutions.	
Perspectives	on	politics	3	(02):	215–233.	
Mondou,	Matthieu,	Grace	Skogstad,	and	David	Houle.	2014.	
Policy	image	resilience,	multidimensionality,	and	
policy	image	management:	a	study	of	US	biofuel	
policy.	Journal	of	Public	Policy	34	(01):	155–180.	
Montalvo,	Jose	G.,	and	Marta	Reynal-Querol.	2005.	Ethnic	
diversity	and	economic	development.	Journal	of	
Development	economics	76	(2):	293–323.	
Moon,	Bruce	E.,	and	William	J.	Dixon.	1985.	Politics,	the	state,	
and	basic	human	needs:	A	cross-national	study.	
American	Journal	of	Political	Science:	661–694.	
Morone,	James	A.	1990.	American	political	culture	and	the	
search	for	lessons	from	abroad.	Journal	of	Health	
Politics,	Policy	and	Law	15	(1):	129–143.	
Mortensen,	Peter	B.	2007.	Stability	and	change	in	public	
policy:	A	longitudinal	study	of	comparative	
subsystem	dynamics.	Policy	Studies	Journal	35	(3):	
373–394.	
Msellati,	Philippe,	Rosa	Ramon,	Ida	Viho,	V.	Noba,	L.	
Mandelbrot,	F.	Dabis,	and	C.	Welffens	Ekra.	1998.	
Prevention	of	mother-to-child	transmission	of	HIV	
in	Africa:	uptake	of	pregnant	women	in	a	clinical	
trial	in	Abidjan,	Côte	d’Ivoire.	Aids	12	(10):	1257–
1258.	
MSF	Access	Campaign.	2012.	Untangling	the	Web	of	
Antiretroviral	Price	Reductions	(15th	Edition).	
Available	at	
<http://www.msfaccess.org/content/untangling-
web-antiretroviral-price-reductions-15th-edition>.	
Mtsolongo,	Thokozile.	2014.	Eastern	Cape	Department	of	
Health	Budget	Analysis.	Public	Service	
Accountability	Monitor.	
Mudur,	Ganapati.	2005.	India	plans	to	audit	clinical	trials.	
BMJ:	British	Medical	Journal	331	(7524):	1044.	
Mukherjee,	Kanchan.	2017.	A	cost	analysis	of	the	Jan	
Aushadhi	scheme	in	India.	International	Journal	of	
Health	Policy	and	Management	6	(5):	253.	
Muntaner,	Carles,	Carme	Borrell,	Edwin	Ng,	Haejoo	Chung,	
Albert	Espelt,	Maica	Rodriguez-Sanz,	Joan	Benach,	
and	Patricia	O’Campo.	2011.	Politics,	welfare	
regimes,	and	population	health:	controversies	and	
evidence.	Sociology	of	health	&	illness	33	(6):	946–
964.	
Muralidhar,	S.	2008.	India.	In	Social	Rights	Jursiprudence,	
edited	by	Malcolm	Langford,	102–124.	Cambridge	
University	Press.	
Murray,	Jill,	Tony	Davies,	and	David	Rees.	2011.	Occupational	
lung	disease	in	the	South	African	mining	industry:	
research	and	policy	implementation.	Journal	of	
public	health	policy	32	(1):	S65–S79.	
Mushtaq,	Muhammad	Umair.	2009.	Public	health	in	British	
India:	A	brief	account	of	the	history	of	medical	
services	and	disease	prevention	in	colonial	India.	
Indian	Journal	of	Community	Medicine	34	(1):	6.	
Myburgh,	James.	2009.	In	the	beginning	there	was	Virodene.	
In	The	Virus,	Vitamins	and	Vegetables:	The	South	
African	HIV/AIDS	Mystery.	Jacana	Media.	
NACO.	2003a.	Annual	Report	2002-03.	National	AIDS	Control	
Organization.	Available	at	
<http://naco.gov.in/documents/annual-reports>.	
NACO.	2006a.	Annual	Report	2005-06.	National	AIDS	Control	
Organization.	Available	at	
<http://naco.gov.in/documents/annual-reports>.	
NACO.	2017.	Annual	Report	2016-17.	National	AIDS	Control	
Organization.	Available	at	
<http://naco.gov.in/documents/annual-reports>.	
NACO.	2006b.	HIV	prevalence	2003–2005,	MSM,	IDU,	FSW.	
National	AIDS	Control	Organization.	
NACO.	2003b.	Note	on	HIV	Estimates	2003.	National	AIDS	
Control	Organization.	
Nannan,	Nadine,	Rob	E.	Dorrington,	Ria	Laubscher,	Nesbert	
Zinyakatira,	and	Debbie	Bradshaw.	2012.	Under-5	
Mortality	in	South	Africa:	Shedding	Some	Light	on	
the	Statistics.	South	African	Medical	Research	
Council.	
National	Human	Rights	Commission.	2004a.	Annual	Report	
2003-2004.	New	Delhi:	National	Human	Rights	
Commission.	
National	Human	Rights	Commission.	2004b.	
Recommendations	of	National	Action	Plan	to	
Operationalize	the	Right	to	Health	Care:	National	
Public	Hearing	On	Right	to	Helath	Care.	New	Delhi:	
NHRC.	Available	at	
<http://www.nhrc.nic.in/dispArchive.asp?fno=874
>.	
National	Intelligence	Council.	2002.	The	Next	Wave	of	
HIV/AIDS:	Nigeria,	Ethiopia,	Russia,	India,	and	
China.	Washington,	DC:	National	Intelligence	
Council.	Available	at	
<https://www.dni.gov/files/documents/Special%2
0Report_The%20Next%20Wave%20of%20HIV_AID
S.pdf>.	
Nattrass,	Nicoli.	2001.	Affidavid	in	TAC	and	Others	versus	
Minister	of	Health	and	Others.	
Nattrass,	Nicoli.	2013.	The	AIDS	Conspiracy.	Columbia	
University	Press.	
Nattrass,	Nicoli.	2004.	The	moral	economy	of	AIDS	in	South	
Africa.	Cambridge	University	Press.	
Navarro,	Vicente.	1995.	The	politics	of	health	care	reform	in	
the	United	States,	1992–1994:	A	historical	review.	
International	Journal	of	Health	Services	25	(2):	
185–201.	
Navarro,	Vicente,	Carles	Muntaner,	Carme	Borrell,	Joan	
Benach,	Águeda	Quiroga,	Maica	Rodríguez-Sanz,	
Núria	Vergés,	and	M.	Isabel	Pasarín.	2006.	Politics	
and	health	outcomes.	The	Lancet	368	(9540):	
1033–1037.	
Navarro,	Vicente,	and	Leiyu	Shi.	2001.	The	political	context	of	
social	inequalities	and	health.	Social	science	&	
medicine	52	(3):	481–491.	
References	
	
334	
Navia,	Patricio,	and	Thomas	D.	Zweifel.	2003.	Democracy,	
dictatorship,	and	infant	mortality	revisited.	Journal	
of	Democracy	14	(3):	90–103.	
Ndirangu,	James,	Marie-Louise	Newell,	Frank	Tanser,	
Abraham	J.	Herbst,	and	Ruth	Bland.	2010.	Decline	
in	early	life	mortality	in	a	high	HIV	prevalence	rural	
area	of	South	Africa:	evidence	of	HIV	prevention	or	
treatment	impact?	AIDS	(London,	England)	24	(4):	
593.	
Ndlovu,	Ntombizodwa,	Gill	Nelson,	Naseema	Vorajee,	and	Jill	
Murray.	2016.	38	years	of	autopsy	findings	in	
South	African	mine	workers.	American	journal	of	
industrial	medicine	59	(4):	307–314.	
Nelson,	Gill,	Brendan	Girdler-Brown,	Ntombizodwa	Ndlovu,	
and	Jill	Murray.	2010.	Three	decades	of	silicosis:	
disease	trends	at	autopsy	in	South	African	gold	
miners.	Environmental	health	perspectives	118	(3):	
421.	
Nelson,	Joan	M.	2007.	Elections,	democracy,	and	social	
services.	Studies	in	Comparative	International	
Development	41	(4):	79–97.	
Neumayer,	Eric.	2005.	Do	international	human	rights	treaties	
improve	respect	for	human	rights?	Journal	of	
conflict	resolution	49	(6):	925–953.	
Nixon,	John,	and	Philippe	Ulmann.	2006.	The	relationship	
between	health	care	expenditure	and	health	
outcomes.	The	European	Journal	of	Health	
Economics	7	(1):	7–18.	
Norheim,	Ole	Frithjof,	and	Bruce	M.	Wilson.	2014.	Health	
Rights	Litigation	and	Access	to	Medicines:	Priority	
Classification	of	Successful	Cases	from	Costa	Rica’s	
Constitutional	Chamber	of	the	Supreme	Court.	
Health	and	human	rights	16:	2.	
North,	Douglass	C.	1990.	Institutions,	institutional	change	and	
economic	performance.	Cambridge	university	
press.	
North,	Douglass	C.,	and	Barry	R.	Weingast.	1989.	
Constitutions	and	commitment:	the	evolution	of	
institutions	governing	public	choice	in	
seventeenth-century	England.	The	journal	of	
economic	history	49	(04):	803–832.	
Nundy,	Samiran,	and	Chandra	M.	Gulhati.	2005.	A	new	
colonialism?-conducting	clinical	trials	in	India.	The	
New	England	journal	of	medicine	352	(16):	1633.	
Nunn,	Amy,	Samuel	Dickman,	Nicoli	Nattrass,	Alexandra	
Cornwall,	and	Sofia	Gruskin.	2012.	The	impacts	of	
AIDS	movements	on	the	policy	responses	to	
HIV/AIDS	in	Brazil	and	South	Africa:	a	comparative	
analysis.	Global	public	health	7	(10):	1031–1044.	
Oberlander,	Jonathan.	2007.	Learning	from	failure	in	health	
care	reform.	New	England	Journal	of	Medicine	357	
(17):	1677–1679.	
Oberlander,	Jonathan.	2010.	Long	time	coming:	why	health	
reform	finally	passed.	Health	Affairs	29	(6):	1112–
1116.	
O’Connell,	Paul.	2010.	The	human	right	to	health	in	an	age	of	
market	hegemony.	In	Global	Health	and	Human	
Rights:	legal	and	philosophical	perspectives,	edited	
by	John	Harrington	and	Maria	Stuttaford,	190.	
Routledge.	
Odhiambo,	Human	Agnes.	2011.	Stop	Making	Excuses:	
Accountability	for	Maternal	Health	Care	in	South	
Africa.	Human	Rights	Watch.	
O’Donnell,	Guillermo.	1993.	On	the	state,	democratization	
and	some	conceptual	problems:	A	Latin	American	
view	with	glances	at	some	postcommunist	
countries.	World	Development	21	(8):	1355–1369.	
Ogata,	Sadako,	and	Amartya	Sen.	2003.	Human	security	now:	
Commission	on	human	security	Final	report.	New	
York:	Commission	on	Human	Security.	
Ohemeng,	Frank	Kwaku,	and	Felix	K.	Anebo.	2012.	The	politics	
of	administrative	reforms	in	Ghana:	Perspectives	
from	path	dependency	and	punctuated	
equilibrium	theories.	International	Journal	of	
Public	Administration	35	(3):	161–176.	
Ooms,	Gorik,	Claire	Brolan,	Natalie	Eggermont,	Asbjørn	Eide,	
Walter	Flores,	Lisa	Forman,	Eric	A.	Friedman,	
Thomas	Gebauer,	Lawrence	O.	Gostin,	and	Peter	S.	
Hill.	2013.	Universal	health	coverage	anchored	in	
the	right	to	health.	Bulletin	of	the	World	Health	
Organization	91	(1):	2–2a.	
Over,	A.	Mead,	Peter	Heywood,	Julian	Gold,	Indrani	Gupta,	
Subhash	Hira,	and	Elliot	Marseille.	2004.	HIV/AIDS	
treatment	and	prevention	in	India:	modeling	the	
costs	and	consequences.	World	Bank.	
Padmavati,	A.	1991.	A	critical	analysis	of	the	law	on	AIDS	in	
India.	Women’s	Global	Network	on	Reproductive	
Rights	Newsletter	(36):	61.	
Page,	Benjamin	I.,	Larry	M.	Bartels,	and	Jason	Seawright.	
2013.	Democracy	and	the	policy	preferences	of	
wealthy	Americans.	Perspectives	on	Politics	11	
(01):	51–73.	
Palella,	Frank	J.,	Kathleen	M.	Delaney,	Anne	C.	Moorman,	
Mark	O.	Loveless,	Jack	Fuhrer,	Glen	A.	Satten,	
Diane	J.	Aschman,	and	Scott	D.	Holmberg.	1998.	
Declining	morbidity	and	mortality	among	patients	
with	advanced	human	immunodeficiency	virus	
infection.	New	England	Journal	of	Medicine	338	
(13):	853–860.	
Parkhurst,	Justin	O.	2004.	The	political	environment	of	HIV:	
lessons	from	a	comparison	of	Uganda	and	South	
Africa.	Social	science	&	medicine	59	(9):	1913–
1924.	
Parks,	Richard	W.	1967.	Efficient	estimation	of	a	system	of	
regression	equations	when	disturbances	are	both	
serially	and	contemporaneously	correlated.	
Journal	of	the	American	Statistical	Association	62	
(318):	500–509.	
Parmar,	Sharanjeet,	and	Namita	Wahi.	2011.	Citizens,	courts	
and	the	right	to	health:	between	promise	and	
progress?	In	Litigating	Health	Rights,	edited	by	
Alicia	Ely	Yamin	and	Siri	Gloppen,	155–189.	
Harvard	University	Press.	
Patel,	Vikram,	Rachana	Parikh,	Sunil	Nandraj,	Priya	
Balasubramaniam,	Kavita	Narayan,	Vinod	K.	Paul,	
AK	Shiva	Kumar,	Mirai	Chatterjee,	and	K.	Srinath	
Reddy.	2015.	Assuring	health	coverage	for	all	in	
India.	The	Lancet	386	(10011):	2422–2435.	
Patterson,	Andrew	C.,	and	Gerry	Veenstra.	2016.	Politics	and	
population	health:	Testing	the	impact	of	electoral	
democracy.	Health	&	place	40:	66–75.	
Paul,	Samuel.	1994.	Does	voice	matter?:	for	public	
accountability,	yes.	Vol.	1388.	World	Bank	
Publications.	
Pedersen,	Duncan.	2002.	Political	violence,	ethnic	conflict,	
and	contemporary	wars:	broad	implications	for	
health	and	social	well-being.	Social	science	&	
medicine	55	(2):	175–190.	
Peerenboom,	Randall,	and	Tom	Ginsburg.	2013.	Law	and	
Development	of	Middle-income	Countries:	
References	
	
335	
Avoiding	the	Middle-income	Trap.	Cambridge	
University	Press.	
Peters,	D.,	A.	Yazbeck,	G.	Ramana,	R.	Sharma,	L.	Pritchett,	and	
Adam	Wagstaff.	2001.	Raising	the	sights:	Better	
health	systems	for	India’s	poor.	The	World	Bank	
(Health,	Nutrition,	Population	Sector	Unit).	
Peterson,	Mark	A.	2011.	It	was	a	different	time:	Obama	and	
the	unique	opportunity	for	health	care	reform.	
Journal	of	health	politics,	policy	and	law	36	(3):	
429–436.	
Petryna,	Adriana.	2009.	When	experiments	travel:	clinical	
trials	and	the	global	search	for	human	subjects.	
Princeton	University	Press.	
Phongpaichit,	Pasuk,	and	Christopher	John	Baker.	2004.	
Thaksin:	The	business	of	politics	in	Thailand.	NIAS	
Press.	
Pick,	William,	Laetitia	Rispel,	and	Shan	Naidoo.	2008.	Poverty,	
health	and	policy:	A	historical	look	at	the	South	
African	experience.	Journal	of	Public	Health	Policy	
29	(2):	165–178.	
Pierson,	Paul.	2000a.	Increasing	returns,	path	dependence,	
and	the	study	of	politics.	American	political	science	
review:	251–267.	
Pierson,	Paul.	2004.	Politics	in	time:	History,	institutions,	and	
social	analysis.	Princeton	University	Press.	
Pierson,	Paul.	1996.	The	new	politics	of	the	welfare	state.	
World	politics	48:	143–179.	
Pierson,	Paul.	2000b.	Three	worlds	of	welfare	state	research.	
Comparative	political	studies	33	(6–7):	791–821.	
Pieters,	Hannah,	Daniele	Curzi,	Alessandro	Olper,	and	Johan	
Swinnen.	2016.	Effect	of	democratic	reforms	on	
child	mortality:	a	synthetic	control	analysis.	The	
Lancet	Global	Health	4	(9):	e627–e632.	
Pieterse,	Marius.	2014.	Can	Rights	Cure?	The	impact	of	human	
rights	litigation	on	South	Africa’s	health	system.	
Pretoria:	Pretoria	University	Law	Press.	
Piper,	Laurence,	and	Heidi	Matisonn.	2009.	Democracy	by	
accident:	the	rise	of	Zuma	and	the	renaissance	of	
the	tripartite	alliance.	Representation	45	(2):	143–
157.	
Planning	Commission	of	India.	2006.	Report	Of	The	Working	
Group	On	Drugs	And	Pharmaceuticals	For	The	
Eleventh	Five-Year	Plan	(2007-2012).	Planning	
Commission	of	India.	
Plümper,	Thomas,	Vera	E.	Troeger,	and	Philip	Manow.	2005.	
Panel	data	analysis	in	comparative	politics:	Linking	
method	to	theory.	European	Journal	of	Political	
Research	44	(2):	327–354.	
Porter,	Dorothy.	1998.	Health,	civilization	and	the	state:	a	
history	of	public	health	from	ancient	to	modern	
times.	Routledge.	
Porter,	Gerard.	2017.	Regulating	clinical	trials	in	India:	the	
economics	of	ethics.	Developing	World	Bioethics.	
Posner,	Eric	A.	2012.	Some	Skeptical	Comments	on	Beth	
Simmons’s’	Mobilizing	for	Human	Rights’.	Journal	
of	International	Law	and	Politics	819	(2012).	44	
(819):	369.	
Powell	Jr,	G.	Bingham,	and	Guy	D.	Whitten.	1993.	A	cross-
national	analysis	of	economic	voting:	taking	
account	of	the	political	context.	American	Journal	
of	Political	Science:	391–414.	
Powell-Jackson,	Timothy,	Arnab	Acharya,	and	Anne	Mills.	
2013.	An	assessment	of	the	quality	of	primary	
health	care	in	India.	Economic	&	Political	Weekly	
48	(19):	53–61.	
Powell-Jackson,	Timothy,	Sanjay	Basu,	Dina	Balabanova,	
Martin	McKee,	and	David	Stuckler.	2011.	
Democracy	and	growth	in	divided	societies:	A	
health-inequality	trap?	Social	science	&	medicine	
73	(1):	33–41.	
Prasad,	Amit	M.,	Salima	Bhatia,	and	Ritu	Agrawal.	2013.	The	
effect	of	the	National	Rural	Health	Mission	on	
health	services	and	outcomes	for	childbirth	in	
India:	a	retrospective	analysis	of	survey	data.	The	
Lancet	382:	11.	
Preston,	Samuel	H.	1975.	The	changing	relation	between	
mortality	and	level	of	economic	development.	
Population	studies	29	(2):	231–248.	
Price,	Max.	1986.	Health	care	as	an	instrument	of	apartheid	
policy	in	South	Africa.	Health	Policy	and	Planning	1	
(2):	158–170.	
Pritchett,	Lant.	n.d.	Is	India	a	Flailing	State?	Detours	on	the	
Four	Lane	Highway	to	Modernization.	HKS	Faculty	
Research	Working	Paper	Series	(RWP09-013).	
Pritchett,	Lant,	and	Martina	Viarengo.	2010.	Explaining	the	
Cross-national	Time	Series	Variation	in	Life	
Expectancy:	Income,	Women’s	Education	Shifts	and	
what	Else?	United	Nations	Development	
Programme.	
Przeworski,	Adam.	2008.	Democracy,	Social	Inclusion,	and	
Development.	In	Participatory	Governance	and	the	
Millennium	Development	Goals,	49.	New	York:	
United	Nations.	
Przeworski,	Adam,	Michael	E.	Alvarez,	Jose	Antonio	Cheibub,	
and	Fernando	Limongi.	2000.	Democracy	and	
development:	political	institutions	and	well-being	
in	the	world,	1950-1990.	Cambridge	University	
Press.	
Puliyel,	Jacob.	2012.	Compensation	for	Victims	of	clinical	
trials:	A	discussion	on	how	current	Indian	rules	and	
guidelines	are	hurting	India.	Journal	of	Clinical	and	
Diagnostic	Research	6	(8):	1367.	
Rajagopal,	Balakrishnan.	2007.	Pro-human	rights	but	anti-
poor?	A	critical	evaluation	of	the	Indian	Supreme	
Court	from	a	social	movement	perspective.	Human	
Rights	Review	8	(3):	157–186.	
Rajaratnam,	Julie	Knoll,	Jake	R.	Marcus,	Abraham	D.	Flaxman,	
Haidong	Wang,	Alison	Levin-Rector,	Laura	Dwyer,	
Megan	Costa,	Alan	D.	Lopez,	and	Christopher	JL	
Murray.	2010.	Neonatal,	postneonatal,	childhood,	
and	under-5	mortality	for	187	countries,	1970–
2010:	a	systematic	analysis	of	progress	towards	
Millennium	Development	Goal	4.	The	Lancet	375	
(9730):	1988–2008.	
Rajkumar,	Andrew	Sunil,	and	Vinaya	Swaroop.	2008.	Public	
spending	and	outcomes:	Does	governance	matter?	
Journal	of	development	economics	86	(1):	96–111.	
Rao,	K.	Sujatha.	2017.	Do	We	Care:	India’s	Health	System.	
New	Delhi:	Oxford	University	Press.	
Rao,	Mohan,	Krishna	D.	Rao,	AK	Shiva	Kumar,	Mirai	
Chatterjee,	and	Thiagarajan	Sundararaman.	2011.	
Human	resources	for	health	in	India.	The	Lancet	
377	(9765):	587–598.	
Rawls,	John.	1999.	A	theory	of	justice.	Belknap	Press.	
Raz,	Joseph.	1984.	On	the	nature	of	rights.	Mind	93	(370):	
194–214.	
Reddy,	KN,	and	V	Selvaraju.	1994.	Health	Expenditure	by	
Government	in	India	1974-5	to	1992-92.	New	
Delhi:	National	Institute	of	Public	Finance	&	Policy.	
References	
	
336	
Reed,	W.	Robert,	and	Rachel	Webb.	2010.	The	PCSE	Estimator	
is	Good--Just	Not	As	Good	As	You	Think.	Journal	of	
Time	Series	Econometrics	2	(1).	
Reed,	W.	Robert,	and	Haichun	Ye.	2011.	Which	panel	data	
estimator	should	I	use?	Applied	Economics	43	(8):	
985–1000.	
Registrar	of	Medicines,	Medicines	Control	Council.	2015.	
Medicines	Control	Council	approves	fixed-dose	
combination	of	tenofovir	disoproxyl	fumarate	and	
emtricitabine	for	pre-exposure	prophylaxis	of	HIV.	
Pretoria:	National	Department	of	Health.	
Reserve	Bank	of	India.	2017.	Indian	Household	Finance.	
Household	Finance	Committee,	Reserve	Bank	of	
India.	
Rispel,	Laetitia,	Pieter	de	Jager,	and	Sharon	Fonn.	2015.	
Exploring	corruption	in	the	South	African	health	
sector.	Health	policy	and	planning	31	(2):	239–249.	
Risse,	Guenter	B.	1999.	Mending	bodies,	saving	souls:	a	
history	of	hospitals.	New	York:	Oxford	University	
Press.	
Risse,	Thomas,	Thomas	Risse-Kappen,	Stephen	C.	Ropp,	and	
Kathryn	Sikkink.	2013.	The	persistent	power	of	
human	rights:	From	commitment	to	compliance.	
Cambridge	University	Press.	
Risse-Kappen,	Thomas,	Stephen	C.	Ropp,	and	Kathryn	Sikkink.	
1999.	The	power	of	human	rights:	international	
norms	and	domestic	change.	Cambridge	University	
Press.	
Roberts,	Jaine.	2009.	The	hidden	epidemic	amongst	former	
miners:	silicosis,	tuberculosis	and	the	occupational	
diseases	in	mines	and	work	act	in	the	Eastern	Cape,	
South	Africa.	Health	Systems	Trust.	
Robins,	Steven	L.	2010.	From	revolution	to	rights	in	South	
Africa:	Social	movements,	NGOs	&	popular	politics	
after	apartheid.	Boydell	&	Brewer.	
Robinson,	Nick.	2013.	A	quantitative	analysis	of	the	Indian	
Supreme	Court’s	workload.	Journal	of	Empirical	
Legal	Studies	10	(3):	570–601.	
Robinson,	Nick.	2009.	Expanding	judiciaries:	India	and	the	rise	
of	the	good	governance	court.	Washington	
University	Global	Studies	Law	Review	8:	1.	
Rodger,	Alison	J.,	Valentina	Cambiano,	Tina	Bruun,	Pietro	
Vernazza,	Simon	Collins,	Jan	Van	Lunzen,	Giulio	
Maria	Corbelli,	Vicente	Estrada,	Anna	Maria	
Geretti,	and	Apostolos	Beloukas.	2016.	Sexual	
activity	without	condoms	and	risk	of	HIV	
transmission	in	serodifferent	couples	when	the	
HIV-positive	partner	is	using	suppressive	
antiretroviral	therapy.	Journal	of	the	American	
Medical	Association	316	(2):	171–181.	
Rodgers,	Gerry	B.	1979.	Income	and	inequality	as	
determinants	of	mortality:	an	international	cross-
section	analysis.	Population	studies	33	(2):	343–
351.	
Rodríguez	Garavito,	César.	2013.	The	Judicialization	of	Health	
Care:	Symptoms,	Diagnosis,	and	Prescriptions.	In	
Law	and	Development	of	Middle-Income	Countries,	
edited	by	Randall	Peerenboom	and	Tom	Ginsburg.	
Rodrik,	Dani.	2000.	Institutions	for	high-quality	growth:	what	
they	are	and	how	to	acquire	them.	Studies	in	
Comparative	International	Development	35	(3):	3–
31.	
Rodrik,	Dani.	2008a.	One	economics,	many	recipes:	
globalization,	institutions,	and	economic	growth.	
Princeton	University	Press.	
Rodrik,	Dani.	2008b.	Second-Best	Institutions.	American	
Economic	Review	98	(2):	100–104.	
Rohlfing,	Ingo.	2008.	What	You	See	and	What	You	Get	Pitfalls	
and	Principles	of	Nested	Analysis	in	Comparative	
Research.	Comparative	Political	Studies	41	(11):	
1492–1514.	
Rosenberg,	Gerald	N.	2008.	The	hollow	hope:	Can	courts	bring	
about	social	change?	University	of	Chicago	Press.	
Ross,	Michael.	2006.	Is	democracy	good	for	the	poor?	
American	Journal	of	Political	Science	50	(4):	860–
874.	
Rudra,	Nita.	2007.	Welfare	states	in	developing	countries:	
unique	or	universal?	Journal	of	Politics	69	(2):	378–
396.	
Ruger,	Jennifer	Prah.	2005a.	Democracy	and	health.	QJM	98	
(4):	299–304.	
Ruger,	Jennifer	Prah.	2005b.	Democracy	and	health.	QJM	98	
(4):	299–304.	
Ruger,	Jennifer	Prah.	2010a.	Health	and	social	justice.	Oxford	
University	Press.	
Ruger,	Jennifer	Prah.	2010b.	Health	capability:	
conceptualization	and	operationalization.	
American	Journal	of	Public	Health	100	(1):	41.	
Ruger,	Jennifer	Prah.	2007.	Health,	health	care,	and	
incompletely	theorized	agreements:	a	normative	
theory	of	health	policy	decision	making.	Journal	of	
health	politics,	policy	and	law	32	(1):	51–87.	
Ruger,	Jennifer	Prah.	2006.	Toward	a	Theory	of	a	Right	to	
Health:	Capability	and	Incompletely	Theorized	
Agreements.	Yale	Journal	of	Law	&	the	Humanities	
18:	273.	
Ruggie,	John	Gerard.	1982.	International	regimes,	
transactions,	and	change:	embedded	liberalism	in	
the	postwar	economic	order.	International	
organization	36	(02):	379–415.	
Sabatier,	Paul	A.,	and	Hank	Jenkins-Smith.	1993.	Policy	change	
and	learning:	An	advocacy	coalition	framework.	
Boulder	CO:	Westview.	
Sachs,	Albie.	1992.	Advancing	Human	Rights	in	South	Africa.	
Oxford	University	Press.	
Sachs,	Albie.	2009.	The	strange	alchemy	of	life	and	law.	OUP	
Oxford.	
Sachs,	Jeffrey	D.	2001.	Macroeconomics	and	health:	investing	
in	health	for	human	development.	Geneva:	World	
Health	Organization.	
Sachs,	Jeffrey	D.,	and	John	W.	McArthur.	2005.	The	
millennium	project:	a	plan	for	meeting	the	
millennium	development	goals.	Lancet	365	(9456):	
347–353.	
Samson,	Michael	J.	2002.	The	social,	economic	and	fiscal	
impact	of	comprehensive	social	security	reform	for	
South	Africa.	Social	Dynamics	28	(2):	69–97.	
Sawyer,	Cheryl	Chriss.	2012.	Child	mortality	estimation:	
estimating	sex	differences	in	childhood	mortality	
since	the	1970s.	PLoS	Med	9	(8):	e1001287.	
Schattschneider,	Elmer	E.	1975.	The	Semi-Sovereign	People:	A	
Realist’s	View	of	Democracy	in	America.	
Wadsworth	Publishing.	
Scheingold,	Stuart	A.	2004.	The	politics	of	rights:	Lawyers,	
public	policy,	and	political	change.	2nd	ed.	
University	of	Michigan	Press.	
Scheppele,	Kim	Lane.	2005.	Democracy	by	judiciary:	Or,	why	
courts	can	be	more	democratic	than	parliaments.	
In	Rethinking	the	rule	of	law	after	communism.	
Central	European	University	Press.	
References	
	
337	
Schmidt,	Vivien	A.	2008.	Discursive	institutionalism:	The	
explanatory	power	of	ideas	and	discourse.	Annual	
Review	of	Political	Science	11	(1):	303.	
Schmidt,	Vivien	A.	2002.	Does	discourse	matter	in	the	politics	
of	welfare	state	adjustment?	Comparative	political	
studies	35	(2):	168–193.	
Schneider,	Helen,	Peter	Barron,	and	Sharon	Fonn.	2007.	The	
promise	and	the	practice	of	transformation	in	
South	Africa’s	health	system.	In	State	of	the	
Nation:	South	Africa	2007,	289–311.	Pretoria:	
HSRC	Press.	
Schneider,	Helen,	and	Lucy	Gilson.	1999.	The	impact	of	free	
maternal	health	care	in	South	Africa.	In	Safe	
Motherhood	initiatives:	critical	issues,	93–101.	
Blackwell	Science.	
Schneider,	Helen,	and	Joanne	Stein.	2001.	Implementing	AIDS	
policy	in	post-apartheid	South	Africa.	Social	
Science	&	Medicine	52	(5):	723–731.	
Seawright,	Jason,	and	John	Gerring.	2008.	Case	Selection	
Techniques	in	Case	Study	Research	A	Menu	of	
Qualitative	and	Quantitative	Options.	Political	
Research	Quarterly	61	(2):	294–308.	
Seekings,	Jeremy.	2007.	‘Not	a	Single	White	Person	Should	Be	
Allowed	to	Go	under’:	Swartgevaar	and	the	Origins	
of	South	Africa’s	Welfare	State,	1924-1929.	Journal	
of	African	History:	375–394.	
Seekings,	Jeremy.	2014.	The	social	and	political	implications	of	
demographic	change	in	post-apartheid	South	
Africa.	The	ANNALS	of	the	American	Academy	of	
Political	and	Social	Science	652	(1):	70–86.	
Seekings,	Jeremy,	and	Nicoli	Nattrass.	2016.	Poverty,	Politics	
and	Policy	in	South	Africa.	Jacana.	
Sell,	Susan	K.,	and	Aseem	Prakash.	2004.	Using	ideas	
strategically:	The	contest	between	business	and	
NGO	networks	in	intellectual	property	rights.	
International	Studies	Quarterly	48	(1):	143–175.	
Selway,	Joel	Sawat.	2015.	Coalitions	of	the	Wellbeing:	How	
Electoral	Rules	and	Ethnic	Politics	Shape	Health	
Policy	in	Developing	Countries.	Cambridge	
University	Press.	
Selway,	Joel	Sawat.	2011.	Electoral	Reform	and	Public	Policy	
Outcomes	in	Thailand:	The	Politics	of	the	30-Baht	
Health	Scheme.	World	Politics	63	(1):	165–202.	
Sen,	Amartya.	1999.	Development	as	freedom.	Oxford	
University	Press.	
Sen,	Amartya.	1983.	Development:	Which	way	now?	The	
Economic	Journal	93	(372):	745–762.	
Sen,	Amartya.	2004.	Elements	of	a	theory	of	human	rights.	
Philosophy	&	Public	Affairs	32	(4):	315–356.	
Sen,	Amartya.	1992.	Missing	women.	BMJ:	British	Medical	
Journal	304	(6827):	587.	
Sen,	Amartya.	2008.	Why	and	how	is	health	a	human	right?	
The	Lancet	372	(9655):	2010–2010.	
Sengupta,	Amit.	2009.	Fatal	trials:	clinical	trials	are	killing	
people.	
Sengupta,	Amit,	and	Samiran	Nundy.	2005.	The	private	health	
sector	in	India:	Is	burgeoning,	but	at	the	cost	of	
public	health	care.	BMJ:	British	Medical	Journal	
331	(7526):	1157.	
Seshadri,	Shreelata	Rao,	Suraj	Parab,	Sandesh	Kotte,	N.	Latha,	
and	Kalyani	Subbiah.	2015.	Decentralization	and	
decision	space	in	the	health	sector:	a	case	study	
from	Karnataka,	India.	Health	policy	and	planning	
31	(2):	171–181.	
Shandra,	John	M.,	Jenna	Nobles,	Bruce	London,	and	John	B.	
Williamson.	2004.	Dependency,	democracy,	and	
infant	mortality:	a	quantitative,	cross-national	
analysis	of	less	developed	countries.	Social	science	
&	medicine	59	(2):	321–333.	
Shandra,	John	M.,	Carrie	L.	Shandra,	and	Bruce	London.	2010.	
Do	non-governmental	organizations	impact	
health?	A	cross-national	analysis	of	infant	
mortality.	International	Journal	of	Comparative	
Sociology	51	(1–2):	137–164.	
Shankar,	Shylashri.	2013.	The	Embedded	Negotiators:	India’s	
Higher	Judiciary	and	Socioeconomic	Rights.	In	
Constitutionalism	of	the	Global	South.	New	York:	
Cambridge	University	Press.	
Shankar,	Shylashri,	and	Pratap	Mehta.	2008.	Courts	and	
Socioeconomic	Rights	in	India.	In	Courting	social	
justice,	edited	by	Daniel	M.	Brinks	and	Varun	
Gauri,	146–82.	Cambridge	University	Press.	
Shapiro,	Martin.	1986.	Courts:	a	comparative	and	political	
analysis.	University	of	Chicago	Press.	
Shapiro,	Martin.	2002.	The	success	of	judicial	review	and	
democracy.	On	Law,	Politics	and	Judicialization:	
149–83.	
Shapiro,	Martin,	and	Alec	Stone	Sweet.	2002.	On	law,	politics,	
and	judicialization.	Oxford	University	Press.	
Sharma,	Sanchita.	2017.	Here’s	why	India	is	struggling	and	
failing	to	control	tuberculosis.	Hindustan	Times.	
Available	at	
<http://www.hindustantimes.com/health-and-
fitness/here-s-why-india-is-struggling-and-failing-
to-control-tuberculosis/story-
urW7VnQiHM2S38yGNTgu7O.html>.	
Sharma,	V.	P.	1996.	Re-emergence	of	malaria	in	India.	The	
Indian	journal	of	medical	research	103:	26–45.	
Shaw,	R.	Paul,	and	Martha	Ainsworth.	1995.	Financing	health	
services	through	user	fees	and	insurancecase	
studies	from	Sub-Saharan	Africa.	World	Bank.	
Shen,	Ce,	and	John	B.	Williamson.	1997.	Child	mortality,	
women’s	status,	economic	dependency,	and	state	
strength:	a	cross-national	study	of	less	developed	
countries.	Social	Forces	76	(2):	667–700.	
Shen,	Ce,	and	John	B.	Williamson.	1999.	Maternal	mortality,	
women’s	status,	and	economic	dependency	in	less	
developed	countries:	a	cross-national	analysis.	
Social	Science	&	Medicine	49	(2):	197–214.	
Shetty,	Priya.	2011.	Vaccine	trial’s	ethics	criticized.	Nature	
Publishing	Group.	
Shiffman,	Jeremy.	2007.	Generating	political	priority	for	
maternal	mortality	reduction	in	5	developing	
countries.	American	Journal	of	Public	Health	97	(5):	
796–803.	
Shiffman,	Jeremy,	and	Stephanie	Smith.	2007.	Generation	of	
political	priority	for	global	health	initiatives:	a	
framework	and	case	study	of	maternal	mortality.	
The	lancet	370	(9595):	1370–1379.	
Shiffman,	Jeremy,	and	Sharmina	Sultana.	2013.	Generating	
political	priority	for	neonatal	mortality	reduction	in	
Bangladesh.	American	Journal	of	Public	Health	103	
(4):	623–631.	
Shukla,	Abhay.	2008.	Jan	Swasthy	Abhiyan.	In	Rural	
Infrastructure:	Sanitation,	Housing,	Health	Care,	
422–32.	Sarup	&	Sons.	
Shukla,	Abhay,	Kerry	Scott,	and	Dhananjay	Kakde.	2011.	
Community	Monitoring	of	Rural	Health	Services	in	
Maharashtra.	Economic	and	Political	Weekly:	78–
85.	
Siegler,	Mark.	1980.	A	physician’s	perspective	on	a	right	to	
health	care.	Jama	244	(14):	1591–1596.	
References	
	
338	
Simelela,	Nono,	and	Willem	Daniel	Francois	Venter.	2014.	A	
brief	history	of	South	Africa’s	response	to	AIDS.	
SAMJ:	South	African	Medical	Journal	104	(3):	249–
251.	
Simmons,	Beth	A.	2000.	International	law	and	state	behavior:	
Commitment	and	compliance	in	international	
monetary	affairs.	American	Political	Science	
Review	94	(04):	819–835.	
Simmons,	Beth	A.	2009.	Mobilizing	for	human	rights:	
international	law	in	domestic	politics.	Cambridge	
University	Press.	
Simons,	Emily,	Matthew	Ferrari,	John	Fricks,	Kathleen	
Wannemuehler,	Abhijeet	Anand,	Anthony	Burton,	
and	Peter	Strebel.	2012.	Assessment	of	the	2010	
global	measles	mortality	reduction	goal:	results	
from	a	model	of	surveillance	data.	The	Lancet	379	
(9832):	2173–2178.	
Siriwan	Pitayarangsarit.	2010.	UHC	and	the	genda	setting	
process.	In	From	Policy	to	Implementation:	
Historical	Events	Durign	2001-2004	of	Universal	
Coverage	in	Thailand.	NHSO.	
Slaughter,	Anne-Marie.	2009.	A	new	world	order.	Princeton	
University	Press.	
Smith,	Katherine.	2013a.	Beyond	evidence	based	policy	in	
public	health:	The	interplay	of	ideas.	Springer.	
Smith,	Katherine.	2013b.	Institutional	filters:	the	translation	
and	re-circulation	of	ideas	about	health	
inequalities	within	policy.	Policy	&	Politics	41	(1):	
81–100.	
Smith,	Katherine	E.,	Sarah	E.	Hill,	and	Claire	Bambra.	2015.	
Health	Inequalities:	Critical	Perspectives.	Oxford	
University	Press.	
Smith,	Rogers.	2009.	Judicial	Power	and	Democracy:	A	
Machiavellian	View	,	ed.	Steven	,	Arthur	Melzer,	
Jerry	Weinberger,	and	M.	Richard	Zinman	
(Philadelphia:	University	of	Pennsylvania	Press,	
2009),	pp.	199-217.	In	The	Supreme	Court	and	the	
Idea	of	Constitutionalism,	edited	by	Steven	Kautz,	
Arthur	Melzer,	Jerry	Weinberger,	and	M.	Richard	
Zinman.	Philadelphia:	University	of	Pennsylvania	
Press.	
Smith,	Rogers	M.	1988.	Political	jurisprudence,	the	“new	
institutionalism,”	and	the	future	of	public	law.	
American	Political	Science	Review	82	(01):	89–108.	
Solar,	Orielle,	and	Alec	Irwin.	2010.	A	conceptual	framework	
for	action	on	the	social	determinants	of	health.	
Social	Determinants	of	Health	Discussion	Paper	2	
(Policy	and	Practice).	Geneva:	World	Health	
Organization.	
Solomon,	Peter	H.	2007.	Courts	and	judges	in	authoritarian	
regimes.	World	Politics	60	(01):	122–145.	
South	Africa	Every	Death	Counts	Writing	Group.	2008.	Every	
death	counts:	use	of	mortality	audit	data	for	
decision	making	to	save	the	lives	of	mothers,	
babies,	and	children	in	South	Africa.	The	Lancet	
371	(9620):	1294–1304.	
South	Africa,	Republic	of.	2012.	Budget	Review	2012.	Pretoria:	
National	Treasury.	
South	Africa,	Republic	of.	2001.	Medium	Term	Budget	Policy	
Statement.	Department	of	Tresury.	
South	Africa,	Republic	of.	1996.	National	Drug	Policy	for	South	
Africa.	Pretoria:	National	Department	of	Health.	
South	Africa,	Republic	of.	1997a.	White	Paper	for	Social	
Welfare.	Pretoria:	Department	of	Social	Welfare.	
South	Africa,	Republic	of.	1997b.	White	Paper	for	teh	
Transformation	of	the	Health	System	in	South	
Africa:	Towards	a	National	Health	System.	National	
Department	of	Health.	
South	Africa,	Republic	of.	2017.	White	Paper:	National	Health	
Insurance	for	South	Africa	-	Towards	Universal	
Coverage.	Pretoria:	National	Department	of	
Health.	
South	African	Human	Rights	Commission.	2015.	Hearing	
Report	Into	Access	to	Emergency	Medical	Services	
in	the	Eastern	Cape.	South	African	Human	Rights	
Commission.	
South	African	Human	Rights	Commission.	2003.	Report:	Site	
Visits	and	Investigation,	Eastern	Cape	Hospitals.	
Southall,	Roger.	2017.	From	liberation	movement	to	party	
machine?	The	ANC	in	South	Africa.	Post-colonial	
Struggles	for	a	Democratic	Southern	Africa:	
Legacies	of	Liberation:	51.	
Southern,	Neil.	2011.	Political	opposition	and	the	challenges	
of	a	dominant	party	system:	The	democratic	
alliance	in	South	Africa.	Journal	of	Contemporary	
African	Studies	29	(3):	281–298.	
Sparks,	Allister.	2003.	Beyond	the	miracle:	Inside	the	new	
South	Africa.	University	of	Chicago	Press.	
Sridhar,	Devi,	Martin	McKee,	Gorik	Ooms,	Claudia	
Beiersmann,	Eric	Friedman,	Hebe	Gouda,	Peter	
Hill,	and	Albrecht	Jahn.	2015.	Universal	health	
coverage	and	the	right	to	health:	from	legal	
principle	to	post-2015	indicators.	International	
journal	of	health	services	45	(3):	495–506.	
Srinivasan,	S.,	and	Anurag	Bhargava.	2009.	Medicine	Prices	
and	Affordability:	A	Policy	Brief	on	Drug	Pricing.	All	
India	Drug	Action	Network.	
Srinivasan,	Sandhya.	2009.	The	clinical	trials	scenario	in	India.	
Economic	and	Political	Weekly:	29–33.	
Stasavage,	David.	2005.	Democracy	and	education	spending	
in	Africa.	American	journal	of	political	science	49	
(2):	343–358.	
Statistics	South	Africa.	2012.	Census	2011	Census	in	brief.	
Statistics	South	Africa.	2016.	Mid-Year	Estimates	2016;	55,9	
million	people	in	South	Africa:		Planning	for	a	
better	tomorrow.	
Stats	SA.	2017.	Mining:	a	brief	history.	Available	at	
<http://www.statssa.gov.za/?p=9720>.	
Stats	SA.	2016.	Mortality	and	causes	of	death	in	South	Africa:	
Findings	from	death	notification,	2015.	Pretoria:	
Statistics	South	Africa.	
Steinberg,	Jonny.	2005.	Prison	overcrowding	and	the	
constitutional	right	to	adequate	accommodation	in	
South	Africa.	Occasional	Pape,	Centre	for	the	Study	
of	Violence	and	Reconciliation,	University	of	Cape	
Town.	
Steinberg,	Jonny.	2008.	Sizwe’s	test:	a	young	man’s	journey	
through	Africa’s	AIDS	epidemic.	Simon	and	
Schuster.	
Steinmo,	Sven,	Kathleen	Anne	Thelen,	and	Frank	Longstreth.	
1992.	Structuring	politics:	Historical	
institutionalism	in	comparative	analysis.	
Cambridge	university	press.	
Steinmo,	Sven,	and	Jan	Watts.	2008.	It’s	the	institutions,	
stupid:	why	comprehensive	national	health	
insurance	always	fails	in	America.	Health	Policy:	
Crisis	and	Reform	in	the	US	Health	Care	Delivery	
System.	5th	ed.	Burlington,	MA:	Jones	and	Bartlett:	
30–36.	
Stephen,	CR,	LJ	Bamford,	ME	Patrick,	MRC	Unit	for	Maternal	
and	Infant,	and	Health	Care	Strategies.	2011.	
Saving	Children:	A	sixth	survey	of	child	healthcare	
References	
	
339	
in	South	Africa.	Pretoria:	South	African	Medical	
Research	Council.	
Stuckler,	David,	Sanjay	Basu,	and	Martin	McKee.	2011.	Health	
care	capacity	and	allocations	among	South	Africa’s	
provinces:	infrastructure–inequality	traps	after	the	
end	of	apartheid.	American	journal	of	public	health	
101	(1):	165–172.	
Stuckler,	David,	Sanjay	Basu,	Martin	McKee,	and	Lawrence	
King.	2008.	Mass	incarceration	can	explain	
population	increases	in	TB	and	multidrug-resistant	
TB	in	European	and	central	Asian	countries.	
Proceedings	of	the	National	Academy	of	Sciences	
105	(36):	13280–13285.	
Stuckler,	David,	Sanjay	Basu,	Martin	McKee,	and	Mark	Lurie.	
2011.	Mining	and	risk	of	tuberculosis	in	sub-
Saharan	Africa.	American	journal	of	public	health	
101	(3):	524–530.	
Sudarshan,	Hanumappa,	and	N.	S.	Prashanth.	2011.	Good	
governance	in	health	care:	the	Karnataka	
experience.	The	Lancet	377	(9768):	790–792.	
Summers,	Lawrence	H.,	and	Lant	Pritchett.	1996.	Wealthier	is	
healthier.	Journal	of	Human	Resources	31	(4):	841–
68.	
Sundararaman,	Thiagarajan,	and	Garima	Gupta.	2011.	Indian	
approaches	to	retaining	skilled	health	workers	in	
rural	areas.	Bulletin	of	the	World	Health	
Organization	89	(1):	73–77.	
Sunder	Rajan,	K.	2007.	Biocapital:	Indian	clinical	trials	and	
surplus	health.	New	Left	Review.	
Sunstein,	Cass.	1993.	Against	positive	rights.	East	European	
Constitutional	Review	2:	35.	
Suresh,	Mayur,	and	Siddharth	Narrain.	2014.	The	Shifting	
Scales	of	Justice:	The	Supreme	Court	in	Neo-liberal	
India.	Orient	Blackswan.	
‘t	Hoen,	Ellen.	2013.	A	victory	for	global	public	health	in	the	
Indian	Supreme	Court.	Journal	of	public	health	
policy	34:	370–374.	
Tarrow,	Sidney.	2010a.	Bridging	the	Quantitative-Qualitative	
Divide.	In	Rethinking	Social	Inquiry,	101–110.	2nd	
ed.	Lantham:	Rowman	&	Littlefield.	
Tarrow,	Sidney.	2010b.	The	strategy	of	paired	comparison:	
Toward	a	theory	of	practice.	Comparative	Political	
Studies	43	(2):	230–259.	
Tate,	C.	Neal,	and	Torbjorn	Vallinder.	1995.	The	global	
expansion	of	judicial	power.	NYU	Press.	
Telisinghe,	Lilanganee,	Katherine	L.	Fielding,	Justin	L.	Malden,	
Yasmeen	Hanifa,	Gavin	J.	Churchyard,	Alison	D.	
Grant,	and	Salome	Charalambous.	2014.	High	
tuberculosis	prevalence	in	a	South	African	prison:	
the	need	for	routine	tuberculosis	screening.	PloS	
one	9	(1):	e87262.	
Thaineua,	Vallop,	Petchsri	Sirinirund,	Aree	Tanbanjong,	Marc	
Lallemant,	Agnes	Soucat,	and	Jean-Louis	
Lamboray.	1998.	From	research	to	practice:	use	of	
short	course	zidovudine	to	prevent	mother-to-
child	HIV	transmission	in	the	context	of	routine	
health	care	in	Northern	Thailand.	Southeast	Asian	
Journal	of	Tropical	Medicine	and	Public	Health.	
Thaiprayoon,	Suriwan,	and	Suwit	Wibulpolprasert.	2017.	
Political	and	Policy	Lessons	from	Thailand’s	UHC	
Experience.	ORF	ISSUE	BRIEF	(174).	
Thelen,	Kathleen.	2004.	How	institutions	evolve:	The	political	
economy	of	skills	in	Germany,	Britain,	the	United	
States,	and	Japan.	Cambridge	University	Press.	
Thomas,	Deborah,	Biraj	Laxmi	Sarangi,	Anu	Garg,	Arti	Ahuja,	
Pramod	Meherda,	Sujata	R.	Karthikeyan,	Pinaki	
Joddar,	Rajendra	Kar,	Jeetendra	Pattnaik,	and	
Ramesh	Druvasula.	2015.	Closing	the	health	and	
nutrition	gap	in	Odisha,	India:	A	case	study	of	how	
transforming	the	health	system	is	achieving	
greater	equity.	Social	Science	&	Medicine	145:	
154–162.	
Thomas,	Trudy.	2013.	A	Blueprint	For	Recovery.	In	Death	and	
Dying	in	the	Eastern	Cape,	27–28.	Johannesburge:	
Section	27.	
Timmermans,	Arco,	and	Peter	Scholten.	2006.	The	political	
flow	of	wisdom:	science	institutions	as	policy	
venues	in	The	Netherlands.	Journal	of	European	
Public	Policy	13	(7):	1104–1118.	
Tobin,	John.	2012.	The	right	to	health	in	international	law.	
Oxford	University	Press.	
Torriente,	Anna,	Alexander	Tadion,	and	Lee-Nah	Hsu.	2016.	
Opening	the	Door	to	Zero	New	HIV	Infections	in	
Closed	Settings.	Health	and	human	rights	18	(1):	
157–168.	
Tosun,	Jale.	2013.	Environmental	policy	change	in	emerging	
market	democracies:	Eastern	Europe	and	Latin	
America	compared.	University	of	Toronto	Press.	
Trapido,	Anna	S.,	Nokuzola	P.	Mqoqi,	Brian	G.	Williams,	Neil	
W.	White,	Albert	Solomon,	Richard	H.	Goode,	Cecil	
M.	Macheke,	Anthony	J.	Davies,	and	Clifford	
Panter.	1998.	Prevalence	of	occupational	lung	
disease	in	a	random	sample	of	former	
mineworkers,	Libode	District,	Eastern	Cape	
Province,	South	Africa.	American	journal	of	
industrial	medicine	34	(4):	305–313.	
Treatment	Action	Campaign.	n.d.	Fact	Sheet:	A	Step	Towards	
ending	Apartheid	in	Health	Care.	
Treatment	Action	Campaign.	2001a.	Meeting	With	Minister	of	
Health	Reveals	Serious	Divisions.	
Treatment	Action	Campaign.	2001b.	TAC	to	Picket	Provincial	
Health	Departments	and	National	Parliament.	
Treatment	Action	Campaign,	and	Section	27.	2013.	Death	and	
Dying	in	the	Eastern	Cape.	
Tsebelis,	George.	2002.	Veto	players:	How	political	institutions	
work.	Princeton	University	Press.	
Tshabalala-Msimang,	Manto.	2001.	Government,	not	courts,	
must	decide	on	HIV/AIDS	and	other	social	policy.	
Sunday	Times.	
Tushnet,	Mark.	2000.	Taking	the	Constitution	away	from	the	
Courts.	Princeton	University	Press.	
Tushnet,	Mark.	2009.	Weak	courts,	strong	rights:	judicial	
review	and	social	welfare	rights	in	comparative	
constitutional	law.	Princeton	University	Press.	
Tushnet,	Mark,	and	Madhav	Khosla.	2015.	Unstable	
Constitutionalism:	Law	and	Politics	in	South	Asia.	
Cambridge	University	Press.	
Udjo,	Eric	O.,	and	Pinky	Lalthapersad-Pillay.	2014.	Estimating	
maternal	mortality	and	causes	in	South	Africa:	
national	and	provincial	levels.	Midwifery	30	(5):	
512–518.	
UN	Committee	on	Economic,	Social	and	Cultural	Rights.	2000.	
General	Comment	14:	The	right	to	the	highest	
attainable	standard	of	health	(Article12).	
E/.12/2000/4.	Geneva:	United	Nations.	
UNAIDS.	2006.	2006	Report	on	the	global	AIDS	epidemic.	
Geneva:	UNAIDS.	
UNAIDS.	2016.	AIDS	Data.	Geneva.	
UNAIDS.	n.d.	AIDSinfo.	Available	at	
<http://aidsinfo.unaids.org/>.	
UNAIDS.	1998.	Report	on	the	global	HIV/AIDS	epidemic.	
Geneva:	UNAIDS.	
References	
	
340	
UNDP.	2002.	Human	Development	Report	(HDR)	2002.	
Oxford:	Oxford	University	Press.	Available	at	
<http://hdr.undp.org/en/reports/global/hdr2002/
>.	Accessed	4	May	2013.	
UNGA.	2015.	The	United	Nations	Standard	Minimum	Rules	for	
the	Treatment	of	Prisoners	(the	Nelson	Mandela	
Rules).	New	Yokrk:	United	Nations.	
United	Nations.	2011.	Sex	Differentials	in	Childhood	Mortality.	
New	York:	UN	Department	of	Economic	and	Social	
Affairs,	Population	Division.	
University	of	Ottawa.	n.d.	JuriGlobe-World	Legal	Systems.	
Available	at	
<http://www.juriglobe.ca/eng/apropos/index.php
>.	Accessed	5	May	2013.	
UNU-WIDER.	2010.	World	Income	Inequality	Database,	v.2.	
Available	at	
<http://website1.wider.unu.edu/wiid/wiid-
documentation1.php>.	Accessed	7	March	2013.	
Van	Bueren,	Geraldine.	2015.	More	Magna	Than	Magna	
Carta:	Magna	Carta’s	Sister–the	Charter	of	the	
Forest.	In	Magna	Carta	and	its	Modern	Legacy,	
194.	
Van	der	Vliet,	Virginia.	2001.	AIDS:	losing"	the	new	struggle"?	
Daedalus	130	(1):	151–184.	
Vearey,	Jo.	2014.	Healthy	migration:	A	public	health	and	
development	imperative	for	south	(ern)	Africa.	
SAMJ:	South	African	Medical	Journal	104	(10):	
663–664.	
Vearey,	Jo,	and	Lorena	Nunez.	2010.	Migration	and	health	in	
South	Africa:	A	review	of	the	current	situation	and	
recommendations	for	achieving	the	World	Health	
Assembly	Resolution	on	the	Health	of	Migrants.	
Pretoria:	International	Organization	for	Migration.	
Velaphi,	S,	Z	Mzolo,	Z	Nazo,	and	M	Adhikari.	2011.	National	
Perinatal	and	Neonatal	Morbidity	and	Mortality	
Triennial	Report.	National	Perinatal	Morbidity	and	
Mortality	Committee.	
Vellakkal,	Sukumar,	Adyya	Gupta,	Zaky	Khan,	David	Stuckler,	
Aaron	Reeves,	Shah	Ebrahim,	Ann	Bowling,	and	Pat	
Doyle.	2017.	Has	India’s	national	rural	health	
mission	reduced	inequities	in	maternal	health	
services?	A	pre-post	repeated	cross-sectional	
study.	Health	policy	and	planning	32	(1):	79–90.	
Vondoepp,	Peter.	2006.	Politics	and	judicial	assertiveness	in	
emerging	democracies:	High	Court	behavior	in	
Malawi	and	Zambia.	Political	Research	Quarterly	
59	(3):	389–399.	
VonDoepp,	Peter.	2013.	The	Rule	of	Law	and	the	Courts.	In	
Routledge	Handbook	of	African	Politics.	Routledge.	
Waldron,	Ingrid.	1987.	Patterns	and	causes	of	excess	female	
mortality	among	children	in	developing	countries.	
World	Health	Statistics	Quarterly	40	(3):	194–210.	
Waldron,	Jeremy.	2000.	Pildes	on	Dworkin’s	Theory	of	Rights.	
The	Journal	of	Legal	Studies	29	(1):	301–307.	
Walker,	Liz,	and	Lucy	Gilson.	2004.	‘We	are	bitter	but	we	are	
satisfied’:	nurses	as	street-level	bureaucrats	in	
South	Africa.	Social	science	&	medicine	59	(6):	
1251–1261.	
Walt,	Gill,	Jeremy	Shiffman,	Helen	Schneider,	Susan	F.	
Murray,	Ruairi	Brugha,	and	Lucy	Gilson.	2008.	
‘Doing’health	policy	analysis:	methodological	and	
conceptual	reflections	and	challenges.	Health	
policy	and	planning	23	(5):	308–317.	
Wang,	Haidong,	Chelsea	A.	Liddell,	Matthew	M.	Coates,	
Meghan	D.	Mooney,	Carly	E.	Levitz,	Austin	E.	
Schumacher,	Henry	Apfel,	Marissa	Iannarone,	
Bryan	Phillips,	and	Katherine	T.	Lofgren.	2014.	
Global,	regional,	and	national	levels	of	neonatal,	
infant,	and	under-5	mortality	during	1990–2013:	a	
systematic	analysis	for	the	Global	Burden	of	
Disease	Study	2013.	The	Lancet	384	(9947):	957–
979.	
Wang,	Joy.	2008.	AIDS	denialism	and’The	humanisation	of	the	
African’.	Race	&	Class	49	(3):	1–18.	
Wass,	Gabriella.	2011.	Coprorate	Activity	and	Human	Rights	in	
India.	Socio	Legal	Information	Cent.	
Waters,	Mike.	2008.	Why	Will	The	Health	Minister	Not	Place	
The	Eastern	Cape	Health	Department	Under	
Administration?	DA	Statements.	
Weede,	Erich.	1993.	The	impact	of	democracy	or	
repressiveness	on	the	quality	of	life,	income	
distribution	and	economic	growth	rates.	
International	Sociology	8	(2):	177–195.	
Weible,	Christopher	M.,	Paul	A.	Sabatier,	and	Kelly	McQueen.	
2009.	Themes	and	variations:	Taking	stock	of	the	
advocacy	coalition	framework.	Policy	Studies	
Journal	37	(1):	121–140.	
Weir,	Margaret.	1992.	Ideas	and	the	politics	of	bounded	
innovation.	In	Structuring	politics:	Historical	
institutionalism	in	comparative	analysis,	188–216.	
Welander,	Anna,	Carl	Hampus	Lyttkens,	and	Therese	Nilsson.	
2015.	Globalization,	democracy,	and	child	health	in	
developing	countries.	Social	Science	&	Medicine	
136:	52–63.	
Whiteside,	Alan.	1986.	Some	aspects	of	labor	relations	
between	the	republic	of	South	Africa	and	its	
neighbouring	states.	Pretoria:	Human	Sciences	
Research	Council.	
Whiteside,	Alan.	2014.	South	Africa’s	Key	Health	Challenges.	
The	Annals	of	the	American	Academy	of	Political	
and	Social	Science	652:	166–185.	
Whiteside,	Alan,	Robert	Mattes,	Samantha	Willan,	and	Ryann	
Manning.	2002.	Examining	HIV/AIDS	in	Southern	
Africa	through	the	eyes	of	ordinary	Southern	
Africans.	AfroBarometer	Working	Papers	(21).	
WHO.	2017.	WHO	Essential	Medicines	List	(EML),	20th	edition.	
Geneva:	World	Health	Organization.	Available	at	
<http://www.who.int/medicines/publications/esse
ntialmedicines/en/>.	
WHO.	2015.	WHO	guideline	on	country	pharmaceutical	
pricing	policies.	Geneva:	World	Health	
Organization.	
WHO,	and	Majid	Cehraghali.	2010.	How	to	develop	a	National	
Essential	Medicines	List.	WHO	18th	Expert	
Committee	on	the	Selection	and	Use	of	Essential	
Medicines,	Draft	Agenda	Item.	
Wigley,	Simon,	and	Arzu	Akkoyunlu-Wigley.	2011.	The	impact	
of	regime	type	on	health:	does	redistribution	
explain	everything?	World	Politics	63	(04):	647–
677.	
Wilkinson,	David,	Marlene	E.	Sach,	and	Salim	S.	Abdool	Karim.	
1997.	Examination	of	attendance	patterns	before	
and	after	introduction	of	South	Africa’s	policy	of	
free	health	care	for	children	aged	under	6	years	
and	pregnant	women.	Bmj	314	(7085):	940.	
Wilkinson,	Richard	G.	1992.	Income	distribution	and	life	
expectancy.	BMJ:	British	Medical	Journal	304	
(6820):	165.	
Wilkinson,	Richard	G.,	and	Kate	E.	Pickett.	2009.	Income	
inequality	and	social	dysfunction.	Annual	Review	of	
Sociology	35:	493–511.	
References	
	
341	
Wilkinson,	Richard	G.,	and	Kate	E.	Pickett.	2007.	The	problems	
of	relative	deprivation:	why	some	societies	do	
better	than	others.	Social	science	&	medicine	65	
(9):	1965–1978.	
Williams,	Brian,	Somya	Gupta,	Matthew	Wollmers,	and	
Reuben	Granich.	2017.	Progress	and	prospects	for	
the	control	of	HIV	and	tuberculosis	in	South	Africa:	
a	dynamical	modelling	study.	The	Lancet	Public	
Health	2	(5):	e223–e230.	
Wilsford,	David.	2005.	Path	dependency,	or	why	history	
makes	it	difficult	but	not	impossible	to	reform	
health	care	systems	in	a	big	way.	Watson	J.,	
Ovseiko	P.,	Health	Care	Systems:	Understanding	
health	care	politics.	New	York,	Routledge:	355–
383.	
Wilson,	Francis.	2001.	Minerals	and	migrants:	how	the	mining	
industry	has	shaped	South	Africa.	Daedalus	130	
(1):	99–121.	
Wilson,	James	Q.	1989.	Bureaucracy:	What	government	
agencies	do	and	why	they	do	it.	Basic	Books.	
Wolff,	Jonathan.	2012.	The	Human	Right	to	Health.	WW	
Norton	&	Company.	
Wood,	B.	Dan.	2010.	Agency	theory	and	the	bureaucracy.	In	
The	Oxford	Handbook	of	American	Bureaucracy,	
edited	by	Robert	Durant.	
Wood,	Elisabeth	Jean.	2000.	Forging	democracy	from	below:	
Insurgent	transitions	in	South	Africa	and	El	
Salvador.	Cambridge	University	Press.	
Workman,	Samuel.	2015.	The	Dynamics	of	Bureaucracy	in	the	
US	Government:	How	Congress	and	Federal	
Agencies	Process	Information	and	Solve	Problems.	
Cambridge	University	Press.	
World	Bank.	2017.	World	Development	Indicators.	DataBank.	
Available	at	
<http://data.worldbank.org/indicator>.	
World	Health	Organization	(WHO).	1946.	Constitution	of	the	
World	Health	Organization.	
World	Health	Organization	(WHO).	2013a.	Essential	medicines	
&	health	products:	the	model	essential	medicines	
list.	Geneva:	WHO.	Available	at	
<http://www.who.int/medicines/services/essmedi
cines_def/en/>.	Accessed	4	February	2015.	
World	Health	Organization	(WHO).	2013b.	Fact	Sheet:	
Women’s	health.	Available	at	http://www.who.int/	
mediacentre/factsheets/fs334/en/.	
World	Health	Organization	(WHO).	2016.	Global	Tuberculosis	
Report	2016.	Genevea:	WHO.	
Worsham,	Jeffrey.	2006.	Up	in	smoke:	Mapping	subsystem	
dynamics	in	tobacco	policy.	Policy	Studies	Journal	
34	(3):	437–452.	
Wullert,	Katherine	E.,	and	John	B.	Williamson.	2016.	
Democracy,	Hybrid	Regimes,	and	Infant	Mortality:	
A	Cross-National	Analysis	of	Sub-Saharan	African	
Nations.	Social	Science	Quarterly.	
Wyszomirski,	Margaret	Jane.	1998.	Lobbying	reform	and	
nonprofit	organizations:	Policy	images	and	
constituent	policy.	Policy	Studies	Journal	26	(3):	
512–525.	
Yamin,	Alicia	Ely.	2015.	Power,	suffering,	and	the	struggle	for	
dignity:	Human	rights	frameworks	for	health	and	
why	they	matter.	University	of	Pennsylvania	Press.	
Yamin,	Alicia	Ely.	2014.	Promoting	Equity	in	Health:	What	Role	
for	Courts?	Health	&	Human	Rights	16	(2).	
Yamin,	Alicia	Ely,	and	Siri	Gloppen.	2011.	Litigating	health	
rights:	can	courts	bring	more	justice	to	health.	
Cambridge:	Harvard	University	Press.	
Yamin,	Alicia	Ely,	and	Oscar	Parra-Vera.	2009.	How	do	courts	
set	health	policy?	The	case	of	the	Colombian	
Constitutional	Court.	PLoS	Medicine	6	(2):	
e1000032.	
Young,	Katharine	G.	2012.	Constituting	economic	and	social	
rights.	Oxford	University	Press.	
Young,	Katharine	G.	2008.	The	minimum	core	of	economic	
and	social	rights:	a	concept	in	search	of	content.	
Yale	International	Law	Journal	33:	113–175.	
Zackin,	Emily.	2008.	Popular	constitutionalism’s	hard	when	
you’re	not	very	popular:	why	the	ACLU	turned	to	
courts.	Law	&	Society	Review	42	(2):	367–396.	
Zille,	Helen.	2009.	The	DA	Can	Win	In	The	Eastern	Cape.	
Democatic	Alliance	Statements.	Available	at	
<https://www.da.org.za/archive/the-da-can-win-
in-the-eastern-cape/>.	
Zuniga,	José	M,	Alan	Whiteside,	Amin	Ghaziani,	and	John	G	
Bartlett.	2008.	A	Decade	of	HAART:	The	
Development	and	Global	Impact	of	Highly	Active	
Antiretroviral	Therapy.	Oxford	University	Press.	
	
	
	
	
	
